| Ident. | Authors (with country if any) | Title |
|---|
| 000017 |
Maja Kojovic [Royaume-Uni] ; Panagiotis Kassavetis [Royaume-Uni] ; Matteo Bologna [Italie] ; Isabel Pareés [Royaume-Uni] ; Ignacio Rubio-Agusti [Espagne] ; Alfredo Beraredelli [Italie] ; Mark J. Edwards [Royaume-Uni] ; John C. Rothwell [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Transcranial magnetic stimulation follow-up study in early Parkinson's disease: A decline in compensation with disease progression? |
| 000019 |
Roberto Erro [Royaume-Uni] ; Paolo Barone [Italie] | Toward the premotor diagnosis of Parkinson's disease: Suggestions from a modelling study. |
| 000031 |
Christos Ganos [Royaume-Uni] ; Jens Bongert [Allemagne] ; Luisa Asmuss [Allemagne] ; Davide Martino [Royaume-Uni] ; Patrick Haggard [Royaume-Uni] ; Alexander Münchau [Allemagne] | The somatotopy of tic inhibition: Where and how much? |
| 000040 |
Anna Sadnicka [Royaume-Uni] ; Mark J. Edwards [Royaume-Uni] | The influence of reward and punishment on motor learning. |
| 000047 |
Davide Martino [Royaume-Uni] ; Giovanna Lagravinese [Italie] ; Elisa Pelosin [Italie] ; Ray Kallol Chaudhuri [Royaume-Uni] ; Carmelo M. Vicario [Royaume-Uni] ; Giovanni Abbruzzese [Italie] ; Laura Avanzino [Italie] | Temporal processing of perceived body movement in cervical dystonia. |
| 000052 |
Joseph M. Masters [Royaume-Uni] ; Jonathan Bestwick [Royaume-Uni] ; Thomas T. Warner [Royaume-Uni] ; Gavin Giovannoni [Royaume-Uni] ; Gordon B. Proctor [Royaume-Uni] ; Alastair J. Noyce [Royaume-Uni] | Systematic review and meta-analysis of salivary protein concentration in Parkinson's disease. |
| 000069 |
Perdita Cheshire [Australie] ; Scott Ayton [Australie] ; Kelly L. Bertram [Australie] ; Helen Ling [Royaume-Uni] ; Abi Li [Royaume-Uni] ; Catriona Mclean [Australie] ; Glenda M. Halliday [Australie] ; Sean S. O'Sullivan [Royaume-Uni] ; Tamas Revesz [Royaume-Uni] ; David I. Finkelstein [Australie] ; Elsdon Storey [Australie] ; David R. Williams [Australie] | Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias. |
| 000070 |
Lisa M. Bunn [Royaume-Uni] ; Jonathan F. Marsden [Royaume-Uni] ; Daniel C. Voyce [Royaume-Uni] ; Paola Giunti [Royaume-Uni] ; Brian L. Day [Royaume-Uni] | Sensorimotor processing for balance in spinocerebellar ataxia type 6. |
| 000073 |
Caroline Williams-Gray [Royaume-Uni] | Seeing Is Believing: Alpha-Synuclein Oligomers in Parkinson's Disease Brain. |
| 000078 |
Calum D. Moulton [Royaume-Uni] ; C W P. Hopkins [Royaume-Uni] ; W Richard Bevan-Jones [Royaume-Uni] | Reply: Suicidality in Huntington's Disease: Distinguishing lithium from other psychotropic medications. |
| 000088 |
Maja Kojovic [Royaume-Uni] ; Matteo Bologna [Italie] ; Mark J. Edwards [Royaume-Uni] ; John C. Rothwell [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Reply to "Transcranial Magnetic Stimulation for Parkinson's Disease". |
| 000102 |
Maria João Forjaz [Espagne] ; Alba Ayala [Espagne] ; Claudia M. Testa [États-Unis] ; Peter G. Bain [Royaume-Uni] ; Rodger Elble [États-Unis] ; Dietrich Haubenberger [Autriche] ; Carmen Rodriguez-Blazquez [Espagne] ; Günther Deuschl [Allemagne] ; Pablo Martinez-Martin [Espagne] | Proposing a Parkinson's disease-specific tremor scale from the MDS-UPDRS. |
| 000104 |
Brook Galna [Royaume-Uni] ; Sue Lord ; David J. Burn ; Lynn Rochester | Progression of gait dysfunction in incident Parkinson's disease: impact of medication and phenotype. |
| 000111 |
Christos Ganos [Royaume-Uni] ; Alicia Garrido [Royaume-Uni] ; Irene Navalpotro-G Mez [Royaume-Uni] ; Lucia Ricciardi [Royaume-Uni] ; Davide Martino [Royaume-Uni] ; Mark J. Edwards [Royaume-Uni] ; Manos Tsakiris [Royaume-Uni] ; Patrick Haggard [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Premonitory urge to tic in Tourette's is associated with interoceptive awareness. |
| 000113 |
David Okai [Royaume-Uni] ; Sally Askey-Jones ; Michael Samuel ; Anthony S. David ; Richard G. Brown | Predictors of response to a cognitive behavioral intervention for impulse control behaviors in Parkinson's disease. |
| 000127 |
Roberto Erro [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Michele Tinazzi [Italie] | Parkinsonism following neuroleptic exposure: A double-hit hypothesis? |
| 000128 |
Marjan Jahanshahi [Royaume-Uni] ; Ignacio Obeso ; Christelle Baunez ; Manuel Alegre ; Paul Krack | Parkinson's disease, the subthalamic nucleus, inhibition, and impulsivity. |
| 000141 |
Mafalda Raposo [Portugal] ; Conceição Bettencourt [Royaume-Uni] ; Patrícia Maciel [Portugal] ; Fuying Gao [États-Unis] ; Amanda Ramos [Portugal] ; Nadiya Kazachkova [Portugal] ; João Vasconcelos [Portugal] ; Teresa Kay [Portugal] ; Ana João Rodrigues [Portugal] ; Bruno Bettencourt [Portugal] ; Jácome Bruges-Armas [Portugal] ; Daniel Geschwind [États-Unis] ; Giovanni Coppola [États-Unis] ; Manuela Lima [Portugal] | Novel candidate blood-based transcriptional biomarkers of Machado-Joseph disease. |
| 000146 |
Matthew E. Gegg [Royaume-Uni] ; Lindsay Sweet [États-Unis] ; Bing H. Wang [États-Unis] ; Lamya S. Shihabuddin [États-Unis] ; Sergio Pablo Sardi [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] | No Evidence for Substrate Accumulation in Parkinson Brains With GBA Mutations |
| 000165 |
Lynn Rochester [Royaume-Uni] ; Alberto J. Espay [États-Unis] | Multidisciplinary rehabilitation in Parkinson's disease: A milestone with future challenges. |
| 000171 |
Helen Ling [Royaume-Uni] ; Yasmine T. Asi [Royaume-Uni] ; Igor N. Petrovic [Royaume-Uni] ; Zeshan Ahmed [Royaume-Uni] ; L K Prashanth [Canada] ; Lili-Naz Hazrati [Canada] ; Masatoyo Nishizawa [Japon] ; Tetsutaro Ozawa [Japon] ; Anthony Lang [Canada] ; Andrew J. Lees [Royaume-Uni] ; Tamas Revesz [Royaume-Uni] ; Janice L. Holton [Royaume-Uni] | Minimal change multiple system atrophy: an aggressive variant? |
| 000176 |
Michael Samuel [Royaume-Uni] ; Maria Rodriguez-Oroz ; Angelo Antonini ; Jonathan M. Brotchie ; Kallol Ray Chaudhuri ; Richard G. Brown ; Wendy R. Galpern ; Melissa J. Nirenberg ; Michael S. Okun ; Anthony E. Lang | Management of impulse control disorders in Parkinson's disease: Controversies and future approaches. |
| 000199 |
K Ray Chaudhuri [Royaume-Uni] ; A. Rizos [Royaume-Uni] ; C. Trenkwalder [Allemagne] ; O. Rascol [France] ; S. Pal [Royaume-Uni] ; D. Martino [Royaume-Uni] ; C. Carroll [Royaume-Uni] ; D. Paviour [Royaume-Uni] ; C. Falup-Pecurariu [Roumanie] ; B. Kessel [Royaume-Uni] ; M. Silverdale [Royaume-Uni] ; A. Todorova [Royaume-Uni] ; A. Sauerbier [Royaume-Uni] ; P. Odin [Suède] ; A. Antonini [Italie] ; P. Martinez-Martin [Espagne] | King's Parkinson's disease pain scale, the first scale for pain in PD: An international validation. |
| 000215 |
L. Silveira-Moriyama [Brésil] ; J. Birchall [Royaume-Uni] ; P. Bain [Royaume-Uni] ; A J Lees [Royaume-Uni] ; N P S. Bajaj [Royaume-Uni] | Hyposmia in SWEDD. |
| 000216 |
Bettina Balint [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Hot topic: Recessive mutations in the a3(VI) collagen gene COL6A3 cause early-onset isolated dystonia. |
| 000220 |
Roberto Erro [Royaume-Uni] ; Joshua Hersheson [Royaume-Uni] ; Christos Ganos [Royaume-Uni] ; Niccol E. Mencacci [Royaume-Uni] ; Maria Stamelou [Royaume-Uni] ; Amit Batla [Royaume-Uni] ; Stefanie Catherine Thust [Royaume-Uni] ; Jose M. Bras [Royaume-Uni] ; Rita J. Guerreiro [Royaume-Uni] ; John Hardy [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Henry Houlden [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | H-ABC syndrome and DYT4: Variable expressivity or pleiotropy of TUBB4 mutations? |
| 000222 |
Gordon W. Duncan [Royaume-Uni] ; Michael J. Firbank [Royaume-Uni] ; Alison J. Yarnall [Royaume-Uni] ; Tien K. Khoo [Australie] ; David J. Brooks [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; John T. O'Brien [Royaume-Uni] | Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease? |
| 000227 |
Mike A. Nalls [États-Unis] ; Valentina Escott-Price [Royaume-Uni] ; Nigel M. Williams [Royaume-Uni] ; Steven Lubbe [Royaume-Uni] ; Margaux F. Keller [États-Unis] ; Huw R. Morris [Royaume-Uni] ; Andrew B. Singleton [États-Unis] | Genetic risk and age in Parkinson's disease: Continuum not stratum. |
| 000237 |
Andrew J. Lees [Royaume-Uni] ; Eduardo Tolosa ; C Warren Olanow | Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin Yahr. |
| 000239 |
Maria Dale [Royaume-Uni] ; John Maltby [Royaume-Uni] ; Rossana Martucci [Royaume-Uni] ; Steve Shimozaki [Royaume-Uni] | Factor analysis of the hospital anxiety and depression scale among a Huntington's disease population. |
| 000241 |
Anam Anzak [Royaume-Uni] ; Simon Little ; Natasha Hulse ; Thomasin Andrews ; Peter Brown ; Michael Samuel ; Keyoumars Ashkan | Excessive neural synchrony in Machado-Joseph disease responsive to subthalamic nucleus stimulation. |
| 000243 |
Joaquim J. Ferreira [Portugal] ; Anne Rosser [Royaume-Uni] ; David Craufurd [Royaume-Uni] ; Ferdinando Squitieri [Italie] ; Nicholas Mallard [États-Unis] ; Bernhard Landwehrmeyer [Allemagne] | Ethyl-eicosapentaenoic acid treatment in Huntington's disease: A placebo-controlled clinical trial. |
| 000244 |
Peter G. Bain [Royaume-Uni] | Essential tremor and senile varieties of action tremor an evolving ART. |
| 000273 |
Fahd Baig [Royaume-Uni] ; Michael Lawton [Royaume-Uni] ; Michal Rolinski [Royaume-Uni] ; Claudio Ruffmann [Royaume-Uni] ; Kannan Nithi [Royaume-Uni] ; Samuel G. Evetts [Royaume-Uni] ; Hugo R. Fernandes [Royaume-Uni] ; Yoav Ben-Shlomo [Royaume-Uni] ; Michele T M. Hu [Royaume-Uni] | Delineating nonmotor symptoms in early Parkinson's disease and first-degree relatives. |
| 000278 |
Roberto Erro [Royaume-Uni] ; Christine Klein [Allemagne] | DYT2 Revealed: Hippocalcin Mutations Cause Autosomal-Recessive Isolated Dystonia. |
| 000290 |
Daniel Weintraub [États-Unis] ; Tanya Simuni [États-Unis] ; Chelsea Caspell-Garcia [États-Unis] ; Christopher Coffey [États-Unis] ; Shirley Lasch [États-Unis] ; Andrew Siderowf [États-Unis] ; Dag Aarsland [Norvège] ; Paolo Barone [Italie] ; David Burn [Royaume-Uni] ; Lama M. Chahine [États-Unis] ; Jamie Eberling [États-Unis] ; Alberto J. Espay [États-Unis] ; Eric D. Foster [États-Unis] ; James B. Leverenz [États-Unis] ; Irene Litvan [États-Unis] ; Irene Richard [États-Unis] ; Matthew D. Troyer [États-Unis] ; Keith A. Hawkins [États-Unis] | Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease. |
| 000307 |
Walter Maetzler [Allemagne] ; Lynn Rochester [Royaume-Uni] | Body-worn sensors--the brave new world of clinical measurement? |
| 000320 |
Chrystalina A. Antoniades [Royaume-Uni] ; Nele Demeyere [Royaume-Uni] ; Christopher Kennard [Royaume-Uni] ; Glyn W. Humphreys [Royaume-Uni] ; Michele T. Hu [Royaume-Uni] | Antisaccades and executive dysfunction in early drug-naive Parkinson's disease: The discovery study. |
| 000321 |
Paresh A. Malhotra [Royaume-Uni] ; Adolfo M. Bronstein [Royaume-Uni] | Antisaccades and executive dysfunction in PD: Two sides of the same coin? |
| 000332 |
Mika H. Martikainen [Royaume-Uni] ; Grainne S. Gorman [Royaume-Uni] ; Paul Goldsmith [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Doug M. Turnbull [Royaume-Uni] ; Andrew M. Schaefer [Royaume-Uni] | Adult-onset myoclonus ataxia associated with the mitochondrial m.8993T>C "NARP" mutation. |
| 000340 |
John C. Steele ; Robert Wresch [États-Unis] ; Samuel D. Hanlon [États-Unis] ; Jay Keystone [Canada] ; Yoav Ben-Shlomo [Royaume-Uni] | A unique retinal epitheliopathy is associated with amyotrophic lateral sclerosis/Parkinsonism-Dementia complex of Guam. |
| 000354 |
Janel O. Johnson [Royaume-Uni] ; Giovanni Stevanin ; Joyce Van De Leemput ; Dena G. Hernandez ; Sampath Arepalli ; Sylvie Forlani ; Reza Zonozi ; J Raphael Gibbs ; Alexis Brice ; Alexandra Durr ; Andrew B. Singleton | A 7.5-Mb duplication at chromosome 11q21-11q22.3 is associated with a novel spastic ataxia syndrome. |
| 000357 |
Alexander Lehn [Royaume-Uni] | Will next-generation sequencing also take us to the next level of understanding disease mechanisms? |
| 000359 |
Brit Mollenhauer [Allemagne] ; Lynn Rochester [Royaume-Uni] ; Alice Chen-Plotkin [États-Unis] ; David Brooks [Royaume-Uni, Danemark] | What Can Biomarkers Tell Us About Cognition in Parkinson's Disease? |
| 000374 |
Daniela Berg [Allemagne] ; Ronald B. Postuma [Canada] ; Bastiaan Bloem [Pays-Bas] ; Piu Chan [République populaire de Chine] ; Bruno Dubois [France] ; Thomas Gasser [Allemagne] ; Christopher G. Goetz [États-Unis] ; Glenda M. Halliday [Australie] ; John Hardy [Royaume-Uni] ; Anthony E. Lang [Canada] ; Irene Litvan [États-Unis] ; Kenneth Marek [États-Unis] ; José Obeso [Espagne] ; Wolfgang Oertel [Allemagne] ; C Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Matthew Stern [États-Unis] ; Günther Deuschl [Allemagne] | Time to Redefine PD? Introductory Statement of the MDS Task Force on the Definition of Parkinson's Disease |
| 000381 |
Jennifer G. Goldman [États-Unis] ; Caroline Williams-Gray [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] ; John E. Duda [États-Unis] ; James E. Galvin [États-Unis] | The spectrum of cognitive impairment in Lewy body diseases |
| 000393 |
Marina Papoutsi [Royaume-Uni] ; Izelle Labuschagne ; Sarah J. Tabrizi ; Julie C. Stout | The cognitive burden in Huntington's disease: pathology, phenotype, and mechanisms of compensation. |
| 000396 |
Maria Stamelou [Royaume-Uni] ; Gavin Charlesworth [Royaume-Uni] ; Carla Cordivari [Royaume-Uni] ; Susanne A. Schneider [Royaume-Uni, Allemagne] ; Georg K Gi [Royaume-Uni, Suisse] ; Una-Marie Sheerin [Royaume-Uni] ; Ignacio Rubio-Agusti [Royaume-Uni] ; Amit Batla [Royaume-Uni] ; Henry Houlden [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | The Phenotypic Spectrum of DYT24 Due to ANO3 Mutations |
| 000408 |
J Mark Cooper [Royaume-Uni] ; Pb Oscar Wiklander [Suède] ; Joel Z. Nordin [Suède] ; Raya Al-Shawi [Royaume-Uni] ; Matthew J. Wood [Royaume-Uni] ; Mansi Vithlani [Royaume-Uni] ; Anthony H V. Schapira [Royaume-Uni] ; J Paul Simons [Royaume-Uni] ; Samir El-Andaloussi [Suède, Royaume-Uni] ; Lydia Alvarez-Erviti [Royaume-Uni] | Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice |
| 000417 |
Anne Rosser [Royaume-Uni] ; Clive N. Svendsen | Stem cells for cell replacement therapy: a therapeutic strategy for HD? |
| 000461 |
Peter Brown [Royaume-Uni] | Propriospinal myoclonus: where do we go from here? |
| 000470 |
Michele T M. Hu [Royaume-Uni] ; Konrad Szewczyk-Kr Likowski [Royaume-Uni] ; Paul Tomlinson [Royaume-Uni] ; Kannan Nithi [Royaume-Uni] ; Michal Rolinski [Royaume-Uni] ; Clara Murray [Royaume-Uni] ; Kevin Talbot [Royaume-Uni] ; Klaus P. Ebmeier [Royaume-Uni] ; Clare E. Mackay [Royaume-Uni] ; Yoav Ben-Shlomo [Royaume-Uni] | Predictors of cognitive impairment in an early stage Parkinson’s disease cohort |
| 000471 |
Elina Tripoliti [Royaume-Uni] ; Patricia Limousin ; Tom Foltynie ; Joseph Candelario ; Iciar Aviles-Olmos ; Marwan I. Hariz ; Ludvic Zrinzo | Predictive factors of speech intelligibility following subthalamic nucleus stimulation in consecutive patients with Parkinson's disease. |
| 000474 |
Eirini Kalliolia [Royaume-Uni] ; Edina Silajdži ; Rajasree Nambron ; Nathan R. Hill ; Anisha Doshi ; Chris Frost ; Hilary Watt ; Peter Hindmarsh ; Maria Björkqvist ; Thomas T. Warner | Plasma melatonin is reduced in Huntington's disease. |
| 000483 |
Amit Batla [Royaume-Uni] ; Roberto Erro ; Maria Stamelou ; Susanne A. Schneider ; Petra Schwingenschuh ; Christos Ganos ; Kailash P. Bhatia | Patients with scans without evidence of dopaminergic deficit: a long-term follow-up study. |
| 000485 |
Roberto Erro [Royaume-Uni] ; Una-Marie Sheerin ; Kailash P. Bhatia | Paroxysmal dyskinesias revisited: a review of 500 genetically proven cases and a new classification. |
| 000502 |
Y T Asi [Royaume-Uni] ; Helen Ling ; Z. Ahmed ; A J Lees ; T. Revesz ; J L Holton | Neuropathological features of multiple system atrophy with cognitive impairment. |
| 000504 |
Yael Hacohen [Royaume-Uni] ; Kumaran Deiva ; Phillipa Pettingill ; Patrick Waters ; Ata Siddiqui ; Pascale Chretien ; Esse Menson ; Jean-Pierre Lin ; Marc Tardieu ; Angela Vincent ; Ming J. Lim | N-methyl-D-aspartate receptor antibodies in post-herpes simplex virus encephalitis neurological relapse. |
| 000510 |
Juan J. Figueroa [États-Unis] ; Wolfgang Singer [États-Unis] ; Ajay Parsaik [États-Unis] ; Eduardo E. Benarroch [États-Unis] ; J. Eric Ahlskog [États-Unis] ; Robert D. Fealey [États-Unis] ; Joseph E. Parisi [États-Unis] ; Paola Sandroni [États-Unis] ; Jay Mandrekar [États-Unis] ; Valeria Iodice [Royaume-Uni] ; Phillip A. Low [États-Unis] ; James H. Bower [États-Unis] | Multiple System Atrophy: Prognostic Indicators of Survival |
| 000516 |
Angus D. Macleod [Royaume-Uni] ; Kate S M. Taylor ; Carl E. Counsell | Mortality in Parkinson's disease: a systematic review and meta-analysis. |
| 000533 |
Karen M. Doherty [Royaume-Uni] ; Thomas T. Warner ; Andrew J. Lees | Late onset ataxia: MSA-C or SCA 17? A gene penetrance dilemma. |
| 000538 |
Alisdair Mcneill [Royaume-Uni] | Is elevated beta-hexosaminidase activity a potential biomarker for Parkinson's disease? |
| 000540 |
David Burn [Royaume-Uni] ; Daniel Weintraub [États-Unis] ; Trevor Robbins [Royaume-Uni] | Introduction: The Importance of Cognition in Movement Disorders |
| 000541 |
Marloes Franssen [Royaume-Uni] ; Charlotte Winward ; Johnny Collett ; Derick Wade ; Helen Dawes | Interventions for fatigue in Parkinson's disease: A systematic review and meta-analysis. |
| 000542 |
Peter Redgrave [Royaume-Uni] ; Nicolas Vautrelle ; Thomas Stafford | Interpretive conundrums when practice doesn't always make perfect. |
| 000552 |
Julien Guevar [Royaume-Uni] ; Steven De Decker ; Luc M L. Van Ham ; Andrea Fischer ; Holger A. Volk | Idiopathic head tremor in English bulldogs. |
| 000562 |
Gordon W. Duncan [Royaume-Uni] ; Tien K. Khoo ; Alison J. Yarnall ; John T. O'Brien ; Shirley Y. Coleman ; David J. Brooks ; Roger A. Barker ; David J. Burn | Health-related quality of life in early Parkinson's disease: the impact of nonmotor symptoms. |
| 000571 |
Lynn Rochester [Royaume-Uni] ; Brook Galna ; Sue Lord ; Dadirayi Mhiripiri ; Gail Eglon ; Patrick F. Chinnery | Gait impairment precedes clinical symptoms in spinocerebellar ataxia type 6. |
| 000573 |
Mark J. Edwards [Royaume-Uni] ; Jon Stone ; Anthony E. Lang | Functional/psychogenic movement disorders: do we know what they are? |
| 000575 |
Jon Stone [Royaume-Uni] ; Roberto Erro | Functional (psychogenic) painful legs moving toes syndrome. |
| 000577 |
Mark J. Edwards [Royaume-Uni] ; Jon Stone ; Anthony E. Lang | From psychogenic movement disorder to functional movement disorder: it's time to change the name. |
| 000607 |
Sarah Marrinan [Royaume-Uni] ; Anton V. Emmanuel ; David J. Burn | Delayed gastric emptying in Parkinson's disease. |
| 000622 |
Maria Stamelou [Royaume-Uni] | Commentary. |
| 000629 |
Iva Stankovic [Serbie] ; Florian Krismer [Autriche] ; Aleksandar Jesic [Serbie] ; Angelo Antonini [Italie] ; Thomas Benke [Autriche] ; Richard G. Brown [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Janice L. Holton [Royaume-Uni] ; Horacio Kaufmann [États-Unis] ; Vladimir S. Kostic [Serbie] ; Helen Ling [Royaume-Uni] ; Wassilios G. Meissner [France] ; Werner Poewe [Autriche] ; Marija Semnic [Serbie] ; Klaus Seppi [Autriche] ; Atsushi Takeda [Japon] ; Daniel Weintraub [États-Unis] ; Gregor K. Wenning [Autriche] | Cognitive impairment in multiple system atrophy |
| 000634 |
Trevor W. Robbins [Royaume-Uni] ; Roshan Cools | Cognitive deficits in Parkinson's disease: a cognitive neuroscience perspective. |
| 000637 |
David Burn [Royaume-Uni] ; Daniel Weintraub [États-Unis] ; Bernard Ravina [États-Unis] ; Irene Litvan [États-Unis] | Cognition in Movement Disorders: Where Can We Hope to be in Ten Years? |
| 000643 |
Bella Huasen [Royaume-Uni] ; Robert Mccreary ; Julian Evans ; Gillian Potter ; Monty Silverdale | Cervical myelopathy secondary to Tourette's syndrome managed by urgent deep brain stimulation. |
| 000647 |
Anna Sadnicka [Royaume-Uni] ; Masashi Hamada ; Kailash P. Bhatia ; John C. Rothwell ; Mark J. Edwards | Cerebellar stimulation fails to modulate motor cortex plasticity in writing dystonia. |
| 000648 |
Elin M. Rees [Royaume-Uni] ; Ruth Farmer ; James H. Cole ; Salman Haider ; Alexandra Durr ; Bernhard Landwehrmeyer ; Rachael I. Scahill ; Sarah J. Tabrizi ; Nicola Z. Hobbs | Cerebellar abnormalities in Huntington's disease: a role in motor and psychiatric impairment? |
| 000664 |
Christos Proukakis [Royaume-Uni] ; Maryiam Shoaee [Royaume-Uni] ; James Morris [Royaume-Uni] ; Timothy Brier [Royaume-Uni] ; Eleanna Kara [Royaume-Uni] ; Una-Marie Sheerin [Royaume-Uni] ; Gavin Charlesworth [Royaume-Uni] ; Eduardo Tolosa [Espagne] ; Henry Houlden [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] ; Anthony H. Schapira [Royaume-Uni] | Analysis of Parkinson's disease brain–derived DNA for alpha-synuclein coding somatic mutations |
| 000680 |
Anna Sadnicka [Royaume-Uni] ; Masashi Hamada ; Kailash P. Bhatia ; John C. Rothwell ; Mark J. Edwards | A reflection on plasticity research in writing dystonia. |
| 000685 |
Amit Batla [Royaume-Uni] ; Kailash P. Bhatia | A new gene for Fahr's syndrome-PDGF-B. |
| 000688 |
Peter Jenner [Royaume-Uni] | A late appearance by the dopamine D-3 receptor. |
| 000704 |
Paul F. Worth [Royaume-Uni] ; Venkataramanan Srinivasan ; Anna Smith ; James I. Last ; Laura L. Wootton ; Paul M. Biggs ; Nicholas P. Davies ; Ellen F. Carney ; Philip J. Byrd ; A Malcolm R. Taylor | Very mild presentation in adult with classical cellular phenotype of ataxia telangiectasia. |
| 000727 |
Maja Kojovic [Royaume-Uni] ; Isabel Pareés ; Tania Lampreia ; Karolina Pienczk-Reclawowicz ; Georgia Xiromerisiou ; Ignacio Rubio-Agusti ; Milica Kramberger ; Miryam Carecchio ; Anas M. Alazami ; Francesco Brancati ; Jaroslaw Slawek ; Zvezdan Pirtosek ; Enza Maria Valente ; Fowzan S. Alkuraya ; Mark J. Edwards ; Kailash P. Bhatia | The syndrome of deafness-dystonia: clinical and genetic heterogeneity. |
| 000770 |
Lisa M. Bunn [Royaume-Uni] ; Jonathan F. Marsden ; Paola Giunti ; Brian L. Day | Stance instability in spinocerebellar ataxia type 6. |
| 000776 |
Christos Proukakis [Royaume-Uni] ; Henry Houlden [Royaume-Uni] ; Anthony H. Schapira [Royaume-Uni] | Somatic Alpha-Synuclein Mutations in Parkinson's Disease: Hypothesis and Preliminary Data |
| 000781 |
Alison J. Yarnall [Royaume-Uni] ; Lynn Rochester ; Mark R. Baker ; Rachel David ; Tien K. Khoo ; Gordan W. Duncan ; Brook Galna ; David J. Burn | Short latency afferent inhibition: a biomarker for mild cognitive impairment in Parkinson's disease? |
| 000782 |
Georg K Gi [Royaume-Uni, Suisse] ; Petra Katschnig [Royaume-Uni, Autriche] ; Mirta Fiorio [Italie] ; Michele Tinazzi [Italie] ; Diane Ruge [Royaume-Uni] ; John Rothwell [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Sensory Tricks in Primary Cervical Dystonia Depend on Visuotactile Temporal Discrimination |
| 000784 |
Anna K. Holl [Royaume-Uni] ; Leonora Wilkinson ; Sarah J. Tabrizi ; Annamaria Painold ; Marjan Jahanshahi | Selective executive dysfunction but intact risky decision-making in early Huntington's disease. |
| 000788 |
Amit Batla [Royaume-Uni] ; Maria Stamelou [Royaume-Uni] ; Niccolo Mencacci [Royaume-Uni, Italie] ; Anthony H. Schapira [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Ropinirole monotherapy induced severe reversible dyskinesias in Parkinson’s disease |
| 000790 |
Marjan Jahanshahi [Royaume-Uni] | Risky choices link the subthalamic nucleus with pathological gambling in Parkinson's disease. |
| 000795 |
Valerie Voon [Royaume-Uni, États-Unis] ; Vindhya Ekanayake [États-Unis] ; Edythe Wiggs [États-Unis] ; Sarah Kranick [États-Unis] ; Rezvan Ameli [États-Unis] ; Neil A. Harrison [Royaume-Uni] ; Mark Hallett [États-Unis] | Response Inhibition in Motor Conversion Disorder |
| 000799 |
Isabel Parees [Royaume-Uni] ; Tabish A. Saifee ; Mark J. Edwards | Reply: To PMID 23737007. |
| 000820 |
Pei-Yun Lee [Royaume-Uni] ; Kris Gadareh ; Mohammad J. Naushahi ; Michael Gresty ; Adolfo M. Bronstein | Protective stepping response in Parkinsonian patients and the effect of vibrotactile feedback. |
| 000825 |
Maria Stamelou [Royaume-Uni] ; Matthew Adams [Royaume-Uni] ; Indran Davagnanam [Royaume-Uni] ; Amit Batla [Royaume-Uni] ; Una Sheerin [Royaume-Uni] ; Kevin Talbot [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Progressive ataxia and palatal tremor associated with dense pontine calcification: A unique case |
| 000829 |
Karen M. Doherty [Royaume-Uni] ; Jonathan D. Rohrer [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Janice L. Holton [Royaume-Uni] ; Jason Warren [Royaume-Uni] | Primary Progressive Aphasia With Parkinsonism |
| 000837 |
Michael G. Heckman [États-Unis] ; Alexandra I. Soto-Ortolaza [États-Unis] ; Jan O. Aasly [Norvège] ; Nadine Abahuni [Allemagne] ; Grazia Annesi ; Justin A. Bacon [États-Unis] ; Soraya Bardien [Afrique du Sud] ; Maria Bozi [Grèce] ; Alexis Brice [France] ; Laura Brighina [Italie] ; Jonathan Carr [Afrique du Sud] ; Marie-Christine Chartier-Harlin [France] ; Efthimios Dardiotis [Grèce] ; Dennis W. Dickson [États-Unis] ; Nancy N. Diehl [États-Unis] ; Alexis Elbaz [France] ; Carlo Ferrarese [Italie] ; Brian Fiske [États-Unis] ; J. Mark Gibson [Irlande (pays)] ; Rachel Gibson [Royaume-Uni] ; Georgios M. Hadjigeorgiou [Grèce] ; Nobutaka Hattori [Japon] ; Faycal Hentati [Tunisie] ; John P. A. Ioannidis [Grèce, États-Unis] ; Magdalena Boczarska-Jedynak [Pologne] ; Barbara Jasinska-Myga [Pologne] ; Beom S. Jeon [Corée du Sud] ; Yun Joong Kim [Corée du Sud] ; Christine Klein [Allemagne] ; Rejko Kruger [Allemagne] ; Elli Kyratzi [Grèce] ; Suzanne Lesage [France] ; Chin-Hsien Lin [Taïwan] ; Timothy Lynch [Irlande (pays)] ; Demetrius M. Maraganore [États-Unis] ; George D. Mellick [Australie] ; Eugénie Mutez [France] ; Christer Nilsson [Suède] ; Grzegorz Opala [Pologne] ; Sung Sup Park [Corée du Sud] ; Simona Petrucci [Italie] ; Andreas Puschmann [Suède] ; Aldo Quattrone [Italie] ; Manu Sharma [Allemagne] ; Peter A. Silburn [Australie] ; Young Ho Sohn [Corée du Sud] ; Leonidas Stefanis [Grèce] ; Vera Tadic [Allemagne] ; Jessie Theuns [Belgique] ; Hiroyuki Tomiyama [Japon] ; Ryan J. Uitti [États-Unis] ; Enza Maria Valente [Italie] ; Christine Van Broeckhoven [Belgique] ; Simone Van De Loo [Allemagne] ; Demetrios K. Vassilatis [Grèce] ; Carles Vilari O-Güell [Canada] ; Linda R. White [Norvège] ; Karin Wirdefeldt [Suède] ; Zbigniew K. Wszolek [Belgique] ; Ruey-Meei Wu [Taïwan] ; Matthew J. Farrer [Canada] ; Owen A. Ross [États-Unis] | Population-specific frequencies for LRRK2 susceptibility variants in the Genetic Epidemiology Of Parkinson’s Disease (GEO-PD) consortium |
| 000843 |
Alberto Albanese [Italie] ; Kailash Bhatia [Royaume-Uni] ; Susan B. Bressman [États-Unis] ; Mahlon R. Delong [États-Unis] ; Stanley Fahn [États-Unis] ; Victor S. C. Fung [Australie] ; Mark Hallett [États-Unis] ; Joseph Jankovic [États-Unis] ; H. A. Jinnah [États-Unis] ; Christine Klein [Allemagne] ; Anthony E. Lang [Canada] ; Jonathan W. Mink [États-Unis] ; Jan K. Teller [États-Unis] | Phenomenology and classification of dystonia: a consensus update |
| 000865 |
Anna Sadnicka [Royaume-Uni] ; Okka Kimmich ; Claudia Pisarek ; Diane Ruge ; Joe Galea ; Panagiotis Kassavetis ; Isabel Pareés ; Tabish Saifee ; Anna Molloy ; David Bradley ; Sean O'Riordan ; Ludvic Zrinzo ; Marwan Hariz ; Kailash P. Bhatia ; Patricia Limousin ; Thomas Foltynie ; John C. Rothwell ; Michael Hutchinson ; Mark J. Edwards | Pallidal stimulation for cervical dystonia does not correct abnormal temporal discrimination. |
| 000870 |
Diego Kaski [Royaume-Uni] ; Tabish A. Saifee ; David Buckwell ; Adolfo M. Bronstein | Ocular tremor in Parkinson's disease is due to head oscillation. |
| 000879 |
John V. Hindle [Royaume-Uni] ; Annette Petrelli ; Linda Clare ; Elke Kalbe | Nonpharmacological enhancement of cognitive function in Parkinson's disease: a systematic review. |
| 000881 |
Gavin Charlesworth [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] | No pathogenic GNAL mutations in 192 sporadic and familial cases of cervical dystonia |
| 000891 |
Marianna Selikhova [Royaume-Uni] ; Peter A. Kempster ; Tamas Revesz ; Janice L. Holton ; Andrew J. Lees | Neuropathological findings in benign tremulous parkinsonism. |
| 000901 |
Sue Lord [Royaume-Uni] ; Brook Galna ; Lynn Rochester | Moving forward on gait measurement: toward a more refined approach. |
| 000902 |
Ignacio Rubio-Agusti [Royaume-Uni] ; Miryam Carecchio ; Kailash P. Bhatia ; Maja Kojovic ; Isabel Parees ; Hoskote S. Chandrashekar ; Emma J. Footitt ; Derek Burke ; Mark J. Edwards ; Robin H L. Lachmann ; Elaine Murphy | Movement disorders in adult patients with classical galactosemia. |
| 000911 |
Sue Lord [Royaume-Uni] ; Brook Galna ; Shirley Coleman ; David Burn ; Lynn Rochester | Mild depressive symptoms are associated with gait impairment in early Parkinson's disease. |
| 000923 |
Gordon W. Duncan [Royaume-Uni] ; Michael J. Firbank ; John T. O'Brien ; David J. Burn | Magnetic resonance imaging: a biomarker for cognitive impairment in Parkinson's disease? |
| 000960 |
Geert Verheyden [Royaume-Uni] ; Joanne Purdey ; Malcolm Burnett ; Jonathan Cole ; Ann Ashburn | Immediate effect of transcranial direct current stimulation on postural stability and functional mobility in Parkinson's disease. |
| 000965 |
Richard W. Walker [Royaume-Uni] ; Andrew Chaplin ; Rebecca L. Hancock ; Rachel Rutherford ; William K. Gray | Hip fractures in people with idiopathic Parkinson's disease: incidence and outcomes. |
| 000973 |
Aikaterina Angeli [Royaume-Uni] ; Niccolo E. Mencacci [Royaume-Uni, Italie] ; Raquel Duran [Royaume-Uni] ; Iciar Aviles-Olmos [Royaume-Uni] ; Zinovia Kefalopoulou [Royaume-Uni] ; Joseph Candelario [Royaume-Uni] ; Sarah Rusbridge [Royaume-Uni] ; Jennifer Foley [Royaume-Uni] ; Priyanka Pradhan [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni] ; Ludvic Zrinzo [Royaume-Uni] ; Marwan Hariz [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] ; John Hardy [Royaume-Uni] ; Patricia Limousin [Royaume-Uni] ; Tom Foltynie [Royaume-Uni] | Genotype and phenotype in Parkinson's disease: Lessons in heterogeneity from deep brain stimulation |
| 000974 |
Kin Y. Mok [Royaume-Uni] ; Susanne A. Schneider [Allemagne, Royaume-Uni] ; Daniah Trabzuni [Royaume-Uni] ; Maria Stamelou [Royaume-Uni] ; Mark Edwards [Royaume-Uni] ; Dalia Kasperaviciute [Royaume-Uni] ; Stuart Pickering-Brown [Royaume-Uni] ; Monty Silverdale [Royaume-Uni] ; John Hardy [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Genomewide association study in cervical dystonia demonstrates possible association with sodium leak channel |
| 000981 |
Amit Batla [Royaume-Uni] ; Maria Stamelou ; Mark J. Edwards ; Isabel Pareés ; Tabish A. Saifee ; Zoe Fox ; Kailash P. Bhatia | Functional movement disorders are not uncommon in the elderly. |
| 000982 |
Isabel Pareés [Royaume-Uni] ; Tabish A. Saifee ; Maja Kojovic ; Panagiotis Kassavetis ; Ignacio Rubio-Agusti ; Anna Sadnicka ; Kailash P. Bhatia ; Mark J. Edwards | Functional (psychogenic) symptoms in Parkinson's disease. |
| 000984 |
Marwan Hariz [Royaume-Uni] | Focused ultrasound thalamotomy improves essential tremor. |
| 000991 |
Isabel Pareés [Royaume-Uni] ; Panagiotis Kassavetis ; Tabish A. Saifee ; Anna Sadnicka ; Marco Davare ; Kailash P. Bhatia ; John C. Rothwell ; Sven Bestmann ; Mark J. Edwards | Failure of explicit movement control in patients with functional motor symptoms. |
| 000994 |
Antonella Macerollo [Royaume-Uni] ; Kailash P. Bhatia | FUS gene mutations cause essential tremor: a surprise but also confirms genetic heterogeneity of essential tremor. |
| 000A04 |
Mark S. Ledoux [États-Unis] ; William T. Dauer [États-Unis] ; Thomas T. Warner [Royaume-Uni] | Emerging Common Molecular Pathways for Primary Dystonia |
| 000A13 |
Maria Stamelou [Royaume-Uni] ; Scarlett C. Lai [Taïwan] ; Annu Aggarwal [Inde] ; Susanne A. Schneider [Royaume-Uni, Allemagne] ; Henry Houlden [Royaume-Uni] ; Tu-Hsueh Yeh [Taïwan] ; Amit Batla [Royaume-Uni] ; Chin-Song Lu [Taïwan] ; Mohit Bhatt [Inde] ; Kailash P. Bhatia [Royaume-Uni] | Dystonic opisthotonus: A “red flag” for neurodegeneration with brain iron accumulation syndromes? |
| 000A34 |
Miryam Carecchio [Royaume-Uni] ; Monia Magliozzi ; Massimiliano Copetti ; Alessandro Ferraris ; Laura Bernardini ; Monica Bonetti ; Giovanni Defazio ; Mark J. Edwards ; Isabella Torrente ; Fabio Pellegrini ; Cristoforo Comi ; Kailash P. Bhatia ; Enza Maria Valente | Defining the epsilon-sarcoglycan (SGCE) gene phenotypic signature in myoclonus-dystonia: a reappraisal of genetic testing criteria. |
| 000A52 |
Thomas Foltynie [Royaume-Uni] | Commentary. |
| 000A56 |
Kailash P. Bhatia [Royaume-Uni] | Commentary for "Progressive ataxia associated with scarring skin lesions and vertical gaze palsy". |
| 000A61 |
Mark J. Edwards [Royaume-Uni] ; T A Saifee | Coactivation of direct and indirect pathways: insights into the basal ganglia and normal movement control. |
| 000A67 |
Roberto Erro [Royaume-Uni] ; Kailash P. Bhatia ; Mark J. Edwards ; Simon F. Farmer ; Carla Cordivari | Clinical diagnosis of propriospinal myoclonus is unreliable: an electrophysiologic study. |
| 000B18 |
Sarah M. Kranick [États-Unis] ; James W. Moore [Royaume-Uni] ; Nadia Yusuf [États-Unis] ; Valeria T. Martinez [États-Unis] ; Kathrin Lafaver [États-Unis] ; Mark J. Edwards [Royaume-Uni] ; Arpan R. Mehta [Royaume-Uni] ; Phoebe Collins [Royaume-Uni] ; Neil A. Harrison [Royaume-Uni] ; Patrick Haggard [Royaume-Uni] ; Mark Hallett [États-Unis] ; Valerie Voon [Royaume-Uni] | Action-effect binding is decreased in motor conversion disorder: implications for sense of agency |
| 000B22 |
Victor S. C. Fung [Australie] ; H. A. Jinnah [États-Unis] ; Kailash Bhatia [Royaume-Uni] ; Marie Vidailhet [France] | ASSESSMENT OF THE PATIENT WITH ISOLATED OR COMBINED DYSTONIA: AN UPDATE ON DYSTONIA SYNDROMES |
| 000B48 |
Maria Stamelou [Royaume-Uni] ; Niall P. Quinn ; Kailash P. Bhatia | "Atypical" atypical parkinsonism: new genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy-a diagnostic guide. |
| 000B54 |
Charlotte Winward [Royaume-Uni] ; Cath Sackley ; Charmaine Meek ; Hooshang Izadi ; Karen Barker ; Derick Wade ; Helen Dawes | Weekly exercise does not improve fatigue levels in Parkinson's disease. |
| 000B83 |
Maria Stamelou [Royaume-Uni] ; Giuseppe Plazzi ; Elio Lugaresi ; Mark J. Edwards ; Kailash P. Bhatia | The distinct movement disorder in anti-NMDA receptor encephalitis may be related to Status Dissociatus: a hypothesis. |
| 000B89 |
Raquel Duran [Royaume-Uni] ; Niccolo E. Mencacci [Royaume-Uni, Italie] ; Aikaterini V. Angeli [Royaume-Uni] ; Maryam Shoai [Royaume-Uni] ; Emma Deas [Royaume-Uni] ; Henry Houlden [Royaume-Uni] ; Atul Mehta [Royaume-Uni] ; Derralynn Hughes [Royaume-Uni] ; Timothy M. Cox [Royaume-Uni] ; Patrick Deegan [Royaume-Uni] ; Anthony H. Schapira [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Patricia Limousin [Royaume-Uni] ; Paul R. Jarman [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] ; John Hardy [Royaume-Uni] ; Tom Foltynie [Royaume-Uni] | The Glucocerobrosidase E326K Variant Predisposes to Parkinson’s Disease, But Does Not Cause Gaucher’s Disease |
| 000B93 |
James T. Teo [Royaume-Uni] ; Mark J. Edwards ; Kailash Bhatia | Tardive dyskinesia is caused by maladaptive synaptic plasticity: a hypothesis. |
| 000B95 |
Laura L. Kilarski [Royaume-Uni] ; Justin P. Pearson ; Victoria Newsway ; Elisa Majounie ; M Duleeka W. Knipe ; Anjum Misbahuddin ; Patrick F. Chinnery ; David J. Burn ; Carl E. Clarke ; Marie-Helene Marion ; Alistair J. Lewthwaite ; David J. Nicholl ; Nicholas W. Wood ; Karen E. Morrison ; Caroline H. Williams-Gray ; Jonathan R. Evans ; Stephen J. Sawcer ; Roger A. Barker ; Mirdhu M. Wickremaratchi ; Yoav Ben-Shlomo ; Nigel M. Williams ; Huw R. Morris | Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease. |
| 000C09 |
Mark J. Edwards [Royaume-Uni] ; Anthony E. Lang ; Kailash P. Bhatia | Stereotypies: a critical appraisal and suggestion of a clinically useful definition. |
| 000C32 |
Katarina Bray [Royaume-Uni] ; Suresh Kumar Chhetri ; Anoop Varma ; Monty Silverdale | Reversible pseudoathetosis induced by cervical myelopathy. |
| 000C48 |
Ammar Kheder [Royaume-Uni] ; Stuart Currie ; Charles Romanowski ; Marios Hadjivassiliou | Progressive ataxia with palatal tremor due to gluten sensitivity. |
| 000C64 |
Andrew Lees [Royaume-Uni] ; Stanley Fahn ; Karla M. Eggert ; Joseph Jankovic [États-Unis] ; Anthony Lang ; Federico Micheli ; M Maral Mouradian ; Wolfgang H. Oertel ; C Warren Olanow ; Werner Poewe [Autriche] ; Olivier Rascol ; Eduardo Tolosa ; David Squillacote ; Dinesh Kumar | Perampanel, an AMPA antagonist, found to have no benefit in reducing "off" time in Parkinson's disease. |
| 000C69 |
David J. Burn [Royaume-Uni] ; Sabine Landau ; John V. Hindle ; Michael Samuel ; Kenneth C. Wilson ; Catherine S. Hurt ; Richard G. Brown | Parkinson's disease motor subtypes and mood. |
| 000C86 |
Claire Hinnell [Royaume-Uni] ; Catherine S. Hurt ; Sabine Landau ; Richard G. Brown ; Michael Samuel | Nonmotor versus motor symptoms: how much do they matter to health status in Parkinson's disease? |
| 000D04 |
Igor N. Petrovic [Royaume-Uni] ; Helen Ling ; Yasmine Asi ; Zeshan Ahmed ; Prashanth L. Kukkle ; Lili-Naz Hazrati ; Anthony E. Lang ; Tamas Revesz ; Janice L. Holton ; Andrew J. Lees | Multiple system atrophy-parkinsonism with slow progression and prolonged survival: a diagnostic catch. |
| 000D20 |
George K. Tofaris [Royaume-Uni] | Lysosome-dependent pathways as a unifying theme in Parkinson's disease. |
| 000D61 |
Kailash P. Bhatia [Royaume-Uni] ; Susanne A. Schneider | Identification of PRRT2 as the causative gene of paroxysmal kinesigenic dyskinesia. |
| 000D62 |
Georgia Xiromerisiou ; Henry Houlden ; Anna Sailer ; Laura Silveira-Moriyama ; John Hardy ; Andrew Lees (neurologue) [Royaume-Uni] | Identical Twins with Leucine Rich Repeat Kinase Type 2 Mutations Discordant for Parkinson's Disease |
| 000D77 |
Sophie E. Winder-Rhodes [Royaume-Uni] ; Pablo Garcia-Reitböck ; Maria Ban ; Jonathan R. Evans ; Thomas S. Jacques ; Anu Kemppinen ; Thomas Foltynie ; Caroline H. Williams-Gray ; Patrick F. Chinnery ; Gavin Hudson ; David J. Burn ; Liesl M. Allcock ; Stephen J. Sawcer ; Roger A. Barker ; Maria Grazia Spillantini | Genetic and pathological links between Parkinson's disease and the lysosomal disorder Sanfilippo syndrome. |
| 000D83 |
Alison Yarnall [Royaume-Uni] | Further evidence that amyloid-β oligomer and cellular prion protein interaction produces deleterious consequences in Alzheimer's disease. |
| 000E04 |
Maria Stamelou [Royaume-Uni] ; Araceli Alonso-Canovas ; Kailash P. Bhatia | Dystonia in corticobasal degeneration: a review of the literature on 404 pathologically proven cases. |
| 000E10 |
Dorothy Cowie [Royaume-Uni] ; Patricia Limousin ; Amy Peters ; Marwan Hariz ; Brian L. Day | Doorway-provoked freezing of gait in Parkinson's disease. |
| 000E23 |
Thomas C. Edwards [Royaume-Uni] ; Ludvic Zrinzo ; Patricia Limousin ; Tom Foltynie | Deep brain stimulation in the treatment of chorea. |
| 000E30 |
Luke A. Massey [Royaume-Uni] ; Caroline Micallef ; Dominic C. Paviour ; Sean S. O'Sullivan ; Helen Ling ; David R. Williams ; Constantinos Kallis ; Janice L. Holton ; Tamas Revesz ; David J. Burn ; Tarek Yousry ; Andrew J. Lees ; Nick C. Fox ; Hans R. J Ger | Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy. |
| 000E52 |
Ignacio Rubio-Agusti [Royaume-Uni] ; Maja Kojovic ; Hoskote S. Chandrashekar ; Mark J. Edwards ; Kailash P. Bhatia | Cervical dystonia and joint hypermobility syndrome: a dangerous combination. |
| 000E63 |
Sean O Owd [Irlande (pays)] ; Denis Curtin [Irlande (pays)] ; Adrian J. Waite [Royaume-Uni] ; Kinley Roberts [Irlande (pays)] ; Niall Pender [Irlande (pays)] ; Valerie Reid [Irlande (pays)] ; Martin O Onnell [Irlande (pays)] ; Nigel M. Williams [Royaume-Uni] ; Huw R. Morris [Royaume-Uni] ; Bryan J. Traynor [États-Unis] ; Timothy Lynch [Irlande (pays)] | C9ORF72 Expansion in Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Also Causes Parkinsonism |
| 000E76 |
Ignacio Rubio-Agusti [Royaume-Uni] ; Maja Kojovic ; Mark J. Edwards ; Elaine Murphy ; Hoskote S. Chandrashekar ; Robin H. Lachmann ; Kailash P. Bhatia | Atypical parkinsonism and cerebrotendinous xanthomatosis: report of a family with corticobasal syndrome and a literature review. |
| 000E87 |
Erwan Bezard [France] ; Zhenyu Yue [États-Unis] ; Deniz Kirik [Suède] ; Maria Grazia Spillantini [Royaume-Uni] | Animal Models of Parkinson’s Disease: limits and relevance to neuroprotection studies |
| 000E97 |
Peter Mccolgan [Royaume-Uni] ; Jonathan R. Evans ; David P. Breen ; Sarah L. Mason ; Roger A. Barker ; Caroline H. Williams-Gray | Addenbrooke's Cognitive Examination-Revised for mild cognitive impairment in Parkinson's disease. |
| 000F09 |
Maria Stamelou [Royaume-Uni] ; Kailash P. Bhatia | A new treatable genetic disorder of manganese metabolism causing dystonia-parkinsonism and cirrhosis: the "new" Wilson's disease? |
| 000F10 |
Rita Horvath [Royaume-Uni] ; Elke Holinski-Feder ; Vivienne C M. Neeve ; Angela Pyle ; Helen Griffin ; Deephthi Ashok ; Charlotte Foley ; Gavin Hudson ; Bernd Rautenstrauss ; Gudrun Nürnberg ; Peter Nürnberg ; Jörg Kortler ; Birgit Neitzel ; Ingelore B Ssmann ; Thahira Rahman ; Bernard Keavney ; John Loughlin ; Sophie Hambleton ; Benedikt Schoser ; Hanns Lochmüller ; Mauro Santibanez-Koref ; Patrick F. Chinnery | A new phenotype of brain iron accumulation with dystonia, optic atrophy, and peripheral neuropathy. |
| 000F29 |
Maja Kojovic [Royaume-Uni] ; Una-Marie Sheerin [Royaume-Uni] ; Ignacio Rubio-Agusti [Royaume-Uni] ; Anirban Saha [Royaume-Uni] ; Jose Bras [Royaume-Uni] ; Vaneesha Gibbons [Royaume-Uni] ; Rodger Palmer [Royaume-Uni] ; Henry Houlden [Royaume-Uni] ; John Hardy [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Young-Onset Parkinsonism due to Homozygous Duplication of α-Synuclein in a Consanguineous Family |
| 000F33 |
Charlotte Winward [Royaume-Uni] ; Cath Sackley [Royaume-Uni] ; Charmaine Meek [Royaume-Uni] ; Hooshang Izadi [Royaume-Uni] ; Karen Barker [Royaume-Uni] ; Derick Wade [Royaume-Uni] ; Helen Dawes [Royaume-Uni] | Weekly Exercise Does Not Improve Fatigue Levels in Parkinson's Disease |
| 000F46 |
Florian Krismer [Autriche] ; Klaus Seppi [Autriche] ; François Tison [France] ; Cristina Sampaio [Portugal] ; Anja Zangerl [Autriche] ; Cecilia Peralta [Autriche, Argentine] ; Farid Yekhlef [France] ; Imad Ghorayeb [France] ; Fabienne Ory-Magne [France] ; Monique Galitzky [France] ; Maria Bozi [Royaume-Uni] ; Tommaso Scaravilli [Royaume-Uni, Italie] ; Carlo Colosimo [Italie] ; Felix Geser [Autriche, Allemagne] ; Olivier Rascol [France] ; Werner Poewe [Autriche] ; Niall P. Quinn [Royaume-Uni] ; Greqor K. Wenning [Autriche] | The Unified Multiple System Atrophy Rating Scale: Intrarater Reliability |
| 000F54 |
Alastair J. Noyce ; Bmedsci Mrcp [Royaume-Uni] ; Connor Treacy [Royaume-Uni] ; Caroline Budu [Royaume-Uni] ; Julian Fearnley [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Gavin Giovannoni [Royaume-Uni] | The New Bradykinesia Akinesia Incoordination (BRAIN) Test: Preliminary Data from an Online Test of Upper Limb Movement |
| 000F66 |
Georgia Xiromerisiou [Royaume-Uni, Grèce] ; Henry Houlden [Royaume-Uni] ; Nikolaos Scarmeas [États-Unis, Grèce] ; Maria Stamelou [Royaume-Uni] ; Eleanna Kara [Royaume-Uni] ; John Hardy [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Prasad Korlipara [Royaume-Uni] ; Patricia Limousin [Royaume-Uni] ; Reema Paudel [Royaume-Uni] ; Georgios M. Hadjigeorgiou [Grèce] ; Kailash P. Bhatia [Royaume-Uni] | THAP1 Mutations And Dystonia Phenotypes: Genotype Phenotype Correlations |
| 000F67 |
Laura L. Kilarski [Royaume-Uni] ; Justin P. Pearson [Royaume-Uni] ; Victoria Newsway [Royaume-Uni] ; Elisa Majounie [Royaume-Uni] ; M. Duleeka W. Knipe [Royaume-Uni] ; Anjum Misbahuddin [Royaume-Uni] ; Patrick F. Chinnery [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Carl E. Clarke [Royaume-Uni] ; Marie-Helene Marion [Royaume-Uni] ; Alistair J. Lewthwaite [Royaume-Uni] ; David J. Nicholl [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] ; Karen E. Morrison [Royaume-Uni] ; Caroline H. Williams-Gray [Royaume-Uni] ; Jonathan R. Evans [Royaume-Uni] ; Stephen J. Sawcer [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] ; Mirdhu M. Wickremaratchi [Royaume-Uni] ; Yoav Ben-Shlomo [Royaume-Uni] ; Nigel M. Williams [Royaume-Uni] ; Huw R. Morris [Royaume-Uni] | Systematic Review and UK-Based Study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in Early-Onset Parkinson's Disease |
| 000F69 |
Susanne A. Schneider [Allemagne, Royaume-Uni] ; John Hardy [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Syndromes of Neurodegeneration with Brain Iron Accumulation (NBIA): an Update on Clinical Presentations, Histological and Genetic Underpinnings, and Treatment Considerations |
| 000F71 |
Elke Peeters [Belgique] ; Peter Vanacker [Belgique] ; Mark Woodhall [Royaume-Uni] ; Angela Vincent [Royaume-Uni] ; Maarten Schrooten [Belgique] ; Wim Vandenberghe [Belgique] | Supranuclear Gaze Palsy in Glycine Receptor Antibody-Positive Progressive Encephalomyelitis With Rigidity and Myoclonus |
| 000F79 |
Mark J. Edwards [Royaume-Uni] ; Anthony E. Lang [Canada] ; Kailash P. Bhatia [Royaume-Uni] | Stereotypies: A Critical Appraisal and Suggestion of a Clinically Useful Definition |
| 001012 |
Maria Stamelou [Royaume-Uni] ; Tabish A. Saifee [Royaume-Uni] ; Mark J. Edwards [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Psychogenic Palatal Tremor May Be Underrecognized: Reappraisal of a Large Series of Cases |
| 001013 |
Alfonso Fasano [Italie] ; Anabela Valadas [Portugal, Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; L. K. Prashanth [Canada] ; Anthony E. Lang [Canada] ; Renato P. Munhoz [Brésil] ; Francesca Morgante [Italie] ; Daniel Tarsy [États-Unis] ; Andrew P. Duker [États-Unis] ; Paolo Girlanda [Italie] ; Anna Rita Bentivoglio [Italie] ; Alberto J. Espay [États-Unis] | Psychogenic Facial Movement Disorders: Clinical Features and Associated Conditions |
| 001016 |
Ammar Kheder [Royaume-Uni] ; Stuart Currie [Royaume-Uni] ; Charles Romanowski [Royaume-Uni] ; Marios Hadjivassiliou [Royaume-Uni] | Progressive Ataxia with Palatal Tremor Due to Gluten Sensitivity |
| 001030 |
Andrew Lees (neurologue) [Royaume-Uni] ; Stanley Fahn [États-Unis] ; Karla M. Eggert [Allemagne] ; Joseph Jankovic [États-Unis] ; Anthony Lang [Canada] ; Federico Micheli [Argentine] ; M. Maral Mouradian [États-Unis] ; Wolfgang H. Oertel [Allemagne] ; C. Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Eduardo Tolosa [Espagne] ; David Squillacote [États-Unis] ; Dinesh Kumar [États-Unis] | Perampanel, an AMPA Antagonist, Found to Have No Benefit in Reducing "Off" Time in Parkinson's Disease |
| 001034 |
David J. Burn [Royaume-Uni] ; Sabine Landau [Royaume-Uni] ; John V. Hindle [Royaume-Uni] ; Michael Samuel [Royaume-Uni] ; Kenneth C. Wilson [Royaume-Uni] ; Catherine S. Hurt [Royaume-Uni] ; Richard G. Brown [Royaume-Uni] | Parkinson's Disease Motor Subtypes and Mood |
| 001043 |
Hugo Morales-Briceno [Mexique] ; Mayela Rodriguez-Violante [Mexique] ; Amin Cervantes-Arriaga [Mexique] ; Sarosh R. Irani [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Laura Silveira-Moriyama [Royaume-Uni, Brésil] | Opsoclonus Myoclonus Syndrome Associated With GQ1b Antibodies |
| 001046 |
Claire Hinnell [Royaume-Uni] ; Catherine S. Hurt [Royaume-Uni] ; Sabine Landau [Royaume-Uni] ; Richard G. Brown [Royaume-Uni] ; Michael Samuel [Royaume-Uni] | Nonmotor Versus Motor Symptoms: How Much Do They Matter to Health Status in Parkinson's Disease? |
| 001058 |
Igor N. Petrovic [Royaume-Uni] ; Helen Ling [Royaume-Uni, Serbie] ; Yasmine Asi [Serbie] ; Zeshan Ahmed [Serbie] ; Prashanth L. Kukkle [Canada] ; Lili-Naz Hazrati [Canada] ; Anthony E. Lang [Canada] ; Tamas Revesz [Serbie] ; Janice L. Holton [Serbie] ; Andrew Lees (neurologue) [Royaume-Uni, Serbie] | Multiple System Atrophy- Parkinsonism with Slow Progression and Prolonged Survival: A Diagnostic Catch |
| 001071 |
J. Paul Bolam [Royaume-Uni] ; Eleftheria K. Pissadaki [Royaume-Uni, Grèce] | Living on the Edge With Too Many Mouths to Feed: Why Dopamine Neurons Die |
| 001079 |
Heike Stockner [Autriche] ; Petra Schwingenschuh [Royaume-Uni, Autriche] ; Atbin Djamshidian [Royaume-Uni] ; Laura Silveira-Moriyama [Royaume-Uni] ; Petra Katschnig [Royaume-Uni, Autriche] ; Klaus Seppi [Autriche] ; John Dickson [Royaume-Uni] ; Mark J. Edwards [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Werner Poewe [Autriche] ; Kailash P. Bhatia [Royaume-Uni] | Is Transcranial Sonography Useful to Distinguish Scans Without Evidence of Dopaminergic Deficit Patients From Parkinson's Disease? |
| 001097 |
Ronald B. Postuma [Canada] ; Dag Aarsland [Norvège] ; Paolo Barone [Italie] ; David J. Burn [Royaume-Uni] ; Christopher H. Hawkes [Royaume-Uni] ; Wolfgang Oertel [Allemagne] ; Tjalf Ziemssen [Allemagne] | Identifying Prodromal Parkinson's Disease: Pre-Motor Disorders in Parkinson's Disease |
| 001098 |
Alisdair Mcneill [Royaume-Uni] ; Raquel Duran [Royaume-Uni] ; Christos Proukakis [Royaume-Uni] ; Jose Bras [Royaume-Uni] ; Derralyn Hughes [Royaume-Uni] ; Atuhl Mehta [Royaume-Uni] ; John Hardy [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] ; Anthony H. V. Schapira [Royaume-Uni] | Hyposmia and Cognitive Impairment in Gaucher Disease Patients and Carriers |
| 001107 |
Núria Seto-Salvia [Espagne] ; Javier Pagonabarraga [Espagne] ; Henry Houlden [Royaume-Uni] ; Berta Pascual-Sedano [Espagne] ; Oriol Dols-Icardo [Espagne] ; Arianna Tucci [Royaume-Uni] ; Coro Paisan-Ruiz [États-Unis] ; Antonia Campolongo [Espagne] ; Sofia Anton-Aguirre [Espagne] ; Inés Martin [Espagne] ; Laia Munoz [Espagne] ; Enric Bufill [Espagne] ; Lluïsa Vilageliu [Espagne] ; Daniel Grinberg [Espagne] ; M Nica Cozar [Espagne] ; Rafael Blesa [Espagne] ; Alberto Lleo [Espagne] ; John Hardy [Royaume-Uni] ; Jaime Kulisevsky [Espagne] ; Jordi Clarimon [Espagne] | Glucocerebrosidase Mutations Confer a Greater Risk of Dementia during Parkinson's Disease Course |
| 001109 |
Sophie E. Winder-Rhodes [Royaume-Uni] ; Pablo Garcia-Reitböck [Royaume-Uni] ; Maria Ban [Royaume-Uni] ; Jonathan R. Evans [Royaume-Uni] ; Thomas S. Jacques [Royaume-Uni] ; Anu Kemppinen [Royaume-Uni] ; Thomas Foltynie [Royaume-Uni] ; Caroline H. Williams-Gray [Royaume-Uni] ; Patrick F. Chinnery [Royaume-Uni] ; Gavin Hudson [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Liesl M. Allcock [Royaume-Uni] ; Stephen J. Sawcer [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] ; Maria Grazia Spillantini [Royaume-Uni] | Genetic and Pathological Links Between Parkinson's Disease and the Lysosomal Disorder Sanfilippo Syndrome |
| 001136 |
Maria Stamelou [Royaume-Uni] ; Karin Tuschl [Royaume-Uni] ; W. K. Chong [Royaume-Uni] ; Andrew K. Burroughs [Royaume-Uni] ; Philippa B. Mills [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Peter T. Clayton [Royaume-Uni] | Dystonia with Brain Manganese Accumulation Resulting From SLC30A10 Mutations: A New Treatable Disorder |
| 001137 |
Claire Hinnell [Royaume-Uni] ; Salman Haider [Royaume-Uni] ; Shane Delamont [Royaume-Uni] ; Chris Clough [Royaume-Uni] ; Nedim Hadzic [Royaume-Uni] ; Michael Samuel [Royaume-Uni] | Dystonia in Mitochondrial Spinocerebellar Ataxia and Epilepsy Syndrome Associated with Novel Recessive POLG Mutations |
| 001138 |
Maria Stamelou [Royaume-Uni] ; Araceli Alonso-Canovas [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Dystonia in Corticobasal Degeneration: A Review of the Literature on 404 Pathologically Proven Cases |
| 001142 |
Dorothy Cowie [Royaume-Uni] ; Patricia Limousin [Royaume-Uni] ; Amy Peters [Royaume-Uni] ; Marwan Hariz [Royaume-Uni] ; Brian L. Day [Royaume-Uni] | Doorway-Provoked Freezing of Gait in Parkinson's Disease |
| 001143 |
Bruno Dubois [France] ; Eduardo Tolosa [Espagne] ; Regina Katzenschlager [Autriche] ; Murat Emre [Turquie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Gunther Schumann [Allemagne] ; Emmanuelle Pourcher [Canada] ; Julian Gray [Suisse] ; Gail Thomas [Royaume-Uni] ; Jina Swartz [Royaume-Uni] ; Timothy Hsu [États-Unis] ; Margaret L. Moline [États-Unis] | Donepezil in Parkinson's Disease Dementia: A Randomized, Double-Blind Efficacy and Safety Study |
| 001147 |
Irene Litvan [États-Unis] ; Jennifer G. Goldman [États-Unis] ; Alexander I. Tröster [États-Unis] ; Ben A. Schmand [Pays-Bas] ; Daniel Weintraub [États-Unis] ; Ronald C. Petersen [États-Unis] ; Brit Mollenhauer [Allemagne] ; Charles H. Adler [États-Unis] ; Karen Marder [États-Unis] ; Caroline H. Williams-Gray [Royaume-Uni] ; Dag Aarsland [Norvège] ; Jaime Kulisevsky [Espagne] ; Maria C. Rodriguez-Oroz [Espagne] ; David J. Burn [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] ; Murat Emre [Turquie] | Diagnostic Criteria for Mild Cognitive Impairment in Parkinson's Disease: Movement Disorder Society Task Force Guidelines |
| 001148 |
Francesca Morgante [Italie] ; Mark J. Edwards [Royaume-Uni] ; Alberto J. Espay [États-Unis] ; Alfonso Fasano [Italie] ; Pablo Mir [Espagne] ; Davide Martino [Italie, Royaume-Uni] | Diagnostic Agreement in Patients with Psychogenic Movement Disorders |
| 001153 |
Louise M. Mcdonald [Royaume-Uni] ; Donna Page [Royaume-Uni] ; Leonora Wilkinson [Royaume-Uni, États-Unis] ; Marjan Jahanshahi [Royaume-Uni] | Deep Brain Stimulation of the Subthalamic Nucleus Improves Sense of Well-Being in Parkinson's Disease |
| 001154 |
Thomas C. Edwards [Royaume-Uni] ; Ludvic Zrinzo [Royaume-Uni] ; Patricia Limousin [Royaume-Uni] ; Tom Foltynie [Royaume-Uni] | Deep Brain Stimulation in the Treatment of Chorea |
| 001156 |
Atbin Djamshidian [Royaume-Uni] ; Sean S. O'Sullivan [Royaume-Uni] ; Yanosh Sanotsky [Ukraine] ; Stephen Sharman [Royaume-Uni] ; Yuriy Matviyenko [Ukraine] ; Thomas Foltynie [Royaume-Uni] ; Rosanna Michalczuk [Royaume-Uni] ; Iciar Aviles-Olmos [Royaume-Uni] ; Ludmyla Fedoryshyn [Ukraine] ; Karen M. Doherty [Royaume-Uni] ; Yuriy Filts [Ukraine] ; Marianna Selikhova [Royaume-Uni] ; Henrietta Bowden-Jones [Royaume-Uni] ; Eileen Joyce [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Bruno B. Averbeck [Royaume-Uni, États-Unis] | Decision Making, Impulsivity, and Addictions: Do Parkinson's Disease Patients Jump to Conclusions? |
| 001159 |
Luke A. Massey [Royaume-Uni] ; Caroline Micallef [Royaume-Uni] ; Dominic C. Paviour [Royaume-Uni] ; Sean S. O'Sullivan [Royaume-Uni] ; Helen Ling [Royaume-Uni] ; David R. Williams [Australie] ; Constantinos Kallis [Royaume-Uni] ; Janice L. Holton [Royaume-Uni] ; Tamas Revesz [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Tarek Yousry ; Med Habil [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Nick C. Fox [Royaume-Uni] ; Hans R. J Ger [Royaume-Uni] | Conventional Magnetic Resonance Imaging in Confirmed Progressive Supranuclear Palsy and Multiple System Atrophy |
| 001175 |
Ignacio Rubio-Agusti [Royaume-Uni, Espagne] ; Maja Kojovic [Royaume-Uni] ; Hoskote S. Chandrashekar [Royaume-Uni] ; Mark J. Edwards [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Cervical Dystonia and Joint Hypermobility Syndrome: A Dangerous Combination |
| 001183 |
Sean O'Dowd [Irlande (pays)] ; Denis Curtin [Irlande (pays)] ; Adrian J. Waite [Royaume-Uni] ; Kinley Roberts [Irlande (pays)] ; Niall Pender [Irlande (pays)] ; Valerie Reid [Irlande (pays)] ; Martin O'Connell [Irlande (pays)] ; Nigel M. Williams [Royaume-Uni] ; Huw R. Morris [Royaume-Uni] ; Bryan J. Traynor [États-Unis] ; Timothy Lynch [Irlande (pays)] | C9ORF72 Expansion in Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Also Causes Parkinsonism |
| 001195 |
Hans-Holger Capelle [Allemagne] ; Christian Blahak [Allemagne] ; Christoph Schrader [Allemagne] ; Hansjorg Baezner [Allemagne] ; Marwan I. Hariz [Suède, Royaume-Uni] ; Tommy Bergenheim [Suède] ; Joachim K. Krauss [Allemagne] | Bilateral Deep Brain Stimulation for Cervical Dystonia in Patients with Previous Peripheral Surgery |
| 001200 |
Ignacio Rubio-Agusti [Royaume-Uni, Espagne] ; Maja Kojovic [Royaume-Uni] ; Mark J. Edwards [Royaume-Uni] ; Elaine Murphy [Royaume-Uni] ; Hoskote S. Chandrashekar [Royaume-Uni] ; Robin H. Lachmann [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Atypical Parkinsonism and Cerebrotendinous Xanthomatosis: Report of a Family With Corticobasal Syndrome and a Literature Review |
| 001219 |
Peter Mccolgan [Royaume-Uni] ; Jonathan R. Evans [Royaume-Uni] ; David P. Breen [Royaume-Uni] ; Sarah L. Mason [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] ; Caroline H. Williams-Gray [Royaume-Uni] | Addenbrooke's Cognitive Examination-Revised for Mild Cognitive Impairment in Parkinson's Disease |
| 001225 |
Hulya Apaydin [Turquie] ; Gulçin Benbir [Turquie] ; Andrew Lees (neurologue) [Royaume-Uni] | A Stimulus-Sensitive Tic Disorder Characterized by Echophenomena and Coprolalia |
| 001227 |
Fabrizio Stocchi [Italie] ; Rupam Borgohain [Inde] ; Marco Onofrj [Italie] ; Anthony H. V. Schapira [Royaume-Uni] ; Mohit Bhatt [Inde] ; Valentina Lucini [Italie] ; Rodolfo Giuliani [Italie] ; Ravi Anand [Suisse] | A Randomized, Double-Blind, Placebo-Controlled Trial of Safinamide as Add-on Therapy in Early Parkinson's Disease Patients |
| 001231 |
Rita Horvath [Royaume-Uni, Allemagne] ; Elke Holinski-Feder [Allemagne] ; Vivienne C. M. Neeve [Royaume-Uni] ; Angela Pyle [Royaume-Uni] ; Helen Griffin [Royaume-Uni] ; Deephthi Ashok [Royaume-Uni] ; Charlotte Foley [Royaume-Uni] ; Gavin Hudson [Royaume-Uni] ; Bernd Rautenstrauss [Allemagne] ; Gudrun Nurnberg [Allemagne] ; Peter Nurnberg [Allemagne] ; Jörg Kortler [Allemagne] ; Birgit Neitzel [Allemagne] ; Ingelore B Ssmann [Allemagne] ; Thahira Rahman [Royaume-Uni] ; Bernard Keavney [Royaume-Uni] ; John Loughlin [Royaume-Uni] ; Sophie Hambleton [Royaume-Uni] ; Benedikt Schoser [Allemagne] ; Hanns Lochmüller [Royaume-Uni] ; Mauro Santibanez-Koref [Royaume-Uni] ; Patrick F. Chinnery [Royaume-Uni] | A New Phenotype of Brain Iron Accumulation with Dystonia, Optic Atrophy, and Peripheral Neuropathy |
| 001239 |
Jon Stone [Royaume-Uni] ; Jeannette Gelauff [Pays-Bas] ; Alan Carson [Royaume-Uni] | A "Twist in the Tale": Altered Perception of Ankle Position in Psychogenic Dystonia |
| 001245 |
Ashley H. Spencer [Royaume-Uni] ; Hugh Rickards ; Alfonso Fasano ; Andrea E. Cavanna | The prevalence and clinical characteristics of punding in Parkinson's disease. |
| 001253 |
Tien K. Khoo [Royaume-Uni] | Parkin inactivation via PARIS (ZNF746) may lead to neurodegeneration in Parkinson's disease. |
| 001272 |
Gerald Stern [Royaume-Uni] | Why catechol? |
| 001275 |
Jose Luis L Pez-Send N [Espagne] ; Ana Royuela [Espagne] ; Patricia Trigo [Espagne] ; Michael Orth [Allemagne] ; Herwig Lange [Allemagne] ; Ralf Reilmann [Allemagne] ; Jennifer Keylock [Royaume-Uni] ; Hugh Rickards [Royaume-Uni] ; Silvia Piacentini [Italie] ; Ferdinando Squitieri [Italie] ; Bernhard Landwehrmeyer [Allemagne] ; Marie-Noelle Witjes-Ane [Pays-Bas] ; Caroline. K. Jurgens [Pays-Bas] ; Raymund. A. C. Roos [Pays-Bas] ; Victor Abraira [Espagne] ; Justo. G. De Yébenes [Espagne] | What is the impact of education on Huntington's disease? |
| 001277 |
Neil K. Archibald [Royaume-Uni] ; Mike P. Clarke [Royaume-Uni] ; Urs P. Mosimann [Royaume-Uni, Suisse] ; David J. Burn [Royaume-Uni] | Visual symptoms in Parkinson's disease and Parkinson's disease dementia |
| 001289 |
Mayela Rodríguez-Violante [Mexique] ; Andrew Lees (neurologue) [Royaume-Uni] ; Amin Cervantes-Arriaga [Mexique] ; Teresa Corona [Mexique] ; Laura Silveira-Moriyama [Royaume-Uni] | Use of smell test identification in Parkinson's disease in Mexico: A matched case‐control study |
| 001296 |
Niall P. Quinn [Royaume-Uni] ; Susanne A. Schneider [Royaume-Uni] ; Petra Schwingenschuh [Royaume-Uni, Autriche] ; Kailash P. Bhatia [Royaume-Uni] | Tremor—some controversial aspects |
| 001300 |
Elina Tripoliti [Royaume-Uni] ; Laura Strong [Royaume-Uni] ; Freya Hickey [Royaume-Uni] ; Tom Foltynie [Royaume-Uni] ; Ludvic Zrinzo [Royaume-Uni] ; Joseph Candelario [Royaume-Uni] ; Marwan Hariz [Royaume-Uni] ; Patricia Limousin [Royaume-Uni] | Treatment of dysarthria following subthalamic nucleus deep brain stimulation for Parkinson's disease |
| 001308 |
Nicola Z. Hobbs [Royaume-Uni] ; Amy V. Pedrick [Royaume-Uni] ; Miranda J. Say [Royaume-Uni] ; Chris Frost [Royaume-Uni] ; Rachelle Dar Santos [Canada] ; Allison Coleman [Canada] ; Aaron Sturrock [Canada] ; David Craufurd [Royaume-Uni] ; Julie C. Stout [Australie] ; Blair R. Leavitt [Canada] ; Josephine Barnes [Royaume-Uni] ; Sarah J. Tabrizi [Royaume-Uni] ; Rachael I. Scahill [Royaume-Uni] | The structural involvement of the cingulate cortex in premanifest and early Huntington's disease |
| 001316 |
Ashley H. Spencer [Royaume-Uni] ; Hugh Rickards [Royaume-Uni] ; Alfonso Fasano [Italie] ; Andrea E. Cavanna [Royaume-Uni] | The prevalence and clinical characteristics of punding in Parkinson's disease |
| 001320 |
Ji Klempí [République tchèque] ; Jana Židovská [République tchèque] ; Jan Štochl [Royaume-Uni] ; V Ra Kebrdlová Ing [République tchèque] ; Tereza Uhrová [République tchèque] ; Jan Roth [République tchèque] | The number of CAG repeats within the normal allele does not influence the age of onset in Huntington's disease |
| 001321 |
Mirdhu M. Wickremaratchi [Royaume-Uni] ; M. Duleeka W. Knipe [Royaume-Uni] ; B. S. Dwarakanath Sastry [Royaume-Uni] ; Elizabeth Morgan [Royaume-Uni] ; Anne Jones [Royaume-Uni] ; Rachel Salmon [Royaume-Uni] ; Richard Weiser [Royaume-Uni] ; Maralyn Moran [Royaume-Uni] ; Debbie Davies [Royaume-Uni] ; Louise Ebenezer [Royaume-Uni] ; Sandip Raha [Royaume-Uni] ; Neil P. Robertson [Royaume-Uni] ; Christopher C. Butler [Royaume-Uni] ; Yoav Ben-Shlomo [Royaume-Uni] ; Huw R. Morris [Royaume-Uni] | The motor phenotype of Parkinson's disease in relation to age at onset |
| 001322 |
Gerald Stern [Royaume-Uni] | The mother of all amine oxidases and the proposed father of amine oxidase inhibitors |
| 001326 |
Adam J. Cassidy [Royaume-Uni] ; Elizabeth R. Williams [Royaume-Uni] ; Paul Goldsmith [Royaume-Uni] ; Stuart N. Baker [Royaume-Uni] ; Mark R. Baker [Royaume-Uni] | The man who could not walk backward: An unusual presentation of neuroferritinopathy |
| 001327 |
Alison Yarnall [Royaume-Uni] ; Lynn Rochester [Royaume-Uni] ; David J. Burn [Royaume-Uni] | The interplay of cholinergic function, attention, and falls in Parkinson's disease |
| 001329 |
Pablo Martinez-Martin [Espagne] ; Carmen Rodriguez-Blazquez [Espagne] ; Monica M. Kurtis [Espagne] ; K. Ray Chaudhuri [Royaume-Uni] | The impact of non‐motor symptoms on health‐related quality of life of patients with Parkinson's disease |
| 001332 |
Sean S. O'Sullivan [Royaume-Uni] ; Mary Johnson [Royaume-Uni] ; David R. Williams [Australie] ; Tamas Revesz [Royaume-Uni] ; Janice L. Holton [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Elaine K. Perry [Royaume-Uni] | The effect of drug treatment on neurogenesis in Parkinson's disease |
| 001335 |
Joana Damásio [Royaume-Uni, Portugal] ; Mark J. Edwards [Royaume-Uni] ; Araceli Alonso-Canovas [Royaume-Uni, Espagne] ; Petra Schwingenschuh [Royaume-Uni, Autriche] ; Georg K Gi [Royaume-Uni, Suisse] ; Kailash P. Bhatia [Royaume-Uni] | The clinical syndrome of primary tic disorder associated with dystonia: A large clinical series and a review of the literature |
| 001338 |
Kailash P. Bhatia [Royaume-Uni] | The Wilson films — Wilson's disease |
| 001345 |
Susanne A. Schneider [Allemagne, Royaume-Uni] ; Peter G. Bain [Royaume-Uni] | The Wilson films — Bilateral postural tremor |
| 001356 |
Lynn Rochester [Royaume-Uni] ; Katherine Baker [Royaume-Uni] ; Alice Nieuwboer [Belgique] ; David Burn [Royaume-Uni] | Targeting dopa‐sensitive and dopa‐resistant gait dysfunction in Parkinson's disease: Selective responses to internal and external cues |
| 001361 |
Stefan T. Schwarz [Royaume-Uni] ; Timothy Rittman [Royaume-Uni] ; Vamsi Gontu [Royaume-Uni] ; Paul S. Morgan [Royaume-Uni] ; Nin Bajaj [Royaume-Uni] ; Dorothee P. Auer [Royaume-Uni] | T1‐Weighted MRI shows stage‐dependent substantia nigra signal loss in Parkinson's disease |
| 001363 |
Christopher Kobylecki [Royaume-Uni] ; Michael P. Hill [Canada] ; Alan R. Crossman [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni, Canada] | Synergistic antidyskinetic effects of topiramate and amantadine in animal models of Parkinson's disease |
| 001366 |
Marwan I. Hariz [Royaume-Uni] | Surgical probings into the basal ganglia: Hemorrhage and hardware‐related risks, and costs of microelectrode recording |
| 001377 |
Philip A. Starr [États-Unis] ; Paul Bejjani [Liban] ; Andres M. Lozano [Canada] ; Leo Verhagen Metman [États-Unis] ; And Marwan I. Hariz [Royaume-Uni] | Stereotactic techniques and perioperative management of DBS in dystonia |
| 001383 |
Carl E. Clarke [Royaume-Uni] ; Smitaa Patel [Royaume-Uni] ; Natalie Ives [Royaume-Uni] ; Caroline Rick [Royaume-Uni] ; Keith Wheatley [Royaume-Uni] ; Richard Gray [Royaume-Uni] | Should treatment for Parkinson's disease start immediately on diagnosis or delayed until functional disability develops? |
| 001397 |
Claudia Trenkwalder [Allemagne] ; Bryan Kies [Afrique du Sud] ; Monika Rudzinska [Pologne] ; Jennifer Fine [Afrique du Sud] ; Janos Nikl [Hongrie] ; Krystyna Honczarenko [Pologne] ; Peter Dioszeghy [Hongrie] ; Dennis Hill [États-Unis] ; Tim Anderson [Nouvelle-Zélande] ; Vilho Myllyla [Finlande] ; Jan Kassubek [Allemagne] ; Malcolm Steiger [Royaume-Uni] ; Marco Zucconi [Italie] ; Eduardo Tolosa [Espagne] ; Werner Poewe [Autriche] ; Erwin Surmann [Allemagne] ; John Whitesides [États-Unis] ; Babak Boroojerdi [Allemagne] ; Kallol Ray Chaudhuri [Royaume-Uni] ; the RECOVER Study Group [Allemagne, Afrique du Sud, Pologne, Hongrie, États-Unis, Nouvelle-Zélande, Finlande, Royaume-Uni, Italie, Espagne, Autriche] | Rotigotine effects on early morning motor function and sleep in Parkinson's disease: A double‐blind, randomized, placebo‐controlled study (RECOVER) |
| 001416 |
D. Aarsland [Norvège] ; L. Marsh [États-Unis] ; A. Schrag [Royaume-Uni] | Reply: Neuropsychiatric symptoms in Parkinson's disease |
| 001421 |
Jan S Tochl [Royaume-Uni] ; Jir Klempír [République tchèque] ; Jan Roth [République tchèque] | Reply: CAG repeat size in the normal HTT allele and age of onset in Huntington's disease |
| 001431 |
Susanne A. Schneider [Allemagne] ; Kailash P. Bhatia [Royaume-Uni] | Recognition of faciobrachial dystonic seizures allowing early intervention with prevention of development of full‐blown limbic encephalitis |
| 001435 |
Carl Fernandes [Royaume-Uni] ; Prashanth Reddy [Royaume-Uni] ; Belinda Kessel [Royaume-Uni] | Rasagiline‐induced serotonin syndrome |
| 001437 |
Kurt A. Jellinger [Autriche] ; Johannes Attems [Royaume-Uni] | Rapidly progressing diffuse Lewy body disease |
| 001442 |
M. Duleeka W. Knipe [Royaume-Uni] ; Mirdhu M. Wickremaratchi [Royaume-Uni] ; Emma Wyatt-Haines [Royaume-Uni] ; Huw R. Morris [Royaume-Uni] ; Yoav Ben-Shlomo [Royaume-Uni] | Quality of life in young‐ compared with late‐onset Parkinson's disease |
| 001446 |
Sarah Kranick [États-Unis] ; Vindhya Ekanayake [États-Unis] ; Valeria Martinez [États-Unis] ; Rezvan Ameli [États-Unis] ; Mark Hallett [États-Unis] ; Valerie Voon [États-Unis, Royaume-Uni] | Psychopathology and psychogenic movement disorders |
| 001447 |
Anthony E. Lang [Canada] ; Valerie Voon [Royaume-Uni] | Psychogenic movement disorders: Past developments, current status, and future directions |
| 001448 |
Kathryn J. Peall [Royaume-Uni] ; Adrian J. Waite [Royaume-Uni] ; Derek J. Blake [Royaume-Uni] ; Mike J. Owen [Royaume-Uni] ; Huw R. Morris [Royaume-Uni] | Psychiatric disorders, myoclonus dystonia, and the epsilon‐sarcoglycan gene: A systematic review |
| 001452 |
Giovanni Fabbrini [Italie] ; Marcello Merello [Argentine] ; Andrew H. Evans [Australie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Janice Holton [Royaume-Uni] ; David R. Williams [Royaume-Uni, Australie] | Progressive parkinsonism, oculomotor abnormalities and autonomic dysfunction: Clinicopathological case |
| 001463 |
Francisco Cardoso [Brésil] ; John Hodges [Australie] ; Andrew H. Evans [Australie] ; Tamas Revesz [Royaume-Uni] ; David R. Williams [Royaume-Uni, Australie] | Postural instability, frontotemporal dementia, and ophthalmoplegia: Clinicopathological case |
| 001468 |
Gun-Marie Hariz [Suède] ; Patricia Limousin [Royaume-Uni] ; Stephen Tisch [Australie] ; Marjan Jahanshahi [Royaume-Uni] ; Anncristine Fjellman-Wiklund [Suède] | Patients' perceptions of life shift after deep brain stimulation for primary dystonia—A qualitative study |
| 001470 |
Phillip Fletcher [Royaume-Uni] ; Alison Leake [Royaume-Uni] ; Marie-Helene Marion [Royaume-Uni] | Patients with Parkinson's disease dementia stay in the hospital twice as long as those without dementia |
| 001474 |
Atbin Djamshidian [Royaume-Uni] ; Francisco Cardoso [Brésil] ; Donald Grosset [Royaume-Uni] ; Henrietta Bowden-Jones [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Pathological gambling in Parkinson's disease—a review of the literature |
| 001475 |
Jonathan Witherick [Royaume-Uni] ; J. Robin Highley [Royaume-Uni] ; Marios Hadjivassiliou [Royaume-Uni] | Pathological findings in a case of stiff person syndrome with anti‐GAD antibodies |
| 001476 |
Petra Katschnig [Royaume-Uni, Autriche] ; Petra Schwingenschuh [Royaume-Uni, Autriche] ; Umair J. Chaudhary [Royaume-Uni] ; Mark J. Edwards [Royaume-Uni] ; Louis Lemieux [Royaume-Uni] ; Matthew C. Walker [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Paroxysmal limb dyskinesia induced by weight: An unusual case of cortical reflex seizures |
| 001477 |
Kailash P. Bhatia [Royaume-Uni] | Paroxysmal dyskinesias |
| 001478 |
Mohan Madhusudanan [Inde] ; Kailash P. Bhatia [Royaume-Uni] ; Bettina Balint [Allemagne] | Paroxysmal craniocervical dyskinesia as manifestation of frontal lobe epilepsy |
| 001483 |
Daniel Weintraub [États-Unis] ; David J. Burn [Royaume-Uni] | Parkinson's disease: The quintessential neuropsychiatric disorder |
| 001487 |
Claudia Trenkwalder [Allemagne] ; Ralf Kohnen [États-Unis, Allemagne] ; Birgit Högl [Autriche] ; Vinod Metta [Royaume-Uni] ; Friederike Sixel-Döring [Allemagne] ; Birgit Frauscher [Autriche] ; Julia Hülsmann [États-Unis, Allemagne] ; Pablo Martinez-Martin [Espagne] ; Kallol Ray Chaudhuri [Royaume-Uni] | Parkinson's disease sleep scale—validation of the revised version PDSS‐2 |
| 001488 |
Michael J. Devine [Royaume-Uni] ; Katrina Gwinn [États-Unis] ; Andrew Singleton [États-Unis] ; John Hardy [Royaume-Uni] | Parkinson's disease and α‐synuclein expression |
| 001490 |
Tien K. Khoo [Royaume-Uni] | Parkin inactivation via PARIS (ZNF746) may lead to neurodegeneration in Parkinson's disease |
| 001494 |
Andrea E. Cavanna [Royaume-Uni] ; Fizzah Ali [Royaume-Uni] ; Hugh Rickards [Royaume-Uni] | Paligraphia and written jocularity in Gilles de la Tourette syndrome |
| 001498 |
Fabrizio Stocchi [Italie] ; Luigi Giorgi [Royaume-Uni] ; Brian Hunter [Royaume-Uni] ; Anthony Hv Schapira [Royaume-Uni] | PREPARED: Comparison of prolonged and immediate release ropinirole in advanced Parkinson's disease |
| 001503 |
Christopher D. Ward [Royaume-Uni] | On doing nothing: Descriptions of sleep, fatigue, and motivation in encephalitis lethargica |
| 001516 |
Dag Aarsland [Norvège] ; Graciela Muniz [Royaume-Uni] ; Fiona Matthews [Royaume-Uni] | Nonlinear decline of mini‐mental state examination in Parkinson's disease |
| 001521 |
Marjan Jahanshahi [Royaume-Uni] ; Virginie Czernecki [France] ; And Mateusz Zurowski [Canada] | Neuropsychological, neuropsychiatric, and quality of life issues in DBS for dystonia |
| 001530 |
Petra Schwingenschuh [Royaume-Uni, Autriche] ; Petra Katschnig [Royaume-Uni, Autriche] ; Stephan Seiler [Autriche] ; Tabish A. Saifee [Royaume-Uni] ; Maria Aguirregomozcorta [Royaume-Uni] ; Carla Cordivari [Royaume-Uni] ; Reinhold Schmidt [Autriche] ; John C. Rothwell [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Mark J. Edwards [Royaume-Uni] | Moving toward “laboratory‐supported” criteria for psychogenic tremor |
| 001532 |
Judith Van Gaalen [Pays-Bas] ; Paola Giunti [Royaume-Uni] ; Bart P. Van De Warrenburg [Pays-Bas] | Movement disorders in spinocerebellar ataxias |
| 001534 |
Miryam Carecchio [Royaume-Uni, Italie] ; Susanne A. Schneider [Royaume-Uni, Allemagne] ; Heidi Chan [Royaume-Uni] ; Robin Lachmann [Royaume-Uni] ; Philip J. Lee [Royaume-Uni] ; Elaine Murphy [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Movement disorders in adult surviving patients with maple syrup urine disease |
| 001546 |
Julius Huebl [Allemagne] ; Thomas Schoenecker [Allemagne] ; Sandy Siegert [Allemagne] ; Christof Brücke [Allemagne] ; Gerd-Helge Schneider [Allemagne] ; Andreas Kupsch [Allemagne] ; Kielan Yarrow [Royaume-Uni] ; Andrea A. Kühn [Allemagne] | Modulation of subthalamic alpha activity to emotional stimuli correlates with depressive symptoms in Parkinson's disease |
| 001549 |
Arpan R. Mehta [Canada, Royaume-Uni] ; Susan H. Fox [Canada] ; Mark Tarnopolsky [Canada] ; Grace Yoon [Canada] | Mitochondrial mimicry of multiple system atrophy of the cerebellar subtype |
| 001552 |
A. Jon Stoessl [Canada] ; David J. Brooks [Royaume-Uni] ; David Eidelberg [États-Unis] | Milestones in neuroimaging |
| 001555 |
Daniela Berg [Allemagne] ; Jonathan D. Steinberger [États-Unis] ; C. Warren Olanow [États-Unis] ; Thomas P. Naidich [États-Unis] ; Tarek A. Yousry [Royaume-Uni] | Milestones in magnetic resonance imaging and transcranial sonography of movement disorders |
| 001558 |
Mark Hallett [États-Unis, Royaume-Uni] ; John Rothwell [Royaume-Uni] | Milestones in clinical neurophysiology |
| 001561 |
Glenda Halliday [Australie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Matthew Stern [États-Unis] | Milestones in Parkinson's disease—Clinical and pathologic features |
| 001563 |
Thomas Gasser [Allemagne] ; John Hardy [Royaume-Uni] ; Yoshikuni Mizuno [Japon] | Milestones in PD genetics |
| 001565 |
Rebecca Stowe [Royaume-Uni] ; Natalie Ives [Royaume-Uni] ; Carl E. Clarke [Royaume-Uni] ; Kelly Handley [Royaume-Uni] ; Alexandra Furmston [Royaume-Uni] ; Katherine Deane [Royaume-Uni] ; J. J. Van Hilten [Pays-Bas] ; Keith Wheatley [Royaume-Uni] ; Richard Gray [Royaume-Uni] | Meta‐analysis of the comparative efficacy and safety of adjuvant treatment to levodopa in later Parkinson's disease |
| 001575 |
Alison J. Yarnall [Royaume-Uni] | Low CSF α‐synuclein levels may facilitate the prediction of synucleinopathies |
| 001577 |
Mark J. Edwards [Royaume-Uni] ; John C. Rothwell [Royaume-Uni] | Losing focus: How paying attention can be bad for movement |
| 001584 |
Michele Tagliati [États-Unis] ; Paul Krack [France] ; Jens Volkmann [Allemagne] ; Tipu Aziz [Royaume-Uni] ; Joachim K. Krauss [Allemagne] ; Andreas Kupsch [Allemagne] ; And Marie Vidailhet [France] | Long‐Term management of DBS in dystonia: Response to stimulation, adverse events, battery changes, and special considerations |
| 001587 |
Mark J. Edwards [Royaume-Uni] ; Araceli Alonso-Canovas [Royaume-Uni] ; Arnette Schrag [Royaume-Uni] ; Bastiaan R. Bloem [Pays-Bas] ; Philip D. Thompson [Australie] ; Kailash Bhatia [Royaume-Uni] | Limb amputations in fixed dystonia: A form of body integrity identity disorder? |
| 001594 |
Petra Katschnig [Royaume-Uni, Autriche] ; João Massano [Royaume-Uni, Portugal] ; Mark J. Edwards [Royaume-Uni] ; Petra Schwingenschuh [Royaume-Uni, Autriche] ; Carla Cordivari [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Late‐onset asymmetric myoclonus: An emerging syndrome |
| 001607 |
Jerry L. Vitek [États-Unis] ; Mahlon R. Delong [États-Unis] ; Philip A. Starr [États-Unis] ; Marwan I. Hariz [Royaume-Uni] ; Leo Verhagen Metman [États-Unis] | Intraoperative neurophysiology in DBS for dystonia |
| 001625 |
Mark J. Edwards [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Carla Cordivari [Royaume-Uni] | Immediate response to botulinum toxin injections in patients with fixed dystonia |
| 001631 |
Jon Stone [Royaume-Uni] ; Mark J. Edwards [Royaume-Uni] | How “psychogenic” are psychogenic movement disorders? |
| 001633 |
Susanne A. Schneider [Allemagne, Royaume-Uni] ; Alfredo Ramirez [Allemagne] ; Kaveh Shafiee [Iran] ; Frank J. Kaiser [Allemagne] ; Alev Erogullari [Allemagne] ; Norbert Brüggemann [Allemagne] ; Susen Winkler [Allemagne] ; Ideh Bahman [Iran] ; Alma Osmanovic [Allemagne] ; Mohammad A. Shafa [Iran] ; Kailish P. Bhatia [Royaume-Uni] ; Hossein Najmabadi [Iran] ; Christine Klein [Allemagne] ; Katja Lohmann [Allemagne] | Homozygous THAP1 mutations as cause of early‐onset generalized dystonia |
| 001643 |
Elena Moro [Canada] ; Alberto Albanese [Italie] ; Joachim K. Krauss [Allemagne] ; Leo Verhagen Metman [États-Unis] ; Marie Vidailhet [France] ; Marwan I. Hariz [Royaume-Uni] | Guest Editors' introduction |
| 001645 |
Marios Politis [Royaume-Uni] ; Wolfgang H. Oertel [Allemagne] ; Kit Wu [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Oliver Pogarell [Allemagne] ; David J. Brooks [Royaume-Uni] ; Anders Bjorklund [Suède] ; Olle Lindvall [Suède] ; Paola Piccini [Royaume-Uni] | Graft‐induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio |
| 001651 |
Omar S. Mian [Royaume-Uni] ; Susanne A. Schneider [Royaume-Uni, Allemagne] ; Petra Schwingenschuh [Royaume-Uni, Autriche] ; Kailash P. Bhatia [Royaume-Uni] ; Brian L. Day [Royaume-Uni] | Gait in SWEDDs patients: Comparison with Parkinson's disease patients and healthy controls |
| 001653 |
Serge Pinto [France] ; Laura Mancini [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni] ; John S. Thornton [Royaume-Uni] ; Elina Tripoliti [Royaume-Uni] ; Tarek A. Yousry [Royaume-Uni] ; Patricia Limousin [Royaume-Uni] | Functional magnetic resonance imaging exploration of combined hand and speech movements in Parkinson's disease |
| 001654 |
Tessel Boertien [Royaume-Uni, Pays-Bas] ; Ludvic Zrinzo [Royaume-Uni] ; Joshua Kahan [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni] ; Marwan Hariz [Royaume-Uni] ; Laura Mancini [Royaume-Uni] ; Patricia Limousin [Royaume-Uni] ; Thomas Foltynie [Royaume-Uni] | Functional imaging of subthalamic nucleus deep brain stimulation in Parkinson's disease |
| 001657 |
Nin Bajaj [Royaume-Uni] ; Derek Soon [Royaume-Uni] ; Niall Quinn [Royaume-Uni] | Fragile X–associated tremor ataxia syndrome sine tremor |
| 001667 |
Peter Jenner [Royaume-Uni] ; J. William Langston [États-Unis] | Explaining ADAGIO: A critical review of the biological basis for the clinical effects of rasagiline |
| 001669 |
Aleksandra Kudlicka [Royaume-Uni] ; Linda Clare [Royaume-Uni] ; John V. Hindle [Royaume-Uni] | Executive functions in Parkinson's disease: Systematic review and meta‐analysis |
| 001671 |
Anthony H. Schapira [Royaume-Uni] ; Peter Jenner [Royaume-Uni] | Etiology and pathogenesis of Parkinson's disease |
| 001679 |
Fernando Alarc N [Équateur] ; Gonzalo Due As [Équateur] ; Andrew Lees (neurologue) [Royaume-Uni] | Encephalitis lethargica due to Epstein–Barr virus infection |
| 001683 |
David J. Burn [Royaume-Uni] | Editor's Introduction to Hot Topics in Movement Disorders: Literature highlights |
| 001686 |
Andreas Kupsch [Allemagne] ; Michele Tagliati [États-Unis] ; Marie Vidailhet [France] ; Tipu Aziz [Royaume-Uni] ; Paul Krack [France] ; Elena Moro [Canada] ; Joachim K. Krauss [Allemagne] | Early postoperative management of DBS in dystonia: Programming, response to stimulation, adverse events, medication changes, evaluations, and troubleshooting |
| 001691 |
Tahir Nazir [Royaume-Uni] ; Alexander M. Thomson [Royaume-Uni] | Domestic violence and mistreatment in patients with parkinsonism: Case reports, mechanisms, and discussion |
| 001709 |
John-Stuart Brittain [Royaume-Uni] ; Ned Jenkinson [Royaume-Uni] ; Peter Holland [Royaume-Uni] ; Raed A. Joundi [Royaume-Uni] ; Alex L. Green [Royaume-Uni] ; Tipu Z. Aziz [Royaume-Uni] | Development of Holmes' tremor following hemi‐cerebellar infarction |
| 001712 |
Tanja Schmitz-Hübsch [Allemagne] ; Mathieu Coudert [France] ; Sophie Tezenas Du Montcel [France] ; Paola Giunti [Royaume-Uni] ; Robyn Labrum [Royaume-Uni] ; Alexandra Dürr [France] ; Pascale Ribai [France] ; Perrine Charles [France] ; Christoph Linnemann [Allemagne] ; Ludger Schöls [Allemagne] ; Maryla Rakowicz [Pologne] ; Rafal Rola [Pologne] ; Elszbieta Zdzienicka [Pologne] ; Roberto Fancellu [Italie] ; Caterina Mariotti [Italie] ; Lazlo Baliko [Hongrie] ; Bela Melegh [Hongrie] ; Alessandro Filla [Italie] ; Elena Salvatore [Italie] ; Bart P. C. Van De Warrenburg [Pays-Bas] ; Sandra Szymanski [Allemagne] ; Jon Infante [Espagne] ; Dagmar Timmann [Allemagne] ; Sylvia Boesch [Autriche] ; Chantal Depondt [Belgique] ; Jun-Suk Kang [Allemagne] ; Jörg B. Schulz [Allemagne] ; Thomas Klopstock [Allemagne] ; Nicole Lossnitzer [Allemagne] ; Bernd Löwe [Allemagne] ; Caroline Frick [Allemagne] ; Daniela Rottl Nder [Allemagne] ; Thomas E. Schlaepfer [Allemagne, États-Unis] ; Thomas Klockgether [Allemagne] | Depression comorbidity in spinocerebellar ataxia |
| 001717 |
Raul Martínez-Fernández [Royaume-Uni, Espagne] ; Ludvic Zrinzo [Royaume-Uni] ; Iciar Aviles-Olmos [Royaume-Uni] ; Marwan Hariz [Royaume-Uni, Suède] ; Irene Martinez-Torres [Royaume-Uni, Espagne] ; Eileen Joyce [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni] ; Patricia Limousin [Royaume-Uni] ; Thomas Foltynie [Royaume-Uni] | Deep brain stimulation for Gilles de la Tourette syndrome: A case series targeting subregions of the globus pallidus internus |
| 001718 |
Diane Ruge [Royaume-Uni] ; Stephen Tisch [Royaume-Uni, Australie] ; Marwan I. Hariz [Royaume-Uni] ; Ludvic Zrinzo [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni] ; Patricia Limousin [Royaume-Uni] ; John C. Rothwell [Royaume-Uni] | Deep brain stimulation effects in dystonia: Time course of electrophysiological changes in early treatment |
| 001720 |
Helen Ling [Royaume-Uni] ; Mark Braschinsky [Estonie] ; Pille Taba [Estonie] ; Siiri-Merike Lüüs [Estonie] ; Karen Doherty [Royaume-Uni] ; Anna Hotter [Autriche] ; Werner Poewe [Autriche] ; Andrew Lees (neurologue) [Royaume-Uni] | Decades of delayed diagnosis in 4 levodopa‐responsive young‐onset monogenetic parkinsonism patients |
| 001742 |
David J. Burn [Royaume-Uni] | Commentary on the postencephalitic cases of Dr. Kinnier Wilson |
| 001744 |
Paolo Barone [Italie] ; Dag Aarsland [Norvège] ; David Burn [Royaume-Uni] ; Murat Emre [Turquie] ; Jaime Kulisevsky [Espagne] ; Daniel Weintraub [États-Unis] | Cognitive impairment in nondemented Parkinson's disease |
| 001746 |
Stephanie M. Van Rooden [Pays-Bas] ; Fabrice Colas [Pays-Bas] ; Pablo Martínez-Martín [Espagne] ; Martine Visser [Pays-Bas] ; Dagmar Verbaan [Pays-Bas] ; Johan Marinus [Pays-Bas] ; Ray K. Chaudhuri [Royaume-Uni] ; Joost N. Kok [Pays-Bas] ; Jacobus J. Van Hilten [Pays-Bas] | Clinical subtypes of Parkinson's disease |
| 001748 |
Katrina Gwinn [États-Unis] ; Michael J. Devine [Royaume-Uni] ; Lee-Way Jin [États-Unis] ; Janel Johnson [États-Unis] ; Thomas Bird [États-Unis] ; Manfred Muenter [États-Unis] ; Cheryl Waters [États-Unis] ; Charles H. Adler [États-Unis] ; Richard Caselli [États-Unis] ; Henry Houlden [Royaume-Uni] ; Grisel Lopez [États-Unis] ; Amanda Singleton [États-Unis] ; John Hardy [Royaume-Uni] ; Andrew Singleton [États-Unis] | Clinical features, with video documentation, of the original familial lewy body parkinsonism caused by α‐synuclein triplication (Iowa kindred) |
| 001750 |
Clare M. Eddy [Royaume-Uni] ; Andrea E. Cavanna [Royaume-Uni] ; Mariangela Gulisano [Italie] ; Antonella Agodi [Italie] ; Martina Barchitta [Italie] ; Paola Calì [Italie] ; Mary M. Robertson [Royaume-Uni] ; Renata Rizzo [Italie] | Clinical correlates of quality of life in Tourette syndrome |
| 001756 |
Isabel Pareés [Royaume-Uni] ; Maja Kojovic [Royaume-Uni] ; L. V. Prasad Korlipara [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Cervical dystonia associated with facioscapulohumeral dystrophy: Expanding the clinical spectrum? |
| 001766 |
Nin P. S. Bajaj [Royaume-Uni] ; Maria Knöbel [Royaume-Uni] ; Vamsi Gontu [Royaume-Uni] ; Peter G. Bain [Royaume-Uni] | Can spiral analysis predict the FP‐CIT SPECT scan result in tremulous patients? |
| 001782 |
Maja Kojovic [Royaume-Uni, Slovénie] ; Antonio Caronni [Royaume-Uni, Italie] ; Matteo Bologna [Royaume-Uni, Italie] ; John C. Rothwell [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Mark J. Edwards [Royaume-Uni] | Botulinum toxin injections reduce associative plasticity in patients with primary dystonia |
| 001798 |
Daniel Van Poppelen [Royaume-Uni, Pays-Bas] ; Tabish A. Saifee [Royaume-Uni] ; Petra Schwingenschuh [Royaume-Uni, Autriche] ; Petra Katschnig [Royaume-Uni, Autriche] ; Kailash P. Bhatia [Royaume-Uni] ; Marina A. Tijssen [Pays-Bas] ; Mark J. Edwards [Royaume-Uni] | Attention to self in psychogenic tremor |
| 001805 |
Jeban Ganesalingam [Royaume-Uni] ; Peter Bain [Royaume-Uni] | Apomorphine‐induced necrotic ulcers |
| 001808 |
Joanna M. Flowers [Royaume-Uni] ; Lucy A. Hicklin [Royaume-Uni] ; Marie-Helene Marion [Royaume-Uni] | Anterior and posterior sagittal shift in cervical dystonia: A clinical and electromyographic study, including a new EMG approach of the longus colli muscle |
| 001811 |
Anthony L. Vaccarino [Canada] ; Karen Anderson [États-Unis] ; Beth Borowsky [États-Unis] ; Kevin Duff [États-Unis] ; Joseph Giuliano [États-Unis] ; Mark Guttman [Canada] ; Aileen K. Ho [Royaume-Uni] ; Michael Orth [Allemagne] ; Jane S. Paulsen [États-Unis] ; Terrence Sills [Canada] ; Daniel P. Van Kammen [États-Unis] ; Kenneth R. Evans [Canada] | An item response analysis of the motor and behavioral subscales of the unified Huntington's disease rating scale in huntington disease gene expansion carriers |
| 001812 |
Helen Ling [Royaume-Uni] ; James M. Polke [Royaume-Uni] ; Mary G. Sweeney [Royaume-Uni] ; Andrea Haworth [Royaume-Uni] ; Catherine A. Sandford [Royaume-Uni] ; Simon J. R. Heales [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] ; Mary B. Davis [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | An intragenic duplication in guanosine triphosphate cyclohydrolase‐1 gene in a dopa‐responsive dystonia family |
| 001814 |
Dimitri Anastasopoulos [Royaume-Uni, Grèce] ; Nafsica Ziavra [Royaume-Uni] ; Eugenia Savvidou [Grèce] ; Peter Bain [Royaume-Uni] ; Adolfo M. Bronstein [Royaume-Uni] | Altered eye‐to‐foot coordination in standing parkinsonian patients during large gaze and whole‐body reorientations |
| 001825 |
Maria Stamelou [Royaume-Uni, Allemagne] ; Maja Kojovic [Royaume-Uni] ; Mark J. Edwards [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Ability to cycle despite severe freezing of gait in atypical parkinsonism in Fahr's syndrome |
| 001826 |
Valerie Voon [Royaume-Uni] ; Christina Brezing [États-Unis] ; Cecile Gallea [États-Unis] ; Mark Hallett [États-Unis] | Aberrant supplementary motor complex and limbic activity during motor preparation in motor conversion disorder |
| 001828 |
Daniela Berg [Allemagne] ; Jana Godau [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Karla Eggert [Allemagne] ; Iiona Csoti [Allemagne] ; Alexander Storch [Allemagne] ; Heiko Huber [Allemagne] ; Monica Morelli-Canelo [Allemagne] ; Maria Stamelou [Allemagne] ; Vincent Ries [Allemagne] ; Martin Wolz [Allemagne] ; Christine Schneider [Allemagne] ; Thérèse Di Paolo [Canada] ; Fabrizio Gasparini [Suisse] ; Sam Hariry [Suisse] ; Marc Vandemeulebroecke [Suisse] ; Walid Abi-Saab [Suisse] ; Katy Cooke [Royaume-Uni] ; Donald Johns [Suisse] ; Baltazar Gomez-Mancilla [Suisse] | AFQ056 treatment of levodopa‐induced dyskinesias: Results of 2 randomized controlled trials |
| 001843 |
E. H. Reynolds [Royaume-Uni] ; D. G. Healy [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | A film of patients with movement disorders made in Queen Square, London in the Mid‐1920s by Samuel Alexander Kinnier Wilson |
| 001853 |
Gerald Stern [Royaume-Uni] | Why Catechol? |
| 001854 |
Jose Luis Lopez-Sendon [Espagne] ; Ana Royuela [Espagne] ; Patricia Trigo [Espagne] ; Michael Orth [Allemagne] ; Herwig Lange [Allemagne] ; Ralf Reilmann [Allemagne] ; Jennifer Keylock [Royaume-Uni] ; Hugh Rickards [Royaume-Uni] ; Silvia Piacentini [Italie] ; Ferdinando Squitieri [Italie] ; Bernhard Landwehrmeyer [Allemagne] ; Marie-Noelle Witjes-Ane [Pays-Bas] ; Caroline K. Jurgens [Pays-Bas] ; Raymund A. C. Roos [Pays-Bas] ; Victor Abraira [Espagne] ; Justo G. De Yebenes [Espagne] | What is the Impact of Education on Huntington's Disease? |
| 001856 |
Mayela Rodriguez-Violante [Mexique] ; Andrew Lees (neurologue) [Royaume-Uni] ; Amin Cervantes-Arriaga [Mexique] ; Teresa Corona [Mexique] ; Laura Silveira-Moriyama [Royaume-Uni] | Use of Smell Test Identification in Parkinson's Disease in Mexico: A Matched Case-Control Study |
| 001859 |
Ji Klempir [République tchèque] ; Jana Zidovska [République tchèque] ; Jan Stochl [Royaume-Uni] ; Vera Kebrdlova [République tchèque] ; Tereza Uhrova [République tchèque] ; Jan Roth [République tchèque] | The Number of CAG Repeats Within the Normal Allele Does Not Influence the Age of Onset in Huntington's Disease |
| 001861 |
Pablo Martinez-Martin [Espagne] ; Carmen Rodriguez-Blazquez [Espagne] ; Monica M. Kurtis [Espagne] ; K. Ray Chaudhuri [Royaume-Uni] | The Impact of Non-Motor Symptoms on Health-Related Quality of Life of Patients with Parkinson's Disease |
| 001870 |
Sarah Kranic [États-Unis] ; Vindhya Ekanayake [États-Unis] ; Valeria Martinez [États-Unis] ; Rezvan Ameli [États-Unis] ; Mark Hallett [États-Unis] ; Valerie Voon [États-Unis, Royaume-Uni] | Psychopathology and Psychogenic Movement Disorders |
| 001872 |
Kailash P. Bhatia [Royaume-Uni] | Paroxysmal Dyskinesias |
| 001887 |
Fernando Alarcon [Équateur] ; Gonzalo Duenas [Équateur] ; Andrew Lees (neurologue) [Royaume-Uni] | Encephalitis Lethargica Due to Epstein-Barr Virus Infection |
| 001889 |
Tanja Schmitz-Hübsch [Allemagne] ; Mathieu Coudert [France] ; Sophie Tezenas Du Montcel [France] ; Paola Giunti [Royaume-Uni] ; Robyn Labrum [Royaume-Uni] ; Alexandra Durr [France] ; Pascale Ribai [France] ; Perrine Charles [France] ; Christoph Linnemann [Allemagne] ; Ludger Schöls [Allemagne] ; Maryla Rakowicz [Pologne] ; Rafal Rola [Pologne] ; Elszbieta Zdzienicka [Pologne] ; Roberto Fancellu [Italie] ; Caterina Mariotti [Italie] ; Lazlo Baliko [Hongrie] ; Bela Melegh [Hongrie] ; Alessandro Filla [Italie] ; Elena Salvatore [Italie] ; Bart P. C. Van De Warrenburg [Pays-Bas] ; Sandra Szymanski [Allemagne] ; Jon Infante [Espagne] ; Dagmar Timmann [Allemagne] ; Sylvia Boesch [Autriche] ; Chantal Depondt [Belgique] ; Jun-Suk Kang [Allemagne] ; Jörg B. Schulz [Allemagne] ; Thomas Klopstock [Allemagne] ; Nicole Lossnitzer [Allemagne] ; Bernd Löwe ; Caroline Frick ; Daniela Rottl Nder ; Thomas E. Schlaepfer ; Thomas Klockgether [Allemagne] | Depression Comorbidity in Spinocerebellar Ataxia |
| 001890 |
Raul Martinez-Fernandez [Royaume-Uni, Espagne] ; Ludvic Zrinzo [Royaume-Uni] ; Iciar Aviles-Olmos [Royaume-Uni] ; Marwan Hariz [Royaume-Uni, Suède] ; Irene Martinez-Torres [Royaume-Uni, Espagne] ; Eileen Joyce [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni] ; Patricia Limousin [Royaume-Uni] ; Thomas Foltynie [Royaume-Uni] | Deep Brain Stimulation for Gilles de la Tourette Syndrome: A Case Series Targeting Subregions of the Globus Pallidus Internus |
| 001905 |
Hugh Rickards [Royaume-Uni] ; Ian Woolf [France] ; Andrea Eugenio Cavanna [Royaume-Uni] | “Trousseau's disease:” A description of the gilles de la tourette syndrome 12 years before 1885 |
| 001907 |
Maja Kojovic [Royaume-Uni] ; Mikko Kuoppam Ki [Finlande] ; Niall Quinn [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | “Progressive delayed‐onset postanoxic dystonia” diagnosed with PANK2 mutations 26 years after onset—An update |
| 001911 |
David R. Williams [Australie, Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | What features improve the accuracy of the clinical diagnosis of progressive supranuclear palsy‐parkinsonism (PSP‐P)? |
| 001918 |
Jennifer De Souza [Royaume-Uni] ; Lisa A. Jones [Royaume-Uni] ; Hugh Rickards [Royaume-Uni] | Validation of self‐report depression rating scales in Huntington's disease |
| 001926 |
Artemis D. Gika [Royaume-Uni] ; Elaine Hughes [Royaume-Uni] ; Sushma Goyal [Royaume-Uni] ; Matthew Sparkes [Royaume-Uni] ; Jean-Pierre Lin [Royaume-Uni] | Trihexyphenidyl for acute life‐threatening episodes due to a dystonic movement disorder in Rett syndrome |
| 001929 |
Zdenka Uhríková [République tchèque, Royaume-Uni] ; Evžen Růži Ka [République tchèque] ; Václav Hlavá [République tchèque] ; Chris D. Nugent [Royaume-Uni] | TremAn: A tool for measuring tremor frequency from video sequences |
| 001935 |
Benedikt Bader [Allemagne] ; Ruth H. Walker [États-Unis] ; Mathias Vogel [Allemagne] ; Mario Prosiegel [Allemagne] ; Jacqueline Mcintosh [Royaume-Uni] ; Adrian Danek [Allemagne] | Tongue protrusion and feeding dystonia: A hallmark of chorea‐acanthocytosis |
| 001943 |
Andrea Eugenio Cavanna [Royaume-Uni] ; Maria Grazia Pattumelli [Italie] ; Tiziana Quarto [Royaume-Uni, Italie] ; Fizzah Ali [Royaume-Uni] ; Hugh Rickards [Royaume-Uni] | The “imprisoned illness:” Motor tic disorder in Rainer Maria Rilke's Notebooks of Malte Laurids Brigge |
| 001945 |
Catherine Dotchin [Royaume-Uni] ; Oliva Msuya ; Richard Walker [Royaume-Uni] | The use of smell identification tests in the diagnosis of Parkinson's disease in Brazil |
| 001954 |
Sebastein F. M. Chastin [Royaume-Uni] ; Katherine Baker [Royaume-Uni] ; Diana Jones [Royaume-Uni] ; David Burn [Royaume-Uni] ; Malcolm H. Granat [Royaume-Uni] ; Lynn Rochester [Royaume-Uni] | The pattern of habitual sedentary behavior is different in advanced Parkinson's disease |
| 001956 |
K. Ray Chaudhuri [Royaume-Uni] ; Cristina Prieto-Jurcynska [Espagne] ; Yogini Naidu [Royaume-Uni] ; Tanya Mitra [Royaume-Uni] ; Belen Frades-Payo [Espagne] ; Susanne Tluk [Royaume-Uni] ; Anne Ruessmann [Allemagne] ; Per Odin [Allemagne] ; Graeme Macphee [Royaume-Uni] ; Fabrizio Stocchi [Italie] ; William Ondo [États-Unis] ; Kapil Sethi [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Juan Carlos Martinez Castrillo [Espagne] ; Pablo Martinez-Martin [Espagne] | The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: An international study using the nonmotor symptoms questionnaire |
| 001964 |
Lynn Rochester [Royaume-Uni] ; Danny Rafferty [Royaume-Uni] ; Catherine Dotchin [Royaume-Uni] ; Oliva Msuya ; Victor Minde ; R. W. Walker [Royaume-Uni] | The effect of cueing therapy on single and dual‐task gait in a drug naïve population of people with Parkinson's disease in northern Tanzania |
| 001981 |
Claire L. Tomlinson [Royaume-Uni] ; Rebecca Stowe [Royaume-Uni] ; Smitaa Patel [Royaume-Uni] ; Caroline Rick [Royaume-Uni] ; Richard Gray [Royaume-Uni] ; Carl E. Clarke [Royaume-Uni] | Systematic review of levodopa dose equivalency reporting in Parkinson's disease |
| 001A02 |
Elizabeth R. Williams [Royaume-Uni] ; Richard E. Jones [Royaume-Uni] ; Stuart N. Baker [Royaume-Uni] ; Mark R. Baker [Royaume-Uni] | Slow orthostatic tremor can persist when walking backward |
| 001A10 |
Joyce Van De Leemput [États-Unis, Royaume-Uni] ; Fabienne Wavrant-De Vrièze [États-Unis] ; Ian Rafferty [États-Unis] ; Jose M. Bras [États-Unis] ; Paola Giunti [Royaume-Uni] ; Elizabeth Mc Fisher [Royaume-Uni] ; John A. Hardy [Royaume-Uni] ; Andrew B. Singleton [États-Unis] ; Henry Houlden [Royaume-Uni] | Sequencing analysis of the ITPR1 gene in a pure autosomal dominant spinocerebellar ataxia series |
| 001A14 |
Tanja Schmitz-Hübsch [Allemagne] ; Mathieu Coudert [France] ; Paola Giunti [Royaume-Uni] ; Christoph Globas [Allemagne] ; Laszlo Baliko [Hongrie] ; Roberto Fancellu [Italie] ; Caterina Mariotti [Italie] ; Alessandro Filla [Italie] ; Maryla Rakowicz [Pologne] ; Perrine Charles [France] ; Pascale Ribai [France] ; Sandra Szymanski [Allemagne] ; Jon Infante [Espagne] ; Bart P. C. Van De Warrenburg [Pays-Bas] ; Alexandra Dürr [France] ; Dagmar Timmann [Allemagne] ; Sylvia Boesch [Autriche] ; Rafal Rola [Pologne] ; Chantal Depondt [Belgique] ; Ludger Schöls [Allemagne] ; Elszbieta Zdzienicka [Pologne] ; Jun-Suk Kang [Allemagne] ; Susanne Ratzka [Allemagne] ; Berry Kremer [Pays-Bas] ; Jörg B. Schulz [Allemagne] ; Thomas Klopstock [Allemagne] ; Bela Melegh [Hongrie] ; Sophie Tezenas Du Montcel [France] ; Thomas Klockgether [Allemagne] | Self‐rated health status in spinocerebellar ataxia—Results from a European multicenter study |
| 001A21 |
Karla Eggert [Allemagne] ; David Squillacote [États-Unis] ; Paolo Barone [Italie] ; Richard Dodel [Allemagne] ; Regina Katzenschlager [Autriche] ; Murat Emre [Turquie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Olivier Rascol [France] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Claudia Trenkwalder [Allemagne] ; Marco Onofrj [Italie] ; Fabrizio Stocchi [Italie] ; Giuseppe Nappi [Italie] ; Vladimir Kostic [Serbie] ; Jagoda Potic [Serbie] ; Evzen Ruzicka [République tchèque] ; Wolfgang Oertel [Allemagne] | Safety and efficacy of perampanel in advanced Parkinson's disease: A randomized, placebo‐controlled study |
| 001A27 |
Atbin Djamshidian [Royaume-Uni, Autriche] ; Ashwani Jha [Royaume-Uni] ; Sean S. O'Sullivan [Royaume-Uni] ; Laura Silveira-Moriyama [Royaume-Uni] ; Clare Jacobson [Royaume-Uni] ; Peter Brown [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Bruno B. Averbeck [Royaume-Uni] | Risk and learning in impulsive and nonimpulsive patients with Parkinson's disease |
| 001A33 |
Ying-Zu Huang [Taïwan] ; John C. Rothwell [Royaume-Uni] ; Chin-Song Lu [Taïwan] ; Jiunjie Wang [Taïwan] ; Rou-Shayn Chen [Taïwan] | Restoration of motor inhibition through an abnormal premotor‐motor connection in dystonia |
| 001A40 |
Alisdair Mcneill [Royaume-Uni] | Response to: ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation |
| 001A42 |
Hu Liang Low [Royaume-Uni] | Reply: The ‘plait sign’ of neurostimulator torsion |
| 001A61 |
Sean S. O'Sullivan [Royaume-Uni] ; Andrew H. Evans [Australie] ; Niall P. Quinn [Royaume-Uni] ; Andrew D. Lawrence [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Reckless generosity in Parkinson's disease |
| 001A63 |
Anthony H. V. Schapira [Royaume-Uni] ; Stefan Albrecht [Allemagne] ; Paolo Barone [Italie] ; Cynthia L. Comella [États-Unis] ; Michael P. Mcdermott [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Kenneth Marek [États-Unis] | Rationale for delayed‐start study of pramipexole in Parkinson's disease: The PROUD study |
| 001A64 |
Edward J. Wild [Royaume-Uni] ; Susie M. D. Henley [Royaume-Uni] ; Nicola Z. Hobbs [Royaume-Uni] ; Chris Frost [Royaume-Uni] ; David G. Macmanus [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] ; Nick C. Fox [Royaume-Uni] ; Sarah J. Tabrizi [Royaume-Uni] | Rate and acceleration of whole‐brain atrophy in premanifest and early Huntington's disease |
| 001A67 |
Robert A. Hauser [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Olivier Rascol [France] ; Paolo Barone [Italie] ; Yoshikuni Mizuno [Japon] ; Laurence Salin [France] ; Monika Haaksma [Autriche] ; Nolwenn Juhel [France] ; Werner Poewe [Autriche] | Randomized, double‐blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease |
| 001A68 |
Catherine Dotchin [Royaume-Uni] ; Richard Walker [Royaume-Uni] | Racial differences in the diagnosis of Parkinson's disease—Not just a North American issue |
| 001A79 |
Valerie Voon [Royaume-Uni, États-Unis] ; Tracy R. Butler [États-Unis] ; Vindhya Ekanayake [États-Unis] ; Cecile Gallea [États-Unis] ; Rezvan Ameli [États-Unis] ; Dennis L. Murphy [États-Unis] ; Mark Hallett [États-Unis] | Psychiatric symptoms associated with focal hand dystonia |
| 001A84 |
Jonathan D. Rohrer [Royaume-Uni] ; Dominic Paviour [Royaume-Uni] ; Adolfo M. Bronstein [Royaume-Uni] ; Sean S. O'Sullivan [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Jason D. Warren [Royaume-Uni] | Progressive supranuclear palsy syndrome presenting as progressive nonfluent aphasia: A neuropsychological and neuroimaging analysis |
| 001A99 |
Kayhan A. Tayarani-Binazir [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; C. Warren Olanow [États-Unis] ; Peter Jenner [Royaume-Uni] | Pramipexole combined with levodopa improves motor function but reduces dyskinesia in MPTP‐treated common marmosets |
| 001B07 |
Victoria Newsway [Royaume-Uni] ; Mark Fish [Royaume-Uni] ; Jonathan D. Rohrer [Royaume-Uni] ; Elisa Majounie [Royaume-Uni] ; Nigel Williams [Royaume-Uni] ; Melissa Hack [Royaume-Uni] ; Jason D. Warren [Royaume-Uni] ; Huw R. Morris [Royaume-Uni] | Perry syndrome due to the DCTN1 G71R mutation: A distinctive levodopa responsive disorder with behavioral syndrome, vertical gaze palsy, and respiratory failure |
| 001B10 |
Andrea E. Cavanna [Royaume-Uni] ; Fizzah Ali [Royaume-Uni] ; James F. Leckman [États-Unis] ; Mary M. Robertson [Royaume-Uni] | Pathological laughter in Gilles de la Tourette syndrome: An unusual phonic tic |
| 001B17 |
Marios Politis [Royaume-Uni] ; Kit Wu [Royaume-Uni] ; Sophie Molloy [Royaume-Uni] ; Peter G. Bain [Royaume-Uni] ; K. Ray Chaudhuri [Royaume-Uni] ; Paola Piccini [Royaume-Uni] | Parkinson's disease symptoms: The patient's perspective |
| 001B22 |
Louisa Clare Johnston [Royaume-Uni] ; Michael John Jackson [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; Andrew Christopher Mccreary [Pays-Bas] ; Peter Jenner [Royaume-Uni] | Pardoprunox reverses motor deficits but induces only mild dyskinesia in MPTP‐treated common marmosets |
| 001B39 |
Naroa Ibarretxe-Bilbao [Espagne] ; Carme Junque [Espagne] ; Maria-Jose Marti [Espagne] ; Francesc Valldeoriola [Espagne] ; Pere Vendrell [Espagne] ; Nuria Bargallo [Espagne] ; Mojtaba Zarei [Royaume-Uni] ; Eduardo Tolosa [Espagne] | Olfactory impairment in Parkinson's disease and white matter abnormalities in central olfactory areas: A voxel‐based diffusion tensor imaging study |
| 001B40 |
Laura Silveira-Moriyama [Royaume-Uni] ; Renato Pupi Munhoz [Brésil] ; Margarete De J. Carvalho [Brésil] ; Salmo Raskin [Brésil] ; Ekaterina Rogaeva [Canada] ; Patricia De C. Aguiar [Brésil] ; Rodrigo A. Bressan [Brésil] ; Andre C. Felicio [Brésil] ; Orlando G. P. Barsottini [Brésil] ; Luiz Augusto F. Andrade [Brésil] ; Hsin F. Chien [Brésil] ; Vincenzo Bonifati [Pays-Bas] ; Egberto R. Barbosa [Brésil] ; Helio A. Teive [Brésil] ; Andrew Lees (neurologue) [Royaume-Uni] | Olfactory heterogeneity in LRRK2 related Parkinsonism |
| 001B48 |
Georg K Gi [Royaume-Uni] ; Christine Klein [Allemagne] ; Nicholas W. Wood [Royaume-Uni] ; Susanne A. Schneider [Royaume-Uni] ; Peter P. Pramstaller [Allemagne, Italie] ; Vera Tadic [Allemagne] ; Niall P. Quinn [Royaume-Uni] ; Bart P. C. Van De Warrenburg [Royaume-Uni, Pays-Bas] ; Kailash P. Bhatia [Royaume-Uni] | Nonmotor symptoms in Parkin gene‐related parkinsonism |
| 001B78 |
Susanne A. Schneider [Royaume-Uni, Allemagne] ; Burkhard Pleger [Royaume-Uni, Allemagne] ; Bogdan Draganski [Royaume-Uni, Allemagne] ; Carla Cordivari [Royaume-Uni] ; John C. Rothwell [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Ray J. Dolan [Royaume-Uni] | Modulatory effects of 5Hz rTMS over the primary somatosensory cortex in focal dystonia—An fMRI‐TMS study |
| 001B81 |
Richard Dodel [Allemagne] ; Annika Spottke [Allemagne] ; Alexander Gerhard [Royaume-Uni] ; Alexander Reuss [Allemagne] ; Sylvia Reinecker [Allemagne] ; Nicole Schimke [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Friederike Sixel-Döring [Allemagne] ; Birgit Herting [Allemagne] ; Christoph Kamm [Allemagne] ; Thomas Gasser [Allemagne] ; Martin Sawires [Autriche] ; Felix Geser [Autriche] ; Martin Köllensperger [Autriche] ; Klaus Seppi [Autriche] ; Manja Kloss [Allemagne] ; Martin Krause [Allemagne] ; Christine Daniels [Allemagne] ; Günther Deuschl [Allemagne] ; Silke Böttger [Allemagne] ; Markus Naumann [Allemagne] ; Axel Lipp [Royaume-Uni] ; Doreen Gruber [Allemagne] ; Andreas Kupsch [Allemagne] ; Yansheng Du [États-Unis] ; Federico Turkheimer [Royaume-Uni] ; David J. Brooks [Royaume-Uni] ; Thomas Klockgether [Allemagne] ; Werner Poewe [Autriche] ; Gregor Wenning [Autriche] ; Carmen Schade-Brittinger [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Karla Eggert [Allemagne] | Minocycline 1‐year therapy in multiple‐system‐atrophy: Effect on clinical symptoms and [11C] (R)‐PK11195 PET (MEMSA‐trial) |
| 001B86 |
Petra Katschnig [Royaume-Uni, Autriche] ; Mark J. Edwards [Royaume-Uni] ; Petra Schwingenschuh [Royaume-Uni, Autriche] ; Maria Aguirregomozcorta [Royaume-Uni] ; Georg K Gi [Royaume-Uni] ; John C. Rothwell [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Mental rotation of body parts and sensory temporal discrimination in fixed dystonia |
| 001B96 |
Elena Moro [Canada] ; Andres M. Lozano [Canada] ; Pierre Pollak [France] ; Yves Agid [France] ; Stig Rehncrona [Suède] ; Jens Volkmann [Allemagne] ; Jaime Kulisevsky [Espagne] ; Jose A. Obeso [Espagne] ; Alberto Albanese [Italie] ; Marwan I. Hariz [Royaume-Uni, Suède] ; Niall P. Quinn [Royaume-Uni] ; Jans D. Speelman [Pays-Bas] ; Alim-Louis Benabid [France] ; Valerie Fraix [France] ; Alexandre Mendes [France] ; Marie-Laure Welter [France] ; Jean-Luc Houeto [France] ; Philippe Cornu [France] ; Didier Dormont [France] ; Annalena L. Tornqvist [Suède] ; Ron Ekberg [Suède] ; Alfons Schnitzler [Allemagne] ; Lars Timmermann [Allemagne] ; Lars Wojtecki [Allemagne] ; Andres Gironell [Espagne] ; Maria C. Rodriguez-Oroz [Espagne] ; Jorge Guridi [Espagne] ; Anna R. Bentivoglio [Italie] ; Maria F. Contarino [Italie, Pays-Bas] ; Luigi Romito [Italie] ; Massimo Scerrati [Italie] ; Marc Janssens [Pays-Bas] ; Anthony E. Lang [Canada] | Long‐term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease |
| 001C07 |
Miryam Carecchio [Italie, Royaume-Uni] ; Alessandra Collini [Italie] ; Cristoforo Comi [Italie] ; Roberto Cantello [Italie] ; Kailash P. Bhatia [Royaume-Uni] ; Francesco Monaco [Italie] | Levodopa‐induced belly dancer's dyskinesias in Parkinson's disease: Report of one case |
| 001C16 |
Alberto J. Espay [États-Unis] ; Dominic C. Paviour [Royaume-Uni] ; John D. O'Sullivan [Australie] ; Robert E. Schmidt [États-Unis] ; Fredy J. Revilla [États-Unis] ; Leo Verhagen Metman [États-Unis] ; David Williams [États-Unis, Royaume-Uni, Australie] | Juvenile levodopa‐responsive Parkinsonism with early orobuccolingual dyskinesias and cognitive impairment |
| 001C18 |
Jennifer Paszek [Allemagne] ; Bettina Pollok [Allemagne] ; Katja Biermann-Ruben [Allemagne] ; Kirsten Müller-Vahl [Allemagne] ; Veit Roessner [Allemagne] ; Götz Thomalla [Allemagne] ; Mary M. Robertson [Royaume-Uni] ; Michael Orth [Allemagne] ; Alfons Schnitzler [Allemagne] ; Alexander Münchau [Allemagne] | Is it a tic?—Twenty seconds to make a diagnosis |
| 001C24 |
Annu Aggarwal [Inde] ; Susanne A. Schneider [Allemagne, Royaume-Uni] ; Henry Houlden [Royaume-Uni] ; Monty Silverdale [Royaume-Uni] ; Reema Paudel [Royaume-Uni] ; Coro Paisan-Ruiz [Royaume-Uni] ; Shrinivas Desai [Inde] ; Mihir Munshi [Inde] ; Darshana Sanghvi [Inde] ; John Hardy [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Mohit Bhatt [Inde] | Indian‐subcontinent NBIA: Unusual phenotypes, novel PANK2 mutations, and undetermined genetic forms |
| 001C34 |
Sean S. O'Sullivan [Royaume-Uni] ; Atbin Djamshidian [Royaume-Uni, Autriche] ; Zeshan Ahmed [Royaume-Uni] ; Andrew H. Evans [Australie] ; Andrew D. Lawrence [Royaume-Uni] ; Janice L. Holton [Royaume-Uni] ; Tamas Revesz [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Impulsive‐compulsive spectrum behaviors in pathologically confirmed progressive supranuclear palsy |
| 001C45 |
Laura Silveira-Moriyama [Royaume-Uni] ; Graham Hughes [Royaume-Uni] ; Alistair Church [Royaume-Uni] ; Hilary Ayling [Royaume-Uni] ; David R. Williams [Royaume-Uni, Australie] ; Aviva Petrie [Royaume-Uni] ; Janice Holton [Royaume-Uni] ; Tamas Revesz [Royaume-Uni] ; Ann Kingsbury [Royaume-Uni] ; Huw R. Morris [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Hyposmia in progressive supranuclear palsy |
| 001C56 |
Sui H. Wong [Royaume-Uni] ; Malcolm J. Steiger [Royaume-Uni] ; Andrew J. Larner [Royaume-Uni] ; Nicholas A. Fletcher [Royaume-Uni] | Hereditary myoclonus dystonia (DYT11): A novel SGCE gene mutation with intrafamilial phenotypic heterogeneity |
| 001C62 |
Sui H. Wong [Royaume-Uni] ; Paul J. W. Mckee [Royaume-Uni] | Greeter's cramp |
| 001D00 |
Sean S. O'Sullivan [Royaume-Uni] ; Atbin Djamshidian [Royaume-Uni, Autriche] ; Andrew H. Evans [Australie] ; Clare M. Loane [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Andrew D. Lawrence [Royaume-Uni] | Excessive hoarding in Parkinson's disease |
| 001D01 |
David J. Brooks [Royaume-Uni] | Examining Braak's hypothesis by imaging Parkinson's disease |
| 001D19 |
Olivier Rascol [France] ; Paolo Barone [Italie] ; Robert A. Hauser [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Anthony H. V. Schapira [Royaume-Uni] ; Laurence Salin [France] ; Mandy Sohr [Allemagne] ; Catherine Debieuvre [France] | Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease |
| 001D23 |
Coro Paisán-Ruiz [Royaume-Uni] ; Rocio Guevara [Royaume-Uni] ; Monica Federoff [Royaume-Uni] ; Hasmet Hanagasi [Turquie] ; Fardaz Sina [Iran] ; Elahe Elahi [Iran] ; Susanne A. Schneider [Royaume-Uni, Allemagne] ; Petra Schwingenschuh [Allemagne] ; Nin Bajaj [Royaume-Uni] ; Murat Emre [Turquie] ; Andrew B. Singleton [États-Unis] ; John Hardy [Royaume-Uni] ; Kailash P. Bhatia [Allemagne] ; Sebastian Brandner [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Henry Houlden [Royaume-Uni] | Early‐onset L‐dopa‐responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations |
| 001D32 |
William G. Ondo [États-Unis] ; Octavian R. Adam [États-Unis] ; Joseph Jankovic [États-Unis] ; Patrick F. Chinnery [Royaume-Uni] | Dramatic response of facial stereotype/tic to tetrabenazine in the first reported cases of neuroferritinopathy in the United States |
| 001D36 |
Leena Subramanian [Royaume-Uni] ; John Vincent Hindle [Royaume-Uni] ; Margaret Cecilia Jackson [Royaume-Uni] ; David E. J. Linden [Royaume-Uni] | Dopamine boosts memory for angry faces in Parkinson's disease |
| 001D42 |
Petra Schwingenschuh [Royaume-Uni, Autriche] ; Diane Ruge [Royaume-Uni] ; Mark J. Edwards [Royaume-Uni] ; Carmen Terranova [Royaume-Uni] ; Petra Katschnig [Royaume-Uni, Autriche] ; Fatima Carrillo [Espagne] ; Laura Silveira-Moriyama [Royaume-Uni] ; Susanne A. Schneider [Royaume-Uni] ; Georg K Gi [Royaume-Uni] ; Francisco J. Palomar [Espagne] ; Penelope Talelli [Royaume-Uni] ; John Dickson [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Pablo Mir [Espagne] ; John C. Rothwell [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson's disease: A clinical and electrophysiological study |
| 001D47 |
Seema Kalra [Royaume-Uni] ; Donald G. Grosset [Royaume-Uni] ; Hani T. S. Benamer [Royaume-Uni] | Differentiating vascular parkinsonism from idiopathic Parkinson's disease: A systematic review |
| 001D48 |
Sigurd D. Süssmuth [Allemagne] ; Ingo Uttner [Allemagne] ; Bernhard Landwehrmeyer [Allemagne] ; Elmar H. Pinkhardt [Allemagne] ; Johannes Brettschneider [Allemagne] ; Axel Petzold [Royaume-Uni] ; Bernd Kramer [Allemagne] ; Jörg B. Schulz [Allemagne] ; Christian Palm [Allemagne] ; Markus Otto [Allemagne] ; Albert C. Ludolph [Allemagne] ; Jan Kassubek [Allemagne] ; Hayrettin Tumani [Allemagne] | Differential pattern of brain‐specific CSF proteins tau and amyloid‐beta in Parkinsonian syndromes |
| 001D57 |
John V. Hindle [Royaume-Uni] ; Leslie Bridges [Royaume-Uni] ; Gurjit Chohan [Royaume-Uni] | Dementia with Lewy bodies associated with ataxia, myoclonus, and cortical blindness |
| 001D70 |
Pablo Arias [Espagne] ; Jamile Vivas [Espagne] ; Kenneth L. Grieve [Espagne, Royaume-Uni] ; Javier Cudeiro [Espagne] | Controlled trial on the effect of 10 days low‐frequency repetitive transcranial magnetic stimulation (rTMS) on motor signs in Parkinson's disease |
| 001D73 |
Andrew H. Evans [Australie, Royaume-Uni] ; Andrew D. Lawrence [Royaume-Uni] ; Silke Appel Cresswell [Canada] ; Regina Katzenschlager [Royaume-Uni, Autriche] ; Andrew Lees (neurologue) [Royaume-Uni] | Compulsive use of dopaminergic drug therapy in Parkinson's disease: Reward and anti‐reward |
| 001D74 |
Barbara Jasinska-Myga [États-Unis, Pologne] ; Jennifer Kachergus [États-Unis] ; Carles Vilari O-Güell [États-Unis] ; Christian Wider [États-Unis] ; Alexandra I. Soto-Ortolaza [États-Unis] ; Mounir Kefi [Tunisie] ; Lefkos T. Middleton [Royaume-Uni] ; Lianna Ishihara-Paul [Royaume-Uni] ; Rachel A. Gibson [Royaume-Uni] ; Rim Amouri [Tunisie] ; Samia Ben Yahmed [Tunisie] ; Samia Ben Sassi [Tunisie] ; Mourad Zouari [Tunisie] ; Ghada El Euch [Tunisie] ; Owen A. Ross [États-Unis] ; Faycal Hentati [Tunisie] ; Matthew J. Farrer [États-Unis] | Comprehensive sequencing of the LRRK2 gene in patients with familial Parkinson's disease from North Africa |
| 001E05 |
Susanne A. Schneider [Royaume-Uni, Allemagne] ; Anthony E. Lang [Canada] ; Elena Moro [Canada] ; Benedikt Bader [Allemagne] ; Adrian Danek [Allemagne] ; Kailash P. Bhatia [Royaume-Uni] | Characteristic head drops and axial extension in advanced chorea‐acanthocytosis |
| 001E07 |
Jane S. Paulsen [États-Unis] ; Chiachi Wang [États-Unis] ; Kevin Duff [États-Unis] ; Roger Barker [Royaume-Uni] ; Martha Nance [États-Unis] ; Leigh Beglinger [États-Unis] ; David Moser [États-Unis] ; Janet K. Williams [États-Unis] ; Sheila Simpson [Royaume-Uni] ; Douglas Langbehn [États-Unis] ; Daniel P. Van Kammen [États-Unis] | Challenges assessing clinical endpoints in early Huntington disease |
| 001E11 |
Jeroen Hoogland [Pays-Bas] ; Rob M. A. De Bie [Pays-Bas] ; Caroline H. Williams-Gray [Royaume-Uni] ; Dino Muslimovi [Pays-Bas] ; Ben Schmand [Pays-Bas] ; Bart Post [Pays-Bas] | Catechol‐O‐methyltransferase val158met and cognitive function in Parkinson's disease |
| 001E26 |
Ann E. Kingsbury [Royaume-Uni] ; Rina Bandopadhyay [Royaume-Uni] ; Laura Silveira-Moriyama [Royaume-Uni] ; Hilary Ayling [Royaume-Uni] ; Constantinos Kallis [Royaume-Uni] ; William Sterlacci [Autriche] ; Hans Maeir [Autriche] ; Werner Poewe [Autriche] ; Andrew Lees (neurologue) [Royaume-Uni] | Brain stem pathology in Parkinson's disease: An evaluation of the Braak staging model |
| 001E42 |
Araceli Alonso-Canovas [Royaume-Uni, Espagne] ; Petra Katschnig [Royaume-Uni] ; Arianna Tucci [Royaume-Uni] ; Miryam Carecchio [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] ; Mark Edwards [Royaume-Uni] ; Juan Carlos Martínez Castrillo [Espagne] ; Derek Burke [Royaume-Uni] ; Simon Heales [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Atypical parkinsonism with apraxia and supranuclear gaze abnormalities in type 1 Gaucher disease. Expanding the spectrum: Case report and literature review |
| 001E45 |
Petra Schwingenschuh [Royaume-Uni, Autriche] ; Petra Katschnig [Royaume-Uni, Autriche] ; Ronald Saurugg [Autriche] ; Erwin Ott [Autriche] ; Kailash P. Bhatia [Royaume-Uni] | Artistic profession: A potential risk factor for dopamine dysregulation syndrome in Parkinson's disease? |
| 001E51 |
Bheeshma Rajagopalan [Royaume-Uni] ; Jane M. Francis [Royaume-Uni] ; Fraser Cooke [Royaume-Uni] ; L. V. Prasad Korlipara [Royaume-Uni] ; Andrew M. Blamire [Royaume-Uni] ; Anthony H. V. Schapira [Royaume-Uni] ; Jason Madan [Royaume-Uni] ; Stefan Neubauer [Royaume-Uni] ; J. Mark Cooper [Royaume-Uni] | Analysis of the factors influencing the cardiac phenotype in Friedreich's ataxia |
| 001E55 |
Marianne J. U. Novak [Royaume-Uni] ; Mary G. Sweeney [Royaume-Uni] ; Abi Li [Royaume-Uni] ; Colm Treacy [Royaume-Uni] ; Hoskote S. Chandrashekar [Royaume-Uni] ; Paola Giunti [Royaume-Uni] ; Robert G. Goold [Royaume-Uni] ; Mary B. Davis [Royaume-Uni] ; Henry Houlden [Royaume-Uni] ; Sarah J. Tabrizi [Royaume-Uni] | An ITPR1 gene deletion causes spinocerebellar ataxia 15/16: A genetic, clinical and radiological description |
| 001E72 |
Susanne A. Schneider [Royaume-Uni] ; Leonora Wilkinson [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Susie M. D. Henley [Royaume-Uni] ; John C. Rothwell [Royaume-Uni] ; Sarah J. Tabrizi [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni] | Abnormal explicit but normal implicit sequence learning in premanifest and early Huntington's disease |
| 001E75 |
Susanne A. Schneider [Royaume-Uni, Allemagne] ; Coro Paisan-Ruiz [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Henry Houlden [Royaume-Uni] ; John Hardy [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation |
| 001E90 |
Barry J. Snow [Nouvelle-Zélande] ; Fiona L. Rolfe [Nouvelle-Zélande] ; Michelle M. Lockhart [Nouvelle-Zélande] ; Christopher M. Frampton [Nouvelle-Zélande] ; John D. O'Sullivan [Australie] ; Victor Fung [Australie] ; Robin A. J. Smith [Nouvelle-Zélande] ; Michael P. Murphy [Royaume-Uni] ; Kenneth M. Taylor [Nouvelle-Zélande] | A double‐blind, placebo‐controlled study to assess the mitochondria‐targeted antioxidant MitoQ as a disease‐modifying therapy in Parkinson's disease |
| 001E97 |
Giuseppe De Palma [Italie] ; Finlay D. Dick [Royaume-Uni] ; Stefano Calzetti [Italie] ; Neil W. Scott [Royaume-Uni] ; Gordon J. Prescott [Royaume-Uni] ; Aileen Osborne [Royaume-Uni] ; Neva Haites [Royaume-Uni] ; Paola Mozzoni [Italie] ; Anna Negrotti [Italie] ; Augusto Scaglioni [Italie] ; Antonio Mutti [Royaume-Uni] | A case‐control study of Parkinson's disease and tobacco use: Gene‐tobacco interactions |
| 001F10 |
Andrea Eugenio Cavanna [Royaume-Uni] ; Maria Grazia Pattumelli [Italie] ; Tiziana Quarto [Royaume-Uni, Italie] ; Fizzah Ali [Royaume-Uni] ; Hugh Rickards [Royaume-Uni] | The "Imprisoned Illness:" Motor Tic Disorder in Rainer Maria Rilke's Notebooks of Malte Laurids Brigge |
| 001F14 |
Tanja Schmitz-Hübsch [Allemagne] ; Mathieu Coudert [France] ; Paola Giunti [Royaume-Uni] ; Christoph Globas [Allemagne] ; Laszlo Baliko [Hongrie] ; Roberto Fancellu [Italie] ; Caterina Mariotti [Italie] ; Alessandro Filla [Italie] ; Maryla Rakowicz [Pologne] ; Perrine Charles [France] ; Pascale Ribai [France] ; Sandra Szymanski [Allemagne] ; Jon Infante [Espagne] ; Bart P. C. Van De Warrenburg [Pays-Bas] ; Alexandra Dürr [France] ; Dagmar Timmann [Allemagne] ; Sylvia Boesch [Autriche] ; Rafal Rola [Pologne] ; Chantal Depondt [Belgique] ; Ludger Schöls [Allemagne] ; Elszbieta Zdzienicka [Pologne] ; Jun-Suk Kang [Allemagne] ; Susanne Ratzka [Allemagne] ; Berry Kremer [Pays-Bas] ; Jörg B. Schulz [Allemagne] ; Thomas Klopstock [Allemagne] ; Bela Melegh [Hongrie] ; Sophie Tezenas Du Montcel [France] ; Thomas Klockgether [Allemagne] | Self-Rated Health Status in Spinocerebellar Ataxia-Results from a European Multiceriter Study |
| 001F23 |
Kayhan A. Tayarani-Binazir [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; C. Warren Olanow [États-Unis] ; Peter Jenner [Royaume-Uni] | Pramipexole Combined with Levodopa Improves Motor Function but Reduces Dyskinesia in MPTP-Treated Common Marmosets |
| 001F26 |
Naroa Ibarretxe-Bilbao [Espagne] ; Carme Junque [Espagne] ; Maria-Jose Marti [Espagne] ; Francesc Valldeoriola [Espagne] ; Pere Vendrell [Espagne] ; Nuria Bargallo [Espagne] ; Mojtaba Zarei [Royaume-Uni] ; Eduardo Tolosa [Espagne] | Olfactory Impairment in Parkinson's Disease and White Matter Abnormalities in Central Olfactory Areas: A Voxel-Based Diffusion Tensor Imaging Study |
| 001F27 |
Laura Silveira-Moriyama [Royaume-Uni] ; Renato Pupi Munhoz [Brésil] ; Margarete De J. Carvalho [Brésil] ; Salmo Raskin [Brésil] ; Ekaterina Rogaeva [Canada] ; Patricia De C. Aguiar [Brésil] ; Rodrigo A. Bressan [Brésil] ; Andre C. Felicio [Brésil] ; Orlando G. P. Barsottini [Brésil] ; Luiz Augusto F. Andrade [Brésil] ; Hsin F. Chien [Brésil] ; Vincenzo Bonifati [Pays-Bas] ; Egberto R. Barbosa [Brésil] ; Helio A. Teive [Brésil] ; Andrew Lees (neurologue) [Royaume-Uni] | Olfactory Heterogeneity in LRRK2 Related Parkinsonism |
| 001F42 |
Laura Silveira-Moriyama [Royaume-Uni] ; Graham Hughes [Royaume-Uni] ; Alistair Church [Royaume-Uni] ; Hilary Ayling [Royaume-Uni] ; David R. Williams [Royaume-Uni, Australie] ; Aviva Petrie [Royaume-Uni] ; Janice Holton [Royaume-Uni] ; Tamas Revesz [Royaume-Uni] ; Ann Kingsbury [Royaume-Uni] ; Huw R. Morris [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Hyposmia in Progressive Supranuclear Palsy |
| 001F55 |
Coro Paisan-Ruiz [Royaume-Uni] ; Rocio Guevara [Royaume-Uni] ; Monica Federoff [Royaume-Uni] ; Hasmet Hanagasi [Turquie] ; Fardaz Sina [Iran] ; Elahe Elahi [Iran] ; Susanne A. Schneider [Royaume-Uni, Allemagne] ; Petra Schwingenschuh [Allemagne] ; Nin Bajaj [Royaume-Uni] ; Murat Emre [Turquie] ; Andrew B. Singleton [États-Unis] ; John Hardy [Royaume-Uni] ; Kailash P. Bhatia [Allemagne] ; Sebastian Brandner [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Henry Houlden [Royaume-Uni] | Early-Onset L-dopa-Responsive Parkinsonism with Pyramidal Signs Due to ATP13A2, PLA2G6, FBX07 and Spatacsin Mutations |
| 001F63 |
Barbara Jasinska-Myga [États-Unis, Pologne] ; Jennifer Kachergus [États-Unis] ; Carles Vilarino-Güell [États-Unis] ; Christian Wider [États-Unis] ; Alexandra I. Soto-Ortolaza [États-Unis] ; Mounir Kefi [Tunisie] ; Lefkos T. Middleton [Royaume-Uni] ; Lianna Ishihara-Paul [Royaume-Uni] ; Rachel A. Gibson [Royaume-Uni] ; Rim Amouri [Tunisie] ; SAMIA BEN YAHMED [Tunisie] ; SAMIA BEN SASSI [Tunisie] ; Mourad Zouari [Tunisie] ; Ghada El Euch [Tunisie] ; Owen A. Ross [États-Unis] ; Faycal Hentati [Tunisie] ; Matthew J. Farrer [États-Unis] | Comprehensive Sequencing of the LRRK2 Gene in Patients with Familial Parkinson's Disease from North Africa |
| 001F69 |
Araceli Alonso-Canovas [Royaume-Uni, Espagne] ; Petra Katschnig [Royaume-Uni] ; Arianna Tucci [Royaume-Uni] ; Miryam Carecchio [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] ; Mark Edwards [Royaume-Uni] ; Juan Carlos Martinez Castrillo [Espagne] ; Derek Burke [Royaume-Uni] ; Simon Heales [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Atypical Parkinsonism with Apraxia and Supranuclear Gaze Abnormalities in Type 1 Gaucher Disease. Expanding the Spectrum: Case Report and Literature Review |
| 001F82 |
Susie M. D. Henley [Royaume-Uni] ; Edward J. Wild [Royaume-Uni] ; Nicola Z. Hobbs [Royaume-Uni] ; Chris Frost [Royaume-Uni] ; David G. Macmanus [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] ; Nick C. Fox [Royaume-Uni] ; Sarah J. Tabrizi [Royaume-Uni] | Whole‐brain atrophy as a measure of progression in premanifest and early Huntington's disease |
| 001F89 |
Christopher M. Knapp [Royaume-Uni] ; Irene Gottlob [Royaume-Uni] ; Rebecca J. Mclean [Royaume-Uni] ; Yusuf A. Rajabally [Royaume-Uni] ; Richard J. Abbott [Royaume-Uni] ; Suzanne Rafelt [Royaume-Uni] ; Frank A. Proudlock [Royaume-Uni] | Vertical optokinetic nystagmus in Parkinson's disease |
| 001F93 |
Nir Giladi [Israël] ; Joseph Tal [Israël] ; Tali Azulay [Israël] ; Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Eldad Melamed [Israël] ; Wolfgang Oertel [Allemagne] ; Werner Poewe [Autriche] ; Fabrizio Stocchi [Italie] ; Eduardo Tolosa [Espagne] | Validation of the freezing of gait questionnaire in patients with Parkinson's disease |
| 002001 |
Leon Poltawski [Royaume-Uni] ; Hazel Edwards [Royaume-Uni] ; Amy Todd [Royaume-Uni] ; Tim Watson [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Cherry Ann James [Royaume-Uni] | Ultrasound treatment of cutaneous side‐effects of infused apomorphine: A randomized controlled pilot study |
| 002005 |
Petra Schwingenschuh [Royaume-Uni, Autriche] ; Carla Cordivari [Royaume-Uni] ; Julia Czerny [Royaume-Uni] ; Marcello Esposito [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Tremor on smiling |
| 002013 |
Katy Mellor ; Anis Ahmed [Royaume-Uni] ; Alexander Thomson [Royaume-Uni] | Tramadol hydrochloride use and acute deterioration in Parkinson's disease tremor |
| 002016 |
Laura Silveira-Moriyama [Royaume-Uni] ; Aviva Petrie [Royaume-Uni] ; David R. Williams [Australie] ; Andrew Evans [Australie] ; Regina Katzenschlager [Autriche] ; Egberto R. Barbosa [Brésil] ; Andrew Lees (neurologue) [Royaume-Uni] | The use of a color coded probability scale to interpret smell tests in suspected parkinsonism |
| 002017 |
Harutomo Hasegawa [Royaume-Uni] ; Nilesh Mundil [Royaume-Uni] ; Michael Samuel [Royaume-Uni] ; Jo Jarosz [Royaume-Uni] ; Keyoumars Ashkan [Royaume-Uni] | The treatment of persistent vascular hemidystonia–hemiballismus with unilateral GPi deep brain stimulation |
| 002039 |
Alfons Schnitzler [Allemagne] ; Christian Münks [Allemagne] ; Markus Butz [Allemagne] ; Lars Timmermann [Allemagne] ; Joachim Gross [Royaume-Uni] | Synchronized brain network associated with essential tremor as revealed by magnetoencephalography |
| 002050 |
Annie W. Hsu [États-Unis] ; Panida A. Piboolnurak [États-Unis] ; Alicia G. Floyd [États-Unis] ; Qiping P. Yu [États-Unis] ; James E. Wraith [Royaume-Uni] ; Marc C. Patterson [États-Unis] ; Seth L. Pullman [États-Unis] | Spiral analysis in Niemann‐Pick disease type C |
| 002051 |
Sumeet Singhal [Royaume-Uni] ; Vamsi Gontu [Royaume-Uni] ; Prajendra Choudhary [Royaume-Uni] ; Dorothee Auer [Royaume-Uni] ; Nin Bajaj [Royaume-Uni] | Spinocerebellar ataxia type 1 mimicking stiff person syndrome |
| 002054 |
Mark Baker [Royaume-Uni] ; Karen Fisher [Royaume-Uni] ; Ming Lai [Royaume-Uni] ; Martin Duddy [Royaume-Uni] ; Stuart Baker [Royaume-Uni] | Slow orthostatic tremor in multiple sclerosis |
| 002060 |
Edward J. Wild [Royaume-Uni] ; Nick C. Fox [Royaume-Uni] | Serial volumetric MRI in Parkinsonian disorders |
| 002061 |
Michele Tinazzi [Italie] ; Mirta Fiorio [Italie, Royaume-Uni] ; Antonio Fiaschi [Italie] ; John C. Rothwell [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Sensory functions in dystonia: Insights from behavioral studies |
| 002077 |
Mark J. Edwards [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Reply: Puschmann “Unverricht‐Lundborg disease—A misnomer” |
| 002084 |
Saša R. Filipovi [Royaume-Uni] ; John C. Rothwell [Royaume-Uni] ; Bart P. Van De Warrenburg [Royaume-Uni, Pays-Bas] ; Kailash Bhatia [Royaume-Uni] | Repetitive transcranial magnetic stimulation for levodopa‐induced dyskinesias in Parkinson's disease |
| 002092 |
Susanne A. Schneider [Royaume-Uni] ; Vrajesh Udani [Inde] ; Charulata Sawant Sankhla [Inde] ; Kailash P. Bhatia [Royaume-Uni] | Recurrent acute dystonic reaction and oculogyric crisis despite withdrawal of dopamine receptor blocking drugs |
| 002099 |
Iracema Leroi [Royaume-Uni] ; Ross Overshott [Royaume-Uni] ; E. Jane Byrne [Royaume-Uni] ; Emily Daniel [Royaume-Uni] ; Alistair Burns [Royaume-Uni] | Randomized controlled trial of memantine in dementia associated with Parkinson's disease |
| 002106 |
Myeong Soo Lee [Corée du Sud, Royaume-Uni] ; Edzard Ernst [Royaume-Uni] | Qigong for movement disorders: A systematic review |
| 002116 |
David J. Brooks [Royaume-Uni] ; Klaus Seppi [Autriche] | Proposed neuroimaging criteria for the diagnosis of multiple system atrophy |
| 002124 |
Daniel G. Healy [Royaume-Uni] ; Gordon T. Ingle [Royaume-Uni] ; Peter Brown [Royaume-Uni] | Pregabalin‐ and gabapentin‐associated myoclonus in a patient with chronic renal failure |
| 002126 |
Mahesh Odiyoor [Royaume-Uni] ; Christopher Kobylecki [Royaume-Uni] ; Richard J. Hackett [Royaume-Uni] ; Monty A. Silverdale [Royaume-Uni] ; Mark W. Kellett [Royaume-Uni] | Pramipexole and gender identity disorder: Expanding the phenotype of hypersexuality in Parkinson's disease |
| 002134 |
William K. Gray [Royaume-Uni] ; Anthony Hildreth [Royaume-Uni] ; Julie A. Bilclough [Royaume-Uni] ; Brian H. Wood [Royaume-Uni] ; Katherine Baker [Royaume-Uni] ; Richard W. Walker [Royaume-Uni] | Physical assessment as a predictor of mortality in people with Parkinson's disease: A study over 7 years |
| 002141 |
Paul Wicks [États-Unis] ; Graeme J. A. Macphee [Royaume-Uni] | Pathological gambling amongst Parkinson's disease and ALS patients in an online community (PatientsLikeMe.com) |
| 002145 |
Mindhu M. Wickremaratchi [Royaume-Uni] ; Elisa Majounie [Royaume-Uni] ; Huw R. Morris [Royaume-Uni] ; Nigel M. Williams [Royaume-Uni] ; Helen Lewis [Royaume-Uni] ; Steven S. Gill [Royaume-Uni] ; Sadaquate Khan [Royaume-Uni] ; Peter Heywood [Royaume-Uni] ; John Hardy [États-Unis, Royaume-Uni] ; Charles M. Wiles [Royaume-Uni] ; Andrew B. Singleton [États-Unis] ; Niall P. Quinn [Royaume-Uni] | Parkin‐related disease clinically diagnosed as a pallido‐pyramidal syndrome |
| 002149 |
Sui H. Wong [Royaume-Uni] ; Bryan R. F. Lecky [Royaume-Uni] ; Malcolm J. Steiger [Royaume-Uni] | Parkinsonism and impulse control disorder: Presentation of a new progranulin gene mutation |
| 002151 |
Vicky L. Marshall [Royaume-Uni] ; Cornelia B. Reininger [Allemagne] ; Moritz Marquardt [Allemagne] ; Jim Patterson [Royaume-Uni] ; Donald M. Hadley [Royaume-Uni] ; Wolfgang H. Oertel [Allemagne] ; Hani T. S. Benamer [Royaume-Uni] ; Paul Kemp [Royaume-Uni] ; David Burn [Royaume-Uni] ; Eduardo Tolosa [Espagne] ; Jamie Kulisevsky [Espagne] ; Luis Cunha [Portugal] ; Durval Costa [Portugal] ; Jan Booij [Pays-Bas] ; Klaus Tatsch [Allemagne] ; K. Ray Chaudhuri [Royaume-Uni] ; Gudrun Ulm [Allemagne] ; Oliver Pogarell [Allemagne] ; Helmut Höffken [Allemagne] ; Anja Gerstner [Allemagne] ; Donald G. Grosset [Royaume-Uni] | Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: A 3‐year European multicenter study with repeat [123I]FP‐CIT SPECT |
| 002153 |
Robin Grant [Royaume-Uni] ; Francesc Graus [Espagne] | Paraneoplastic movement disorders |
| 002178 |
Diederik E. Tenback [Pays-Bas] ; Peter N. Van Harten [Pays-Bas] ; Jim Van Os [Pays-Bas, Royaume-Uni] | Non‐therapeutic risk factors for onset of tardive dyskinesia in schizophrenia: A meta‐analysis |
| 002181 |
Gavin Hudson [Royaume-Uni] ; Watcharee Tiangyou [Royaume-Uni] ; Andrea Stutt [Royaume-Uni] ; Martin Eccles [Royaume-Uni] ; Louise Robinson [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Patrick F. Chinnery [Royaume-Uni] | No association between common POLG1 variants and sporadic idiopathic Parkinson's disease |
| 002184 |
Nicola Pavese [Royaume-Uni] ; Naheed L. Khan [Royaume-Uni] ; Christoph Scherfler [Royaume-Uni] ; Lisa Cohen [Royaume-Uni] ; David J. Brooks [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Paola Piccini [Royaume-Uni] | Nigrostriatal dysfunction in homozygous and heterozygous parkin gene carriers: An 18F‐dopa PET progression study |
| 002233 |
Sophie Molloy [Royaume-Uni] ; Thais Minett [Brésil] ; John T. O'Brien [Royaume-Uni] ; Ian G. Mckeith [Royaume-Uni] ; David J. Burn [Royaume-Uni] | Levodopa use and sleep in patients with dementia with Lewy bodies |
| 002235 |
Bettina Pollok [Allemagne] ; Houssain Makhloufi [Allemagne] ; Markus Butz [Allemagne] ; Joachim Gross [Royaume-Uni] ; Lars Timmermann [Allemagne] ; Lars Wojtecki [Allemagne] ; Alfons Schnitzler [Allemagne] | Levodopa affects functional brain networks in parkinsonian resting tremor |
| 002243 |
Bhaskara P. Shelley [Royaume-Uni] ; John R. Hodges [Royaume-Uni, Australie] ; Christopher M. Kipps [Royaume-Uni] ; John H. Xuereb [Royaume-Uni] ; Thomas H. Bak [Royaume-Uni] | Is the pathology of corticobasal syndrome predictable in life? |
| 002244 |
Roy Elbers [Pays-Bas] ; Erwin E. H. Van Wegen [Pays-Bas] ; Lynn Rochester [Royaume-Uni] ; Victoria Hetherington [Royaume-Uni] ; Alice Nieuwboer [Belgique] ; Anne-Marie Willems [Belgique] ; Diana Jones [Royaume-Uni] ; Gert Kwakkel [Pays-Bas] | Is impact of fatigue an independent factor associated with physical activity in patients with idiopathic Parkinson's disease? |
| 002246 |
Holger Honig [Allemagne] ; Angelo Antonini [Italie] ; Pablo Martinez-Martin [Espagne] ; Ian Forgacs [Royaume-Uni] ; Guy C. Faye [Royaume-Uni] ; Thomas Fox [Allemagne] ; Karen Fox [Allemagne] ; Francesca Mancini [Italie] ; Margherita Canesi [Italie] ; Per Odin [Allemagne] ; K. Ray Chaudhuri [Royaume-Uni] | Intrajejunal levodopa infusion in Parkinson's disease: A pilot multicenter study of effects on nonmotor symptoms and quality of life |
| 002255 |
Peter G. Bain [Royaume-Uni] ; Xuguang Liu [Royaume-Uni] ; Tipu Z. Aziz [Royaume-Uni] | Increase in the tactile catchment area of a sensory trick for alleviating blepharospasm following pallidal DBS |
| 002261 |
Davide Martino [Italie] ; Russell C. Dale [Australie] ; Donald L. Gilbert [États-Unis] ; Gavin Giovannoni [Royaume-Uni] ; James F. Leckman [États-Unis] | Immunopathogenic mechanisms in tourette syndrome: A critical review |
| 002262 |
David J. Brooks [Royaume-Uni] | Imaging amyloid in Parkinson's disease dementia and dementia with Lewy bodies with positron emission tomography |
| 002263 |
Marcello Esposito [Royaume-Uni] ; Mark J. Edwards [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Peter Brown [Royaume-Uni] ; Carla Cordivari [Royaume-Uni] | Idiopathic spinal myoclonus: A clinical and neurophysiological assessment of a movement disorder of uncertain origin |
| 002265 |
Coro Paisán-Ruiz [Royaume-Uni] ; Javier Ruiz-Martinez [Espagne] ; Marta Ruibal [Espagne] ; Kin Y. Mok [Royaume-Uni] ; Begona Indakoetxea [Espagne] ; Ana Gorostidi [Espagne] ; José F. Martí Mass [Espagne] | Identification of a novel THAP1 mutation at R29 amino‐acid residue in sporadic patients with early‐onset dystonia |
| 002277 |
Christine Klein [Allemagne, Canada] ; Susanne A. Schneider [Allemagne, Royaume-Uni] ; Anthony E. Lang [Canada] | Hereditary parkinsonism: Parkinson disease look‐alikes—An algorithm for clinicians to “PARK” genes and beyond |
| 002279 |
Aileen K. Ho [Royaume-Uni] ; Abigail S. Gilbert [Royaume-Uni] ; Sarah L. Mason [Royaume-Uni] ; Anna O. Goodman [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] | Health‐related quality of life in Huntington's disease: Which factors matter most? |
| 002283 |
Christopher Kobylecki [Royaume-Uni] ; Monty A. Silverdale [Royaume-Uni] ; Anoop Varma [Royaume-Uni] ; Jeremy P. R. Dick [Royaume-Uni] ; Mark W. Kellett [Royaume-Uni] | HIV‐associated parkinsonism with levodopa‐induced dyskinesia and response to highly‐active antiretroviral therapy |
| 002287 |
Edward J. Newman [Royaume-Uni] ; Katherine A. Grosset [Royaume-Uni] ; Donald G. Grosset [Royaume-Uni] | Geographical difference in Parkinson's disease prevalence within West Scotland |
| 002296 |
Susanne A. Schneider [Royaume-Uni] ; Coro Paisan-Ruiz [Royaume-Uni] ; Ines Garcia-Gorostiaga [Royaume-Uni, Espagne] ; Niall P. Quinn [Royaume-Uni] ; Yvonne G. Weber ; Holger Lerche [Allemagne] ; John Hardy [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | GLUT1 gene mutations cause sporadic paroxysmal exercise‐induced dyskinesias |
| 002301 |
Stefan J. Cano [Royaume-Uni] ; Afsane Riazi [Royaume-Uni] ; Anthony H. V. Schapira [Royaume-Uni] ; J. Mark Cooper [Royaume-Uni] ; Jeremy C. Hobart [Royaume-Uni] | Friedreich's ataxia impact scale: A new measure striving to provide the flexibility required by today's studies |
| 002304 |
Sarah Teixeira Camargos [Brésil] ; Leonardo Oliveira Dornas [Brésil] ; Parastoo Momeni [États-Unis] ; Andrew Lees (neurologue) [Royaume-Uni] ; John Hardy [Royaume-Uni] ; Andrew Singleton [États-Unis] ; Francisco Cardoso [Brésil] | Familial Parkinsonism and early onset Parkinson's disease in a Brazilian movement disorders clinic: Phenotypic characterization and frequency of SNCA, PRKN, PINK1, and LRRK2 mutations |
| 002318 |
Daniel G. Healy [Royaume-Uni] ; Susan Bressman [États-Unis] ; John Dickson [Royaume-Uni] ; Laura Silveira-Moriyama [Royaume-Uni] ; Susanne A. Schneider [Royaume-Uni] ; Sean S. O. Sullivan [Royaume-Uni] ; Luke Massey [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Karen Shaw [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Jamshed Bomanji [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Evidence for pre and postsynaptic nigrostriatal dysfunction in the fragile X tremor–Ataxia syndrome |
| 002336 |
Irene Martinez-Torres [Royaume-Uni] ; Patricia Limousin [Royaume-Uni] ; Steve Tisch [Australie] ; Rupert Page [Royaume-Uni] ; Ashwin Pinto [Royaume-Uni] ; Thomas Foltynie [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Marwan I. Hariz [Royaume-Uni] ; Ludvic Zrinzo [Royaume-Uni] | Early and marked benefit with GPi DBS for Lubag syndrome presenting with rapidly progressive life‐threatening dystonia |
| 002340 |
Marian L. Evatt [États-Unis] ; K. Ray Chaudhuri [Royaume-Uni] ; Kelvin L. Chou [États-Unis] ; Ester Cubo [Espagne] ; Vanessa Hinson [États-Unis] ; Katie Kompoliti [États-Unis] ; Chengwu Yang [États-Unis] ; Werner Poewe [États-Unis] ; Olivier Rascol [Autriche] ; Cristina Sampaio [France, Portugal] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] | Dysautonomia rating scales in Parkinson's disease: Sialorrhea, dysphagia, and constipation—Critique and recommendations by movement disorders task force on rating scales for Parkinson's disease |
| 002343 |
Rodney W. H. Walker [Royaume-Uni] ; Zuzana Walker [Royaume-Uni] | Dopamine transporter single photon emission computerized tomography in the diagnosis of dementia with Lewy bodies |
| 002347 |
Esther M. Sammler [Royaume-Uni] ; Robert J. Swingler [Royaume-Uni] ; Arlene Stuart [Royaume-Uni] ; Miratul Muqit [Royaume-Uni] | Dopamine dysregulation syndrome in a patient with early onset Parkinsonism and Parkin gene mutations |
| 002350 |
Lynn Rochester [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Gillian Woods [Royaume-Uni] ; Jon Godwin [Royaume-Uni] ; Alice Nieuwboer [Belgique] | Does auditory rhythmical cueing improve gait in people with Parkinson's disease and cognitive impairment? A Feasibility study |
| 002352 |
William K. Gray [Royaume-Uni] ; Brian H. Wood [Royaume-Uni] ; Richard W. Walker [Royaume-Uni] | Do autonomic function tests in people with Parkinson's disease predict survival rates at 7 years follow‐up? |
| 002366 |
Samantha Hettige [Royaume-Uni] ; Mike Samuel ; Chris Clough [Royaume-Uni] ; Natasha Hulse [Royaume-Uni] ; Keyoumars Ashkan [Royaume-Uni] | Deep brain stimulation for Parkinson's disease when HIV coexists |
| 002378 |
Susanne A. Schneider [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; John Hardy [Royaume-Uni] | Complicated recessive dystonia parkinsonism syndromes |
| 002381 |
Jose A. Obeso [Espagne] ; Anthony H. Schapira [Royaume-Uni] | Compensatory mechanisms in Parkinson's disease |
| 002400 |
Graeme J. A. Macphee [Royaume-Uni] ; Claire Copeland [Royaume-Uni] ; David Stewart [Royaume-Uni] ; Katherine Grosset [Royaume-Uni] ; Donald G. Grosset [Royaume-Uni] | Clinical follow up of pathological gambling in Parkinson's disease in the West Scotland study |
| 002404 |
Mark Wardle [Royaume-Uni] ; Huw R. Morris [Royaume-Uni] ; Neil P. Robertson [Royaume-Uni] | Clinical and genetic characteristics of non‐Asian dentatorubral‐pallidoluysian atrophy: A systematic review |
| 002417 |
Roger Lane [États-Unis] ; Yunsheng He [États-Unis] ; Christopher Morris [Royaume-Uni] ; James B. Leverenz [États-Unis] ; Murat Emre [Turquie] ; Clive Ballard [Royaume-Uni] | BuChE‐K and APOE ϵ4 allele frequencies in Lewy body dementias, and influence of genotype and hyperhomocysteinemia on cognitive decline |
| 002448 |
Jenny Jamnadas-Khoda [Royaume-Uni] ; Suma Koshy [Inde] ; Christopher J. Mathias [Royaume-Uni] ; Uday B. Muthane [Inde] ; Mona Ragothaman [Inde] ; Subbakrishna K. Dodaballapur [Inde] | Are current recommendations to diagnose orthostatic hypotension in Parkinson's disease satisfactory? |
| 002451 |
Ned Jenkinson [Royaume-Uni] ; Dipanker Nandi [Royaume-Uni] ; Kalai Muthusamy [Royaume-Uni] ; Nicola J. Ray [Royaume-Uni] ; Ralph Gregory [Royaume-Uni] ; John F. Stein [Royaume-Uni] ; Tipu Z. Aziz [Royaume-Uni] | Anatomy, physiology, and pathophysiology of the pedunculopontine nucleus |
| 002461 |
Donald Grosset [Royaume-Uni] ; Angelo Antonini [Italie] ; Margherita Canesi [Italie] ; Gianni Pezzoli [Italie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Karen Shaw [Royaume-Uni] ; Esther Cubo [Espagne] ; Pablo Martinez-Martin [Espagne] ; Olivier Rascol [France] ; Laurence Negre-Pages [France] ; Ana Senard [France] ; Johannes Schwarz [Allemagne] ; Karl Strecker [Allemagne] ; Heinz Reichmann [Allemagne] ; Alexander Storch [Allemagne] ; Matthias Löhle [Allemagne] ; Fabrizio Stocchi [Italie] ; Katherine Grosset [Royaume-Uni] | Adherence to antiparkinson medication in a multicenter European study |
| 002462 |
Laura Silveira-Moriyama [Royaume-Uni] ; Dharshana Sirisena [Sri Lanka] ; Pasan Gamage [Sri Lanka] ; Ranjanie Gamage [Sri Lanka] ; Rohan De Silva [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Adapting the Sniffin' Sticks to diagnose Parkinson's disease in Sri Lanka |
| 002466 |
Edward J. Newman [Royaume-Uni] ; Kieran Breen [Royaume-Uni] ; Jim Patterson [Royaume-Uni] ; Donald M. Hadley [Royaume-Uni] ; Katherine A. Grosset [Royaume-Uni] ; Donald G. Grosset [Royaume-Uni] | Accuracy of Parkinson's disease diagnosis in 610 general practice patients in the West of Scotland |
| 002469 |
Yasushi Osaki [Royaume-Uni, Japon] ; Yoav Ben-Shlomo [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Gregor K. Wenning [Autriche] ; Niall P. Quinn [Royaume-Uni] | A validation exercise on the new consensus criteria for multiple system atrophy |
| 002473 |
Adrienne Curtis [Royaume-Uni] ; Ian Mitchell [Royaume-Uni] ; Smitaa Patel [Royaume-Uni] ; Natalie Ives [Royaume-Uni] ; Hugh Rickards [Royaume-Uni] | A pilot study using nabilone for symptomatic treatment in Huntington's disease |
| 002482 |
Patric Blomstedt [Suède] ; Marwan I. Hariz [Suède, Royaume-Uni] ; Stephen Tisch [Australie] ; Monica Holmberg [Suède] ; Tommy A. Bergenheim [Suède] ; Lars Forsgren [Suède] | A family with a hereditary form of torsion dystonia from Northern Sweden treated with bilateral pallidal deep brain stimulation |
| 002491 |
Laura Silveira-Moriyama [Royaume-Uni] ; Aviva Petrie [Royaume-Uni] ; David R. Williams [Australie] ; Andrew Evans [Australie] ; Regina Katzenschlager [Autriche] ; Egberto R. Barbosa [Brésil] ; Andrew Lees (neurologue) [Royaume-Uni] | The Use of a Color Coded Probability Scale to Interpret Smell Tests in Suspected Parkinsonism |
| 002497 |
Sasa R. Filipovie [Royaume-Uni] ; John C. Rothwell [Royaume-Uni] ; Bart P. Van De Warrenburg [Royaume-Uni, Pays-Bas] ; Kailash Bhatia [Royaume-Uni] | Repetitive Transcranial Magnetic Stimulation for Levodopa-Induced Dyskinesias in Parkinson's Disease |
| 002518 |
Sarah Teixeira Camargos [Brésil] ; Leonardo Oliveira Dornas [Brésil] ; Parastoo Momeni [États-Unis] ; Andrew Lees (neurologue) [Royaume-Uni] ; John Hardy [Royaume-Uni] ; Andrew Singleton [États-Unis] ; Francisco Cardoso [Brésil] | Familial Parkinsonism and Early Onset Parkinson's Disease in a Brazilian Movement Disorders Clinic : Phenotypic Characterization and Frequency of SNCA, PRKN, PINK1, and LRRK2 Mutations |
| 002529 |
Jenny Jamnadas-Khoda [Royaume-Uni] ; Suma Koshy [Inde] ; Christopher J. Mathias [Royaume-Uni] ; Uday B. Muthane [Inde] ; Mona Ragothaman [Inde] ; Subbakrishna K. Dodaballapur [Inde] | Are Current Recommendations to Diagnose Orthostatic Hypotension in Parkinson's Disease Satisfactory? |
| 002531 |
Laura Silveira-Moriyama [Royaume-Uni] ; Dharshana Sirisena [Sri Lanka] ; Pasan Gamage [Sri Lanka] ; Ranjanie Gamage [Sri Lanka] ; Rohande Silva [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Adapting the Sniffin' Sticks to Diagnose Parkinson's Disease in Sri Lanka |
| 002538 |
Lynn Rochester [Royaume-Uni] ; Alice Nieuwboer [Belgique] ; Katherine Baker [Royaume-Uni] ; Victoria Hetherington [Royaume-Uni] ; Anne-Marie Willems [Belgique] ; Gert Kwakkel [Pays-Bas] ; Erwin Van Wegen [Pays-Bas] ; Inge Lim [Pays-Bas] ; Diana Jones [Royaume-Uni] | Walking speed during single and dual tasks in Parkinson's disease: Which characteristics are important? |
| 002548 |
Vasiliki Koukouni [Royaume-Uni] ; Enza Maria Valente [Italie] ; Carla Cordivari [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] | Unusual familial presentation of epsilon‐sarcoglycan gene mutation with falls and writer's cramp |
| 002564 |
Christopher Kobylecki [Royaume-Uni] ; Andrew G. Marshall [Royaume-Uni] ; Anoop Varma [Royaume-Uni] ; Mark W. Kellett [Royaume-Uni] ; Jeremy P. R. Dick [Royaume-Uni] ; Monty A. Silverdale [Royaume-Uni] | Topiramate‐responsive cerebellar axial postural tremor |
| 002570 |
Laura Silveira-Moriyama [Royaume-Uni] ; Margarete De Jesus Carvalho [Brésil] ; Regina Katzenschlager [Autriche] ; Aviva Petrie [Royaume-Uni] ; Ronald Ranvaud [Brésil] ; Egberto Reis Barbosa [Brésil] ; Andrew Lees (neurologue) [Royaume-Uni] | The use of smell identification tests in the diagnosis of Parkinson's disease in Brazil |
| 002571 |
Monty A. Silverdale [Canada, Royaume-Uni] ; Susanne A. Schneider [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Anthony E. Lang [Canada] | The spectrum of orolingual tremor—A proposed classification system |
| 002576 |
Christopher H. Hawkes [Royaume-Uni] | The prodromal phase of sporadic Parkinson's disease: Does it exist and if so how long is it? |
| 002577 |
Catherine Dotchin [Royaume-Uni] ; Olivia Msuya ; John Kissima ; John Massawe ; Ali Mhina ; Addess Moshy ; Eric Aris ; Ahmed Jusabani ; David Whiting [Royaume-Uni] ; Gabriel Masuki ; Richard Walker [Royaume-Uni] | The prevalence of Parkinson's disease in rural Tanzania |
| 002579 |
Nee K. Chew [Royaume-Uni] ; Pablo Mir [Royaume-Uni, Espagne] ; Mark J. Edwards [Royaume-Uni] ; Carla Cordivari [Royaume-Uni] ; Davide Martino [Royaume-Uni, Italie] ; Susanne A. Schneider [Royaume-Uni] ; Hee-Tae Kim [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | The natural history of Unverricht‐Lundborg disease: A report of eight genetically proven cases |
| 002587 |
Victoria A. Goodwin [Royaume-Uni] ; Suzanne H. Richards [Royaume-Uni] ; Rod S. Taylor [Royaume-Uni] ; Adrian H. Taylor [Royaume-Uni] ; John L. Campbell [Royaume-Uni] | The effectiveness of exercise interventions for people with Parkinson's disease: A systematic review and meta‐analysis |
| 002589 |
Wendy Phillips [Royaume-Uni] ; Kathleen M. Shannon [États-Unis] ; Roger A. Barker [Royaume-Uni] | The current clinical management of Huntington's disease |
| 002593 |
Anthony H. V. Schapira [Royaume-Uni] | The clinical relevance of levodopa toxicity in the treatment of Parkinson's disease |
| 002594 |
Andrew Lees (neurologue) [Royaume-Uni] ; Marianna Selikhova [Royaume-Uni] ; Luiz Augusto Andrade [Brésil] ; Charles Duyckaerts [France] | The black stuff and Konstantin Nikolaevich Tretiakoff |
| 002599 |
Andrew Lees (neurologue) [Royaume-Uni] ; Brigadier Michael R. Koe | The Progressive Supranuclear Palsy Association's Sixth International Medical Workshop |
| 002605 |
Marwan I. Hariz [Royaume-Uni] | Thalamic stimulation does not involve a high rate of suicide |
| 002611 |
Sonja Scholz [États-Unis, Royaume-Uni] ; Andrew Singleton [États-Unis] | Susceptibility genes in movement disorders |
| 002636 |
Pablo Martinez-Martin [Espagne] ; Martine Visser [Pays-Bas] ; Carmen Rodriguez-Blazquez [Espagne] ; Johan Marinus [Pays-Bas] ; K. Ray Chaudhuri [Royaume-Uni] ; Jacobus J. Van Hilten [Pays-Bas] | SCOPA‐sleep and PDSS: Two scales for assessment of sleep disorder in Parkinson's disease |
| 002639 |
Paolo Barone [Italie] ; David J. Burn [Royaume-Uni] ; Teus Van Laar [Pays-Bas] ; Chuanchieh Hsu [États-Unis] ; Werner Poewe [Autriche] ; Roger M. Lane [États-Unis] | Rivastigmine versus placebo in hyperhomocysteinemic Parkinson's disease dementia patients |
| 002662 |
Shibley Rahman [Royaume-Uni] ; Harry J. Griffin [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni] | Quality of life in Parkinson's disease: The relative importance of the symptoms |
| 002669 |
Petra Schwingenschuh [Royaume-Uni, Autriche] ; Claustre Pont-Sunyer [Royaume-Uni, Espagne] ; Robert Surtees [Royaume-Uni] ; Mark J. Edwards [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Psychogenic movement disorders in children: A report of 15 cases and a review of the literature |
| 002672 |
James T. H. Teo [Royaume-Uni] ; Susanne A. Schneider [Royaume-Uni] ; Binith J. Cheeran [Royaume-Uni] ; Miguel Fernandez-Del-Olmo [Espagne] ; Paola Giunti [Royaume-Uni] ; John C. Rothwell [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Prolonged cortical silent period but normal sensorimotor plasticity in spinocerebellar ataxia 6 |
| 002675 |
Peter Jenner [Royaume-Uni] | Preventing and controlling dyskinesia in Parkinson's disease—A view of current knowledge and future opportunities |
| 002705 |
Marianna Selikhova [Royaume-Uni, Russie] ; Ljuda Fedoryshyn [Ukraine] ; Yuri Matviyenko [Ukraine] ; Irena Komnatska [Ukraine] ; Marianna Kyrylchuk [Ukraine] ; Lesrek Krolicki [Pologne] ; Andrzej Friedman [Pologne] ; Andrew Taylor [Royaume-Uni] ; H. Rolf J Ger [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Yanush Sanotsky [Ukraine] | Parkinsonism and dystonia caused by the illicit use of ephedrone—A longitudinal study |
| 002709 |
Hani T. S. Benamer [Royaume-Uni] ; Rajith De Silva [Royaume-Uni] ; Khurram A. Siddiqui ; Donald G. Grosset [Royaume-Uni] | Parkinson's disease in Arabs: A systematic review |
| 002714 |
Peter Brown [Royaume-Uni] ; Alexandre Eusebio [Royaume-Uni] | Paradoxes of functional neurosurgery: Clues from basal ganglia recordings |
| 002717 |
Petra Schwingenschuh [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Painful moving tongue in a patient with the painful legs moving toes syndrome |
| 002725 |
Tim Anderson [Nouvelle-Zélande] ; Linda Luxon [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Susan Daniel [Royaume-Uni] ; C. David Marsden [Nouvelle-Zélande] ; Adolfo Bronstein [Royaume-Uni] | Oculomotor function in multiple system atrophy: Clinical and laboratory features in 30 patients |
| 002727 |
Rita Joao Guerreiro [États-Unis, Portugal] ; Isabel Santana [Portugal] ; Jose Miguel Bras [États-Unis, Portugal] ; Tamas Revesz [Royaume-Uni] ; Olinda Rebelo [Portugal] ; Maria Helena Ribeiro [Portugal] ; Beatriz Santiago [Portugal] ; Catarina Resende Oliveira [Portugal] ; Andrew Singleton [États-Unis] ; John Hardy [États-Unis, Royaume-Uni] | Novel progranulin mutation: Screening for PGRN mutations in a Portuguese series of FTD/CBS cases |
| 002728 |
Sarah Teixeira Camargos [Brésil] ; Francisco Cardoso [Brésil] ; Parastoo Momeni [États-Unis] ; Juliana Gurgel Gianetti [Brésil] ; Andrew Lees (neurologue) [Royaume-Uni] ; John Hardy [États-Unis, Royaume-Uni] ; Andrew Singleton [États-Unis] | Novel GCH1 mutation in a Brazilian family with dopa‐responsive dystonia |
| 002729 |
Sean S. O'Sullivan [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Janice L. Holton [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Normal dopamine transporter single photon‐emission CT scan in corticobasal degeneration |
| 002731 |
Sean S. O'Sullivan [Royaume-Uni] ; David R. Williams [Royaume-Uni, Australie] ; David A. Gallagher [Royaume-Uni] ; Luke A. Massey [Royaume-Uni] ; Laura Silveira-Moriyama [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Nonmotor symptoms as presenting complaints in Parkinson's disease: A clinicopathological study |
| 002743 |
Michael P. Dean [Royaume-Uni] ; Ruth Gilmore [Royaume-Uni] | Myoclonus affecting speech reduced by concurrent handwriting |
| 002752 |
Marwan I. Hariz [Royaume-Uni, Suède] ; Stig Rehncrona [Suède] ; Niall P. Quinn [Royaume-Uni] ; Johannes D. Speelman [Pays-Bas] ; Carin Wensing [Pays-Bas] | Multicenter study on deep brain stimulation in Parkinson's disease: An independent assessment of reported adverse events at 4 years |
| 002758 |
Susanne A. Schneider [Royaume-Uni] ; Penelope Talelli [Royaume-Uni] ; Binith J. Cheeran [Royaume-Uni] ; Naheed L. Khan [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] ; John C. Rothwell [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Motor cortical physiology in patients and asymptomatic carriers of parkin gene mutations |
| 002770 |
Amit S. Kulkarni [États-Unis] ; Rajesh Balkrishnan [États-Unis] ; Roger T. Anderson [États-Unis] ; Heather M. Edin [États-Unis] ; Jeff Kirsch [Royaume-Uni] ; Mark A. Stacy [États-Unis] | Medication adherence and associated outcomes in medicare health maintenance organization‐enrolled older adults with Parkinson's disease |
| 002787 |
C. Warren Olanow [États-Unis] ; Andrew Lees (neurologue) [Royaume-Uni] ; Jose Obeso [Espagne] | Levodopa therapy for Parkinson's disease: Challenges and future prospects |
| 002803 |
Inge Lim [Pays-Bas] ; Erwin Van Wegen [Pays-Bas] ; Diana Jones [Royaume-Uni] ; Lynn Rochester [Royaume-Uni] ; Alice Nieuwboer [Belgique] ; Anne Marie Willems [Belgique] ; Katherine Baker [Royaume-Uni] ; Vicki Hetherington [Royaume-Uni] ; Gert Kwakkel [Pays-Bas] | Identifying fallers with Parkinson's disease using home‐based tests: Who is at risk? |
| 002806 |
Edward J. Wild [Royaume-Uni] ; Ese E. Mudanohwo [Royaume-Uni] ; Mary G. Sweeney [Royaume-Uni] ; Susanne A. Schneider [Royaume-Uni] ; Jon Beck [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Martin N. Rossor [Royaume-Uni] ; Mary B. Davis [Royaume-Uni] ; Sarah J. Tabrizi [Royaume-Uni] | Huntington's disease phenocopies are clinically and genetically heterogeneous |
| 002808 |
Christopher F. Mcnicoll [États-Unis] ; Jeanne C. Latourelle [États-Unis] ; Marcy E. Macdonald [États-Unis] ; Mark F. Lew [États-Unis] ; Oksana Suchowersky [Canada] ; Christine Klein [Allemagne] ; Lawrence I. Golbe [États-Unis] ; Margery H. Mark [États-Unis] ; John H. Growdon [États-Unis] ; G. Frederick Wooten [États-Unis] ; Ray L. Watts [États-Unis] ; Mark Guttman [Canada] ; Brad A. Racette [États-Unis] ; Joel S. Perlmutter [États-Unis] ; Anwar Ahmed [États-Unis] ; Holly A. Shill [États-Unis] ; Carlos Singer [États-Unis] ; Marie H. Saint-Hilaire [États-Unis] ; Tiffany Massood [États-Unis] ; Karen W. Huskey [États-Unis] ; Anita L. Destefano [États-Unis] ; Tammy Gillis [États-Unis] ; Jayalakshmi Mysore [États-Unis] ; Stefano Goldwurm [Italie] ; Gianni Pezzoli [Italie] ; Kenneth B. Baker [États-Unis] ; Ilia Itin [États-Unis] ; Irene Litvan [États-Unis] ; Garth Nicholson [Australie] ; Alastair Corbett [Australie] ; Martha Nance [États-Unis] ; Edward Drasby [États-Unis] ; Stuart Isaacson [États-Unis] ; David J. Burn [Royaume-Uni] ; Patrick F. Chinnery [Royaume-Uni] ; Peter P. Pramstaller [Italie] ; Jomana Al-Hinti [États-Unis] ; Anette T. Moller [Danemark] ; Karen Ostergaard [Danemark] ; Scott J. Sherman [États-Unis] ; Richard Roxburgh [Nouvelle-Zélande] ; Barry Snow [Nouvelle-Zélande] ; John T. Slevin [États-Unis] ; Franca Cambi [États-Unis] ; James F. Gusella [États-Unis] ; Richard H. Myers [États-Unis] | Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: The GenePD study |
| 002813 |
Qin Chen [République populaire de Chine] ; Xue-Ping Chen [République populaire de Chine] ; Ling Zou [République populaire de Chine] ; Dong Zhou [République populaire de Chine] ; Qi-Yong Gong [République populaire de Chine, Royaume-Uni] ; Jean-Marc Burgunder [République populaire de Chine, Suisse] ; Hui-Fang Shang [République populaire de Chine] | High brain iron level in asymptomatic carriers of heterozygous ceruloplasmin gene mutations |
| 002818 |
Hugh Rickards [Royaume-Uni] ; Clare Wood [Royaume-Uni] ; Andrea E. Cavanna [Royaume-Uni] | Hassler and Dieckmann's seminal paper on stereotactic thalamotomy for Gilles de la Tourette syndrome: Translation and critical reappraisal |
| 002835 |
Susanne A. Schneider [Royaume-Uni] ; Mary M. Robertson [Royaume-Uni] ; Renata Rizzo [Italie] ; Jeremy Turk [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Michael Orth [Royaume-Uni, Allemagne] | Fragile X syndrome associated with tic disorders |
| 002836 |
Aileen K. Ho [Royaume-Uni] ; John L. Bradshaw [Australie] ; Robert Iansek [Australie] | For better or worse: The effect of levodopa on speech in Parkinson's disease |
| 002840 |
Hu Liang Low [Canada, Royaume-Uni] ; Christopher R. Honey [Canada] | Focal childhood‐onset, action induced primary hip dystonia treated with pallidal deep brain stimulation |
| 002856 |
Barbara Leinweber [Allemagne] ; J. Carsten Möller [Allemagne] ; Andre Scherag [Allemagne] ; Ulrike Reuner [Allemagne] ; Peter Günther [Allemagne] ; Christoph J. G. Lang [Allemagne] ; Hartmut H. J. Schmidt [Allemagne] ; Christoph Schrader [Allemagne] ; Oliver Bandmann [Royaume-Uni] ; Anna Czlonkowska [Pologne] ; Wolfgang H. Oertel [Allemagne] ; Harald Hefter [Allemagne] | Evaluation of the Unified Wilson's Disease Rating Scale (UWDRS) in German patients with treated Wilson's disease |
| 002878 |
Elina Tripoliti [Royaume-Uni] ; Ludvic Zrinzo [Royaume-Uni] ; Irene Martinez-Torres [Royaume-Uni] ; Stephen Tisch [Royaume-Uni] ; Eleanor Frost [Royaume-Uni] ; Ellie Borrell [Royaume-Uni] ; Marwan I. Hariz [Royaume-Uni] ; Patricia Limousin [Royaume-Uni] | Effects of contact location and voltage amplitude on speech and movement in bilateral subthalamic nucleus deep brain stimulation |
| 002880 |
Myeong Soo Lee [Royaume-Uni, Corée du Sud] ; Byung-Cheul Shin [Corée du Sud] ; Jae Cheol Kong [Corée du Sud] ; Edzard Ernst [Royaume-Uni] | Effectiveness of acupuncture for Parkinson's disease: A systematic review |
| 002890 |
Susanne A. Schneider [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Dystonia in the Woodhouse Sakati syndrome: A new family and literature review |
| 002919 |
Angelo Antonini [Italie] ; Patrizia Berto [Italie] ; Stefania Lopatriello [Italie] ; Filippo Tamma [Italie] ; Lieven Annemans [Belgique] ; Mike Chambers [Royaume-Uni] | Cost‐effectiveness of 123I‐FP‐CIT SPECT in the differential diagnosis of essential tremor and Parkinson's disease in Italy |
| 002923 |
Stephen Tisch [Royaume-Uni] ; John C. Rothwell [Royaume-Uni] ; Ludvic Zrinzo [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Marwan Hariz [Royaume-Uni] ; Patricia Limousin [Royaume-Uni] | Cortical evoked potentials from pallidal stimulation in patients with primary generalized dystonia |
| 002929 |
Maria G. Motlagh [États-Unis, Iran] ; Arshia Seddigh [Iran, Royaume-Uni] ; Behnoosh Dashti [Iran] ; James F. Leckman [États-Unis] ; Javad Alaghband-Rad [Iran, Canada] | Consanguineous Iranian kindreds with severe Tourette syndrome |
| 002943 |
Daisy L. Whitehead [Royaume-Uni] ; Ann D. M. Davies [Royaume-Uni] ; Jeremy R. Playfer [Royaume-Uni] ; Christopher J. Turnbull [Royaume-Uni] | Circadian rest‐activity rhythm is altered in Parkinson's disease patients with hallucinations |
| 002952 |
Marios Hadjivassiliou [Royaume-Uni] ; Sabrina Boscolo [Italie] ; Enrico Tongiorgi [Italie] ; Richard A. Grünewald [Royaume-Uni] ; Basil Sharrack [Royaume-Uni] ; David S. Sanders [Royaume-Uni] ; Nicola Woodroofe [Royaume-Uni] ; G. Aelwyn B. Davies-Jones [Royaume-Uni] | Cerebellar ataxia as a possible organ‐specific autoimmune disease |
| 002992 |
Georg K Gi [Royaume-Uni] ; Petra Schwingenschuh [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Arm swing is reduced in idiopathic cervical dystonia |
| 002995 |
Carl E. Clarke [Royaume-Uni] | Are delayed‐start design trials to show neuroprotection in Parkinson's disease fundamentally flawed? |
| 002A03 |
Bart P. C. Van De Warrenburg [Royaume-Uni, Pays-Bas] ; Andrew J. Church [Royaume-Uni] ; Davide Martino [Royaume-Uni, Italie] ; Paul M. Candler [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Gavin Giovannoni [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] | Antineuronal antibodies in Parkinson's disease |
| 002A11 |
Giacomo Koch [Royaume-Uni, Italie] ; Susanne Schneider [Royaume-Uni] ; Tobias B Umer [Allemagne] ; Michele Franca [Royaume-Uni] ; Alexander Münchau [Allemagne] ; Binith Cheeran [Royaume-Uni] ; Miguel Fernandez Del Olmo [Royaume-Uni, Espagne] ; Carla Cordivari [Royaume-Uni] ; Elisabeth Rounis [Royaume-Uni] ; Carlo Caltagirone [Italie] ; Kailash Bhatia [Royaume-Uni] ; John C. Rothwell [Royaume-Uni] | Altered dorsal premotor–motor interhemispheric pathway activity in focal arm dystonia |
| 002A22 |
Nafsika Frima [Royaume-Uni] ; Jamal Nasir [Royaume-Uni] ; Richard A. Grünewald [Royaume-Uni] | Abnormal vibration‐induced illusion of movement in idiopathic focal dystonia: An endophenotypic marker? |
| 002A25 |
Michele Tinazzi [Italie] ; Sara Simonetto [Italie] ; Laura Franco [Italie] ; Kailash P. Bhatia [Royaume-Uni] ; Giuseppe Moretto [Italie] ; Antonio Fiaschi [Italie] ; Cristina Deluca [Italie] | Abduction finger sign: A new sign to detect unilateral functional paralysis of the upper limb |
| 002A40 |
Josef Priller [Allemagne] ; Daniel Ecker [Allemagne] ; Bernhard Landwehrmeyer [Allemagne] ; David Craufurd [Royaume-Uni] | A Europe‐wide assessment of current medication choices in Huntington's disease |
| 002A49 |
Laura Silveira-Moriyama [Royaume-Uni] ; Margarete De Jesus Carvalho [Brésil] ; Regina Katzenschlager [Autriche] ; Aviva Petrie [Royaume-Uni] ; Ronald Ranvaud [Brésil] ; Egberto Reis Barbosa [Brésil] ; Andrew Lees (neurologue) [Royaume-Uni] | The Use of Smell Identification Tests in the Diagnosis of Parkinson's Disease in Brazil |
| 002A56 |
Pablo Martinez-Martin [Espagne] ; Martine Visser [Pays-Bas] ; Carmen Rodriguez-Blazquez [Espagne] ; Johan Marinus [Pays-Bas] ; K. Ray Chaudhuri [Royaume-Uni] ; Jacobus J. Van Hilten [Pays-Bas] | SCOPA-Sleep and PDSS : Two Scales for Assessment of Sleep Disorder in Parkinson's Disease |
| 002A65 |
Rita Joao Guerreiro [États-Unis, Portugal] ; Isabel Santana [Portugal] ; Jose Miguel Bras [États-Unis, Portugal] ; Tamas Revesz [Royaume-Uni] ; Olinda Rebelo [Portugal] ; Maria Helena Ribeiro [Portugal] ; Beatriz Santiago [Portugal] ; Catarina Resende Oliveira [Portugal] ; Andrew Singleton [États-Unis] ; John Hardy [États-Unis, Royaume-Uni] | Novel Progranulin Mutation : Screening for PGRN Mutations in a Portuguese Series of FTD/CBS Cases |
| 002A66 |
Sarah Teixeira Camargos [Brésil] ; Francisco Cardoso [Brésil] ; Parastoo Momeni [États-Unis] ; Juliana Gurgel Gianetti [Brésil] ; Andrew Lees (neurologue) [Royaume-Uni] ; John Hardy [États-Unis, Royaume-Uni] ; Andrew Singleton [États-Unis] | Novel GCH1 Mutation in a Brazilian Family with Dopa-Responsive Dystonia |
| 002A75 |
HU LIANG LOW [Canada, Royaume-Uni] ; Christopher R. Honey [Canada] | Focal Childhood-Onset, Action Induced Primary Hip Dystonia Treated with Pallidal Deep Brain Stimulation |
| 002A76 |
MYEONG SOO LEE [Royaume-Uni] ; Byung-Cheul Shin [Corée du Sud] ; JAE CHEOL KONG [Corée du Sud] ; Edzard Ernst [Royaume-Uni] | Effectiveness of Acupuncture for Parkinson Disease : a Systematic Review |
| 002A93 |
Jan Zijlmans [Royaume-Uni, Pays-Bas] ; Andrew Evans [Royaume-Uni] ; Flavia Fontes [Royaume-Uni] ; Regina Katzenschlager [Royaume-Uni, Autriche] ; Svetoslav Gacinovic [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Durval Costa [Royaume-Uni, Portugal] | [123I] FP‐CIT spect study in vascular parkinsonism and Parkinson's disease |
| 002B10 |
Andrew Lees (neurologue) [Royaume-Uni] | Unresolved issues relating to the Shaking Palsy on the celebration of James Parkinson's 250th birthday |
| 002B12 |
Anne-Marie Willems [Belgique] ; Alice Nieuwboer [Belgique] ; Fabienne Chavret [Belgique] ; Kaat Desloovere [Belgique] ; René Dom [Belgique] ; Lynn Rochester [Royaume-Uni] ; Gert Kwakkel [Pays-Bas] ; Erwin Van Wegen [Pays-Bas] ; Diana Jones [Royaume-Uni] | Turning in Parkinson's disease patients and controls: The effect of auditory cues |
| 002B24 |
Shinji Saiki [Royaume-Uni] ; Akira Sano [Japon] ; Adrian Danek [Allemagne] ; Glenn Irvine [Royaume-Uni] ; Ruth H. Walker [États-Unis] | Third International Neuroacanthocytosis Symposium: The Asian Perspective |
| 002B31 |
Bart P. C. Van De Warrenburg [Royaume-Uni, Pays-Bas] ; Carla Cordivari [Royaume-Uni] ; Aisling M. Ryan [Royaume-Uni] ; Rahul Phadke [Royaume-Uni] ; Janice L. Holton [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Mike G. Hanna [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] | The phenomenon of disproportionate antecollis in Parkinson's disease and multiple system atrophy |
| 002B33 |
Kallol Ray Chaudhuri [Royaume-Uni] ; Pablo Martinez-Martin [Espagne] ; Richard G. Brown [Royaume-Uni] ; Kapil Sethi [États-Unis] ; Fabrizio Stocchi [Italie] ; Per Odin [Allemagne] ; William Ondo [États-Unis] ; Kazuo Abe [Japon] ; Graeme Macphee [Royaume-Uni] ; Doug Macmahon [Royaume-Uni] ; Paolo Barone [Italie] ; Martin Rabey [Israël] ; Alison Forbes [Royaume-Uni] ; Kieran Breen [Royaume-Uni] ; Susanne Tluk [Royaume-Uni] ; Yogini Naidu [Royaume-Uni] ; Warren Olanow [États-Unis] ; Adrian J. Williams [Royaume-Uni] ; Sue Thomas [Royaume-Uni] ; David Rye [États-Unis] ; Yoshio Tsuboi [Japon] ; Annette Hand [Royaume-Uni] ; Anthony H. V. Schapira [Royaume-Uni] | The metric properties of a novel non‐motor symptoms scale for Parkinson's disease: Results from an international pilot study |
| 002B35 |
Vasiliki Koukouni [Royaume-Uni] ; Davide Martino [Royaume-Uni, Italie] ; Gennarina Arabia [Royaume-Uni, Italie] ; Niall P. Quinn [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | The entity of young onset primary cervical dystonia |
| 002B36 |
Susanne A. Schneider [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | The entity of jaw tremor and dystonia |
| 002B49 |
Paolo Barone [Italie] ; Janice Lamb [Royaume-Uni] ; Amanda Ellis [Royaume-Uni] ; Zoe Clarke [Royaume-Uni] | Sumanirole versus placebo or ropinirole for the adjunctive treatment of patients with advanced Parkinson's disease |
| 002B56 |
Leonardo Bonilha [États-Unis] ; Paulien M. De Vries [Pays-Bas] ; Diana J. Vincent [États-Unis] ; Chris Rorden [États-Unis] ; Paul S. Morgan [Royaume-Uni] ; Mark W. Hurd [États-Unis] ; Nada Besenski [États-Unis] ; Kenneth J. Bergmann [États-Unis] ; Vanessa K. Hinson [États-Unis] | Structural white matter abnormalities in patients with idiopathic dystonia |
| 002B68 |
Hasmet Ayhan Hanagasi [Turquie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Janel O. Johnson [Royaume-Uni, États-Unis] ; Andrew Singleton [États-Unis] ; Murat Emre [Turquie] | Smoking‐responsive juvenile‐onset Parkinsonism |
| 002B74 |
Yoshitaka Yamanaka [Japon] ; Masato Asahina [Japon] ; Christopher J. Mathias [Royaume-Uni] ; Yuichi Akaogi [Japon] ; Yu Koyama [Japon] ; Takamichi Hattori [Japon] | Skin vasodilator response to local heating in multiple system atrophy |
| 002B79 |
Jonathan M. Schott [Royaume-Uni] ; David R. Williams [Royaume-Uni] ; Richard J. Butterworth [Royaume-Uni] ; John C. Janssen [Royaume-Uni] ; Andrew J. Larner [Royaume-Uni] ; Janice L. Holton [Royaume-Uni] ; Martin N. Rossor [Royaume-Uni] | Shunt responsive progressive supranuclear palsy? |
| 002B89 |
Lianna Ishihara [Royaume-Uni] ; Rachel A. Gibson [Royaume-Uni] ; Liling Warren [États-Unis] ; Rim Amouri [Tunisie] ; Kelly Lyons [États-Unis] ; Catherine Wielinski [États-Unis] ; Christine Hunter [États-Unis] ; Jina E. Swartz [Royaume-Uni] ; Ramu Elango [Royaume-Uni] ; P. Anthony Akkari [États-Unis] ; David Leppert [Royaume-Uni] ; Linda Surh [Royaume-Uni] ; Kevin H. Reeves [États-Unis] ; Siwan Thomas [Royaume-Uni] ; Leigh Ragone [États-Unis] ; Nobutaka Hattori [Japon] ; Rajesh Pahwa [États-Unis] ; Joseph Jankovic [États-Unis] ; Martha Nance [États-Unis] ; Alan Freeman [États-Unis] ; Neziha Gouider-Khouja [Tunisie] ; Mounir Kefi [Tunisie] ; Mourad Zouari [Tunisie] ; Samia Ben Sassi [Tunisie] ; Samia Ben Yahmed [Tunisie] ; Ghada El Euch-Fayeche [Tunisie] ; Lefkos Middleton [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Ray L. Watts [États-Unis] ; Faycal Hentati [Tunisie] | Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families |
| 002B91 |
Björn Holmberg [Suède] ; Jan-Ove Johansson [Suède] ; Werner Poewe [Autriche] ; Gregor Wenning [Autriche] ; Niall P. Quinn [Royaume-Uni] ; Chris Mathias [Royaume-Uni] ; Eduardo Tolosa [Espagne] ; Adriana Cardozo [Espagne] ; Nil Dizdar [Suède] ; Olivier Rascol [France] ; Tarik Slaoui [France] | Safety and tolerability of growth hormone therapy in multiple system atrophy: A double‐blind, placebo‐controlled study |
| 002B93 |
Nir Giladi [Israël] ; Babak Boroojerdi [Allemagne] ; Amos D. Korczyn [Israël] ; David J. Burn [Royaume-Uni] ; Carl E. Clarke [Royaume-Uni] ; Anthony H. V. Schapira [Royaume-Uni] | Rotigotine transdermal patch in early Parkinson's disease: A randomized, double‐blind, controlled study versus placebo and ropinirole |
| 002B95 |
Christoph Scherfler [Autriche] ; Johannes Schwarz [Allemagne] ; Angelo Antonini [Italie] ; Donald Grosset [Royaume-Uni] ; Francesc Valldeoriola [Espagne] ; Kenneth Marek [États-Unis] ; Wolfgang Oertel [Allemagne] ; Eduardo Tolosa [Espagne] ; Andrew Lees (neurologue) [Royaume-Uni] ; Werner Poewe [Autriche] | Role of DAT‐SPECT in the diagnostic work up of Parkinsonism |
| 002C09 |
Michele Hu [Royaume-Uni] ; David Brooks [Royaume-Uni] ; Jo Hajnal [Royaume-Uni] | Reply: Nigral degeneration and striatal dopaminergic dysfunction in idiopathic and parkin‐linked Parkinson's disease |
| 002C34 |
Donna Page [Royaume-Uni] ; Anthony Butler [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni] | Quality of life in focal, segmental, and generalized dystonia |
| 002C37 |
David R. Williams [Australie, Royaume-Uni] ; Janice L. Holton [Royaume-Uni] ; Kate Strand [Royaume-Uni] ; Tamas Revesz [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Pure akinesia with gait freezing: A third clinical phenotype of progressive supranuclear palsy |
| 002C51 |
Ibrahim M. Norlinah [Royaume-Uni, Malaisie] ; Kailash P. Bhatia [Royaume-Uni] ; Karen Stergaard [Danemark] ; Robin Howard [Royaume-Uni] ; Gennarina Arabia [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] | Primary lateral sclerosis mimicking atypical parkinsonism |
| 002C53 |
Pablo Martinez-Martin [Espagne] ; Anthony H. V. Schapira [Royaume-Uni] ; Fabrizio Stocchi [Italie] ; Kapil Sethi [États-Unis] ; Per Odin [Allemagne] ; Graeme Macphee ; Richard G. Brown [Royaume-Uni] ; Yogini Naidu [Royaume-Uni] ; Lisa Clayton [Royaume-Uni] ; Kazuo Abe [Japon] ; Yoshio Tsuboi [Japon] ; Dough Macmahon [Royaume-Uni] ; Paolo Barone [Italie] ; Martin Rabey [Israël] ; Ubaldo Bonuccelli [Italie] ; Alison Forbes [Royaume-Uni] ; Kieran Breen [Royaume-Uni] ; Susanne Tluk [Royaume-Uni] ; C. Warren Olanow [États-Unis] ; Sue Thomas [Royaume-Uni] ; David Rye [États-Unis] ; Annette Hand [Royaume-Uni] ; Adrian J. Williams [Royaume-Uni] ; William Ondo [États-Unis] ; K. Ray Chaudhuri [Royaume-Uni] | Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; Study using nonmotor symptoms questionnaire in 545 patients |
| 002C59 |
Birgit Herting [Allemagne] ; Bettina Beuthien-Baumann [Allemagne] ; Katrin Pöttrich [Allemagne] ; Markus Donix [Allemagne] ; Antje Triemer [Allemagne] ; Johannes B. Lampe [Allemagne] ; Rüdiger Von Kummer [Allemagne] ; Karl Herholz [Royaume-Uni] ; Heinz Reichmann [Allemagne] ; Vjera A. Holthoff [Allemagne] | Prefrontal cortex dysfunction and depression in atypical parkinsonian syndromes |
| 002C63 |
Andrew J. Lawrence [Royaume-Uni] ; Andrew D. Blackwell [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] ; Francesca Spagnolo [Italie] ; Luke Clark [Royaume-Uni] ; Michael R. F. Aitken [Royaume-Uni] ; Barbara J. Sahakian [Royaume-Uni] | Predictors of punding in Parkinson's disease: Results from a questionnaire survey |
| 002C65 |
Paul Mccrone [Royaume-Uni] ; Liesl M. Allcock [Royaume-Uni] ; David J. Burn [Royaume-Uni] | Predicting the cost of Parkinson's disease |
| 002C72 |
Katherine Grosset [Royaume-Uni] ; Donald Grosset [Royaume-Uni] | Pill counts, self reports, and electronic monitoring—Which is most informative in the study of therapy adherence in Parkinson's disease? |
| 002C77 |
Bart P. C. Van De Warrenburg [Royaume-Uni, Pays-Bas] ; Carla Cordivari [Royaume-Uni] ; Peter Brown [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Persisting hyperekplexia after idiopathic, self‐limiting brainstem encephalopathy |
| 002C81 |
Susanne A. Schneider [Royaume-Uni] ; Mark J. Edwards [Royaume-Uni] ; Pablo Mir [Royaume-Uni, Espagne] ; Carla Cordivari [Royaume-Uni] ; Juzar Hooker [Royaume-Uni] ; John Dickson [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Patients with adult‐onset dystonic tremor resembling parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs) |
| 002C96 |
Philip Duffey [Royaume-Uni] ; Neil Jenkins [Royaume-Uni] ; David King [Royaume-Uni] | Palatal tremor and orofacial stereotypies within the locked‐in syndrome |
| 002D28 |
Anjum Misbahuddin [Royaume-Uni] ; Mark Placzek [Royaume-Uni] ; Graham Lennox [Royaume-Uni] ; Jan-Willem Taanman [Royaume-Uni] ; Thomas T. Warner [Royaume-Uni] | Myoclonus–dystonia syndrome with severe depression is caused by an exon‐skipping mutation in the ε‐sarcoglycan gene |
| 002D84 |
David R. Williams [Royaume-Uni] | James Parkinson's London |
| 002D88 |
Ronald B. Postuma [Canada] ; Christina Wolfson [Canada] ; Ali Rajput [Canada] ; A. Jon Stoessl [Canada] ; W. R. Wayne Martin [Canada] ; Oksana Suchowersky [Canada] ; Sylvain Chouinard [Canada] ; Michel Panisset [Canada] ; Mandar S. Jog [Royaume-Uni] ; David A. Grimes [Canada] ; Connie Marras [Canada] ; Anthony E. Lang [Canada] | Is there seasonal variation in risk of Parkinson's disease? |
| 002D94 |
Sui H. Wong [Royaume-Uni] ; Zenita Cowen [Royaume-Uni] ; Elizabeth Anne Allen [Royaume-Uni] ; Peter K. Newman [Royaume-Uni] | Internet gambling and other pathological gambling in Parkinson's disease: A case series |
| 002E25 |
David Gosal [Irlande (pays)] ; Timothy Lynch [Irlande (pays)] ; Owen A. Ross [États-Unis] ; Kristoffer Haugarvoll [États-Unis] ; Matthew J. Farrer [États-Unis] ; J. Mark Gibson [Royaume-Uni] | Global distribution and reduced penetrance: Lrrk2 R1441C in an Irish Parkinson's disease kindred |
| 002E28 |
David R. Williams [Royaume-Uni] ; Alan M. Pittman [Royaume-Uni] ; Tamas Revesz [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Rohan De Silva [Royaume-Uni] | Genetic variation at the tau locus and clinical syndromes associated with progressive supranuclear palsy |
| 002E36 |
Anthony H. V. Schapira [Royaume-Uni] | Future directions in the treatment of Parkinson's disease |
| 002E37 |
Irena Rektorova [République tchèque] ; Jennifer Barrett [Canada] ; Michal Mikl [République tchèque] ; Ivan Rektor [République tchèque] ; Tomas Paus [Canada, Royaume-Uni] | Functional abnormalities in the primary orofacial sensorimotor cortex during speech in Parkinson's disease |
| 002E43 |
Joseph H. Friedman [États-Unis] ; Richard G. Brown [Royaume-Uni] ; Cynthia Comella [États-Unis] ; Carol E. Garber [États-Unis] ; Lauren B. Krupp [États-Unis] ; Jau-Shin Lou [États-Unis] ; Laura Marsh [États-Unis] ; Lillian Nail [États-Unis] ; Lisa Shulman [États-Unis] ; C. Barr Taylor [États-Unis] | Fatigue in Parkinson's disease: A review |
| 002E51 |
Stefan J. Cano [Royaume-Uni] ; Alan J. Thompson [Royaume-Uni] ; Khailash Bhatia [Royaume-Uni] ; Ray Fitzpatrick [Royaume-Uni] ; Thomas T. Warner [Royaume-Uni] ; Jeremy C. Hobart [Royaume-Uni] | Evidence‐based guidelines for using the Short Form 36 in cervical dystonia |
| 002E77 |
Prasanth M. Raju [Royaume-Uni] ; Richard W. Walker [Royaume-Uni] ; Mark A. Lee [Royaume-Uni] | Dyskinesia induced by gabapentin in idiopathic Parkinson's disease |
| 002E86 |
Eman M. Khedr [Égypte] ; John C. Rothwell [Royaume-Uni] ; Ola A. Shawky [Égypte] ; Mohammed A. Ahmed [Égypte] ; Nageh Foly K [Égypte] ; Ahmed Hamdy [Égypte] | Dopamine levels after repetitive transcranial magnetic stimulation of motor cortex in patients with Parkinson's disease: Preliminary results |
| 002E92 |
Dominic C. Paviour [Royaume-Uni] ; John S. Thornton [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; H. Rolf J Ger [Royaume-Uni] | Diffusion‐weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple‐system atrophy from progressive supranuclear palsy |
| 002E96 |
Daniel G. Healy [Royaume-Uni] | Did Géricault's “Madwoman Obsessed With Gambling” have Parkinson's disease? |
| 002E97 |
Bruno Dubois [France] ; David Burn [Royaume-Uni] ; Christopher Goetz [États-Unis] ; Dag Aarsland [Norvège] ; Richard G. Brown [Royaume-Uni] ; Gerald A. Broe [Australie] ; Dennis Dickson [États-Unis] ; Charles Duyckaerts [France] ; Jefferey Cummings [États-Unis] ; Serge Gauthier [Canada] ; Amos Korczyn [Israël] ; Andrew Lees (neurologue) [Royaume-Uni] ; Richard Levy [France] ; Irene Litvan [États-Unis] ; Yoshikuni Mizuno [Japon] ; Ian G. Mckeith [Royaume-Uni] ; C. Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Eduardo Tolosa [Espagne] ; Murat Emre [Turquie] | Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force |
| 002E99 |
Bernard Ravina [États-Unis] ; Karen Marder [États-Unis] ; Hubert H. Fernandez [États-Unis] ; Joseph H. Friedman [États-Unis] ; William Mcdonald [États-Unis] ; Diane Murphy [États-Unis] ; Dag Aarsland [États-Unis] ; Debra Babcock [États-Unis] ; Jefferey Cummings [États-Unis] ; Jean Endicott [États-Unis] ; Stewart Factor [États-Unis] ; Wendy Galpern [États-Unis] ; Andrew Lees (neurologue) [Royaume-Uni] ; Laura Marsh [États-Unis] ; Mark Stacy [États-Unis] ; Katrina Gwinn-Hardy [États-Unis] ; Valerie Voon [États-Unis] ; Christopher Goetz [États-Unis] | Diagnostic criteria for psychosis in Parkinson's disease: Report of an NINDS, NIMH work group |
| 002F00 |
Graeme J. A. Macphee [Royaume-Uni] ; David A. Stewart [Royaume-Uni] | Diagnosis of Parkinsonism in older patients receiving sodium valproate |
| 002F12 |
Anne-Fleur Van Rootselaar [Pays-Bas] ; Sandra M. A. Van Der Salm [Pays-Bas] ; Lo J. Bour [Pays-Bas] ; Mark J. Edwards [Royaume-Uni] ; Peter Brown [Royaume-Uni] ; Eleonora Aronica [Pays-Bas] ; Johanna M. Rozemuller-Kwakkel [Pays-Bas] ; Peter J. Koehler [Pays-Bas] ; Johannes H. T. M. Koelman [Pays-Bas] ; John C. Rothwell [Royaume-Uni] ; Marina A. J. Tijssen [Pays-Bas] | Decreased cortical inhibition and yet cerebellar pathology in ‘familial cortical myoclonic tremor with epilepsy’ |
| 002F15 |
Shankar Kamath [Royaume-Uni] ; Nin Bajaj [Royaume-Uni] | Crack dancing in the United Kingdom: Apropos a video case presentation |
| 002F16 |
John V. Hindle [Royaume-Uni] ; Catherine M. Hindle [Royaume-Uni] ; Peter Hobson [Royaume-Uni] | Co‐morbidity and the frequency of general practitioner consultations in Parkinson's disease in the United Kingdom |
| 002F54 |
Wayne A. Hening [États-Unis] ; Richard P. Allen [États-Unis] ; K. Ray Chaudhuri [Royaume-Uni] ; Magdolna Hornyak [Allemagne] ; Hochang B. Lee [États-Unis] ; John Winkelman [États-Unis] ; Robert Yoakum [États-Unis] | Clinical significance of RLS |
| 002F55 |
Friedrich Asmus [Allemagne] ; Anita Devlin [Royaume-Uni] ; Marita Munz [Allemagne] ; Alexander Zimprich [Autriche] ; Thomas Gasser [Allemagne] ; Patrick F. Chinnery [Royaume-Uni] | Clinical differentiation of genetically proven benign hereditary chorea and myoclonus‐dystonia |
| 002F56 |
Murat Emre [Turquie] ; Dag Aarsland [Norvège] ; Richard Brown [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Charles Duyckaerts [France] ; Yoshikino Mizuno [Japon] ; Gerald Anthony Broe [Australie] ; Jeffrey Cummings [États-Unis] ; Dennis W. Dickson [États-Unis] ; Serge Gauthier [Canada] ; Jennifer Goldman [États-Unis] ; Christopher Goetz [États-Unis] ; Amos Korczyn [Israël] ; Andrew Lees (neurologue) [Royaume-Uni] ; Richard Levy [France] ; Irene Litvan [États-Unis] ; Ian Mckeith [Royaume-Uni] ; Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; Christina Sampaio [Portugal] ; Eduardo Tolosa [Espagne] ; Bruno Dubois [France] | Clinical diagnostic criteria for dementia associated with Parkinson's disease |
| 002F57 |
Christopher Turner [Royaume-Uni] ; J. Mark Cooper [Royaume-Uni] ; Anthony H. V. Schapira [Royaume-Uni] | Clinical correlates of mitochondrial function in Huntington's disease muscle |
| 002F61 |
Paul T. Francis [Royaume-Uni] ; Elaine K. Perry [Royaume-Uni] | Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies |
| 002F67 |
John M. Walshe [Royaume-Uni] | Cause of death in Wilson disease |
| 002F86 |
Jagdish C. Sharma [Royaume-Uni] | Body weight in patients with Parkinson's disease |
| 002F87 |
Hee T. Kim [Royaume-Uni] ; Mark J. Edwards [Royaume-Uni] ; Jess Tyson [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Maria Bitner-Glindzicz [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Blepharospasm and limb dystonia caused by Mohr‐Tranebjaerg syndrome with a novel splice‐site mutation in the deafness/dystonia peptide gene |
| 002F94 |
Naomi M. Warren [Royaume-Uni] ; Margaret A. Piggott [Royaume-Uni] ; Elizabeth Greally [Royaume-Uni] ; Michelle Lake [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; David J. Burn [Royaume-Uni] | Basal ganglia cholinergic and dopaminergic function in progressive supranuclear palsy |
| 003018 |
Regina Katzenschlager [Royaume-Uni, Autriche] ; Michael J. Jackson [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; Kim Stockwell [Royaume-Uni] ; Kayhan A. Tayarani-Binazir [Royaume-Uni] ; Mohammed Zubair [Royaume-Uni] ; Lance A. Smith [Royaume-Uni] ; Peter Jenner [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Antiparkinsonian activity of L‐propyl‐L‐leucyl‐glycinamide or melanocyte‐inhibiting factor in MPTP‐treated common marmosets |
| 003019 |
Davide Martino [Royaume-Uni, Italie] ; Giovanni Defazio [Italie] ; Andrew J. Church [Royaume-Uni] ; Russell C. Dale [Royaume-Uni] ; Gavin Giovannoni [Royaume-Uni] ; Mary M. Robertson [Royaume-Uni] ; Michael Orth [Royaume-Uni] | Antineuronal antibody status and phenotype analysis in Tourette's syndrome |
| 003028 |
Elizabeth Coulthard [Royaume-Uni] ; Anthony Rudd [Royaume-Uni] ; E. Diane Playford [Royaume-Uni] ; Musad Husain [Royaume-Uni] | Alien limb following posterior cerebral artery stroke: Failure to recognize internally generated movements? |
| 003043 |
Tobias B Umer [Allemagne] ; Cüneyt Demiralay [Allemagne] ; Ute Hidding [Allemagne] ; Rosalia Bikmullina [Allemagne] ; Rick C. Helmich [Allemagne] ; Silke Wunderlich [Allemagne] ; John Rothwell [Royaume-Uni] ; Joachim Liepert [Allemagne] ; Hartwig R. Siebner [Allemagne] ; Alexander Münchau [Allemagne] | Abnormal plasticity of the sensorimotor cortex to slow repetitive transcranial magnetic stimulation in patients with writer's cramp |
| 003054 |
Rob J. Forsyth [Royaume-Uni] ; Artemis D. Gika [Royaume-Uni] ; Ieke Ginjaar [Pays-Bas] ; Marina A. J. Tijssen [Pays-Bas] | A novel GLRA1 mutation in a recessive hyperekplexia pedigree |
| 003058 |
Ruth M. Pickering [Royaume-Uni] ; Yvette A. M. Grimbergen [Pays-Bas] ; Una Rigney [Royaume-Uni] ; Ann Ashburn [Royaume-Uni] ; Gordon Mazibrada [Royaume-Uni] ; Brian Wood [Royaume-Uni] ; Peggy Gray [Canada] ; Graham Kerr [Australie] ; Bastiaan R. Bloem [Pays-Bas] | A meta‐analysis of six prospective studies of falling in Parkinson's disease |
| 003062 |
Carlos Singer [États-Unis] ; Janice Lamb [Royaume-Uni] ; Amanda Ellis [Royaume-Uni] ; Gary Layton [Royaume-Uni] | A comparison of sumanirole versus placebo or ropinirole for the treatment of patients with early Parkinson's disease |
| 003063 |
Pooja Dassan [Royaume-Uni] ; Charles Clarke [Royaume-Uni] ; David J. Sharp [Royaume-Uni] | A case of poststreptococcal opsoclonus‐myoclonus syndrome |
| 003068 |
Jan Zijlmans [Royaume-Uni, Pays-Bas] ; Andrew Evans [Royaume-Uni] ; Flavia Fontes [Royaume-Uni] ; Regina Katzenschlager [Royaume-Uni, Autriche] ; Svetoslav Gacinovic [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Durval Costa [Royaume-Uni, Portugal] | [123I] FP-CIT spect study in vascular parkinsonism and Parkinson's disease |
| 003070 |
Kallol Ray Chaudhuri [Royaume-Uni] ; Pablo Martinez-Martin [Espagne] ; Richard G. Brown [Royaume-Uni] ; Kapil Sethi [États-Unis] ; Fabrizio Stocchi [Italie] ; Per Odin [Allemagne] ; William Ondo [États-Unis] ; Kazu Abe [Japon] ; Graeme Macphee [Royaume-Uni] ; Doug Macmahon [Royaume-Uni] ; Paolo Barone [Italie] ; Martin Rabey [Israël] ; Alison Forbes ; Kieran Breen [Royaume-Uni] ; Susanne Tluk [Royaume-Uni] ; Yogini Naidu [Royaume-Uni] ; Warren Olanow [États-Unis] ; Adrian J. Williams [Royaume-Uni] ; Sue Thomas [Royaume-Uni] ; David Rye [États-Unis] ; Yoshio Tsuboi [Japon] ; Annette Hand [Royaume-Uni] ; Anthony H. V. Schapira [Royaume-Uni] | The metric properties of a novel non-motor symptoms scale for parkinson's disease : Results from an international pilot study |
| 003074 |
Hasmet Ayhan Hanagasi [Turquie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Janel O. Johnson [Royaume-Uni, États-Unis] ; Andrew Singleton [États-Unis] ; Murat Emre [Turquie] | Smoking-responsive juvenile-onset Parkinsonism |
| 003080 |
Pablo Martinez-Martin [Espagne] ; Anthony H. V. Schapira [Royaume-Uni] ; Fabrizio Stocchi [Italie] ; Kapil Sethi [États-Unis] ; Per Odin [Allemagne] ; Graeme Macphee [Royaume-Uni] ; Richard G. Brown [Royaume-Uni] ; Yogini Naidu [Royaume-Uni] ; Lisa Clayton [Royaume-Uni] ; Kazuo Abe [Japon] ; Yoshio Tsuboi [Japon] ; Dough Macmahon [Royaume-Uni] ; Paolo Barone [Italie] ; Martin Rabey [Israël] ; Ubaldo Bonuccelli [Italie] ; Alison Forbes [Royaume-Uni] ; Kieran Breen [Royaume-Uni] ; Susanne Tluk [Royaume-Uni] ; C. Warren Olanow [États-Unis] ; Sue Thomas [Royaume-Uni] ; David Rye [États-Unis] ; Annette Hand [Royaume-Uni] ; Adrian J. Williams [Royaume-Uni] ; William Ondo [États-Unis] ; K. Ray Chaudhuri [Royaume-Uni] | Prevalence of nonmotor symptoms in parkinson's disease in an international setting; Study using nonmotor symptoms questionnaire in 545 patients |
| 003119 |
Lianna Ishihara [Royaume-Uni] ; Carol Brayne [Royaume-Uni] | What is the evidence for a premorbid parkinsonian personality: A systematic review |
| 003131 |
Christoph Scherfler [Royaume-Uni] ; Naheed L. Khan [Royaume-Uni] ; Nicola Pavese [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; David J. Brooks [Royaume-Uni] ; Paola P. Piccini [Royaume-Uni] | Upregulation of dopamine D2 receptors in dopaminergic drug‐naive patients with parkin gene mutations |
| 003137 |
Jamal Nasir [Royaume-Uni] ; Nafsika Frima [Royaume-Uni] ; Ben Pickard [Royaume-Uni] ; M. Pat Malloy [Royaume-Uni] ; Lingping Zhan [Royaume-Uni] ; Richard Grünewald [Royaume-Uni] | Unbalanced whole arm translocation resulting in loss of 18p in dystonia |
| 003149 |
Andrew Lees (neurologue) [Royaume-Uni] | The Progressive Supranuclear Palsy Association's Fifth International Medical Workshop |
| 003150 |
Alexandre Castro-Caldas [Portugal] ; Paul Delwaide [Belgique] ; Wolfgang Jost [Allemagne] ; Marcelo Merello [Argentine] ; Adrian Williams [Royaume-Uni] ; Paolo Lamberti [Italie] ; Miguel Aguilar [Espagne] ; Susanna Del Signore [France] ; Pierre Cesaro [France] | The Parkinson–Control study: A 1‐year randomized, double‐blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease |
| 003151 |
Ina Schmitt [Allemagne] ; Ullrich Wüllner [Allemagne] ; Daniel G. Healy [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] ; Heike Kölsch [Allemagne] ; Reinhard Heun [Allemagne] | The ADH1C stop mutation in multiple system atrophy patients and healthy probands in the United Kingdom and Germany |
| 003154 |
Michele Tinazzi [Italie] ; Mirta Fiorio [Italie] ; Clementina Stanzani [Italie] ; Giuseppe Moretto [Italie] ; Nicola Smania [Italie] ; Antonio Fiaschi [Italie] ; Kailash P. Bhatia [Royaume-Uni] ; John C. Rothwell [Royaume-Uni] | Temporal discrimination of two passive movements in writer's cramp |
| 003166 |
Vicky L. Marshall [Royaume-Uni] ; Jim Patterson [Royaume-Uni] ; Donald M. Hadley [Royaume-Uni] ; Katherine A. Grosset [Royaume-Uni] ; Donald G. Grosset [Royaume-Uni] | Successful antiparkinsonian medication withdrawal in patients with Parkinsonism and normal FP‐CIT SPECT |
| 003176 |
Michelle J. Porritt [Australie] ; Ann E. Kingsbury [Royaume-Uni] ; Andrew J. Hughes [Australie] ; David W. Howells [Australie] | Striatal dopaminergic neurons are lost with Parkinson's disease progression |
| 003183 |
Daan J. Kamphuis [Pays-Bas] ; Hans Koelman [Pays-Bas] ; Andrew Lees (neurologue) [Royaume-Uni] ; Marina A. J. Tijssen [Pays-Bas] | Sporadic rapid‐onset dystonia–parkinsonism presenting as Parkinson's disease |
| 003192 |
Dennis A. Nowak [Royaume-Uni, Allemagne] ; Stephen Tisch [Royaume-Uni] ; Marwan Hariz [Royaume-Uni] ; Patricia Limousin [Royaume-Uni] ; Helge Topka [Allemagne] ; John C. Rothwell [Royaume-Uni] | Sensory timing cues improve akinesia of grasping movements in Parkinson's disease: A comparison to the effects of subthalamic nucleus stimulation |
| 003196 |
Carla Cordivari [Royaume-Uni] ; Vijay Peter Misra [Royaume-Uni] ; Angela Vincent [Royaume-Uni] ; Santiago Catania [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Andrew John Lees [Royaume-Uni] | Secondary nonresponsiveness to botulinum toxin A in cervical dystonia: The role of electromyogram‐guided injections, botulinum toxin A antibody assay, and the extensor digitorum brevis test |
| 003199 |
Kirstie N. Anderson [Royaume-Uni] ; Ian E. Smith [Royaume-Uni] ; John M. Shneerson [Royaume-Uni] | Rhythmic movement disorder (head banging) in an adult during rapid eye movement sleep |
| 003213 |
Tanja Schmitz-Hübsch [Allemagne] ; Sophie Tezenas Du Montcel [France] ; Laszlo Baliko [Hongrie] ; Sylvia Boesch [Autriche] ; Sara Bonato [Belgique] ; Roberto Fancellu [Italie] ; Paola Giunti [Royaume-Uni] ; Christoph Globas [Allemagne] ; Jun-Suk Kang [Allemagne] ; Berry Kremer [Pays-Bas] ; Caterina Mariotti [Italie] ; Bela Melegh [Hongrie] ; Maryla Rakowicz [Pologne] ; Rafal Rola [Pologne] ; Sylvie Romano [Italie] ; Lodger Schöls [Allemagne] ; Sandra Szymanski [Allemagne] ; Bart P. C. Van De Warrenburg [Pays-Bas] ; Elzbieta Zdzienicka [Pologne] ; Alexandra Dürr [France] ; Thomas Klockgether [Allemagne] | Reliability and validity of the International Cooperative Ataxia Rating Scale: A study in 156 spinocerebellar ataxia patients |
| 003217 |
Dominic C. Paviour [Royaume-Uni] ; Shona L. Price [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Nick C. Fox [Royaume-Uni] | Regional brain volumes distinguish PSP, MSA‐P, and PD: MRI‐based clinico‐radiological correlations |
| 003219 |
Alex J. Sinclair [Royaume-Uni] ; Lucy Barling [Royaume-Uni] ; Simon Nightingale [Royaume-Uni] | Recurrent dystonia in homocystinuria: A metabolic pathogenesis |
| 003231 |
Laura Silveira-Moriyama [Royaume-Uni] ; Andrew H. Evans [Royaume-Uni] ; Regina Katzenschlager [Royaume-Uni, Autriche] ; Andrew Lees (neurologue) [Royaume-Uni] | Punding and dyskinesias |
| 003241 |
Felix Geser [Autriche] ; Gregor K. Wenning [Autriche] ; Klaus Seppi [Autriche] ; Michaela Stampfer-Kountchev [Autriche] ; Christoph Scherfler [Autriche] ; Martin Sawires [Autriche] ; Carolin Frick [Autriche] ; Jean-Pierre Ndayisaba [Autriche] ; Hanno Ulmer [Autriche] ; Maria T. Pellecchia [Italie] ; Paolo Barone [Italie] ; Hee T. Kim [Royaume-Uni] ; Juzar Hooker [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Adriana Cardozo [Espagne] ; Eduardo Tolosa [Espagne] ; Michael Abele [Allemagne] ; Thomas Klockgether [Allemagne] ; Karen Stergaard [Danemark] ; Erik Dupont [Danemark] ; Nicole Schimke [Allemagne] ; Karla M. Eggert [Allemagne] ; Wolfgang Oertel [Allemagne] ; Ruth Djaldetti [Israël] ; Werner Poewe [Autriche] | Progression of multiple system atrophy (MSA): A prospective natural history study by the European MSA Study Group (EMSA SG) |
| 003243 |
Katherine A. Grosset [Royaume-Uni] ; Graeme Macphee [Royaume-Uni] ; Guru Pal [Royaume-Uni] ; David Stewart [Royaume-Uni] ; Andrew Watt [Royaume-Uni] ; Jim Davie [Royaume-Uni] ; D. G. Grosset [Royaume-Uni] | Problematic gambling on dopamine agonists: Not such a rarity |
| 003248 |
Jens Carsten Möller [Allemagne] ; Barbara Leinweber [Allemagne] ; Ida Rissling [Allemagne] ; Wolfgang Herman Oertel [Allemagne] ; Oliver Bandmann [Royaume-Uni] ; Hartmut H. Schmidt [Allemagne] | Prevalence of the H1069Q mutation in ATP7B in discordant pairs with early‐onset Parkinson's Disease |
| 003255 |
Alessandro Paluzzi [Royaume-Uni] ; Peter G. Bain [Royaume-Uni] ; Xuguang Liu [Royaume-Uni] ; John Yianni [Royaume-Uni] ; Kumar Kumarendran [Royaume-Uni] ; Tipu Z. Aziz [Royaume-Uni] | Pregnancy in dystonic women with in situ deep brain stimulators |
| 003276 |
Kate S. M. Taylor [Royaume-Uni] ; Carl E. Counsell [Royaume-Uni] ; Clare E. Harris [Royaume-Uni] ; Joanna C. Gordon [Royaume-Uni] ; W. Cairns S. Smith [Royaume-Uni] | Pilot study of the incidence and prognosis of degenerative Parkinsonian disorders in Aberdeen, United Kingdom: Methods and preliminary results |
| 003278 |
Wolfgang H. Oertel [Allemagne] ; Erik Wolters [Pays-Bas] ; Cristina Sampaio [Portugal] ; Santiago Gimenez-Roldan [Espagne] ; Bruno Bergamasco [Italie] ; Max Dujardin [France] ; Donald G. Grosset [Royaume-Uni] ; Guy Arnold [Allemagne] ; Klaus L. Leenders [Pays-Bas] ; Hans-Peter Hundemer [États-Unis] ; Alberto Lled [États-Unis] ; Andrew Wood [États-Unis] ; Paul Frewer [États-Unis] ; Johannes Schwarz [Allemagne] | Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study |
| 003279 |
Paula R. Arantes [Brésil] ; Ellison F. Cardoso [Brésil] ; Maria Barreiros [Brésil] ; Manoel J. Teixeira [Brésil] ; Márcia R. Gonçalves [Brésil] ; Egberto R. Barbosa [Brésil] ; Sukhi Shergill Sukwinder [Royaume-Uni] ; Claudia C. Leite [Brésil] ; Edson Amaro Jr. [Brésil, Royaume-Uni] | Performing functional magnetic resonance imaging in patients with Parkinson's disease treated with deep brain stimulation |
| 003304 |
Peter Feys [Belgique] ; Werner F. Helsen [Belgique] ; Sabine Verschueren [Belgique] ; Stephan P. Swinnen [Belgique] ; Isabel Klok [Belgique] ; Ann Lavrysen [Belgique] ; Bart Nuttin [Belgique] ; Pierre Ketelaer [Belgique] ; Xuguang Liu [Royaume-Uni] | Online movement control in multiple sclerosis patients with tremor: Effects of tendon vibration |
| 003316 |
Caroline H. Williams-Gray [Royaume-Uni] ; An Goris [Royaume-Uni, Belgique] ; Thomas Foltynie [Royaume-Uni] ; Joanne Brown [Royaume-Uni] ; Melanie Maranian [Royaume-Uni] ; Amie Walton [Royaume-Uni] ; D. Alastair Compston [Royaume-Uni] ; Stephen J. Sawcer [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] | No alterations in α‐synuclein gene dosage observed in sporadic Parkinson's disease |
| 003317 |
Michele T. M. Hu [Royaume-Uni] ; Christoph Scherfler [Royaume-Uni] ; Naheed L. Khan [Royaume-Uni] ; Jo V. Hajnal [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] ; David J. Brooks [Royaume-Uni] | Nigral degeneration and striatal dopaminergic dysfunction in idiopathic and parkin‐linked Parkinson's disease |
| 003319 |
Paola Piccini [Royaume-Uni] ; David J. Brooks [Royaume-Uni] | New developments of brain imaging for Parkinson's disease and related disorders |
| 003323 |
Meirav Balas [Israël] ; Chava Peretz [Israël] ; Samih Badarny [Israël] ; Richard B. Scott [Royaume-Uni] ; Nir Giladi [Israël] | Neuropsychological profile of DYT1 dystonia |
| 003328 |
Johannes Brettschneider [Allemagne] ; Axel Petzold [Royaume-Uni] ; Sigurd D. Sü Muth [Allemagne] ; Georg B. Landwehrmeyer [Allemagne] ; Albert C. Ludolph [Allemagne] ; Jan Kassubek [Allemagne] ; Hayrettin Tumani [Allemagne] | Neurofilament heavy‐chain NfHSMI35 in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromes |
| 003330 |
Daniel G. Healy [Royaume-Uni] ; Patrick M. Abou-Sleiman [Royaume-Uni] ; Kourosh R. Ahmadi [Royaume-Uni] ; Sonia Gandhi [Royaume-Uni] ; Miratul M. Muqit [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Janice L. Holton [Royaume-Uni] ; Tamas Revesz [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] | NR4A2 genetic variation in sporadic Parkinson's disease: A genewide approach |
| 003346 |
Uday B. Muthane [Inde] ; Yasha T. Chickabasaviah [Inde] ; Jasmine Henderson [Australie] ; Ann E. Kingsbury [Royaume-Uni] ; Linda Kilford [Royaume-Uni] ; Susarla K. Shankar [Inde] ; D. K. Subbakrishna [Inde] ; Andrew Lees (neurologue) [Royaume-Uni] | Melanized nigral neuronal numbers in Nigerian and British individuals |
| 003347 |
Andrew J. Larner [Royaume-Uni] | Medical hazards of the internet: Gambling in Parkinson's disease |
| 003359 |
Davina J. Hensman [Royaume-Uni] ; Peter G. Bain [Royaume-Uni] | Levodopa can worsen tremor associated with dystonia |
| 003366 |
Hon-Chung Fung [États-Unis, Royaume-Uni, Taïwan] ; Chiung-Mei Chen [Taïwan] ; John Hardy [États-Unis, Royaume-Uni] ; Dena Hernandez [États-Unis] ; Andrew Singleton [États-Unis] ; Yih-Ru Wu [Taïwan] | Lack of G2019S LRRK2 mutation in a cohort of Taiwanese with sporadic Parkinson's disease |
| 003376 |
Kallol Ray Chaudhuri [Royaume-Uni] ; Pablo Martinez-Martin [Espagne] ; Anthony H. V. Schapira [Royaume-Uni] ; Fabrizio Stocchi [Italie] ; Kapil Sethi [États-Unis] ; Per Odin [Allemagne] ; Richard G. Brown [Royaume-Uni] ; William Koller [États-Unis] ; Paolo Barone [Italie] ; Graeme Macphee [Royaume-Uni] ; Linda Kelly [Royaume-Uni] ; Martin Rabey [Israël] ; Doug Macmahon [Royaume-Uni] ; Sue Thomas [Royaume-Uni] ; William Ondo [États-Unis] ; David Rye [États-Unis] ; Alison Forbes [Royaume-Uni] ; Susanne Tluk [Royaume-Uni] ; Vandana Dhawan [Royaume-Uni] ; Annette Bowron [Royaume-Uni] ; Adrian J. Williams [Royaume-Uni] ; Charles W. Olanow [États-Unis] | International multicenter pilot study of the first comprehensive self‐completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study |
| 003380 |
Mark A. Lee [Royaume-Uni] ; Richard W. Walker [Royaume-Uni] ; Anthony J. Hildreth [Royaume-Uni] ; Wendy M. Prentice [Royaume-Uni] | Individualized assessment of quality of life in idiopathic Parkinson's disease |
| 003383 |
Alexander Gerhard [Royaume-Uni] ; Iris Trender-Gerhard [Royaume-Uni] ; Federico Turkheimer [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; David J. Brooks [Royaume-Uni] | In vivo imaging of microglial activation with [11C](R)‐PK11195 PET in progressive supranuclear palsy |
| 003388 |
Emma L. Stack [Royaume-Uni] ; Ann M. Ashburn [Royaume-Uni] | Impaired bed mobility and disordered sleep in Parkinson's disease |
| 003394 |
Philip Duffey [Royaume-Uni] ; Caroline Brown [Royaume-Uni] | Iatrogenic botulism in an amateur weight‐lifter |
| 003398 |
Aileen K. Ho [Royaume-Uni] ; Anna O. G. Robbins [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] | Huntington's disease patients have selective problems with insight |
| 003400 |
Dominic C. Paviour [Royaume-Uni] ; H. Rolf J Ger [Royaume-Uni] ; Leonora Wilkinson [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Holmes tremor: Application of modern neuroimaging techniques |
| 003401 |
John M. Walshe [Royaume-Uni] | History of Wilson's disease: 1912 to 2000 |
| 003406 |
Tim M. Young [Royaume-Uni] ; Masato Asahina [Royaume-Uni, Japon] ; Laura Watson [Royaume-Uni] ; Christopher J. Mathias [Royaume-Uni] | Hemodynamic effects of clonidine in two contrasting models of autonomic failure: Multiple system atrophy and pure autonomic failure |
| 003440 |
Julie Kaye [Royaume-Uni] ; Heather Gage [Royaume-Uni] ; Alan Kimber [Royaume-Uni] ; Lesley Storey [Royaume-Uni] ; Patrick Trend [Royaume-Uni] | Excess burden of constipation in Parkinson's disease: A pilot study |
| 003457 |
David Burn [Royaume-Uni] ; Murat Emre [Turquie] ; Ian Mckeith [Royaume-Uni] ; Peter Paul De Deyn [Belgique] ; Dag Aarsland [Norvège] ; Chuanchieh Hsu [États-Unis] ; Roger Lane [États-Unis] | Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease |
| 003458 |
Aurélie Funkiewiez [France] ; Claire Ardouin [France] ; Roshan Cools [Royaume-Uni] ; Paul Krack [France] ; Valérie Fraix [France] ; Alina Batir [France] ; Stephan Chabardès [France] ; Alim-Louis Benabid [France] ; Trevor W. Robbins [Royaume-Uni] ; Pierre Pollak [France] | Effects of levodopa and subthalamic nucleus stimulation on cognitive and affective functioning in Parkinson's disease |
| 003465 |
Eman M. Khedr [Égypte] ; John C. Rothwell [Royaume-Uni] ; Ola A. Shawky [Égypte] ; Mohamed A. Ahmed [Égypte] ; Ahmed Hamdy [Égypte] | Effect of daily repetitive transcranial magnetic stimulation on motor performance in Parkinson's disease |
| 003470 |
Olivier Rascol [France] ; Bruno Dubois [France] ; Alexandre Castro Caldas [Portugal] ; Stephen Senn [Royaume-Uni] ; Susanna Del Signore [France] ; Andrew Lees (neurologue) [Royaume-Uni] | Early piribedil monotherapy of Parkinson's disease: A planned seven‐month report of the REGAIN study |
| 003484 |
Xuguang Liu [Royaume-Uni] ; Peter G. Bain [Royaume-Uni] | Direction of tremor oscillation in spiral drawings reveals proximal versus distal muscle involvement |
| 003490 |
Francisco Cardoso [Brésil] ; Andrew Lees (neurologue) [Royaume-Uni] | Did Gustav Mahler have Sydenham's chorea? |
| 003492 |
Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Amos D. Korczyn [Israël] ; Peter P. De Deyn [Belgique] ; Carl E. Clarke [Royaume-Uni] ; Anthony E. Lang [Canada] ; Mona Abdalla [Royaume-Uni] | Development of dyskinesias in a 5‐year trial of ropinirole and L‐dopa |
| 003502 |
Ali R. Rezai [États-Unis] ; Brian H. Kopell [États-Unis] ; Robert E. Gross [États-Unis] ; Jerrold L. Vitek [États-Unis] ; Ashwini D. Sharan [États-Unis] ; Patricia Limousin [Royaume-Uni] ; Alim-Louis Benabid [France] | Deep brain stimulation for Parkinson's disease: Surgical issues |
| 003511 |
Afsane Riazi [Royaume-Uni] ; Stefan J. Cano [Royaume-Uni] ; J. Mark Cooper [Royaume-Uni] ; Jane L. Bradley [Royaume-Uni] ; Anthony H. V. Schapira [Royaume-Uni] ; Jeremy C. Hobart [Royaume-Uni] | Coordinating outcomes measurement in ataxia research: Do some widely used generic rating scales tick the boxes? |
| 003522 |
Robin S. Kingswell [Royaume-Uni] ; David Caird [Allemagne] | Comments and corrections on the REAL DOSE study |
| 003523 |
Anne-Fleur Van Rootselaar [Pays-Bas, Royaume-Uni] ; Natasha M. Maurits [Pays-Bas] ; Johannes H. T. M. Koelman [Pays-Bas] ; Johannes H. Van Der Hoeven [Pays-Bas] ; Lo J. Bour [Pays-Bas] ; Klaus L. Leenders [Pays-Bas] ; Peter Brown [Royaume-Uni] ; Marina A. J. Tijssen [Pays-Bas] | Coherence analysis differentiates between cortical myoclonic tremor and essential tremor |
| 003529 |
Liesl M. Allcock [Royaume-Uni] ; Rose Anne Kenny [Royaume-Uni] ; David J. Burn [Royaume-Uni] | Clinical phenotype of subjects with Parkinson's disease and orthostatic hypotension: Autonomic symptom and demographic comparison |
| 003535 |
David Millar [Royaume-Uni] ; Philipa Griffiths [Royaume-Uni] ; Adam J. Zermansky [Royaume-Uni] ; David J. Burn [Royaume-Uni] | Characterizing behavioral and cognitive dysexecutive changes in progressive supranuclear palsy |
| 003539 |
Stephen Tisch [Royaume-Uni] ; Patricia Limousin [Royaume-Uni] ; John C. Rothwell [Royaume-Uni] ; Peter Asselman [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Marwan Hariz [Royaume-Uni] | Changes in blink reflex excitability after globus pallidus internus stimulation for dystonia |
| 003545 |
Theodora Gioltzoglou [Grèce] ; Ioannis Milonas [Grèce] ; Andrew Lees (neurologue) [Royaume-Uni] | Case of DYT1 dystonia triggered by bite from a moray |
| 003554 |
Stefanie Klaffke [Royaume-Uni] ; Inke R. König [Allemagne] ; Fritz Poustka [Allemagne] ; Andreas Ziegler [Allemagne] ; Johannes Hebebrand [Allemagne] ; Oliver Bandmann [Royaume-Uni] | Brain‐derived neurotrophic factor: A genetic risk factor for obsessive–compulsive disorder and Tourette syndrome? |
| 003560 |
Susanne A. Schneider [Royaume-Uni] ; Mark J. Edwards [Royaume-Uni] ; Carla Cordivari [Royaume-Uni] ; William N. Macleod [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Botulinum toxin a may be efficacious as treatment for jaw tremor in Parkinson's disease |
| 003564 |
Kristian Winge [Danemark] ; Clare J. Fowler [Royaume-Uni] | Bladder dysfunction in Parkinsonism: Mechanisms, prevalence, symptoms, and management |
| 003576 |
Davide Martino [Royaume-Uni, Italie] ; Nee-Kong Chew [Royaume-Uni, Malaisie] ; Pablo Mir [Royaume-Uni, Espagne] ; Mark J. Edwards [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Atypical movement disorders in antiphospholipid syndrome |
| 003580 |
Liana Fidani [Grèce] ; Kallirhoe Kalinderi [Grèce] ; Sevasti Bostantjopoulou [Grèce] ; Jordi Clarimon [États-Unis] ; Antonis Goulas [Grèce] ; Zoe Katsarou [Grèce] ; John Hardy [États-Unis, Royaume-Uni] ; Alexandros Kotsis [Grèce] | Association of the Tau haplotype with Parkinson's disease in the Greek population |
| 003587 |
Mirdhu Wickremaratchi [Royaume-Uni] ; Huw R. Morris [Royaume-Uni] ; Imad M. Ali [Royaume-Uni] | Aripiprazole associated with severe exacerbation of Parkinson's disease |
| 003589 |
Michael P. Hill [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni] ; Steven G. Mcguire [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni, Canada] ; Alan R. Crossman [Royaume-Uni] ; Catherine Rochat [France] ; Mark J. Millan [France] | Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP‐lesioned marmosets: Mediation by D2, not D3, dopamine receptors |
| 003598 |
Pablo Mir [Royaume-Uni, Espagne] ; Francesca Gilio [Italie] ; Mark Edwards [Royaume-Uni] ; Maurizio Inghilleri [Italie] ; Kailash P. Bhatia [Royaume-Uni] ; John C. Rothwell [Royaume-Uni] ; Niall Quinn [Royaume-Uni] | Alteration of central motor excitability in a patient with hemimasticatory spasm after treatment with botulinum toxin injections |
| 003604 |
Susanne A. Schneider [Royaume-Uni] ; Mark J. Edwards [Royaume-Uni] ; Stephen E. Grill [États-Unis] ; Suzanne Goldstein [États-Unis] ; Su Kanchana [États-Unis] ; Niall P. Quinn [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Mark Hallett [États-Unis] ; Stephen G. Reich [États-Unis] | Adult‐onset primary lower limb dystonia |
| 003607 |
Mark J. Edwards [Royaume-Uni] ; Ying-Zu Huang [Royaume-Uni, Taïwan] ; Pablo Mir [Royaume-Uni, Espagne] ; John C. Rothwell [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Abnormalities in motor cortical plasticity differentiate manifesting and nonmanifesting DYT1 carriers |
| 003623 |
Alexandre Castro-Caldas [Portugal] ; Paul Delwaide [Belgique] ; Wolfgang Jost [Allemagne] ; Marcelo Merello [Argentine] ; Adrian Williams [Royaume-Uni] ; Paolo Lamberti [Italie] ; Miguel Aguilar [Espagne] ; Susanna Del Signore [France] ; Pierre Cesaro [France] | The parkinson-control study : A 1-year randomized, double- blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in parkinson's disease |
| 003632 |
Tanja Schmitz-Hübsch [Allemagne] ; Sophie Tezenas Du Montcel [France] ; Laszlo Baliko [Hongrie] ; Sylvia Boesch [Autriche] ; Sara Bonato [Belgique] ; Roberto Fancellu [Italie] ; Paola Giunti [Royaume-Uni] ; Christoph Globas [Allemagne] ; Jun-Suk Kang [Allemagne] ; Berry Kremer [Pays-Bas] ; Caterina Mariotti [Italie] ; Bela Melegh [Hongrie] ; Maryla Rakowicz [Pologne] ; Rafal Rola [Pologne] ; Sylvie Romano [Italie] ; Lodger Schols [Allemagne] ; Sandra Szymanski [Allemagne] ; Bart P. C. Van De Warrenburg [Pays-Bas] ; Elzbieta Zdzienicka [Pologne] ; Alexandra Dürr [France] ; Thomas Klockgether [Allemagne] | Reliability and validity of the international cooperative ataxia rating scale : A study in 156 spinocerebellar ataxia patients |
| 003634 |
Laura Silveira-Moriyama [Royaume-Uni] ; Andrew H. Evans [Royaume-Uni] ; Regina Katzenschlager [Royaume-Uni, Autriche] ; Andrew Lees (neurologue) [Royaume-Uni] | Punding and dyskinesias |
| 003687 |
Daniel G. Healy ; Patrick M. Abou-Sleiman ; Niall Quinn ; Kourosh R. Ahmadi ; Tetsutaro Ozawa [Japon] ; Christoph Kamm [Allemagne] ; Ullrich Wullner ; Wolfgang H. Oertel [Allemagne] ; Katrin Burk [Allemagne] ; Erik Dupont [Danemark] ; Maria T. Pellecchia [Italie] ; Eduardo Tolosa [Espagne] ; Thomas Gasser [Allemagne] ; Janice L. Holton ; Tamas Revesz ; David B. Goldstein ; Andrew Lees (neurologue) [Royaume-Uni] ; Nicholas W. Wood | UCHL‐1 gene in multiple system atrophy: A haplotype tagging approach |
| 003691 |
Katherine Grosset [Royaume-Uni] ; Donald Grosset [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Trial of subtherapeutic pergolide in de novo Parkinson's disease |
| 003698 |
David J. Burn [Royaume-Uni] ; Naomi M. Warren [Royaume-Uni] | Toward future therapies in progressive supranuclear palsy |
| 003700 |
Monty A. Silverdale [Royaume-Uni] ; S. L. Nicholson [Royaume-Uni] ; A. R. Crossman [Royaume-Uni] ; J. M. Brotchie [Canada] | Topiramate reduces levodopa‐induced dyskinesia in the MPTP‐lesioned marmoset model of Parkinson's disease |
| 003709 |
Paul Morrish [Royaume-Uni] | The meaning of negative DAT SPECT and F‐Dopa PET scans in patients with clinical Parkinson's disease |
| 003710 |
Michel Goedert [Royaume-Uni] | Tau gene mutations and their effects |
| 003718 |
Katherine A. Grosset [Royaume-Uni] ; Ian Bone [Royaume-Uni] ; Donald G. Grosset [Royaume-Uni] | Suboptimal medication adherence in Parkinson's disease |
| 003725 |
Clement T. Loy [Royaume-Uni] ; Mary G. Sweeney [Royaume-Uni] ; Mary B. Davis [Royaume-Uni] ; Adrian J. Wills [Royaume-Uni] ; Guy V. Sawle [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Sarah J. Tabrizi [Royaume-Uni] | Spinocerebellar ataxia type 17: Extension of phenotype with putaminal rim hyperintensity on magnetic resonance imaging |
| 003727 |
Douglas E. Crompton [Royaume-Uni] ; Patrick F. Chinnery [Royaume-Uni] ; David Bates [Royaume-Uni] ; Timothy J. Walls [Royaume-Uni] ; Margaret J. Jackson [Royaume-Uni] ; Andrew J. Curtis [Royaume-Uni] ; John Burn [Royaume-Uni] | Spectrum of movement disorders in neuroferritinopathy |
| 003738 |
Eva Andermann [Canada] ; Adrian Danek [Allemagne] ; Glenn Irvine [Royaume-Uni] ; Hans H. Jung [Suisse] ; Luca Rampoldi [Italie] ; François Tison [France] ; Ruth H. Walker [États-Unis] | Second International Neuroacanthocytosis Symposium: Expanding the spectrum of choreatic syndromes: Montreal Neurological Hospital and Institute, April 17–19 |
| 003743 |
H. A. Jinnah [États-Unis] ; Ellen J. Hess [États-Unis] ; Mark S. Ledoux [États-Unis] ; Nutan Sharma [États-Unis] ; Mark G. Baxter [Royaume-Uni] ; Mahlon R. Delong [États-Unis] | Rodent models for dystonia research: Characteristics, evaluation, and utility |
| 003747 |
Albert Marchetti [États-Unis] ; Raf Magar [États-Unis] ; Leslie Findley [Royaume-Uni] ; Jan P. Larsen [Norvège] ; Zvezdan Pirtosek [Slovénie] ; Evzen R Užižka [République tchèque] ; Robert Jech [République tchèque] ; Jaroslaw Sławek [Pologne] ; Fayyaz Ahmed [Royaume-Uni] | Retrospective evaluation of the dose of dysport and BOTOX in the management of cervical dystonia and blepharospasm: The REAL DOSE study |
| 003748 |
Vicky Marshall [Royaume-Uni] ; Donald Grosset [Royaume-Uni] | Reply: The meaning of negative DAT and F‐Dopa PET scans in a patient with clinical Parkinson's disease |
| 003754 |
Carlo Colosimo [Italie] ; Yasushi Osaki [Royaume-Uni] ; Nicola Vanacore [Italie] ; Andrew Lees (neurologue) [Royaume-Uni] | Reply: Lack of association between progressive supranuclear palsy and arterial hypertension: A clinicopathological study |
| 003775 |
Hee Tae Kim [Royaume-Uni] ; Simon Shields [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Niall Quinn [Royaume-Uni] | Progressive supranuclear palsy‐like phenotype associated with bilateral hypoxic–ischemic striopallidal lesions |
| 003783 |
Michael Scott [Royaume-Uni] ; Muhammad Chowdhury [Niger, Royaume-Uni] | Pregnancy in Parkinson's disease: Unique case report and review of the literature |
| 003795 |
Katherine A. Grosset [Royaume-Uni] ; Donald G. Grosset [Royaume-Uni] | Patient‐perceived involvement and satisfaction in Parkinson's disease: Effect on therapy decisions and quality of life |
| 003801 |
Naheed L. Khan [Royaume-Uni] ; Paola Giunti [Royaume-Uni] ; Mary G. Sweeney [Royaume-Uni] ; Christoph Scherfler [Royaume-Uni] ; Michael O. Brien [Royaume-Uni] ; Paola Piccini [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Parkinsonism and nigrostriatal dysfunction are associated with spinocerebellar ataxia type 6 (SCA6) |
| 003802 |
John Hardy [États-Unis, Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Parkinson's disease: A broken nosology |
| 003805 |
Naheed L. Khan [Royaume-Uni] ; Wagner Horta [Brésil] ; Louise Eunson [Royaume-Uni] ; Elizabeth Graham [Royaume-Uni] ; Janel O. Johnson [États-Unis] ; Shannon Chang [États-Unis] ; Mary Davis [Royaume-Uni] ; Andrew Singleton [États-Unis] ; Nicholas W. Wood [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Parkin disease in a Brazilian kindred: Manifesting heterozygotes and clinical follow‐up over 10 years |
| 003812 |
Brian Wood [Royaume-Uni] ; Richard Walker [Royaume-Uni] | Osteoporosis in Parkinson's disease |
| 003828 |
Dominic C. Paviour [Royaume-Uni] ; Tamas Revesz [Royaume-Uni] ; Janice L. Holton [Royaume-Uni] ; Andrew Evans [Royaume-Uni] ; Jan-Edvin Olsson [Suède] ; Andrew Lees (neurologue) [Royaume-Uni] | Neuronal intranuclear inclusion disease: Report on a case originally diagnosed as dopa‐responsive dystonia with Lewy bodies |
| 003835 |
Anjum Misbahuddin [Royaume-Uni] ; Mark R. Placzek [Royaume-Uni] ; Jan-Willem Taanman [Royaume-Uni] ; Steve Gschmeissner [Royaume-Uni] ; Giampietro Schiavo [Royaume-Uni] ; J. Mark Cooper [Royaume-Uni] ; Thomas T. Warner [Royaume-Uni] | Mutant torsinA, which causes early‐onset primary torsion dystonia, is redistributed to membranous structures enriched in vesicular monoamine transporter in cultured human SH‐SY5Y cells |
| 003837 |
Lance A. Smith [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Ghassan Al-Barghouthy [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; Mikko Kuoppamaki [Royaume-Uni, Finlande] ; C. Warren Olanow [États-Unis] ; Peter Jenner [Royaume-Uni] | Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP‐treated drug‐naïve primates |
| 003853 |
Katherine A. Grosset [Royaume-Uni] ; John L. Reid [Royaume-Uni] ; Donald G. Grosset [Royaume-Uni] | Medicine‐taking behavior: Implications of suboptimal compliance in Parkinson's disease |
| 003869 |
Jan Lewerenz [Allemagne] ; Bartosz Zurowski [Allemagne] ; Lars Jenicke [Allemagne] ; Tobias B Umer [Allemagne] ; Andrew Lees (neurologue) [Royaume-Uni] ; Alexander Münchau [Allemagne] | Lesion of the dorsorostral midbrain sparing the nigrostriatal tract mimics axial rigidity seen in progressive supranuclear palsy |
| 003872 |
David R. Williams [Royaume-Uni] ; Ali Hadeed [Jordanie] ; Amir S. Najim Al-Din [Royaume-Uni] ; Abdel-Latif Wreikat [Jordanie] ; Andrew Lees (neurologue) [Royaume-Uni] | Kufor Rakeb Disease: Autosomal recessive, levodopa‐responsive parkinsonism with pyramidal degeneration, supranuclear gaze palsy, and dementia |
| 003875 |
Dominic C. Paviour [Royaume-Uni] ; David Williams [Royaume-Uni] ; Clare J. Fowler [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Is sphincter electromyography a helpful investigation in the diagnosis of multiple system atrophy? A retrospective study with pathological diagnosis |
| 003882 |
Stefan J. Cano [Royaume-Uni] ; Jeremy C. Hobart [Royaume-Uni] ; Paul E. Hart [Royaume-Uni] ; L. V. Prasad Korlipara [Royaume-Uni] ; Anthony H. V. Schapira [Royaume-Uni] ; J. Mark Cooper [Royaume-Uni] | International cooperative ataxia rating scale (ICARS): Appropriate for studies of Friedreich's ataxia? |
| 003883 |
Peter Feys [Belgique, Royaume-Uni] ; Werner F. Helsen [Belgique] ; Xuguang Liu [Royaume-Uni] ; Bart Nuttin [Belgique] ; Ann Lavrysen [Belgique] ; Stephan P. Swinnen [Belgique] ; Pierre Ketelaer [Belgique] | Interaction between eye and hand movements in multiple sclerosis patients with intention tremor |
| 003892 |
Mark Stacy [États-Unis] ; Annette Bowron [Royaume-Uni] ; Mark Guttman [Canada] ; Robert Hauser [États-Unis] ; Kim Hughes [Royaume-Uni] ; Jan Petter Larsen [Norvège] ; Peter Lewitt [États-Unis] ; Wolfgang Oertel [Allemagne] ; Niall Quinn [Royaume-Uni] ; Kapil Sethi [États-Unis] ; Fabrizio Stocchi [Italie] | Identification of motor and nonmotor wearing‐off in Parkinson's disease: Comparison of a patient questionnaire versus a clinician assessment |
| 003894 |
Niall P. Quinn [Royaume-Uni] | How to diagnose multiple system atrophy |
| 003895 |
Felix Geser [Autriche] ; Gregor K. Wenning [Autriche] ; Werner Poewe [Autriche] ; Ian Mckeith [Royaume-Uni] | How to diagnose dementia with Lewy bodies: State of the art |
| 003898 |
Katherine Grosset [Royaume-Uni] ; Donald Grosset [Royaume-Uni] | Hedonistic homeostatic dysregulation in Parkinson's disease and excess dopamine replacement therapy |
| 003921 |
Suresh Sagili [Royaume-Uni] ; Raman Malhotra [Royaume-Uni] ; John Elston [Royaume-Uni] | Facial palsy‐induced blepharospasm relieved by a Bangerter foil |
| 003932 |
Henry Woodford [Royaume-Uni] ; Richard Walker [Royaume-Uni] | Emergency hospital admissions in idiopathic Parkinson's disease |
| 003957 |
John M. Walshe [Royaume-Uni] | Diagnostic significance of reduced serum caeruloplasmin concentration in neurological disease |
| 003963 |
Jagdish C. Sharma [Royaume-Uni] ; M. Vassallo [Royaume-Uni] ; I. N. Ross [Royaume-Uni] | Current controversies: Levodopa in the treatment of Parkinson's disease |
| 003968 |
Regina Katzenschlager [Royaume-Uni, Autriche] ; Andrew Hughes [Australie] ; Andrew Evans [Royaume-Uni] ; Alice J. Manson [Royaume-Uni] ; Marion Hoffman [Australie] ; Lesley Swinn [Royaume-Uni] ; Hilary Watt [Royaume-Uni] ; Kailash Bhatia [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: A prospective study using single‐dose challenges |
| 003973 |
H. R. Morris [Royaume-Uni] ; Adolfo M. Bronstein [Royaume-Uni] ; Christopher E. Shaw [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; S. Love [Royaume-Uni] | Clinical grand round: A rapidly progressive pyramidal and extrapyramidal syndrome with a supranuclear gaze palsy |
| 003984 |
Jeremy D. Isaacs [Royaume-Uni] ; James Rakshi [Royaume-Uni] ; Richard Baker [Royaume-Uni] ; David J. Brooks [Royaume-Uni] ; Anthony N. Warrens [Royaume-Uni] | Chorea associated with thyroxine replacement therapy |
| 003987 |
Serge Pinto [France, Royaume-Uni] ; Michèle Gentil [France] ; Paul Krack [France] ; Paul Sauleau [France] ; Valérie Fraix [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France] | Changes induced by levodopa and subthalamic nucleus stimulation on parkinsonian speech |
| 003989 |
Nicola Vanacore [Italie] ; Vincenzo Bonifati [Italie] ; Giovanni Fabbrini [Italie] ; Carlo Colosimo [Italie] ; Giuseppe De Michele [Italie] ; Roberto Marconi [Italie] ; Fabrizio Stocchi [Italie] ; David Nicholl [Royaume-Uni] ; Ubaldo Bonuccelli [Italie] ; Michele De Mari [Italie] ; Peter Vieregge [Allemagne] ; Giuseppe Meco [Italie] | Case–control study of multiple system atrophy |
| 003990 |
D. H. Mckee [Royaume-Uni] ; J. D. Sussman [Royaume-Uni] | Case report: Severe acute Parkinsonism associated with streptococcal infection and antibasal ganglia antibodies |
| 003995 |
Stephane Thobois [Royaume-Uni, France] ; Stephen Tisch [Royaume-Uni] ; Jing Xie-Brustolin [France] ; Patrick Mertens [France] ; Marwan I. Hariz [Royaume-Uni] ; Isabelle Benatru [France] ; Emmanuel Broussolle [France] ; Patricia Limousin-Dowsey [Royaume-Uni] | Can chronic subthalamic nucleus stimulation induce de novo tremor in Parkinson's disease? |
| 003A00 |
Emma J. Burton [Royaume-Uni] ; Ian G. Mckeith [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; John T. O'Brien [Royaume-Uni] | Brain atrophy rates in Parkinson's disease with and without dementia using serial magnetic resonance imaging |
| 003A10 |
Dominique Caparros-Lefebvre [France] ; Andrew Lees (neurologue) [Royaume-Uni] | Atypical unclassifiable parkinsonism on Guadeloupe: An environmental toxic hypothesis |
| 003A18 |
Andrew J. Larner [Royaume-Uni] | Antony van Leeuwenhoek and the description of diaphragmatic flutter (respiratory myoclonus) |
| 003A21 |
Davide Martino [Italie, Royaume-Uni] ; Andrew J. Church [Royaume-Uni] ; Russell C. Dale [Royaume-Uni] ; Gavin Giovannoni [Royaume-Uni] | Antibasal ganglia antibodies and PANDAS |
| 003A31 |
George K. Tofaris [Royaume-Uni] ; Maria Grazia Spillantini [Royaume-Uni] | Alpha‐synuclein dysfunction in Lewy body diseases |
| 003A35 |
Pablo Mir [Royaume-Uni, Espagne] ; Mark J. Edwards [Royaume-Uni] ; Andrew R. J. Curtis [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] | Adult‐onset generalized dystonia due to a mutation in the neuroferritinopathy gene |
| 003A44 |
Dag Aarsland [Norvège] ; Julia Zaccai [Royaume-Uni] ; Carol Brayne [Royaume-Uni] | A systematic review of prevalence studies of dementia in Parkinson's disease |
| 003A46 |
Giovanni Fabbrini [Italie] ; Francesco Brancati [Italie] ; Laura Vacca [Italie] ; Enza Maria Valente [Italie] ; Andrea Nemeth [Royaume-Uni] ; Angela Meesaq [Royaume-Uni] ; Nuala Sykes [Royaume-Uni] ; Bruno Dallapiccola [Italie] ; Alfredo Berardelli [Italie] | A novel family with an unusual early‐onset generalized dystonia |
| 003A59 |
HEE TAE KIM [Royaume-Uni] ; Simon Shields [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Niall Quinn [Royaume-Uni] | Progressive supranuclear palsy-like phenotype associated with bilateral hypoxic-ischemic striopallidal lesions |
| 003A74 |
Dominique Caparros-Lefebvre [France] ; Andrew Lees (neurologue) [Royaume-Uni] | Atypical unclassifiable parkinsonism on guadeloupe : An environmental toxic hypothesis |
| 003A75 |
Andrew J. Lamer [Royaume-Uni] | Antony van Leeuwenhoek and the description of diaphragmatic flutter (respiratory myoclonus) |
| 003A92 |
K. Ray Chaudhuri [Royaume-Uni] ; Vandena Dhawan [Royaume-Uni] ; Sumit Basu [Royaume-Uni] ; Gordon Jackson [Royaume-Uni] ; Per Odin [Allemagne] | Valvular heart disease and fibrotic reactions may be related to ergot dopamine agonists, but non‐ergot agonists may also not be spared |
| 003B06 |
Marwan Hariz [Royaume-Uni] ; Patric Blomstedt [Suède] ; Patricia Limousin [Royaume-Uni] | The myth of microelectrode recording in ensuring a precise location of the DBS electrode within the sensorimotor part of the subthalamic nucleus |
| 003B08 |
Matthew J. Hansard [Royaume-Uni] ; Lance A. Smith [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Sharon C. Cheetham [Royaume-Uni] ; Peter Jenner [Royaume-Uni] | The monoamine reuptake inhibitor BTS 74 398 fails to evoke established dyskinesia but does not synergise with levodopa in MPTP‐treated primates |
| 003B13 |
Katherine Grosset [Royaume-Uni] ; Fiona Needleman [Royaume-Uni] ; Graeme Macphee [Royaume-Uni] ; Donald Grosset [Royaume-Uni] | Switching from ergot to nonergot dopamine agonists in Parkinson's disease: A clinical series and five‐drug dose conversion table |
| 003B28 |
Richard A. Armstrong [Royaume-Uni] ; Peter L. Lantos [Royaume-Uni] ; Nigel J. Cairns [États-Unis] | Spatial patterns of α‐synuclein positive glial cytoplasmic inclusions in multiple system atrophy |
| 003B33 |
John Yianni [Royaume-Uni] ; Dipankar Nandi [Royaume-Uni] ; Kevin Bradley [Royaume-Uni] ; Nigel Soper [Royaume-Uni] ; Ralph Gregory [Royaume-Uni] ; Carole Joint [Royaume-Uni] ; John Stein [Royaume-Uni] ; Richard Scott [Royaume-Uni] ; Tipu Aziz [Royaume-Uni] | Senile chorea treated by deep brain stimulation—A clinical, neurophysiological and functional imaging study |
| 003B37 |
Jan C. M. Zijlmans [Royaume-Uni, Pays-Bas] ; Berengere Debilly [France] ; Olivier Rascol [France] ; Andrew Lees (neurologue) [Royaume-Uni] ; Franck Durif [France] | Safety of entacapone and apomorphine coadministration in levodopa‐treated Parkinson's disease patients: Pharmacokinetic and pharmacodynamic results of a multicenter, double‐blind, placebo‐controlled, cross‐over study |
| 003B39 |
Alastair Wilkins [Royaume-Uni] ; Jerry M. Brown [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] | SCA2 presenting as levodopa‐responsive parkinsonism in a young patient from the United Kingdom: A case report |
| 003B43 |
Peter Hobson [Royaume-Uni] ; Jolyon Meara [Royaume-Uni] | Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom |
| 003B45 |
Simon Heales [Royaume-Uni] ; Francesca Crawley [Royaume-Uni] ; Peter Rudge [Royaume-Uni] | Reversible parkinsonism following heroin pyrolysate inhalation is associated with tetrahydrobiopterin deficiency |
| 003B48 |
Xuguang Liu [Royaume-Uni] ; Jignesh Tailor [Royaume-Uni] ; Shouyan Wang [Royaume-Uni] ; John Yianni [Royaume-Uni] ; Ralph Gregory [Royaume-Uni] ; John Stein [Royaume-Uni] ; Tipu Aziz [Royaume-Uni] | Reversal of hypertonic co‐contraction after bilateral pallidal stimulation in generalised dystonia: A clinical and electromyogram case study |
| 003B49 |
John A. Chaddock [Royaume-Uni] ; John R. Purkiss [Royaume-Uni] ; Frances C. G. Alexander [Royaume-Uni] ; Sarah Doward [Royaume-Uni] ; Sarah J. Fooks [Royaume-Uni] ; Lorna M. Friis [Royaume-Uni] ; Yper H. J. Hall [Royaume-Uni] ; Elizabeth R. Kirby [Royaume-Uni] ; Nicola Leeds [Royaume-Uni] ; Hilary J. Moulsdale [Royaume-Uni] ; Anthony Dickenson [Royaume-Uni] ; G. Mark Green [Royaume-Uni] ; Wahida Rahman [Royaume-Uni] ; Rie Suzuki [Royaume-Uni] ; Michael J. Duggan [Royaume-Uni] ; Conrad P. Quinn [Royaume-Uni, Géorgie (pays)] ; Clifford C. Shone [Royaume-Uni] ; Keith A. Foster [Royaume-Uni] | Retargeted clostridial endopeptidases: Inhibition of nociceptive neurotransmitter release in vitro, and antinociceptive activity in in vivo models of pain |
| 003B54 |
John Yianni [Royaume-Uni] ; Tipu Aziz [Royaume-Uni] ; Peter Bain [Royaume-Uni] | Reply: Globus pallidus internus deep brain stimulation for dystonic conditions: a prospective audit. |
| 003B55 |
Richard B. Scott [Royaume-Uni] | Reply: Executive cognitive defects in primary dystonia |
| 003B63 |
Niall P. Quinn [Royaume-Uni] ; Kailash Bhatia [Royaume-Uni] | Re: Yianni et al., Globus pallidus internus deep brain stimulation for dystonic conditions: A prospective audit |
| 003B70 |
Galit Kleiner-Fisman [Canada] ; Anthony E. Lang [Canada] ; Catherine Bergeron [Canada] ; David J. Burn [Royaume-Uni] ; Dominic C. Paviour [Royaume-Uni] | Rapidly progressive behavioral changes and parkinsonism in a 68‐year‐old man |
| 003B76 |
Andrew H. Evans [Royaume-Uni] ; Regina Katzenschlager [Royaume-Uni] ; Dominic Paviour [Royaume-Uni] ; John D. O'Sullivan [Australie] ; Silke Appel [Royaume-Uni] ; Andrew D. Lawrence [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Punding in Parkinson's disease: Its relation to the dopamine dysregulation syndrome |
| 003B90 |
Stuart J. M. Weatherby [Royaume-Uni] ; Philippa Woolner [Royaume-Uni] ; Carl E. Clarke [Royaume-Uni] | Pregnancy in stiff‐limb syndrome |
| 003C13 |
Thomas Foltynie [Royaume-Uni] ; Terry E. Goldberg [États-Unis] ; Simon G. J. Lewis [Royaume-Uni] ; Andrew D. Blackwell [Royaume-Uni] ; Bhaskar S. Kolachana [États-Unis] ; Daniel R. Weinberger [États-Unis] ; Trevor W. Robbins [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] | Planning ability in Parkinson's disease is influenced by the COMT val158met polymorphism |
| 003C17 |
Kai Wohlfarth [Allemagne] ; Knut Kampe [Royaume-Uni] ; Hans Bigalke [Allemagne] | Pharmacokinetic properties of different formulations of botulinum neurotoxin type A |
| 003C19 |
Pascal Grosse [Royaume-Uni, Allemagne] ; M. Edwards [Royaume-Uni] ; M. A. J. Tijssen [Pays-Bas] ; A. Schrag [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] ; Peter Brown [Royaume-Uni] | Patterns of EMG–EMG coherence in limb dystonia |
| 003C20 |
Stefan J. Cano [Royaume-Uni] ; Jeremy C. Hobart [Royaume-Uni] ; Ray Fitzpatrick [Royaume-Uni] ; Kailash Bhatia [Royaume-Uni] ; Alan J. Thompson [Royaume-Uni] ; Thomas T. Warner [Royaume-Uni] | Patient‐based outcomes of cervical dystonia: A review of rating scales |
| 003C26 |
Pablo Martínez-Martín [Espagne] ; Carlos Salvador [Espagne] ; Luis Menéndez-Guisasola [Espagne] ; Sonia González [Espagne] ; Aurelio Tobías [Espagne] ; Javier Almazán [Espagne] ; K. Ray Chaudhuri [Royaume-Uni] | Parkinson's disease sleep scale: Validation study of a Spanish version |
| 003C30 |
Alan L. Whone [Royaume-Uni] ; Sarah Von Spiczak [Royaume-Uni] ; Mark Edwards [Royaume-Uni] ; Enza-Maria Valente [Royaume-Uni] ; Alexander Hammers [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; David J. Brooks [Royaume-Uni] | Opioid binding in DYT1 primary torsion dystonia: An 11C‐diprenorphine PET study |
| 003C31 |
Ying-Zu Huang [Royaume-Uni] ; Mark J. Edwards [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; John C. Rothwell [Royaume-Uni] | One‐Hz repetitive transcranial magnetic stimulation of the premotor cortex alters reciprocal inhibition in DYT1 dystonia |
| 003C32 |
Shilpa Jain [Royaume-Uni] ; Jill Dawson [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; E. Diane Playford [Royaume-Uni] | Occupational therapy in multiple system atrophy: A pilot randomized controlled trial |
| 003C33 |
Jason D. Warren [Royaume-Uni] ; Michele T. M. Hu [Royaume-Uni] ; Malcolm Galloway [Royaume-Uni] ; Richard J. Greenwood [Royaume-Uni] ; Martin N. Rossor [Royaume-Uni] | Observations on the human rejection behaviour syndrome: Denny–Brown revisited |
| 003C37 |
Susan Fox [Royaume-Uni] ; Montague Silverdale [Royaume-Uni] ; Mark Kellett [Royaume-Uni] ; Rhys Davies [Royaume-Uni] ; Malcolm Steiger [Royaume-Uni] ; Nicholas Fletcher [Royaume-Uni] ; Alan Crossman [Royaume-Uni] ; Jonathan Brotchie [Royaume-Uni, Canada] | Non‐subtype‐selective opioid receptor antagonism in treatment of levodopa‐induced motor complications in Parkinson's disease |
| 003C39 |
Carla Cordivari [Royaume-Uni] ; V. Peter Misra [Royaume-Uni] ; Santiago Catania [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | New therapeutic indications for botulinum toxins |
| 003C46 |
Willibald Gerschlager [Royaume-Uni, Autriche] ; Alexander Münchau [Allemagne] ; Regina Katzenschlager [Royaume-Uni] ; Peter Brown [Royaume-Uni] ; John C. Rothwell [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Natural history and syndromic associations of orthostatic tremor: A review of 41 patients |
| 003C51 |
Christopher G. Goetz [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Royaume-Uni] ; Glenn T. Stebbins [États-Unis] ; Carl Counsell [Portugal] ; Nir Giladi [Israël] ; Robert G. Holloway [États-Unis] ; Charity G. Moore [États-Unis] ; Gregor K. Wenning [Autriche] ; Melvin D. Yahr [États-Unis] ; Lisa Seidl [États-Unis] | Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease |
| 003C59 |
Kate S. M. Taylor [Royaume-Uni] ; Carl E. Counsell [Royaume-Uni] ; Joanna C. Gordon [Royaume-Uni] ; Clare E. Harris [Royaume-Uni] | Maximizing patient consent for video recording |
| 003C63 |
Andrew H. Evans [Royaume-Uni] ; Durval C. Costa ; Sveto Gacinovic [Royaume-Uni] ; Regina Katzenschlager [Royaume-Uni] ; John D. O'Sullivan [Australie] ; Simon Heales [Royaume-Uni] ; Phillip Lee [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | L‐dopa–responsive Parkinson's syndrome in association with phenylketonuria: In vivo dopamine transporter and D2 receptor findings |
| 003C69 |
C. Warren Olanow [États-Unis] ; Yves Agid [France] ; Yoshi Mizuno [Japon] ; Alberto Albanese [Italie] ; U. Bonucelli [Italie] ; Philip Damier [France] ; Justo De Yebenes [Espagne] ; Oscar Gershanik [Argentine] ; Mark Guttman [Canada] ; F. Grandas [Espagne] ; Mark Hallett [États-Unis] ; Ole Hornykiewicz [Autriche] ; Peter Jenner [Royaume-Uni] ; R. Katzenschlager [Royaume-Uni] ; William J. Langston [États-Unis] ; Peter Lewitt [États-Unis] ; Eldad Melamed [Israël] ; M. A. Mena [Espagne] ; P. P. Michel [France] ; Catherine Mytilineou [États-Unis] ; Jose A. Obeso [Espagne] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; R. Raisman-Vozari [France] ; Ali H. Rajput [Canada] ; Olivier Rascol [France] ; Christina Sampaio [Portugal] ; Fabrizio Stocchi [Italie] | Levodopa in the treatment of Parkinson's disease: Current controversies |
| 003C85 |
Alexander Gerhard [Royaume-Uni] ; Justin Watts [Royaume-Uni, États-Unis] ; Iris Trender-Gerhard [Royaume-Uni] ; Federico Turkheimer [Royaume-Uni] ; Richard B. Banati [Royaume-Uni] ; Kailash Bhatia [Royaume-Uni] ; David J. Brooks [Royaume-Uni] | In vivo imaging of microglial activation with [11C](R)‐PK11195 PET in corticobasal degeneration |
| 003C92 |
John Mcauley [Royaume-Uni] ; John Rothwell [Royaume-Uni] | Identification of psychogenic, dystonic, and other organic tremors by a coherence entrainment test |
| 003C98 |
Aileen K. Ho [Royaume-Uni, Australie] ; Anna O. G. Robbins [Royaume-Uni] ; Stephen J. Walters [Royaume-Uni] ; Stephen Kaptoge [Royaume-Uni] ; Barbara J. Sahakian [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] | Health‐related quality of life in Huntington's disease: A comparison of two generic instruments, SF‐36 and SIP |
| 003D07 |
Andrew Lees (neurologue) [Royaume-Uni] ; Michael R. Koe [Royaume-Uni] | Fourth progressive supranuclear palsy (PSP–Europe) international medical workshop: Report on the fourth PSP–Europe international medical workshop |
| 003D09 |
Aijaz A. Khan [Royaume-Uni] ; Jon D. Sussman [Royaume-Uni] | Focal dystonia after removal of a parietal meningioma |
| 003D11 |
Anthony E. Lang [Canada] ; Andrew Lees (neurologue) [Royaume-Uni] | Farewell from the outgoing editors |
| 003D27 |
Maaike Bakker [Pays-Bas] ; Rianne A. J. Esselink [Pays-Bas] ; Marten Munneke [Pays-Bas] ; Patricia Limousin-Dowsey [Royaume-Uni] ; Hans D. Speelman [Pays-Bas] ; Bastiaan R. Bloem [Pays-Bas] | Effects of stereotactic neurosurgery on postural instability and gait in Parkinson's disease |
| 003D41 |
Camille B. Carroll [Royaume-Uni] ; Peter G. Bain [Royaume-Uni] | Do on‐off variations cause discrepancies in the historical items of the UPDRS? |
| 003D46 |
Dominic C. Paviour [Royaume-Uni] ; Robert A. H. Surtees [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Diagnostic considerations in juvenile parkinsonism |
| 003D50 |
Gregor K. Wenning [Autriche] ; Franc Ois Tison [France] ; Klaus Seppi [Autriche] ; Cristina Sampaio [Portugal] ; Anja Diem [Autriche] ; Farid Yekhlef [France] ; Imad Ghorayeb [France] ; Fabienne Ory [France] ; Monique Galitzky [France] ; Tommaso Scaravilli [Royaume-Uni] ; Maria Bozi [Royaume-Uni] ; Carlo Colosimo [Italie] ; Sid Gilman [États-Unis] ; Clifford W. Shults [États-Unis] ; Niall P. Quinn [Royaume-Uni] ; Olivier Rascol [France] ; Werner Poewe [Autriche] | Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS) |
| 003D52 |
Dorothea Sesardic [Royaume-Uni] ; Russell G. A. Jones [Royaume-Uni] ; Tong Leung [Royaume-Uni] ; Toni Alsop [Royaume-Uni] ; Robert Tierney [Royaume-Uni] | Detection of antibodies against botulinum toxins |
| 003D67 |
Jan C. M. Zijlmans [Royaume-Uni, Pays-Bas] ; Susan E. Daniel [Royaume-Uni] ; Andrew J. Hughes [Royaume-Uni, Australie] ; Tamas Révész [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis |
| 003D78 |
Anthony C. Pereira [Royaume-Uni] ; Mark J. Edwards [Royaume-Uni] ; Philip C. Buttery [Royaume-Uni] ; Christopher H. Hawkes [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Gavin Giovannoni [Royaume-Uni] ; Marios Hadjivassiliou [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Choreic syndrome and coeliac disease: A hitherto unrecognised association |
| 003D87 |
Nicola Pavese [Royaume-Uni] ; Ornella Rimoldi [Royaume-Uni] ; Alexander Gerhard [Royaume-Uni] ; David J. Brooks [Royaume-Uni] ; Paola Piccini [Royaume-Uni] | Cardiovascular effects of methamphetamine in Parkinson's disease patients |
| 003D88 |
Dora A. Lozsadi [Royaume-Uni] ; Alan Forster [Royaume-Uni] ; Nicholas A. Fletcher [Royaume-Uni] | Cannabis‐induced propriospinal myoclonus |
| 003D89 |
Keith Wheatley [Royaume-Uni] ; Carl E. Clarke [Royaume-Uni] ; Natalie Ives [Royaume-Uni] ; Richard Gray [Royaume-Uni] | Cabergoline versus levodopa monotherapy |
| 003E13 |
Zoe Katsarou [Grèce] ; Sevasti Bostantjopoulou [Grèce] ; Viv Peto [Royaume-Uni] ; Anna Kafantari [Grèce] ; Elizabeth Apostolidou [Grèce] ; Eleni Peitsidou [Grèce] | Assessing quality of life in Parkinson's disease: Can a short‐form questionnaire be useful? |
| 003E22 |
Ann E. Kingsbury [Royaume-Uni] ; Susan E. Daniel [Royaume-Uni] ; Hardev Sangha [Royaume-Uni] ; Sarah Eisen [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Oliver J. F. Foster [Royaume-Uni] | Alteration in α‐synuclein mRNA expression in Parkinson's disease |
| 003E25 |
Mark J. Edwards [Royaume-Uni] ; Russell C. Dale [Royaume-Uni] ; Andrew J. Church [Royaume-Uni] ; Eleni Trikouli [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Gavin Giovannoni [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Adult‐onset tic disorder, motor stereotypies, and behavioural disturbance associated with antibasal ganglia antibodies |
| 003E29 |
Y. Osaki [Royaume-Uni, Japon] ; Y. Ben-Shlomo [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; S. E. Daniel [Royaume-Uni] ; C. Colosimo [Italie] ; G. Wenning [Autriche] ; N. Quinn [Royaume-Uni] | Accuracy of clinical diagnosis of progressive supranuclear palsy |
| 003E31 |
Carl E. Clarke [Royaume-Uni] | A “cure” for Parkinson's disease: Can neuroprotection be proven with current trial designs? |
| 003E39 |
Katherine Grosset [Royaume-Uni] ; Donald Grosset [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Trial of subtherapeutic pergolide in de novo Parkinson's disease |
| 003E41 |
MOHAMED FAROUK ALLAM [Espagne] ; Michael J. Campbell [Royaume-Uni] ; Albert Hofman [Pays-Bas] ; Amparo Serrano Del Castillo [Espagne] ; Rafael Fernandez-Crehuet Navajas [Espagne] | Smoking and Parkinson's disease: Systematic review of prospective studies |
| 003E43 |
H. A. Jinnah [États-Unis] ; Ellen J. Hess [États-Unis] ; Mark S. Ledoux [États-Unis] ; Nutan Sharma [États-Unis] ; Mark G. Baxter [Royaume-Uni] ; Mahlon R. Delong [États-Unis] | Rodent models for dystonia research : Characteristics, evaluation, and utility |
| 003E44 |
XUGUANG LIU [Royaume-Uni] ; Jignesh Tailor [Royaume-Uni] ; SHOUYAN WANG [Royaume-Uni] ; John Yianni [Royaume-Uni] ; Ralph Gregory [Royaume-Uni] ; John Stein [Royaume-Uni] ; Tipu Aziz [Royaume-Uni] | Reversal of hypertonic co-contraction after bilateral pallidal stimulation in generalised dystonia: A clinical and electromyogram case study |
| 003E46 |
Galit Kleiner-Fisman [Canada] ; Anthony E. Lang [Canada] ; Catherine Bergeron [Canada] ; David J. Burn [Royaume-Uni] ; Dominic C. Paviour [Royaume-Uni] | Rapidly progressive behavioral changes and parkinsonism in a 68-year-old man |
| 003E52 |
Pablo Martinez-Martin [Espagne] ; Carlos Salvador [Espagne] ; Luis Menendez-Guisasola [Espagne] ; Sonia Gonzalez [Espagne] ; Aurelio Tobias [Espagne] ; Javier Almazan [Espagne] ; K. Ray Chaudhuri [Royaume-Uni] | Parkinson's Disease Sleep scale: Validation study of a Spanish version |
| 003E57 |
Lance A. Smith [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Ghassan Al-Barghouthy [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; Mikko Kuoppamaki [Royaume-Uni, États-Unis] ; Warren Olanow [Finlande] ; Peter Jenner [Royaume-Uni] | Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP-treated drug-naïve primates |
| 003E94 |
David Bateman [Royaume-Uni] | Valuable tool for patients with orthostatic tremor |
| 003E96 |
David J. Burn [Royaume-Uni] ; John T. O'Brien [Royaume-Uni] | Use of functional imaging in parkinsonism and dementia |
| 003E98 |
Mark Edwards [Royaume-Uni] ; Nicholas Wood [Royaume-Uni] ; Kailash Bhatia [Royaume-Uni] | Unusual phenotypes in DYT1 dystonia: A report of five cases and a review of the literature |
| 003F02 |
Regina Katzenschlager [Royaume-Uni] ; Adriana Cardozo [Espagne] ; M. Rosario Avila Cobo [Espagne] ; Eduardo Tolosa [Espagne] ; Andrew Lees (neurologue) [Royaume-Uni] | Unclassifiable parkinsonism in two European tertiary referral centres for movement disorders |
| 003F15 |
John M. Walshe [Royaume-Uni] | The story of penicillamine: A difficult birth |
| 003F18 |
Dominique Twelves [Royaume-Uni] ; Kate S. M. Perkins [Royaume-Uni] ; Carl Counsell [Royaume-Uni] | Systematic review of incidence studies of Parkinson's disease |
| 003F26 |
Russell C. Dale [Royaume-Uni] ; Andrew J. Church [Royaume-Uni] ; Isobel Heyman [Royaume-Uni] | Striatal encephalitis after varicella zoster infection complicated by Tourettism |
| 003F30 |
Jonathan A. Norton [Royaume-Uni] ; Duncan E. Wood [Royaume-Uni] ; Jonathan F. Marsden [Royaume-Uni] ; Brian L. Day [Royaume-Uni] | Spinally generated electromyographic oscillations and spasms in a low‐thoracic complete paraplegic |
| 003F33 |
Mikko Kuoppam Ki [Royaume-Uni] ; Paula Giunti [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Slowly progressive cerebellar ataxia and cervical dystonia: Clinical presentation of a new form of spinocerebellar ataxia? |
| 003F52 |
Vicky Marshall [Royaume-Uni] ; Donald Grosset [Royaume-Uni] | Role of dopamine transporter imaging in routine clinical practice |
| 003F59 |
J. D. Warren [Royaume-Uni] ; N. W. Wood [Royaume-Uni] | Reply |
| 003F66 |
Wolfgang H. Oertel [Allemagne] ; Tobias W Chter [Allemagne] ; Niall P. Quinn [Royaume-Uni] ; Gudrun Ulm [Allemagne] ; Dirk Brandst Dter [Allemagne] | Reduced genital sensitivity in female patients with multiple system atrophy of parkinsonian type |
| 003F70 |
Prithiva Navan [Royaume-Uni] ; Leslie J. Findley [Royaume-Uni] ; Jim A. R. Jeffs [Royaume-Uni] ; Ronald K. B. Pearce [Royaume-Uni] ; Peter G. Bain [Royaume-Uni] | Randomized, double‐blind, 3‐month parallel study of the effects of pramipexole, pergolide, and placebo on parkinsonian tremor |
| 003F75 |
P. K. Morrish [Royaume-Uni] | REAL and CALM: What have we learned? |
| 003F84 |
Hani T. S. Benamer [Royaume-Uni] ; Wolfgang H. Oertel [Allemagne] ; Jim Patterson [Royaume-Uni] ; Donald M. Hadley [Royaume-Uni] ; Oliver Pogarell [Allemagne] ; H. Höffken [Allemagne] ; A. Gerstner [Allemagne] ; Donald G. Grosset [Royaume-Uni] | Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: Part 1. Baseline and 3‐month observations |
| 003F86 |
Andrew Sharott [Royaume-Uni] ; Jon Marsden [Royaume-Uni] ; Peter Brown [Royaume-Uni] | Primary orthostatic tremor is an exaggeration of a physiological response to instability |
| 003F87 |
S. Anand Trip [Royaume-Uni] ; Stephen J. Wroe [Royaume-Uni] | Primary orthostatic tremor associated with a persistent cerebrospinal fluid monoclonal IgG band |
| 004008 |
Maria Bozi [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Paroxysmal exercise‐induced dystonia as a presenting feature of young‐onset Parkinson's disease |
| 004011 |
Murat Emre [Turquie] ; Andrew Lees (neurologue) [Royaume-Uni] | Parkinsonism and dementia: Synucleinopathies, Tauopathies and Beyond |
| 004012 |
Andrew Lees (neurologue) [Royaume-Uni] | Parkinson's syndrome associated with neurofibrillary degeneration and tau pathologic findings |
| 004019 |
Peter Brown [Royaume-Uni] | Oscillatory nature of human basal ganglia activity: Relationship to the pathophysiology of Parkinson's disease |
| 004021 |
Tibor Kovács [Hongrie, Royaume-Uni] ; Mátyás I. Papp [Hongrie] ; Nigel J. Cairns [Royaume-Uni] ; M. Nadeem Khan [Royaume-Uni] ; Peter L. Lantos [Royaume-Uni] | Olfactory bulb in multiple system atrophy |
| 004022 |
Christopher Hawkes [Royaume-Uni] | Olfaction in neurodegenerative disorder |
| 004024 |
Michael P. Hill [Royaume-Uni] ; Erwan Bezard [France] ; Steven G. Mcguire [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Canada] ; Ann Michel [Belgique] ; Renee Grimée [Belgique] ; Henrik Klitgaard [Belgique] | Novel antiepileptic drug levetiracetam decreases dyskinesia elicited by L‐dopa and ropinirole in the MPTP‐lesioned marmoset |
| 004027 |
Christopher D. Ward [Royaume-Uni] | Neuropsychiatric interpretations of postencephalitic movement disorders |
| 004030 |
Jane E. Warren [Australie] ; Marie Vidailhet [France] ; Christopher S. Kneebone [Australie] ; Niall P. Quinn [Royaume-Uni] ; Philip D. Thompson [Australie] | Myoclonus in spinal dysraphism |
| 004036 |
Anthoy E. Lang [Canada] ; Andrew Lees (neurologue) [Royaume-Uni] ; Günther Deuschl [Allemagne] ; Christopher Goetz [États-Unis] | Movement disorders offers electronic manuscript submission |
| 004038 |
Michael Orth [Royaume-Uni] ; Sarah J. Tabrizi [Royaume-Uni] | Models of Parkinson's disease |
| 004045 |
Marina A. J. Tijssen [Pays-Bas, Royaume-Uni] ; Peter Brown [Royaume-Uni] ; David Macmanus [Royaume-Uni] ; Mary A. Mclean [Royaume-Uni] ; Charles Davie [Royaume-Uni] | Magnetic resonance spectroscopy of cerebral cortex is normal in hereditary hyperekplexia due to mutations in the GLRA1 gene |
| 004047 |
Markus Naumann [Allemagne] ; A. Peter Moore [Royaume-Uni] | Long‐term safety of botulinum toxin type A |
| 004057 |
Carlo Colosimo [Italie, Royaume-Uni] ; Yasushi Osaki [Royaume-Uni] ; Nicola Vanacore [Italie] ; Andrew Lees (neurologue) [Royaume-Uni] | Lack of association between progressive supranuclear palsy and arterial hypertension: A clinicopathological study |
| 004061 |
Barry M. Seemungal [Royaume-Uni] ; Mary Faldon [Royaume-Uni] ; Tamas Revesz [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; David S. Zee [États-Unis] ; Adolfo M. Bronstein [Royaume-Uni] | Influence of target size on vertical gaze palsy in a pathologically proven case of progressive supranuclear palsy |
| 004068 |
John Hardy [États-Unis, Royaume-Uni] | Impact of genetic analysis on Parkinson's disease research |
| 004070 |
Paul K. Morrish [Royaume-Uni] | How valid is dopamine transporter imaging as a surrogate marker in research trials in Parkinson's disease? |
| 004073 |
Adrian Wills [Royaume-Uni] | Hereditary neuroferritinopathy presenting with palatal tremor, orofacial dyskinesias, bulbar symptoms, and unsteadiness of gait |
| 004075 |
Peter Hagell [Suède] ; Diane Whalley [Royaume-Uni] ; Stephen P. Mckenna [Royaume-Uni] ; Olle Lindvall [Suède] | Health status measurement in Parkinson's disease: Validity of the PDQ‐39 and Nottingham Health Profile |
| 004079 |
John Yianni [Royaume-Uni] ; Peter Bain [Royaume-Uni] ; Nir Giladi [Israël] ; Marieta Auca [Israël] ; Ralph Gregory [Royaume-Uni] ; Carole Joint [Royaume-Uni] ; Dipankar Nandi [Royaume-Uni] ; John Stein [Royaume-Uni] ; Richard Scott [Royaume-Uni] ; Tipu Aziz [Royaume-Uni] | Globus pallidus internus deep brain stimulation for dystonic conditions: A prospective audit |
| 004081 |
Marwan I. Hariz [Suède, Royaume-Uni] | From functional neurosurgery to “interventional” neurology: Survey of publications on thalamotomy, pallidotomy, and deep brain stimulation for Parkinson's disease from 1966 to 2001 |
| 004085 |
Juha-Matti Savola [Finlande] ; Michael Hill [Royaume-Uni] ; Mia Engstrom [Finlande] ; Hannele Merivuori [Finlande] ; Siegfried Wurster [Finlande] ; Steven G. Mcguire [Royaume-Uni] ; Susan H. Fox [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni, Canada] | Fipamezole (JP‐1730) is a potent α2 adrenergic receptor antagonist that reduces levodopa‐induced dyskinesia in the MPTP‐lesioned primate model of Parkinson's disease |
| 004087 |
Niall Quinn [Royaume-Uni] ; Mikko Kuoppam Ki [Royaume-Uni, Finlande] | Fast micrographia and pallidal pathology |
| 004091 |
David J. Burn [Royaume-Uni] ; Elise N. Rowan [Royaume-Uni] ; Thais Minett [Royaume-Uni] ; Jonathon Sanders [Royaume-Uni] ; Pat Myint [Royaume-Uni] ; Jonathon Richardson [Royaume-Uni] ; Alan Thomas [Royaume-Uni] ; Jane Newby [Royaume-Uni] ; Jenny Reid [Royaume-Uni] ; John T. O'Brien [Royaume-Uni] ; Ian G. Mckeith [Royaume-Uni] | Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: A cross‐sectional comparative study |
| 004093 |
Richard B. Scott [Royaume-Uni] ; Ralph Gregory [Royaume-Uni] ; Joanna Wilson [Royaume-Uni] ; Sarah Banks [Royaume-Uni] ; Anna Turner [Royaume-Uni] ; Simon Parkin [Royaume-Uni] ; Nir Giladi [Israël] ; Carol Joint [Royaume-Uni] ; Tipu Aziz [Royaume-Uni] | Executive cognitive deficits in primary dystonia |
| 004094 |
Emma Mcintosh [Royaume-Uni] ; Alastair Gray [Royaume-Uni] ; Tipu Aziz [Royaume-Uni] | Estimating the costs of surgical innovations: The case for subthalamic nucleus stimulation in the treatment of advanced Parkinson's disease |
| 004096 |
Mark Edwards [Royaume-Uni] ; Geoffrey Schott [Royaume-Uni] ; Kailash Bhatia [Royaume-Uni] | Episodic focal lingual dystonic spasms |
| 004107 |
Gregorio Segovia [Royaume-Uni, Espagne] ; Francisco Mora [Espagne] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni] | Effects of CB1 cannabinoid receptor modulating compounds on the hyperkinesia induced by high‐dose levodopa in the reserpine‐treated rat model of Parkinson's disease |
| 004108 |
Lance A. Smith [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Matthew J. Hansard [Royaume-Uni] ; Eleni Maratos [Royaume-Uni] ; Peter Jenner [Royaume-Uni] | Effect of pulsatile administration of levodopa on dyskinesia induction in drug‐naïve MPTP‐treated common marmosets: Effect of dose, frequency of administration, and brain exposure |
| 004111 |
Anthony E. Lang ; Andrew Lees (neurologue) [Royaume-Uni] | Editorial |
| 004114 |
Prithiva Navan [Royaume-Uni] ; Leslie J. Findley [Royaume-Uni] ; Jim A. R. Jeffs [Royaume-Uni] ; Ronald K. B. Pearce [Royaume-Uni] ; Peter G. Bain [Royaume-Uni] | Double‐blind, single‐dose, cross‐over study of the effects of pramipexole, pergolide, and placebo on rest tremor and UPDRS part III in Parkinson's disease |
| 004119 |
Paola P. Piccini [Royaume-Uni] | Dopamine transporter: Basic aspects and neuroimaging |
| 004120 |
Andrew Lees (neurologue) [Royaume-Uni] ; Donald G. Grosset [Royaume-Uni] | Dopamine transporter imaging |
| 004125 |
Leslie Findley [Royaume-Uni] ; Manjit Aujla [Royaume-Uni] ; Peter G. Bain [Royaume-Uni] ; Mary Baker [Royaume-Uni] ; Catherine Beech [Royaume-Uni] ; Clive Bowman [Royaume-Uni] ; Jeremy Holmes [Royaume-Uni] ; Wendy K. Kingdom [Royaume-Uni] ; Douglas G. Macmahon [Royaume-Uni] ; Viv Peto [Royaume-Uni] ; Jeremy R. Playfer [Royaume-Uni] | Direct economic impact of Parkinson's disease: A research survey in the United Kingdom |
| 004132 |
Durval C. Costa [Royaume-Uni, Portugal] ; Zuzana Walker [Royaume-Uni] ; Rodney W. H. Walker [Royaume-Uni] ; Flávia R. G. Fontes [Royaume-Uni] | Dementia with Lewy bodies versus Alzheimer's disease: Role of dopamine transporter imaging |
| 004133 |
Jonathan M. Schott [Royaume-Uni] ; Jessica E. Simon [Royaume-Uni] ; Nick C. Fox [Royaume-Uni] ; Andrew P. King [Royaume-Uni] ; M. Nadeem Khan [Royaume-Uni] ; Lisa Cipolotti [Royaume-Uni] ; Dominic C. Paviour [Royaume-Uni] ; John M. Stevens [Royaume-Uni] ; Martin N. Rossor [Royaume-Uni] | Delineating the sites and progression of in vivo atrophy in multiple system atrophy using fluid‐registered MRI |
| 004140 |
David J. Burn [Royaume-Uni] ; Ian G. Mckeith [Royaume-Uni] | Current treatment of dementia with Lewy bodies and dementia associated with Parkinson's disease |
| 004143 |
Naida L. Graham [Royaume-Uni] ; Thomas H. Bak [Royaume-Uni] ; John R. Hodges [Royaume-Uni] | Corticobasal degeneration as a cognitive disorder |
| 004149 |
Pascal Grosse [Royaume-Uni, Allemagne] ; Andrea Kühn [Royaume-Uni, Allemagne] ; Carla Cordivari [Royaume-Uni] ; Peter Brown [Royaume-Uni] | Coherence analysis in the myoclonus of corticobasal degeneration |
| 004150 |
Marjan Jahanshahi [Royaume-Uni] ; John Rowe [Royaume-Uni] ; Rebecca Fuller [Royaume-Uni, États-Unis] | Cognitive executive function in dystonia |
| 004157 |
Saeed Bohlega [Arabie saoudite] ; Adel Al-Jishi [Bahreïn] ; Carol Dobson-Stone [Royaume-Uni] ; Luca Rampoldi [Royaume-Uni, Italie] ; Parthasarathi Saha [Arabie saoudite] ; Hatem Murad [Arabie saoudite] ; Abid Kareem [Arabie saoudite] ; George Roberts [Arabie saoudite] ; Anthony P. Monaco [Royaume-Uni] | Chorea‐acanthocytosis: Clinical and genetic findings in three families from the Arabian peninsula |
| 004158 |
David Mckee [Royaume-Uni] ; Paul Talbot [Royaume-Uni] | Chorea as a presenting feature of variant Creutzfeldt‐Jakob disease |
| 004162 |
Robert A. Weeks [Royaume-Uni] ; Francisco Scaravilli [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Camille Carroll [Royaume-Uni] ; Masud Husain [Royaume-Uni] ; Peter Rudge [Royaume-Uni] | Cerebral amyloid angiopathy and motor neurone disease presenting with a progressive supranuclear palsy‐like syndrome |
| 004178 |
Tamas Revesz [Royaume-Uni] ; Janice L. Holton [Royaume-Uni] | Anatamopathological spectrum of tauopathies |
| 004179 |
Enza-Maria Valente [Italie] ; Anjum Misbahuddin [Royaume-Uni] ; Francesco Brancati [Italie] ; Mark R. Placzek [Royaume-Uni] ; Barbara Garavaglia [Italie] ; Sergio Salvi [Italie] ; Andrea Nemeth [Royaume-Uni] ; Charles Shaw-Smith [Royaume-Uni] ; Nardo Nardocci [Italie] ; Anna-Rita Bentivoglio [Italie] ; Alfredo Berardelli [Italie] ; Roberto Eleopra [Italie] ; Bruno Dallapiccola [Italie] ; Thomas T. Warner [Royaume-Uni] | Analysis of the ϵ‐sarcoglycan gene in familial and sporadic myoclonus‐dystonia: Evidence for genetic heterogeneity |
| 004183 |
Graham T. A. Warner [Royaume-Uni] ; John H. Mcauley [Royaume-Uni] | Alcohol‐induced paroxysmal nonkinesogenic dyskinesia after pallidal hypoxic insult |
| 004188 |
Anthony E. Lang ; Andrew Lees (neurologue) [Royaume-Uni] | Acknowledgment of reviewers |
| 004191 |
Stephen Butterworth [Royaume-Uni] ; Sue Francis [Royaume-Uni] ; Edward Kelly [États-Unis] ; Francis Mcglone [Royaume-Uni] ; Richard Bowtell [Royaume-Uni] ; Guy V. Sawle [Royaume-Uni] | Abnormal cortical sensory activation in dystonia: An fMRI study |
| 004235 |
Willibald Gerschlager [Autriche, Royaume-Uni] ; Gerhard Bencsits [Autriche] ; Walter Pirker [Autriche] ; Bastiaan R. Bloem [Royaume-Uni, Pays-Bas] ; Susanne Asenbaum [Autriche] ; Daniella Prayer [Autriche] ; Jan C. M. Zijlmans [Royaume-Uni] ; Martha Hoffmann [Autriche] ; Thomas Brücke [Autriche] | [123I]β‐CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease |
| 004241 |
Simon G. Parkin [Royaume-Uni] ; Ralph P. Gregory [Royaume-Uni] ; Richard Scott [Royaume-Uni] ; Peter Bain [Royaume-Uni] ; Peter Silburn [Australie] ; Bruce Hall [Australie] ; Richard Boyle [Australie] ; Carole Joint [Royaume-Uni] ; Tipu Z. Aziz [Royaume-Uni] | Unilateral and bilateral pallidotomy for idiopathic Parkinson's disease: A case series of 115 patients |
| 004243 |
E. Nikfekr [Royaume-Uni] ; K. Kerr [Royaume-Uni] ; S. Attfield [Royaume-Uni] ; E. D. Playford [Royaume-Uni] | Trunk movement in Parkinson's disease during rising from seated position |
| 004259 |
Ronald K. B. Pearce [Royaume-Uni] ; Lance A. Smith [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Tara Banerji [Royaume-Uni] ; Jorgen Scheel-Krüger [Danemark] ; Peter Jenner [Royaume-Uni] | The monoamine reuptake blocker brasofensine reverses akinesia without dyskinesia in MPTP‐treated and levodopa‐primed common marmosets |
| 004263 |
Peter Brown [Royaume-Uni] | The Startle syndrome |
| 004269 |
Katherine H. O. Deane [Royaume-Uni] ; Caroline Ellis-Hill [Royaume-Uni] ; Diana Jones [Royaume-Uni] ; Renata Whurr [Royaume-Uni] ; Yoav Ben-Shlomo [Royaume-Uni] ; E. Diane Playford [Royaume-Uni] ; Carl E. Clarke [Royaume-Uni] | Systematic review of paramedical therapies for Parkinson's disease |
| 004280 |
Susan H. Fox [Royaume-Uni] ; Brian Henry [Royaume-Uni] ; Michael Hill [Royaume-Uni] ; Alan Crossman [Royaume-Uni] ; Jonathan Brotchie [Royaume-Uni] | Stimulation of cannabinoid receptors reduces levodopa‐induced dyskinesia in the MPTP‐lesioned nonhuman primate model of Parkinson's disease |
| 004291 |
Kin-Lun Tsang [Royaume-Uni] ; Susan Daniel [Royaume-Uni] ; Rick Stell [Australie] ; Peter Brown [Royaume-Uni] ; Niall Quinn [Royaume-Uni] | Sixty‐Six‐Year‐Old woman with unexplained falls followed five years later by severe generalized myoclonus |
| 004300 |
J. C. Rothwell [Royaume-Uni] ; C. D. Mackinnon [Royaume-Uni] ; J. Valls-Solé [Royaume-Uni] | Role of brainstem–spinal projections in voluntary movement |
| 004307 |
Roger N. Rosenberg ; Michael Aminoff ; Francois Boller ; Per Soelberg Soerensen ; Robert C. Griggs ; Mark Hallett ; Vladimir Hachinski ; Richard T. Johnson ; Christopher Kennard ; Anthony E. Lang ; Andrew Lees (neurologue) [Royaume-Uni] ; Robert Lisak ; John Newsom-Davis ; Timothy A. Pedley ; Michael E. Selzer ; Douglas Zochodne | Reporting clinical trials: Full access to all the data |
| 004310 |
Lance A. Smith [Royaume-Uni] ; Banu C. Tel [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Matthew J. Hansard [Royaume-Uni] ; Rogelio Braceras [Royaume-Uni] ; Céline Bonhomme [France] ; Claire Chezaubernard [France] ; Susanna Del Signore [France] ; Sarah Rose [Royaume-Uni] ; Peter Jenner [Royaume-Uni] | Repeated administration of piribedil induces less dyskinesia than L‐dopa in MPTP‐treated common marmosets: A behavioural and biochemical investigation |
| 004311 |
Roger A. Barker [Royaume-Uni] | Repairing the brain in Parkinson's disease: Where next? |
| 004315 |
Susan H. Fox [Royaume-Uni] ; Mark Kellett [Royaume-Uni] ; A. Peter Moore [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni] | Randomised, double‐blind, placebo‐controlled trial to assess the potential of cannabinoid receptor stimulation in the treatment of dystonia |
| 004318 |
Alastair Gray [Royaume-Uni] ; Iain Mcnamara [Royaume-Uni] ; Tipu Aziz [Royaume-Uni] ; Ralph Gregory [Royaume-Uni] ; Peter Bain [Royaume-Uni] ; Joanna Wilson [Royaume-Uni] ; Richard Scott [Royaume-Uni] | Quality of life outcomes following surgical treatment of Parkinson's disease |
| 004322 |
Mikko Kuoppam Ki [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Niall Quinn [Royaume-Uni] | Progressive delayed‐onset dystonia after cerebral anoxic insult in adults |
| 004330 |
Russell C. Dale [Royaume-Uni] ; Andrew J. Church [Royaume-Uni] ; Robert A. H. Surtees [Royaume-Uni] ; Edward J. Thompson [Royaume-Uni] ; Gavin Giovannoni [Royaume-Uni] ; Brian G. R. Neville [Royaume-Uni] | Post‐Streptococcal autoimmune neuropsychiatric disease presenting as paroxysmal dystonic choreoathetosis |
| 004332 |
Jan Zijlmans [Royaume-Uni, Pays-Bas] ; Jan Booij [Pays-Bas] ; Jaap Valk [Pays-Bas] ; Andrew Lees (neurologue) [Royaume-Uni] ; Martin Horstink [Pays-Bas] | Posttraumatic tremor without parkinsonism in a patient with complete contralateral loss of the nigrostriatal pathway |
| 004334 |
Patricia Dowsey-Limousin [Royaume-Uni] | Postoperative management of Vim DBS for tremor |
| 004357 |
François Tison [France] ; Farid Yekhlef [France] ; Virginie Chrysostome [France] ; Eric Balestre [France] ; Niall P. Quinn [Royaume-Uni] ; Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche] | Parkinsonism in multiple system atrophy: Natural history, severity (UPDRS‐III), and disability assessment compared with Parkinson's disease |
| 004370 |
Francesco Brancati [Italie] ; Giovanni Defazio [Italie] ; Viviana Caputo [Italie] ; Enza Maria Valente [Italie, Royaume-Uni] ; Antonio Pizzuti [Italie] ; Paolo Livrea [Italie] ; Alfredo Berardelli [Italie] ; Bruno Dallapiccola [Italie] | Novel Italian family supports clinical and genetic heterogeneity of primary adult‐onset torsion dystonia |
| 004375 |
Nicola Modugno [Italie] ; Yusaku Nakamura [Italie] ; Sven Bestmann [Royaume-Uni] ; Antonio Curra [Italie] ; Alfredo Berardelli [Italie] ; John Rothwell [Royaume-Uni] | Neurophysiological investigations in patients with primary writing tremor |
| 004393 |
Anthony E. Lang ; Andrew Lees (neurologue) [Royaume-Uni] | Management of Parkinson's disease: An evidence‐based review |
| 004394 |
Marina A. J. Tijssen [Pays-Bas] ; Monique N. Vergouwe [Pays-Bas] ; J. Gert Van Dijk [Pays-Bas] ; Michelle Rees [Royaume-Uni] ; Rune R. Frants [Pays-Bas] ; Peter Brown [Royaume-Uni] | Major and minor form of hereditary hyperekplexia |
| 004410 |
Patrick F. Chinnery [Royaume-Uni] ; Paul J. Reading [Royaume-Uni] ; Emma L. Mccarthy [Royaume-Uni] ; Ann Curtis [Royaume-Uni] ; David J. Burn [Royaume-Uni] | Late‐onset axial jerky dystonia due to the DYT1 deletion |
| 004415 |
Paul Morrish [Royaume-Uni] | Is it time to abandon functional imaging in the study of neuroprotection? |
| 004417 |
Xuguang Liu [Royaume-Uni] ; Ivan C. Griffin [Royaume-Uni] ; Simon G. Parkin [Royaume-Uni] ; R. Christopher Miall [Royaume-Uni] ; Jeremy G. Rowe [Royaume-Uni] ; Ralph P. Gregory [Royaume-Uni] ; Richard B. Scott [Royaume-Uni] ; Tipu Z. Aziz [Royaume-Uni] ; John F. Stein [Royaume-Uni] | Involvement of the medial pallidum in focal myoclonic dystonia: A clinical and neurophysiological case study |
| 004425 |
Alexander Münchau [Royaume-Uni, Allemagne] ; Michael Orth [Royaume-Uni] ; John C. Rothwell [Royaume-Uni] ; Vincenzo Di Lazzaro [Italie] ; Antonio Oliviero [Italie] ; Paolo Profice [Italie] ; Pietro Tonali [Italie] ; Peter P. Pramstaller [Italie] ; Kailash P. Bhatia [Royaume-Uni] | Intracortical inhibition is reduced in a patient with a lesion in the posterolateral thalamus |
| 004432 |
Laura Camfield [Royaume-Uni] ; Yoav Ben-Shlomo [Royaume-Uni] ; Thomas T. Warner [Royaume-Uni] | Impact of cervical dystonia on quality of life |
| 004442 |
Carole Joint [Royaume-Uni] ; Dipankar Nandi [Royaume-Uni] ; Simon Parkin [Royaume-Uni] ; Ralph Gregory [Royaume-Uni] ; Tipu Aziz [Royaume-Uni] | Hardware‐Related problems of deep brain stimulation |
| 004445 |
Sian D. Spacey [Royaume-Uni, Canada] ; Enza-Maria Valente [Royaume-Uni, Italie] ; Gurusidheshwar M. Wali [Inde] ; Thomas T. Warner [Royaume-Uni] ; Paul R. Jarman [Royaume-Uni] ; Anthony H. V. Schapira [Royaume-Uni] ; Peter H. Dixon [Royaume-Uni] ; Mary B. Davis [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] | Genetic and clinical heterogeneity in paroxysmal kinesigenic dyskinesia: Evidence for a third EKD gene |
| 004449 |
Michael H. Barnett [Royaume-Uni] ; Paul R. Jarman [Royaume-Uni] ; Simon J. R. Heales [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Further case of paroxysmal exercise‐induced dystonia and some insights into pathogenesis |
| 004469 |
S. H. Subramony [États-Unis] ; Dena Hernandez [États-Unis] ; Amanda Adam [États-Unis] ; Stephanie Smith-Jefferson [États-Unis] ; Jennifer Hussey [États-Unis] ; Katrina Gwinn-Hardy [États-Unis] ; Timothy Lynch [États-Unis, Irlande (pays)] ; Olga Mcdaniel [États-Unis] ; John Hardy [États-Unis, Royaume-Uni] ; Matt Farrer [États-Unis] ; Andrew Singleton [États-Unis] | Ethnic differences in the expression of neurodegenerative disease: Machado‐Joseph disease in Africans and Caucasians |
| 004476 |
Annie Lannuzel [France] ; Cécile Hermann [France] ; Chérine Yousry [France] ; Andrew Lees (neurologue) [Royaume-Uni] ; Dominique Caparros-Lefebvre [France] | Encephalomyelitis with rigidity complicating human immunodeficiency virus infection |
| 004483 |
Willibald Gerschlager [Royaume-Uni] ; Peter Brown [Royaume-Uni] | Effect of treatment with intravenous immunoglobulin on quality of life in patients with stiff‐person syndrome |
| 004485 |
Katherine A. Johnson [Australie] ; Ross Cunnington [Australie, Royaume-Uni] ; John L. Bradshaw [Australie] ; Edmond Chiu [Australie] ; Robert Iansek [Australie] | Effect of an attentional strategy on movement‐related potentials recorded from subjects with Huntington's disease |
| 004486 |
Anthony Lang ; Andrew Lees (neurologue) [Royaume-Uni] | Editorial |
| 004488 |
Sandhiran Patchay [France, Royaume-Uni] ; Yves Gahéry [France] ; Georges Serratrice [France] | Early postural adjustments associated with gait initiation and age‐related walking difficulties |
| 004489 |
Carla Cordivari [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; V. Peter Misra [Royaume-Uni] ; Peter Brown [Royaume-Uni] | EMG–EMG coherence in writer's cramp |
| 004503 |
A. J. Larner [Royaume-Uni] | Did Charles Dickens describe progressive supranuclear palsy in 1857? |
| 004506 |
Marina A. J. Tijssen [Royaume-Uni, Pays-Bas] ; Alex Münchau [Royaume-Uni] ; John F. Marsden [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Peter Brown [Royaume-Uni] | Descending control of muscles in patients with cervical dystonia |
| 004527 |
Jason D. Warren [Royaume-Uni] ; Catherine J. Mummery [Royaume-Uni] ; Amir S. Al-Din [Royaume-Uni] ; Peter Brown [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] | Corticobasal degeneration syndrome with basal ganglia calcification: Fahr's disease as a corticobasal look‐alike? |
| 004533 |
Joanna Seni W [Pologne] ; Thomas Bak [Royaume-Uni] ; Jolanta Gajda [Pologne] ; Renata Poniatowska [Pologne] ; Anna Czlonkowska [Pologne] | Cognitive functioning in neurologically symptomatic and asymptomatic forms of Wilson's disease |
| 004544 |
Joanne E. Nash [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni] | Characterisation of striatal NMDA receptors involved in the generation of parkinsonian symptoms: Intrastriatal microinjection studies in the 6‐OHDA‐lesioned rat |
| 004552 |
Dipankar Nandi [Royaume-Uni] ; Tipu Z. Aziz [Royaume-Uni] ; Xuguang Liu [Royaume-Uni] ; John F. Stein [Royaume-Uni] | Brainstem motor loops in the control of movement |
| 004554 |
Dirk Dressler [Royaume-Uni] ; Hans Bigalke [Allemagne] | Botulinum toxin antibody type A titres after cessation of botulinum toxin therapy |
| 004558 |
John D. O'Sullivan [Royaume-Uni] ; John Rothwell [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Peter Brown [Royaume-Uni] | Bilaterally coherent tremor resembling enhanced physiological tremor: Report of three cases |
| 004562 |
David J. Burn [Royaume-Uni] | Beyond the iron mask: Towards better recognition and treatment of depression associated with Parkinson's disease |
| 004563 |
Mikko Kuoppam Ki [Royaume-Uni] ; Ghassan Al-Barghouthy [Royaume-Uni] ; Michael Jackson [Royaume-Uni] ; Lance Smith [Royaume-Uni] ; Bai-Yun Zeng [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Peter Jenner [Royaume-Uni] | Beginning‐of‐dose and rebound worsening in MPTP‐treated common marmosets treated with levodopa |
| 004570 |
François Tison [France] ; Farid Yekhlef [France] ; Eric Balestre [France] ; Virginie Chrysostome [France] ; Niall Quinn [Royaume-Uni] ; Gregor K. Wenning [France] ; Werner Poewe [Autriche] | Application of the International Cooperative Ataxia Scale rating in multiple system atrophy |
| 004571 |
Alice J. Manson [Royaume-Uni] ; Kirsten Turner [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: Long‐term follow‐up study of 64 patients |
| 004576 |
Michele T. M. Hu [Royaume-Uni] ; K. Ray Chaudhuri [Royaume-Uni] ; Jozef Jarosz [Royaume-Uni] ; Lidia Yaguez [Royaume-Uni] ; David J. Brooks [Royaume-Uni] | An imaging study of parkinsonism among African‐Caribbean and Indian London communities |
| 004579 |
Valsamma Eapen [Royaume-Uni, Émirats arabes unis] ; Andrew Lees (neurologue) [Royaume-Uni] ; J. P. W. F. Lakke [Pays-Bas] ; Michael R. Trimble [Royaume-Uni] ; Mary M. Robertson [Royaume-Uni] | Adult‐onset tic disorders |
| 004582 |
Lavanya Vijayaraghavan [Royaume-Uni] ; Ennapadam S. Krishnamoorthy [Singapour] ; Richard G. Brown [Royaume-Uni] ; Michael R. Trimble [Royaume-Uni] | Abulia: A Delphi survey of British neurologists and psychiatrists |
| 004590 |
Willibald Gerschlager [Autriche, Royaume-Uni] ; Gerhard Bencsits [Autriche] ; Walter Pirker [Autriche] ; Bastiaan R. Bloem [Royaume-Uni, Pays-Bas] ; Susanne Asenbaum [Autriche] ; Daniella Prayer [Autriche] ; Jan C. M. Zijlmans [Royaume-Uni] ; Martha Hoffmann [Autriche] ; Thomas Brücke [Autriche] | [123I]β-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease |
| 004601 |
Patricia Dowsey-Limousin [Royaume-Uni] | Postoperative management of Vim DBS for tremor |
| 004610 |
XUGUANG LIU [Royaume-Uni] ; Ivan C. Griffin [Royaume-Uni] ; Simon G. Parkin [Royaume-Uni] ; R. Christopher Miall [Royaume-Uni] ; Jeremy G. Rowe [Royaume-Uni] ; Ralph P. Gregory [Royaume-Uni] ; Richard B. Scott [Royaume-Uni] ; Tipu Z. Aziz [Royaume-Uni] ; John F. Stein [Royaume-Uni] | Involvement of the medial pallidum in focal myoclonic dystonia: A clinical and neurophysiological case study |
| 004623 |
A. J. Lamer [Royaume-Uni] | Did Charles Dickens describe progressive supranuclear palsy in 1857? |
| 004635 |
Joanna Seniow [Pologne] ; Thomas Bak [Royaume-Uni] ; Jolanta Gajda [Pologne] ; Renata Poniatowska [Pologne] ; Anna Czlonkowska [Pologne] | Cognitive functioning in neurologically symptomatic and asymptomatic forms of Wilson's disease |
| 004655 |
John D. O'Sullivan [Royaume-Uni] ; Peter Brown [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Unusual tremor associated with a posterolateral thalamic lesion in a drummer |
| 004662 |
Carla Cordivari [Royaume-Uni] ; V. Peter Misra [Royaume-Uni] ; Santiago Catania [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Treatment of dystonic clenched fist with botulinum toxin |
| 004672 |
A. Danek [Allemagne] ; F. Tison [France] ; J. Rubio [Royaume-Uni] ; M. Oechsner [Allemagne] ; W. Kalckreuth [Allemagne] ; A. P. Monaco [Royaume-Uni] | The chorea of McLeod syndrome |
| 004681 |
A. Münchau [Royaume-Uni, Allemagne] ; S. R. Filipovic ; A. Oester-Barkey ; N. P. Quinn [Royaume-Uni] ; J. C. Rothwell ; K. P. Bhatia [Royaume-Uni] | Spontaneously changing muscular activation pattern in patients with cervical dystonia |
| 004685 |
Hugh Rickards [Royaume-Uni] | Signing coprolalia and attempts to disguise in a man with prelingual deafness |
| 004692 |
Paul J. Reading [Royaume-Uni] ; Anna K. Luce [Royaume-Uni] ; Ian G. Mckeith [Royaume-Uni] | Rivastigmine in the treatment of parkinsonian psychosis and cognitive impairment: Preliminary findings from an open trial |
| 004696 |
Niall Quinn [Royaume-Uni] | Rhythmic Tremor of the Palate and Other Cranial Limb Muscles, With Cerebellar Ataxia: Consider Whipple's Disease |
| 004699 |
Georg Berding [Allemagne] ; Per Odin [Allemagne] ; David J. Brooks [Royaume-Uni] ; Guido Nikkhah [Allemagne] ; Cordula Matthies [Allemagne] ; Thomas Peschel [Allemagne] ; Mona Shing [Allemagne] ; Hans Kolbe [Allemagne] ; Jörg Van Den Hoff [Allemagne] ; Harald Fricke [Allemagne] ; Reinhard Dengler [Allemagne] ; Madjid Samii [Allemagne] ; Wolfram H. Knapp [Allemagne] | Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [18F]FDG‐PET |
| 004707 |
William Koller [États-Unis] ; Andrew Lees (neurologue) [Royaume-Uni] ; Miroslava Doder [Royaume-Uni] ; Mariese Hely [Australie] | Randomized trial of tolcapone versus pergolide as add‐on to levodopa therapy in Parkinson's disease patients with motor fluctuations |
| 004727 |
Ilias Papathanasiou [Royaume-Uni] ; Lea Macdonald [Royaume-Uni] ; Renata Whurr [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni] | Perceived stigma in Spasmoic Torticollis |
| 004745 |
Susan H. Fox [Royaume-Uni] ; Brian Henry [Royaume-Uni] ; Micheal P. Hill [Royaume-Uni] ; David Peggs [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni] | Neural mechanisms underlying peak‐dose dyskinesia induced by levodopa and apomorphine are distinct: Evidence from the effects of the alpha2 adrenoceptor antagonist idazoxan |
| 004753 |
Paul Krack [France, Allemagne] ; Rajeev Kumar [États-Unis] ; Claire Ardouin [France] ; Patricia Limousin Dowsey [France, Royaume-Uni] ; John M. Mcvicker [États-Unis] ; Alim-Louis Benabid [France] ; Pierre Pollak [France] | Mirthful laughter induced by subthalamic nucleus stimulation |
| 004764 |
L. Munro-Davies [Royaume-Uni] ; J. Winter [Royaume-Uni] ; T. Z. Aziz [Royaume-Uni] ; J. Stein [Royaume-Uni] | Kainate acid lesions of the pedunculopontine region in the normal behaving primate |
| 004766 |
Andrew Lees (neurologue) [Royaume-Uni] | Jumpers |
| 004775 |
Dennis W. Dickson [États-Unis] ; Brian Anderton [Royaume-Uni] ; Huw Morris [Royaume-Uni] ; John Hodges [Royaume-Uni] ; Thomas H. Bak [Royaume-Uni] ; B. Dubois [France] ; B. Pillon [France] ; T. Bak [France] ; R. Rafal [France] ; J. Grafman [France] ; Lawrence I. Golbe [États-Unis] ; John Steele [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; Marie Vidailhet [France] ; S. Rivaud-Pechoux [France] ; Irene Livan [États-Unis] ; Charles Pierrot-Deseilligny [France] ; Clare J. Fowler [Royaume-Uni] ; Timothy Lynch [Irlande (pays)] ; Catherine Bergeron [Canada] ; Kailash Bhatia [Royaume-Uni] ; Martin N. Rossor [Royaume-Uni] ; Gregor K. Wenning [États-Unis, Royaume-Uni, France, Irlande (pays), Canada, Allemagne] ; Christopher J. Mathias [Royaume-Uni] ; Thomas Klockgether [Allemagne] ; M. Abele [Allemagne] ; U. Wullner [Allemagne] ; Peter Lantos [Royaume-Uni] ; David J. Brooks [Royaume-Uni] ; Dominique Caparros-Lefebvre [France] | International Medical Workshop covering progressive supranuclear palsy, multiple system atrophy and cortico basal degeneration |
| 004808 |
Andrea S. Winkler [Royaume-Uni] ; Joanne Marsden [Royaume-Uni] ; Matthew Parton [Royaume-Uni] ; Peter J. Watkins [Royaume-Uni] ; K. Ray Chaudhuri [Royaume-Uni] | Erythropoietin deficiency and anaemia in multiple system atrophy |
| 004814 |
Peter Brown [Royaume-Uni] ; Philip D. Thompson [Australie] | Electrophysiological aids to the diagnosis of psychogenic jerks, spasms, and tremor |
| 004819 |
Anthony E. Lang ; Andrew Lees (neurologue) [Royaume-Uni] | Editorial |
| 004820 |
Anthony E. Lang ; Andrew Lees (neurologue) [Royaume-Uni] | Editorial |
| 004836 |
Alberto Albanese [Italie] ; Ubaldo Bonuccelli [Italie] ; Christine Brefel [France] ; K. Ray Chaudhuri [Royaume-Uni] ; Carlo Colosimo [Italie] ; Tobias Eichhorn [Allemagne] ; Eldad Melamed [Israël] ; Pierre Pollak [France] ; Teus Van Laar [Pays-Bas] ; Mario Zappia [Italie] | Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease |
| 004842 |
S. Bostantjopoulou [Grèce] ; Z. Katsarou [Grèce] ; A. Papadimitriou [Grèce] ; V. Veletza [Grèce] ; G. Hatzigeorgiou [Grèce] ; A. Lees [Royaume-Uni] | Clinical features of parkinsonian patients with the α‐synuclein (G209A) mutation |
| 004845 |
Krishna P. Datla [Royaume-Uni] ; Stavia B. Blunt [Royaume-Uni] ; David T. Dexter [Royaume-Uni] | Chronic L‐DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6‐OHDA or FeCl3 nigrostriatal lesions |
| 004849 |
Miratul M. K. Muqit [Royaume-Uni] ; James S. Rakshi [Royaume-Uni] ; Raad A. Shakir [Royaume-Uni] ; A. J. Larner [Royaume-Uni] | Catatonia or abulia? A difficult differential diagnosis |
| 004851 |
C. Chuang [Royaume-Uni] ; R. S. Kocen [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; S. E. Daniel [Royaume-Uni] | Case with both multiple system atrophy and primary progressive multiple sclerosis with discussion of the difficulty in their differential diagnosis |
| 004864 |
Simon Parkin [Royaume-Uni] ; Tipu Aziz [Royaume-Uni] ; Ralph Gregory [Royaume-Uni] ; Peter Bain [Royaume-Uni] | Bilateral internal globus pallidus stimulation for the treatment of spasmodic torticollis |
| 004867 |
Christine Klein [Allemagne] ; Grant S. Stewart [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; A. Malcolm. R. Taylor [Royaume-Uni] | Ataxia without telangiectasia revisited: Update on genetic findings in two brothers with an ataxia‐telangiectasia‐like disorder |
| 004872 |
Eleni C. Maratos [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Ronald K. B. Pearce [Royaume-Uni] ; Peter Jenner [Royaume-Uni] | Antiparkinsonian activity and dyskinesia risk of ropinirole and L‐DOPA combination therapy in drug naive MPTP‐lesioned common marmosets (Callithrix jacchus) |
| 004884 |
A. P. Moore [Royaume-Uni] ; R. A. Ade-Hall [Royaume-Uni] ; M. Mcdowell [Royaume-Uni] ; L. Rosenbloom [Royaume-Uni] ; K. Mohammed [Royaume-Uni] ; H. P. J. Walsh [Royaume-Uni] ; R. A. Ade-Hall [Royaume-Uni] ; A. P. Moore [Royaume-Uni] | ABSTRACTS SUBMITTED TO THE FLORIDA BOTULINUM TOXIN CONFERENCE NOV 1999 |
| 004886 |
Connie Marras [Canada] ; Anthony E. Lang [Canada] ; Lee Cyn Ang [Canada] ; Jcm Zijlmans [Royaume-Uni] ; G. K. Wenning [Autriche] | 69‐Year‐old man with gait disturbance and parkinsonism |
| 004895 |
L. Munro-Davies [Royaume-Uni] ; J. Winter [Royaume-Uni] ; T. Z. Aziz [Royaume-Uni] ; J. Stein [Royaume-Uni] | Kainate acid lesions of the pedunculopontine region in the normal behaving primate |
| 004912 |
T S Benamer [Royaume-Uni] ; J. Patterson ; D G Grosset ; J. Booij ; K. De Bruin ; E. Van Royen ; J D Speelman ; M H Horstink ; H J Sips ; R A Dierckx ; J. Versijpt ; D. Decoo ; C. Van Der Linden ; D M Hadley ; M. Doder ; A J Lees ; D C Costa ; S. Gacinovic ; W H Oertel ; O. Pogarell ; H. Hoeffken ; K. Joseph ; K. Tatsch ; J. Schwarz ; V. Ries | Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. |
| 004918 |
C. Warren Olanow [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Tom Roth [États-Unis] | Waking up to sleep episodes in Parkinson's Disease |
| 004923 |
David S. Latchman [Royaume-Uni] ; Robert S. Coffin [Royaume-Uni] | Viral vectors in the treatment of Parkinson's disease |
| 004927 |
Hani T. S. Benamer [Royaume-Uni] ; Aline J. C. Russell [Royaume-Uni] ; Donald M. Hadley [Royaume-Uni] ; Donald G. Grosset [Royaume-Uni] | Unilateral arm tremor as the sole feature of ischemic stroke: A 5‐year follow up |
| 004940 |
Evelyn Jaros [Royaume-Uni] ; David J. Burn [Royaume-Uni] | The pathogenesis of multiple system atrophy: Past, present, and future |
| 004941 |
Patrick Haggard [Royaume-Uni] ; Sam Rodgers [Royaume-Uni] | The movement disorder of Nicolas Poussin (1594–1665) |
| 004942 |
Thomas Klockgether [Allemagne] ; Ullrich Wüllner [Allemagne] ; Alexander Spauschus [Royaume-Uni] ; Bernd Evert [Allemagne] | The molecular biology of the autosomal‐dominant cerebellar ataxias |
| 004947 |
I. Reuter [Royaume-Uni] ; S. Harder [Allemagne] ; M. Engelhardt [Allemagne] ; H. Baas [Allemagne] | The effect of exercise on pharmacokinetics and pharmacodynamics of levodopa |
| 004950 |
Carl Nikolaus Homann ; Klaudia Suppan ; Karoline Wenzel ; Gavin Giovannoni [Royaume-Uni] ; Gert Ivanic ; Susanne Horner ; Erwin Ott ; Hans Peter Hartung | The bradykinesia akinesia incoordination test (BRAIN TEST©), an objective and user‐friendly means to evaluate patients with Parkinsonism |
| 004964 |
Huw R. Morris [Royaume-Uni] ; Alice J. Thacker [Royaume-Uni] ; Peter K. Newman [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Sign language tics in a prelingually deaf man |
| 004973 |
H. R. Morris [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Reply |
| 004983 |
Martín Nogués [Argentine] ; Angel Cammarota [Argentine] ; Claudia Solá [Argentine] ; Peter Brown [Royaume-Uni] | Propriospinal myoclonus in ischemic myelopathy secondary to a spinal dural arteriovenous fistula |
| 004987 |
K. F. Bhattacharya [Royaume-Uni] ; I. Giannakikou [Royaume-Uni] ; N. Munroe [Royaume-Uni] ; K. Ray Chaudhuri [Royaume-Uni] | Primary anticholinergic‐responsive Pisa syndrome |
| 004A04 |
Paul R. Jarman [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Charles Davie [Royaume-Uni] ; Simon J. R. Heales [Royaume-Uni] ; Nora Turjanski [Royaume-Uni] ; Simon D. Taylor-Robinson [Royaume-Uni] ; C. David Marsden [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] | Paroxysmal dystonic choreoathetosis: Clinical features and investigation of pathophysiology in a large family |
| 004A07 |
Niall Quinn [Royaume-Uni] ; Demetrius Maraganore [États-Unis] | Parkinsonism following electrical injury to the hand |
| 004A18 |
John D. O'Sullivan [Royaume-Uni] ; Hasmet A. Hanagasi [Royaume-Uni] ; Susan E. Daniel [Royaume-Uni] ; Phillip Tidswell [Royaume-Uni] ; Stephen W. Davies [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Neuronal intranuclear inclusion disease and juvenile Parkinsonism |
| 004A23 |
D. M. Sheppard [Royaume-Uni, Australie] ; J. L. Bradshaw [Australie] ; N. Georgiou [Australie] ; J. A. Bradshaw [Australie] ; P. Lee [Australie] | Movement sequencing in children with Tourette's syndrome and attention deficit hyperactivity disorder |
| 004A25 |
Fernando Alarc N ; Gonzalo Due As ; Nelson Cevallos ; Andrew Lees (neurologue) [Royaume-Uni] | Movement disorders in 30 patients with tuberculous meningitis |
| 004A32 |
Maria Teresa Dotti [Italie] ; Carla Battisti [Italie] ; Alessandro Malandrini [Italie] ; Antonio Federico [Italie] ; Justin P. Rubio [Australie] ; Giuseppe Circiarello [Italie] ; Anthony P. Monaco [Royaume-Uni] | McLeod syndrome and neuroacanthocytosis with a novel mutation in the XK gene |
| 004A57 |
Alice J. Manson [Royaume-Uni] ; Elena Iakovidou [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Idazoxan is ineffective for levodopa‐induced dyskinesias in Parkinson's disease |
| 004A76 |
Kailash P. Bhatia [Royaume-Uni] ; Robert C. Griggs [États-Unis] ; Louis J. Ptá Ek [États-Unis] | Episodic movement disorders as channelopathies |
| 004A77 |
Rebecca J. Carter [Royaume-Uni] ; Mark J. Hunt [Royaume-Uni] ; A. Jennifer Morton [Royaume-Uni] | Environmental stimulation increases survival in mice transgenic for exon 1 of the Huntington's disease gene |
| 004A78 |
Sarah A. Treseder [Royaume-Uni] ; Lance A. Smith [Royaume-Uni] ; Peter Jenner [Royaume-Uni] | Endogenous dopaminergic tone and dopamine agonist action |
| 004A80 |
Andrew Lees (neurologue) [Royaume-Uni] ; Anthony E. Lang | Editorial |
| 004A89 |
Ram N Leiguarda [Argentine] ; Marcelo Merello [Argentine] ; Jorge Balej [Argentine] ; Sergio Starkstein [Argentine] ; Martín Nogues [Argentine] ; C. David Marsden [Royaume-Uni] | Disruption of spatial organization and interjoint coordination in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy |
| 004A94 |
Oliver Bandmann [Royaume-Uni] ; Jenny R. Vaughan [Royaume-Uni] ; Peter Holmans [Royaume-Uni] ; C. David Marsden [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] | Detailed genotyping demonstrates association between the slow acetylator genotype for N‐Acetyltransferase 2 (NAT2) and familial parkinson's disease |
| 004B01 |
Hani T. S. Benamer [Royaume-Uni] ; Jim Patterson [Royaume-Uni] ; David J. Wyper [Royaume-Uni] ; Donald M. Hadley [Royaume-Uni] ; G. J. A. Macphee [Royaume-Uni] ; Donald G. Grosset [Royaume-Uni] | Correlation of Parkinson's disease severity and duration with 123I‐FP‐CIT SPECT striatal uptake |
| 004B02 |
Andrew Gillies [Royaume-Uni] ; Gordon Arbuthnott [Royaume-Uni] | Computational models of the basal ganglia |
| 004B10 |
John Bowen ; Tejal Mitchell ; Ronald Pearce ; Niall Quinn [Royaume-Uni] | Chorea in new variant Creutzfeldt‐Jakob disease |
| 004B19 |
D. Dressler [Royaume-Uni] ; G. Dirnberger [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] ; A. Irmer [Allemagne] ; N. P. Quinn [Royaume-Uni] ; H. Bigalke [Allemagne] ; C. D. Marsden [Royaume-Uni] | Botulinum toxin antibody testing: Comparison between the mouse protection assay and the mouse lethality assay |
| 004B24 |
Elena Moro [France] ; Rianne A. J. Esselink [France] ; Nadège Van Blercom [France] ; Elena Caputo [France] ; Pierre Pollak [France] ; Patricia Limousin [Royaume-Uni] ; Marwan I. Hariz [Suède] | Bilateral subthalamic nucleus stimulation in a parkinsonian patient with previous unilateral pallidotomy and thalamotomy |
| 004B34 |
K. Ray Chaudhuri ; M. T. M. Hu [Royaume-Uni] ; D. J. Brooks [Royaume-Uni] | Atypical parkinsonism in Afro‐Caribbean and Indian origin immigrants to the UK |
| 004B49 |
Gregor K. Wenning [Autriche] ; Kurt J. Jellinger [Autriche] ; Niall P. Quinn [Royaume-Uni] ; Werner Poewe [Autriche] | An early report of striatonigral degeneration |
| 004B59 |
Hani T. S. Benamer [Royaume-Uni] ; Jim Patterson [Royaume-Uni] ; Donald G. Grosset [Royaume-Uni] ; J. Booij [Royaume-Uni] ; K. De Bruin [Royaume-Uni] ; E. Van Royen [Royaume-Uni] ; J. D. Speelman [Pays-Bas] ; M. H. I. M. Horstink [Pays-Bas] ; H. J. W. A. Sips [Pays-Bas] ; R. A. Dierckx [Belgique] ; J. Versijpt [Belgique] ; D. Decoo [Belgique] ; C. Van Der Linden [Belgique] ; D. M. Hadley ; M. Doder [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; D. C. Costa [Royaume-Uni] ; S. Gacinovic [Royaume-Uni] ; W. H. Oertel [Allemagne] ; O. Pogarell [Allemagne] ; H. Hoeffken [Allemagne] ; K. Joseph [Allemagne] ; K. Tatsch [Belgique] ; J. Schwarz [Allemagne] ; V. Ries [Allemagne] | Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]‐FP‐CIT SPECT imaging: The [123I]‐FP‐CIT study group |
| 004B65 |
A. Münchau [Royaume-Uni] ; E. M. Valente [Royaume-Uni] ; M. B. Davis [Royaume-Uni] ; V. Stinton [Royaume-Uni] ; N. W. Wood [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | A Yorkshire family with adult‐onset cranio‐cervical primary torsion dystonia |
| 004B66 |
Susan H. Fox [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni] | 5‐HT2C receptor binding is increased in the substantia nigra pars reticulata in Parkinson's disease |
| 004B79 |
F. Alarcon [Royaume-Uni] ; G. Duenas [Royaume-Uni] ; N. Cevallos [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Movement disorders in 30 patients with tuberculous meningitis |
| 004B89 |
D. Dressier [Royaume-Uni] ; G. Dirnberger [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] ; A. Irmer [Allemagne] ; N. P. Quinn [Royaume-Uni] ; H. Bigalke [Allemagne] ; C. D. Marsden [Royaume-Uni] | Botulinum toxin antibody testing : Comparison between the mouse protection assay and the mouse lethality assay |
| 004B90 |
K. Ray Chaudhuri [Royaume-Uni] ; M. T. M. Hu [Royaume-Uni] ; D. J. Brooks [Royaume-Uni] | Atypical parkinsonism in Afro-Caribbean and Indian origin immigrants to the UK |
| 004B91 |
Susan H. Fox [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni] | 5-HT2C receptor binding is increased in the substantia nigra pars reticulata in Parkinson's disease |
| 004B93 |
B. Henry [Royaume-Uni] ; S H Fox ; D. Peggs ; A R Crossman ; J M Brotchie | The alpha2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson's disease. |
| 004C07 |
Banati [Royaume-Uni] ; Blunt [Royaume-Uni] ; Graeber [Allemagne] | What does apoptosis have to do with Parkinson's disease? |
| 004C22 |
Brian Henry [Royaume-Uni] ; Susan H. Fox [Royaume-Uni] ; David Peggs [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni] | The α2‐adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti‐parkinsonian actions of L‐dopa in the MPTP‐lesioned primate model of Parkinson's disease |
| 004C23 |
Ann E. Kingsbury [Royaume-Uni] ; C. David Marsden [Royaume-Uni] ; Oliver J. F. Foster [Royaume-Uni] | The vulnerability of nigral neurons to Parkinson's disease is unrelated to their intrinsic capacity for dopamine synthesis: An in situ hybridization study |
| 004C42 |
A. Churchyard [Royaume-Uni] ; C. J. Mathias [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Selegiline‐induced postural hypotension in Parkinson's disease: A longitudinal study on the effects of drug withdrawal |
| 004C45 |
Dilip Mathen [Royaume-Uni] ; C. David Marsden [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | SSRI‐induced reversal of levodopa benefit in two patients with dopa‐responsive dystonia |
| 004C55 |
Paul Krack [France, Allemagne] ; Pierre Pollak [France] ; Dominique Hoffmann [France] ; Abdelhamid Benazzouz [France] ; Alim-Louis Benabid [France] ; Patricia Limousin Dowsey [France, Royaume-Uni] | Reply |
| 004C57 |
Sandip Shaunak [Royaume-Uni] ; Erin O'Sullivan [Royaume-Uni] ; Staira Blunt [Royaume-Uni] ; Mark Lawden [Royaume-Uni] ; Trevor Crawford [Royaume-Uni] ; Leslie Henderson [Royaume-Uni] ; Christopher Kennard [Royaume-Uni] | Remembered saccades with variable delay in Parkinson's disease |
| 004C64 |
Gregor K. Wenning [Autriche] ; Georg Ebersbach [Autriche] ; Marc Verny [France] ; K. Ray Chaudhuri [Royaume-Uni] ; Kurt Jellinger [Autriche] ; Ann Mckee [États-Unis] ; Werner Poewe [États-Unis] ; Irene Litvan [États-Unis] | Progression of falls in postmortem‐confirmed Parkinsonian disorders |
| 004C66 |
Huw R. Morris [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Primary antiphospholipid syndrome presenting as a corticobasal degeneration syndrome |
| 004C77 |
J. M. Walshe [Royaume-Uni] | Penicillamine: The treatment of first choice for patients with Wilson's disease |
| 004C81 |
Sundus H. Alusi [Royaume-Uni] ; Ian Colquhoun [Royaume-Uni] ; Tom Sensky [Royaume-Uni] ; Peter G. Bain [Royaume-Uni] | Pathologic laughter resulting from a large midbrain arteriovenous malformation |
| 004C99 |
Huw R. Morris [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] | Neurofibrillary tangle parkinsonian disorders—tau pathology and tau genetics |
| 004D00 |
Jeffery Kimber [Royaume-Uni] ; Laura Watson [Royaume-Uni] ; Christopher J. Mathias [Royaume-Uni] | Neuroendocrine responses to levodopa in multiple system atrophy (MSA) |
| 004D23 |
Emanuele Cassetta [Italie] ; Nicoletta Del Grosso [Italie] ; Anna Rita Bentivoglio [Italie] ; Enza Maria Valente [Italie, Royaume-Uni] ; Marina Frontali [Italie] ; Alberto Albanese [Italie, Suisse] | Italian family with cranial cervical dystonia: Clinical and genetic study |
| 004D28 |
Lees [Royaume-Uni] | In memoriam |
| 004D38 |
Marcelo Merello [Argentine] ; Andrew Lees (neurologue) [Royaume-Uni] ; Jorge Balej [Argentine] ; Angel Cammarota [Argentine] ; Ram N Leiguarda [Argentine] | GPi Firing rate modification during beginning‐of‐dose motor deterioration following acute administration of apomorphine |
| 004D58 |
Anthony E. Lang ; Andrew Lees (neurologue) [Royaume-Uni] | Editorial |
| 004D67 |
Andrea H. Németh [Royaume-Uni] ; Kerry R. Mills [Royaume-Uni] ; John S. Elston [Royaume-Uni] ; Adrian Williams [Royaume-Uni] ; Eimear Dunne [Royaume-Uni] ; Nigel M. Hyman [Royaume-Uni] | Do the same genes predispose to Gilles de la Tourette syndrome and dystonia? Report of a new family and review of the literature |
| 004D75 |
Han-Cheng Wang [Taïwan] ; Wei-Chih Hsu [Taïwan] ; Peter Brown [Royaume-Uni] | Cortical tremor secondary to a frontal cortical lesion |
| 004D82 |
Mansoor [Royaume-Uni] ; Prichard [Royaume-Uni] ; J. P. Hobson [Royaume-Uni] ; Meara [Royaume-Uni] | Clinical assessment of olfactory dysfunction in Parkinson's disease |
| 004D89 |
Martin C. Prevett [Royaume-Uni] ; Martin N. Rossor [Royaume-Uni] | Central pontine and extrapontine myelinolysis presenting with parkinsonism in a patient with cystic fibrosis |
| 004D97 |
Peter Brown [Royaume-Uni] ; C. David Marsden [Royaume-Uni] | Bradykinesia and impairment of EEG desynchronization in Parkinson's disease |
| 004E17 |
Roberto Ceravolo [Italie] ; Stefania Salvetti [Italie] ; Paola Piccini [Royaume-Uni] ; Claudio Lucetti [Italie] ; Gianna Gambaccini [Italie] ; Ubaldo Bonuccelli [Italie] | Acute and chronic effects of clozapine in essential tremor |
| 004E18 |
Anthony E. Lang ; Andrew Lees (neurologue) [Royaume-Uni] | Acknowledgment of reviewers |
| 004E28 |
Jacqueline M. Graham [Royaume-Uni] ; Harvey J. Sagar [Royaume-Uni] | A data‐driven approach to the study of heterogeneity in idiopathic Parkinson's disease: identification of three distinct subtypes |
| 004E36 |
B. Henry [Royaume-Uni] ; S. H. Fox [Royaume-Uni] ; D. Peggs [Royaume-Uni] ; A. R. Crossman [Royaume-Uni] ; J. M. Brotchie [Royaume-Uni] | The α2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-Parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson's disease |
| 004E40 |
J. M. Brotchie [Royaume-Uni] ; S. H. Fox [Royaume-Uni] | Quantitative assessment of dyskinesias in subhuman primates |
| 004E52 |
R. K. B. Pearce [Royaume-Uni] | L-dopa and dyskinesias in normal monkeys |
| 004E55 |
P. Brown [Royaume-Uni] ; A. Manson [Royaume-Uni] | Dyskinesias assessment and ambulatory devices |
| 004E66 |
Angelika Richter [Allemagne] ; Brotchie [Royaume-Uni] ; Crossman [Royaume-Uni] ; Löscher [Allemagne] | [3H]‐2‐Deoxyglucose uptake study in mutant dystonic hamsters: Abnormalities in discrete brain regions of the motor system |
| 004E70 |
Michael R. Trimble [Royaume-Uni] ; Renata Whurr [Royaume-Uni] ; Gerald Brookes [Royaume-Uni] ; Mary M. Robertson [Royaume-Uni] | Vocal tics in gilles de la tourette syndrome treated with botulinum toxin injections |
| 004E84 |
Davie [Royaume-Uni] | The role of spectroscopy in parkinsonism |
| 004F04 |
Korczyn [Israël] ; David J. Brooks [Royaume-Uni] ; Ehrout R. Brunt [Pays-Bas] ; Warner H. Poewe [Autriche] ; Olivier Rascol [France] ; Fabrizzio Stocchi [Italie] | Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: A 6‐month interim report of a 3‐year study |
| 004F05 |
Rascol [France] ; David J. Brooks [Royaume-Uni] ; Ehrout R. Brunt [Pays-Bas] ; Amos D. Korczyn [Israël] ; Warner H. Poewe [Autriche] ; Fabrizzio Stocchi [Italie] | Ropinirole in the treatment of early Parkinson's disease: A 6‐month interim report of a 5‐year levodopa‐controlled study |
| 004F09 |
Michele T. M. Hu [Royaume-Uni] ; K. Ray Chaudhuri [Royaume-Uni] | Repetitive belching, aerophagia, and torticollis in Huntington's disease: A case report |
| 004F26 |
John C. Rothwell [Royaume-Uni] | Physiology and Anatomy of Possible Oscillators in the Central Nervous System |
| 004F31 |
How R. Morris [Royaume-Uni] ; Neville F. Moriabadi [Royaume-Uni] ; Lees [Royaume-Uni] ; David J. Dick [Norfolk] ; Nora F. Moriabadi [Royaume-Uni] ; D. Turjanski [Royaume-Uni] | Parkinsonism following electrical injury to the hand |
| 004F37 |
Andrew G. Riedl [Royaume-Uni] ; Paul M. Watts [Royaume-Uni] ; Jenner [Royaume-Uni] ; C. David Marsden [Royaume-Uni] | P450 enzymes and Parkinson's disease: The story so far |
| 004F44 |
Dressler [Royaume-Uni] ; T. Scaravilli [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Nicotine nasal spray is not reliable treatment for blepharospasm: Results of a pilot study |
| 004F68 |
Ali H. Rajput [Canada] ; Alex Rajput [Canada] ; Anthony E. Lang [Canada] ; Rajeev Kumar [Canada] ; Ryan J. Uitti [États-Unis] ; David G. Le Couteur [Australie] ; Sally J. Mccann [Australie] ; Mark W. Becher [États-Unis] ; Christopher A. Ross [États-Unis] ; Richard Hardie [Royaume-Uni] | Letters to the Editor |
| 004F72 |
Duffey [Royaume-Uni] ; Alan Coulthard [Royaume-Uni] ; David J. Burn [Royaume-Uni] | Late observation of the Goutières Aicardi syndrome |
| 004F74 |
Neill R. Hughes [Royaume-Uni] ; Alexander T. Mcknight [Royaume-Uni] ; Geoffrey N. Woodruff [Royaume-Uni] ; Michael P. Hill [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Brotchie [Royaume-Uni] | Kappa‐opioid receptor agonists increase locomotor activity in the monoamine‐depleted rat model of parkinsonism |
| 004F78 |
Robert Surtees [Royaume-Uni] ; Peter Clayton [Royaume-Uni] | Infantile parkinsonism‐dystonia: Tyrosine hydroxylase deficiency |
| 004F81 |
Diane Playford [Royaume-Uni] ; Richard E. Passingham [Royaume-Uni] ; C. David Marsden [Royaume-Uni] ; David J. Brooks [Royaume-Uni] | Increased activation of frontal areas during arm movement in idiopathic torsion dystonia |
| 004F87 |
Rosinda M. Oliverira [Royaume-Uni, Brésil] ; Jennifer M. Gurd [Royaume-Uni] ; Phillip Nixon [Royaume-Uni] ; John C. Marshall [Royaume-Uni] ; Passingham [Royaume-Uni] | Hypometria in Parkinson's disease: Automatic versus controlled processing |
| 004F92 |
Richard B. Banati [Royaume-Uni] ; Susan E. Daniel [Royaume-Uni] ; Blunt [Royaume-Uni] | Glial pathology but absence of apoptotic nigral neurons in long‐standing Parkinson's disease |
| 004F94 |
Oliver Bandmann [Royaume-Uni] ; C. David Marsden [Royaume-Uni] ; Wood [Royaume-Uni] | Genetic aspects of Parkinson's disease |
| 004F95 |
Hanna [Royaume-Uni] ; Mary B. Davis [Royaume-Uni] ; Mary G. Sweeney [Royaume-Uni] ; Madi Noursadeghi [Royaume-Uni] ; Christopher J. Ellis ; Perry Elliot [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] ; C. David Marsden [Royaume-Uni] | Generalized chorea in two patients harboring the Friedreich's ataxia gene trinucleotide repeat expansion |
| 005002 |
Henning Boecker [Royaume-Uni, Allemagne] ; David J. Brooks [Royaume-Uni] | Functional Imaging of Tremor |
| 005019 |
Gudex [Danemark] ; Maurice R. Hawthorne [Royaume-Uni] ; Anthony G. Butler [Royaume-Uni] ; Philip Duffey [Royaume-Uni] | Effect of dystonia and botulinum toxin treatment on health‐related quality of life |
| 005020 |
Rascol [France] ; Kasia Sieradzan [Royaume-Uni] ; Hélène Peyro-Saint-Paul [France] ; Claire Thalamas [France] ; Christine Brefel-Courbon [France] ; Jean Michel Senard [France] ; Philippe Ladure [France] ; Jean Louis Montastruc [France] ; Andrew Lees (neurologue) [Royaume-Uni] | Efaroxan, an alpha‐2 antagonist, in the treatment of progressive supranuclear palsy |
| 005029 |
Payne [Royaume-Uni] ; Roger G. Sutcliffe [Royaume-Uni] ; Jacqueline M. Campbell [Royaume-Uni] ; Glenda Favor [Royaume-Uni] ; David Russell [Royaume-Uni] ; Neil K. Bennett [Royaume-Uni] ; Debbie J. Clarke [Royaume-Uni] ; Richard Branton [Royaume-Uni] ; R. Wayne Davies [Royaume-Uni] ; Elaine Simpson [Royaume-Uni] ; Catherine Tsang [Royaume-Uni] ; Ronald H. Baxendale [Royaume-Uni] | Disordered locomotion in the AS/AGU mutant rat and the effects of L‐dopa or fetal midbrain grafts |
| 005034 |
Ronald K. B. Pearce [Royaume-Uni] ; Tara Banerji [Royaume-Uni] ; Jenner [Royaume-Uni] ; C. David Marsden [Royaume-Uni] | De novo administration of ropinirole and bromocriptine induces less dyskinesia than L‐dopa in the MPTP‐treated marmoset |
| 005035 |
Ann E. Kingsbury [Royaume-Uni] ; C. David Mardsen [Royaume-Uni] ; Oliver J. F. Foster [Royaume-Uni] | DNA fragmentation in human substantia nigra: Apoptosis or perimortem effect? |
| 005040 |
Günther Deuschl [Allemagne] ; Peter Bain [Royaume-Uni] ; Mitchell Brin [États-Unis] | Consensus Statement of the Movement Disorder Society on Tremor |
| 005054 |
P. G. Bain [Royaume-Uni] | Clinical Measurement of Tremor |
| 005083 |
Brotchie [Royaume-Uni] | Adjuncts to dopamine replacement: A pragmatic approach to reducing the problem of dyskinesia in Parkinson's disease |
| 005085 |
Wang [Taïwan] ; Peter Brown [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Acute movement disorders with bilateral basal ganglia lesions in uremia |
| 005086 |
Brown [Royaume-Uni] ; Daniel M. Corcos [Royaume-Uni, États-Unis] ; John C. Rothwell [Royaume-Uni] | Action tremor and weakness in Parkinson's disease: A study of the elbow extensors |
| 005101 |
A. Richter [Allemagne] ; J. M. Brotchie [Royaume-Uni] ; A. R. Crossman [Royaume-Uni] ; W. Löscher [Allemagne] | [3H]-2-Deoxyglucose uptake study in mutant dystonic hamsters : Abnormalities in discrete brain regions of the motor system |
| 005108 |
J. C. Rothwell [Royaume-Uni] ; K. Higuchi [Japon] ; J. A. Obeso [Espagne] | The offset cortical potential : An electrical correlate of movement inhibition in man |
| 005110 |
D. J. Burn [Royaume-Uni] ; A. Coulthard [Royaume-Uni] ; S. Connolly [Royaume-Uni] ; N. E. F. Cartlidge [Royaume-Uni] | Tardive diaphragmatic flutter |
| 005114 |
A. D. Korczyn [Israël] ; D. J. Brooks [Royaume-Uni] ; E. R. Brunt [Pays-Bas] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; F. Stocchi [Italie] | Ropinirole versus bromocriptine in the treatment of early Parkinson's disease : A 6-month interim report of a 3-year study |
| 005115 |
Olivier Rascol [France] ; D. J. Brooks [Royaume-Uni] ; E. R. Brunt [Pays-Bas] ; A. D. Korczyn [Israël] ; Werner Poewe [Autriche] ; F. Stocchi [Italie] | Ropinirole in the treatment of early Parkinson's disease : A 6-month interim report of a 5-year levodopa-controlled study |
| 005131 |
P. Jenner [Royaume-Uni] | Oxidative mechanisms in nigral cell death in Parkinson's disease |
| 005134 |
D. Dressler [Royaume-Uni] ; T. Scaravilli [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Nicotine nasal spray is not reliable treatment for blepharospasm : Results of a pilot study |
| 005137 |
M. S. Schwartz [Royaume-Uni] ; D. R. Wren [Royaume-Uni] ; J. Filshie [Royaume-Uni] | Neuromyotonia in a muscle flap producing a convulsing breast : Successful treatment with botulinum toxin |
| 005141 |
P. Duffey [Royaume-Uni] ; A. Coulthard ; D. J. Burn | Late observation of the Goutières Aicardi syndrome |
| 005147 |
E. D. Playford [Royaume-Uni] ; R. E. Passingham [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; D. J. Brooks [Royaume-Uni] | Increased activation of frontal areas during arm movement in idiopathic torsion dystonia |
| 005150 |
R. M. Oliveira [Royaume-Uni, Brésil] ; J. M. Gurd [Royaume-Uni] ; P. Nixon ; J. C. Marshall [Royaume-Uni] ; R. E. Passingham [Royaume-Uni] | Hypometria in Parkinson's disease : Automatic versus controlled processing |
| 005155 |
M. G. Hanna [Royaume-Uni] ; M. B. Davis [Royaume-Uni] ; M. G. Sweeney [Royaume-Uni] ; M. Noursadeghi [Royaume-Uni] ; C. J. Ellis [Royaume-Uni] ; P. Elliot [Royaume-Uni] ; N. W. Wood [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Generalized chorea in two patients harboring the Friedreich's ataxia gene trinucleotide repeat expansion |
| 005162 |
C. M. Gudex [Danemark] ; M. R. Hawthorne [Royaume-Uni] ; A. G. Butler [Royaume-Uni] ; P. Duffey [Royaume-Uni] | Effect of dystonia and botulinum toxin treatment on health-related quality of life |
| 005163 |
Olivier Rascol [France] ; K. Sieradzan [Royaume-Uni] ; H. Peyro-Saint-Paul [France] ; C. Thalamas [France] ; C. Brefel-Courbon [France] ; J. M. Senard [France] ; P. Ladure [France] ; J. L. Montastruc [France] ; A. Lees [Royaume-Uni] | Efaroxan, an alpha-2 antagonist, in the treatment of progressive supranuclear palsy |
| 005166 |
A. P. Payne [Royaume-Uni] ; R. G. Sutcliffe [Royaume-Uni] ; J. M. Campbell [Royaume-Uni] ; G. Favor [Royaume-Uni] ; D. Russell [Royaume-Uni] ; N. K. Bennett [Royaume-Uni] ; D. J. Clarke [Royaume-Uni] ; R. Branton [Royaume-Uni] ; R. W. Davies [Royaume-Uni] ; E. Simpson [Royaume-Uni] ; C. Tsang [Royaume-Uni] ; R. H. Baxendale [Royaume-Uni] | Disordered locomotion in the AS/AGU mutant rat and the effects of L-dopa or fetal midbrain grafts |
| 005188 |
J. M. Brotchie [Royaume-Uni] | Adjuncts to dopamine replacement : A pragmatic approach to reducing the problem of dyskinesia in Parkinson's disease |
| 005190 |
H.-C. Wang [Taïwan] ; P. Brown [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Acute movement disorders with bilateral basal ganglia lesions in uremia |
| 005191 |
P. Brown [Royaume-Uni] ; D. M. Corcos [Royaume-Uni, États-Unis] ; J. C. Rothwell [Royaume-Uni] | Action tremor and weakness in Parkinson's disease : A study of the elbow extensors |
| 005215 |
Rickards [Royaume-Uni] ; Mary M. Robertson [Royaume-Uni] | Vomiting and retching in gilles de la tourette syndrome: A report of ten cases and a review of the literature |
| 005224 |
Bisdorff [Royaume-Uni, Luxembourg (pays)] ; Bronstein [Royaume-Uni] ; C. Wolsley [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Torticollis due to disinhibition of the vestibulo‐collic reflex in a patient with Steele‐Richardson‐Olszewski syndrome |
| 005225 |
Dupont [Danemark] ; Jean-Marc Burgunder [Suisse] ; Leslie J. Findley [Royaume-Uni] ; Jan-Edvin Olsson [Suède] ; Ernest Dorflinger [États-Unis] | Tolcapone added to levodopa in stable parkinsonian patients: A double‐blind placebo‐controlled study |
| 005228 |
Christine Klein [Royaume-Uni] ; Richard Brown [Royaume-Uni] ; Gregor Wenning [Royaume-Uni] ; Quinn [Royaume-Uni] | The “cold hands sign” in multiple system atrophy |
| 005241 |
Werhahn [Royaume-Uni, Allemagne] ; Brown [Royaume-Uni] ; P. D. Thompson [Royaume-Uni, Australie] ; C. D. Marsden [Royaume-Uni] | The clinical features and prognosis of chronic posthypoxic myoclonus |
| 005255 |
Brown [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; David Barnes [Royaume-Uni] ; Damien R. Wren [Royaume-Uni] ; C. David Marsden [Royaume-Uni] | Spinal rigidity following acute myelitis |
| 005273 |
Anthony E. Lang ; Andrew Lees (neurologue) [Royaume-Uni] | Redundant Publication |
| 005276 |
Charles A. Davie [Royaume-Uni] ; Gareth J. Barker [Royaume-Uni] ; Christine Machado [Royaume-Uni] ; David H. Miller [Royaume-Uni] ; Lees [Royaume-Uni] | Proton magnetic resonance spectroscopy in steele‐richardson‐olszewski syndrome |
| 005279 |
Katie Kompoliti [États-Unis] ; Eric J. Pappert [États-Unis] ; Christopher G. Goetz [États-Unis] ; Blair Ford [États-Unis] ; Nicholas W. Wood [Royaume-Uni] | Progressive cognitive decline with truncal/limb ataxia and ballistic movements |
| 005285 |
Chaudhuri [Royaume-Uni] ; Catherine Ellis [Royaume-Uni] ; Sarah Love-Jones [Royaume-Uni] ; Thomas Thomaides [Royaume-Uni] ; Susan Clift [Royaume-Uni] ; Christopher J. Mathias [Royaume-Uni] ; J. David Parkes [Royaume-Uni] | Postprandial hypotension and parkinsonian state in parkinson's disease |
| 005290 |
Anastasopoulos [Grèce, Royaume-Uni] ; K. Bhatia [Royaume-Uni] ; A. Bisdorff [Royaume-Uni] ; A. M. Bronstein [Royaume-Uni] ; M. A. Gresty [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Perception of spatial orientation in spasmodic torticollis part I: The postural vertical |
| 005291 |
Bhatia [Royaume-Uni] ; Valerie L. Soland [Royaume-Uni] ; Mohit H. Bhatt [Inde] ; Niall P. Quinn [Royaume-Uni] ; C. David Marsden [Royaume-Uni] | Paroxysmal exercise‐induced dystonia: Eight new sporadic cases and a review of the literature |
| 005293 |
Turjanski [Royaume-Uni] ; Brian Pentland [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; David J. Brooks [Royaume-Uni] | Parkinsonism associated with acute intracranial hematomas: An [18F]dopa positron‐emission tomography study |
| 005295 |
Kellett [Royaume-Uni] ; Gavin R. Young [Royaume-Uni] ; Nicholas A. Fletcher [Royaume-Uni] | Painful tonic spasms and pure motor hemiparesis due to lacunar pontine infarct |
| 005300 |
Wenning [Royaume-Uni, Autriche] ; F. Tison [Royaume-Uni] ; Y. Ben Shlomo [Royaume-Uni] ; S. E. Daniel [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] | Multiple system atrophy: A review of 203 pathologically proven cases |
| 005302 |
Clarke [Royaume-Uni] ; C. Sampaio [Portugal] | Movement disorders cochrane collaborative review group |
| 005306 |
M. Gu [Royaume-Uni] ; M. T. Gash [Royaume-Uni] ; J. M. Cooper [Royaume-Uni] ; G. K. Wenning [Royaume-Uni] ; S. E. Daniel [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; Schapira [Royaume-Uni] | Mitochondrial respiratory chain function in multiple system atrophy |
| 005316 |
G. K. Wenning [Royaume-Uni] ; S. J. M. Smith [Royaume-Uni] | Magnetic brain stimulation in multiple system atrophy |
| 005325 |
G. Fénelon [France] ; G. Percheron [France] ; Joseph Jankovic [États-Unis] ; Manfred Gerlach [Allemagne] ; Kay Double [Allemagne] ; Peter Riederer [Allemagne] ; Etienne Hirsch [France] ; Kurt Jellinger [Autriche] ; Peter Jenner [Royaume-Uni] ; Alfred Trautwein [Allemagne] ; Moussa B. H. Youdim [Israël] ; Andrzej Friedman [Pologne] ; J. Galazka-Friedman [Pologne] ; E. R. Bauminger [Israël] ; D. Hechel [Israël] ; I. Nowik [Israël] ; M. Barcikowska [Pologne] ; M. Nomoto [Japon] ; S. Kaseda [Japon] ; S. Iwata [Japon] ; M. Osame [Argentine] ; T. Fukuda [Japon] ; Federico Micheli [Argentine] ; María Clara Scorticati [Argentine] ; Pratap Chand [Oman] ; P. C. Jacob [Oman] | Letter to the editor |
| 005340 |
Fitzpatrick [Royaume-Uni] ; Viv Peto [Royaume-Uni] ; Crispin Jenkinson [Royaume-Uni] ; Richard Greenhall [Royaume-Uni] ; Nigel Hyman [Royaume-Uni] | Health‐related quality of life in parkinson's disease: A study of outpatient clinic attenders |
| 005349 |
Blunt [Royaume-Uni] ; N. M. Khalil [Royaume-Uni] ; G. D. Perkin [Royaume-Uni] | Facial myokymia in multiple system atrophy |
| 005355 |
Lance A. Smith ; Ariel Gordin ; Jenner [Finlande] ; C. David Marsden [Royaume-Uni] | Entacapone enhances levodopa‐induced reversal of motor disability in MPTP‐treated common marmosets |
| 005366 |
M. W. Becher [Royaume-Uni] ; D. C. Rubinsztein [Royaume-Uni] ; J. Leggo [Royaume-Uni] ; M. V. Wagster [Royaume-Uni] ; O. C. Stine [Royaume-Uni] ; N. G. Ranen [Royaume-Uni] ; M. L. Franz [Royaume-Uni] ; M. H. Abbott [Royaume-Uni, États-Unis] ; M. Sherr [Royaume-Uni] ; J. C. Macmillan ; L. Barron [Royaume-Uni] ; M. Porteous [Royaume-Uni] ; P. S. Harper ; Ross [Royaume-Uni, États-Unis] | Dentatorubral and pallidoluysian atrophy (DRPLA) Clinical and neuropathological findings in genetically confirmed north american and european pedigrees |
| 005383 |
Blunt [Royaume-Uni] ; Russel J. M. Lane [Royaume-Uni] ; Nora Turjanski [Royaume-Uni] ; G. David Perkin [Royaume-Uni] | Clinical features and management of two cases of encephalitis lethargica |
| 005391 |
Yasuhiro Nagahama [Japon] ; Fukuyama [Japon] ; Nora Turjanski [Royaume-Uni] ; Angus Kennedy [Royaume-Uni] ; Hiroshi Yamauchi [Japon] ; Yasuomi Ouchi [Japon] ; Jun Kimura [Japon] ; David J. Brooks [Royaume-Uni] ; Hiroshi Shibasaki [Japon] | Cerebral glucose metabolism in corticobasal degeneration: Comparison with progressive supranuclear palsy and normal controls |
| 005392 |
G. K. Wenning [Royaume-Uni] ; E. Kraft [Royaume-Uni] ; R. Beck [Royaume-Uni] ; C. J. Fowler [Royaume-Uni] ; C. J. Mathias [Royaume-Uni] ; Quinn [Royaume-Uni] ; A. E. Harding [Royaume-Uni] | Cerebellar presentation of multiple system atrophy |
| 005394 |
Brown [Royaume-Uni] ; J. C. Rothwell [Royaume-Uni] ; J. M. Stevens [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Cerebellar axial postural tremor |
| 005410 |
Xuguang Liu [Royaume-Uni] ; Miall [Royaume-Uni] ; Tipu Z. Aziz [Royaume-Uni] ; Jackie A. Palace [Royaume-Uni] ; Patrick N. Haggard [Royaume-Uni] ; John F. Stein [Royaume-Uni] | Analysis of action tremor and impaired control of movement velocity in multiple sclerosis during visually guided wrist‐tracking tasks |
| 005417 |
Anthony E. Lang ; Andrew Lees (neurologue) [Royaume-Uni] | Acknowledgment of reviewers |
| 005434 |
H. Rickards [Royaume-Uni] ; M. M. Robertson [Royaume-Uni] | Vomiting and retching in Gilles de la Tourette syndrome: A report of ten cases and a review of the literature |
| 005439 |
C. E. Clarke [Royaume-Uni] ; M. Lowry [Royaume-Uni] ; A. Horsman [Royaume-Uni] | Unchanged basal ganglia N-acetylaspartate and glutamate in idiopathic Parkinson's disease measured by proton magnetic resonance spectroscopy |
| 005442 |
A. R. Bisdorff [Royaume-Uni] ; A. M. Bronstein [Royaume-Uni] ; C. Wolsley [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Torticollis due to disinhibition of the vestibulo-collic reflex in a patient with Steele-Richardson-Olszewski syndrome |
| 005443 |
E. Dupont [Danemark] ; J.-M. Burgunder [Suisse] ; L. J. Findley [Royaume-Uni] ; J.-E. Olsson [Suède] ; E. Dorflinger [États-Unis] | Tolcapone added to levodopa in stable parkinsonian patients : A double-blind placebo-controlled study |
| 005452 |
K. J. Werhahn [Royaume-Uni] ; P. Brown [Royaume-Uni] ; P. D. Thompson [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | The clinical features and prognosis of chronic posthypoxic myoclonus |
| 005459 |
P. Brown [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; D. Barnes [Royaume-Uni] ; D. R. Wren [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Spinal rigidity following acute myelitis |
| 005474 |
K. Ray Chaudhuri [Royaume-Uni] ; C. Ellis ; S. Love-Jones ; T. Thomaides ; S. Clift ; C. J. Mathias ; J. D. Parkes | Postprandial hypotension and parkinsonian state in Parkinson's disease |
| 005477 |
D. Anastasopoulos [Grèce, Royaume-Uni] ; K. Bhatia [Royaume-Uni] ; A. Bisdorff [Royaume-Uni] ; A. M. Bronstein [Royaume-Uni] ; M. A. Gresty [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Perception of spatial orientation in spasmodic torticollis part I: The postural vertical |
| 005478 |
K. P. Bhatia [Royaume-Uni] ; V. L. Soland [Royaume-Uni] ; M. H. Bhatt [Inde] ; N. P. Quinn [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Paroxysmal exercise-induced dystonia : Eight new sporadic cases and a review of the literature |
| 005479 |
N. Turjanski [Royaume-Uni] ; B. Pentland [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; D. J. Brooks [Royaume-Uni] | Parkinsonism associated with acute intracranial hematomas : An [18F]dopa positron-emission tomography study |
| 005480 |
P. K. Morrish [Royaume-Uni] | Parkinson's disease is not a long-latency illness |
| 005481 |
M. W. Kellett [Royaume-Uni] ; G. R. Young [Royaume-Uni] ; N. A. Fletcher [Royaume-Uni] | Painful tonic spasms and pure motor hemiparesis due to lacunar pontine infarct |
| 005484 |
G. K. Wenning [Royaume-Uni, Autriche] ; F. Tison [Royaume-Uni] ; Y. Ben Shlomo [Royaume-Uni] ; S. E. Daniel [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] | Multiple system atrophy : A review of 203 pathologically proven cases |
| 005486 |
C. E. Clarke [Royaume-Uni] ; C. Sampaio [Portugal] | Movement disorders cochrane collaborative review group |
| 005499 |
R. Fitzpatrick [Royaume-Uni] ; V. Peto [Royaume-Uni] ; C. Jenkinson [Royaume-Uni] ; R. Greenhall [Royaume-Uni] ; N. Hyman [Royaume-Uni] | Health-related quality of life in Parkinson's disease : A study of outpatient clinic attenders |
| 005504 |
S. B. Blunt [Royaume-Uni] ; N. M. Khalil [Royaume-Uni] ; G. D. Perkin [Royaume-Uni] | Facial myokymia in multiple system atrophy |
| 005524 |
S. B. Blunt [Royaume-Uni] ; R. J. M. Lane [Royaume-Uni] ; N. Turjanski [Royaume-Uni] ; G. D. Perkin [Royaume-Uni] | Clinical features and management of two cases of Encephalitis lethargica |
| 005532 |
P. Brown [Royaume-Uni] ; J. C. Rothwell [Royaume-Uni] ; J. M. Stevens [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Cerebellar axial postural tremor |
| 005565 |
Quirk [Royaume-Uni] ; G. L. Sheean [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Treatment of nonoccupational limb and trunk dystonia with botulinum toxin |
| 005582 |
G. K. Wenning [Royaume-Uni] ; R. Granata [Italie] ; P. M. Laboyrie ; N. P. Quinn [Royaume-Uni] ; Jenner ; C. D. Marsden [Royaume-Uni] | Reversal of behavioural abnormalities by fetal allografts in a novel rat model of striatonigral degeneration |
| 005584 |
Jolanta Opacka-Juffry [Royaume-Uni] ; David J. Brooks [Royaume-Uni] | Reply |
| 005591 |
Taylor‐Robinson [Royaume-Uni] ; R. A. Weeks [Royaume-Uni] ; D. J. Bryant [Royaume-Uni] ; J. Sargentoni [Royaume-Uni] ; C. D. Marcus [Royaume-Uni] ; A. E. Harding [Royaume-Uni] ; D. J. Brooks [Royaume-Uni] | Proton magnetic resonance spectroscopy in Huntington's disease: Evidence in favour of the glutamate excitotoxic theory? |
| 005599 |
B. Zeng [Royaume-Uni] ; Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Partial reversal of increased preproenkephalin messenger ribonucleic acid (mRNA) and decreased preprotachykinin mRNA by foetal dopamine cells in unilateral 6‐Hydroxydopamine–Lesioned rat striatum parallels functional recovery |
| 005607 |
G. K. Wenning [Royaume-Uni] ; F. Tison [Royaume-Uni] ; L. Elliott [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; Daniel [Royaume-Uni] | Olivopontocerebellar pathology in multiple system atrophy |
| 005615 |
Haw ; Thomas R. E. Barnes [Royaume-Uni] ; Kate Clark ; Paul Crichton [Royaume-Uni] ; Dora Kohen [Royaume-Uni] | Movement Disorder in Down's syndrome: A possible marker of the severity of mental handicap |
| 005636 |
D. J. Werring [Royaume-Uni] ; K. Ray Chaudhuri [Royaume-Uni] | Human immunodeficiency virus‐related progressive multifocal leukoencephalopathy presenting with an akinetic rigid syndrome |
| 005639 |
Valerie L. Soland [Canada] ; Kailash P. Bhatia [Royaume-Uni] ; Geoffrey L. Sheean [Royaume-Uni] ; C. David Marsden [Royaume-Uni] | Hereditary geniospasm: Two new families |
| 005646 |
Blunt [Royaume-Uni] ; Peter G. Richards [Royaume-Uni] ; Nofal Khalil [Royaume-Uni] | Foot dystonia and lumbar canal stenosis |
| 005647 |
Valerie L. Soland [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Maria A. Volonte [Italie] ; Marsden [Royaume-Uni] | Focal task‐specific tremors |
| 005648 |
O. C. Cockerell [Royaume-Uni] ; P. Rudge [Royaume-Uni] | Focal dystonia secondary to superficial siderosis |
| 005651 |
Gregor K. Wenning [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Susan E. Daniel [Royaume-Uni] ; Helen Garratt [Royaume-Uni] ; C. David Marsden [Royaume-Uni] | Facial dystonia in pathologically proven multiple system atrophy: A video report |
| 005654 |
Quinn [Royaume-Uni] | Essential myoclonus and myoclonus dystonia |
| 005662 |
Anthony E. Lang ; Andrew Lees (neurologue) [Royaume-Uni] | Editorial |
| 005663 |
Anthony E. Lang [Canada] ; Andrew Lees (neurologue) [Royaume-Uni] | Editorial |
| 005672 |
Quinn [Royaume-Uni] ; Richard Brown [Royaume-Uni] ; David Craufurd [Royaume-Uni] ; Serge Goldman [Belgique] ; John Hodges [Royaume-Uni] ; Karl Kieburtz [États-Unis] ; Olle Lindvall [Suède] ; John Macmillan ; Raymund Roos [Pays-Bas] | Core assessment program for intracerebral transplantation in Huntington's disease (CAPIT‐HD) |
| 005685 |
Pairoj Boonkongchuen [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Case of torticollis occurring following electrical injury |
| 005688 |
Kullmann [Royaume-Uni] ; R. S. Howard [Royaume-Uni] ; D. H. Miller [Royaume-Uni] ; N. P. Hirsh [Royaume-Uni] ; P. Brown [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Brainstem encephalopathy with stimulus‐sensitive myoclonus leading to respiratory arrest, but with recovery: A description of two cases and review of the literature |
| 005700 |
C. Klein [Royaume-Uni] ; G. K. Wenning [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; Marsden [Royaume-Uni] | Ataxia without telangiectasia masquerading as benign hereditary chorea |
| 005710 |
Lance Smith [Royaume-Uni] ; Maria De Salvia [Royaume-Uni] ; Jenner [Royaume-Uni] ; C. David Marsden [Royaume-Uni] | An appraisal of the antiparkinsonian activity of piribedil in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐treated common marmosets |
| 005711 |
Jendroska [Allemagne] ; Andrew Lees (neurologue) [Royaume-Uni] ; Werner Poewe [Autriche] ; Susan E. Daniel [Royaume-Uni] | Amyloid β‐peptide and the dementia of Parkinson's diease |
| 005722 |
M. Samuel [Royaume-Uni] ; M. Manford [Royaume-Uni] ; G. Sheean [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | A neuromyotonic process in a transposed latissimus dorsi muscle stemming from radiotherapy and peripheral surgery |
| 005727 |
D. J. Burn [Royaume-Uni] ; N. E. F. Cartlidge [Royaume-Uni] | A case of parkinsonism associated with multiple sclerosis |
| 005733 |
J. A. Quirk [Royaume-Uni] ; G. L. Sheean [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Treatment of nonoccupational limb and trunk dystonia with botulinum toxin |
| 005747 |
S. D. Taylor-Robinson [Royaume-Uni] ; R. A. Weeks ; D. J. Bryant [Royaume-Uni] ; J. Sargentoni [Royaume-Uni] ; C. D. Marcus [Royaume-Uni] ; A. E. Harding ; D. J. Brooks | Proton magnetic resonance spectroscopy in Huntington's disease : Evidence in favour of the glutamate excitotoxic theory ? |
| 005757 |
C. M. Haw [Royaume-Uni] ; T. R. E. Barnes ; K. Clark ; P. Chrichton ; D. Kohen | Movement disorder in down's syndrome : A possible marker of the severity of mental handicap |
| 005765 |
S. B. Blunt [Royaume-Uni] ; P. G. Richards [Royaume-Uni] ; N. Khalil [Royaume-Uni] | Foot dystonia and lumbar canal stenosis |
| 005769 |
N. P. Quinn [Royaume-Uni] | Essential myoclonus and myoclonic dystonia |
| 005785 |
D. M. Kullmann [Royaume-Uni] ; R. S. Howard [Royaume-Uni] ; D. H. Miller [Royaume-Uni] ; N. P. Hirsch [Royaume-Uni] ; P. Brown [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Brainstem encephalopathy with stimulus-sensitive myoclonus leading to respiratory arrest, but with recovery : A description of two cases and review of the literature |
| 005788 |
K. Jendroska [Allemagne] ; Andrew Lees (neurologue) [Royaume-Uni] ; Werner Poewe [Autriche] ; S. E. Daniel [Royaume-Uni] | Amyloid β-peptide and the dementia of Parkinson's disease |
| 005807 |
Walters ; Michael S. Aldrich [États-Unis] ; Richard Allen [États-Unis] ; Sonia Ancoli-Israel [États-Unis] ; David Buchholz [États-Unis] ; Sudhansu Chokroverty [États-Unis] ; Giorgio Coccagna [Italie] ; Christopher Earley [États-Unis] ; Bruce Ehrenberg [États-Unis] ; T. G. Feest [Royaume-Uni] ; Wayne Hening [États-Unis] ; Neil Kavey [États-Unis] ; Gilles Lavigne [Canada] ; Joseph Lipinski [États-Unis] ; Elio Lugaresi [Italie] ; Pasquale Montagna [Italie] ; Jacques Montplaisir [Canada] ; Sarah S. Mosko [États-Unis] ; Wolfgang Oertel [Allemagne] ; Daniel Picchietti [États-Unis] ; Thomas Pollm Cher [Allemagne] ; Renata Shafor [États-Unis] ; Robert C. Smith [États-Unis] ; Wenche Telstad [Norvège] ; Claudia Trenkwalder [Allemagne] ; Christian Von Scheele [Suède] ; Arthur S. Walters [États-Unis] ; J. Catesby Ware ; Marco Zucconi [Italie] | Toward a better definition of the restless legs syndrome |
| 005809 |
W. Van Der Kamp [Royaume-Uni] ; Rothwell [Royaume-Uni] ; P. D. Thompson [Royaume-Uni] ; B. L. Day [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | The movement‐related cortical potential is abnormal in patients with idiopathic torsion dystonia |
| 005815 |
R. K. B. Pearce [Royaume-Uni] ; C. H. Hawkes [Royaume-Uni] ; Daniel [Royaume-Uni] | The anterior olfactory nucleus in Parkinson's disease |
| 005817 |
M. Vidailhet [Royaume-Uni] ; P. R. Atchison [Royaume-Uni] ; F. Stocchi [Royaume-Uni] ; P. D. Thompson [Royaume-Uni] ; J. C. Rothwell [Royaume-Uni] ; Marsden [Royaume-Uni] | The Bereitschaftspotential preceding stepping in patients with isolated gait ignition failure |
| 005820 |
Goetz [États-Unis] ; Glenn T. Stebbins [États-Unis] ; Teresa A. Chmura [États-Unis] ; Stanley Fahn [États-Unis] ; Harold L. Klawans [États-Unis] ; C. David Marsden [Royaume-Uni] | Teaching tape for the motor section of the unified Parkinson's disease rating scale |
| 005849 |
Markus [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; G. Lennox [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; D. C. Costa [Royaume-Uni] | Patterns of regional cerebral blood flow in corticobasal degeneration studied using HMPAO SPECT; comparison with Parkinson's disease and normal controls |
| 005859 |
C. Tranchant [France] ; K. P. Bhatia [Royaume-Uni] ; Marsden [Royaume-Uni] | Movement disorders in multiple sclerosis |
| 005860 |
Haaxma [Pays-Bas] ; A. Van Boxtel [Pays-Bas] ; W. H. Brouwer [Pays-Bas] ; L. N. H. Goeken [Pays-Bas] ; J. J. Denier Van Der Gon [Pays-Bas] ; J. G. Colebatch [Royaume-Uni] ; A. Martin [Royaume-Uni] ; D. J. Brooks [Royaume-Uni] ; J. Noth [Allemagne] ; C. D. Marsden [Royaume-Uni] | Motor function in a patient with bilateral lesions of the globus pallidus |
| 005861 |
Klaus Jendroska [Royaume-Uni] ; Martin N. Rossor [Allemagne, Royaume-Uni] ; Christopher J. Mathias [Allemagne, Royaume-Uni] ; Daniel [Royaume-Uni, Allemagne] | Morphological overlap between corticobasal degeneration and Pick's disease: A clinicopathological report |
| 005873 |
Opacka‐Juffry [Royaume-Uni] ; David J. Brooks [Royaume-Uni] | L‐Dihydroxyphenylalanine and its decarboxylase: New ideas on their neuroregulatory roles |
| 005874 |
J. M. Cooper [Royaume-Uni] ; S. E. Daniel [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; Schapira [Royaume-Uni] | L‐Dihydroxyphenylalanine and complex I deficiency in Parkinson's disease brain |
| 005880 |
M. C. Ball [Royaume-Uni] ; H. J. Sagar [Royaume-Uni] | Levodopa in pregnancy |
| 005884 |
Julian Fearnley [Royaume-Uni] ; Peter Rudge [Royaume-Uni] ; Brain Bank [Royaume-Uni] ; Joseph Jankovic [États-Unis] ; M. H. Marion [France] ; P. Krack [Allemagne] | Letters to the editor |
| 005896 |
R. A. Weeks [Royaume-Uni] ; C. G. Clough [Royaume-Uni] | Hemichorea due to cryptococcal meningitis |
| 005914 |
Clarke [Royaume-Uni] | Does levodopa therapy delay death in Parkinson's disease? A review of the evidence |
| 005919 |
Colebatch [Australie] ; V. Di Lazzaro [Royaume-Uni] ; A. Quartarone [Royaume-Uni] ; J. C. Rothwell [Royaume-Uni] ; M. Gresty [Royaume-Uni] | Click‐evoked vestibulocollic reflexes in torticollis |
| 005921 |
R. K. B. Pearce ; M. Jackson ; L. Smith ; Jenner ; C. D. Marsden [Royaume-Uni] | Chronic L‐DOPA administration induces dyskinesias in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐treated common marmoset (Callithrix jacchus) |
| 005925 |
V. Planté-Bordeneuve [Royaume-Uni] ; O. Bandmann [Royaume-Uni] ; G. Wenning [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; S. E. Daniel [Royaume-Uni] ; Harding [Royaume-Uni] | CYP2D6‐debrisoquine hydroxylase gene polymorphism in multiple system atrophy |
| 005938 |
Scolding [Royaume-Uni] ; S. M. Smith [Royaume-Uni] ; S. Sturman [Royaume-Uni] ; G. B. Brookes [Royaume-Uni] ; Lees [Royaume-Uni] | Auctioneer's jaw: A case of occupational oromandibular hemidystonia |
| 005961 |
G. K. Wenning [Royaume-Uni] ; M. T. O'Connell [Royaume-Uni] ; P. N. Patsalos [Royaume-Uni] ; Quinn [Royaume-Uni] | A clinical and pharmacokinetic case study of an interaction of levodopa and antituberculous therapy in Parkinson's disease |
| 005992 |
H. S. Markus [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; G. Lennox ; C. D. Marsden ; D. C. Costa | Patterns of regional cerebral blood flow in corticobasal degeneration studies using HMPAO SPECT ; comparison with Parkinson's disease and normal controls |
| 005A03 |
J. M. Cooper [Royaume-Uni] ; S. E. Daniel ; C. D. Marsden ; A. H. V. Schapira [Royaume-Uni] | L-dihyroxyphenalanine and complex I deficiency in Parkinson's disease brain |
| 005A04 |
J. Opacka-Juffry [Royaume-Uni] ; D. J. Brooks | L-dihydroxyphenylalanine and its decarboxylase : new ideas on their neuroregulatory roles |
| 005A21 |
C. E. Clarke [Royaume-Uni] | Does levodopa therapy delay death in Parkinson's disease ? A review of the evidence |
| 005A26 |
V. Plante-Bordeneuve [Royaume-Uni] ; O. Bandmann ; G. Wenning ; N. P. Quinn ; S. E. Daniel ; A. E. Harding | CYP2D6-debrisoquine hydroxylase gene polymorphism in multiple system atrophy |
| 005A35 |
N. J. Scolding [Royaume-Uni] ; S. M. Smith [Royaume-Uni] ; S. Sturman ; G. B. Brookes [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Auctioneer's jaw : a case of occupational oromandibular hemidystonia |
| 005A57 |
G K Wenning [Royaume-Uni] ; N. Quinn ; M. Magalh Es ; C. Mathias ; S E Daniel | "Minimal change" multiple system atrophy. |
| 005A63 |
Haug [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Geoffrey B. Arden [Royaume-Uni] ; Wolfgang H. Oertel [Allemagne] ; Walter Paulus [Allemagne] | Visual thresholds to low‐contrast pattern displacement, color contrast, and luminance contrast stimuli in Parkinson's disease |
| 005A65 |
Kailash P. Bhatia [Royaume-Uni] ; Gabriel Lera [Royaume-Uni] ; Philip J. Luthert [Royaume-Uni] ; Marsden [Royaume-Uni] | Vascular chorea: Case report with pathology |
| 005A71 |
J. N. Caviness [Royaume-Uni] ; A. Gabellini [Royaume-Uni] ; C. S. Kneebone [Australie] ; P. D. Thompson [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Marsden [Royaume-Uni] | Unusual focal dyskinesias: The ears, the shoulders, the back, and the abdomen |
| 005A74 |
V. Planté-Bordeneuve [Royaume-Uni] ; M. B. Davis [Royaume-Uni] ; D. M. Maraganore [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; Harding [Royaume-Uni] | Tyrosine hydroxylase polymorphism in familial and sporadic Parkinson's disease |
| 005A80 |
D. Dressler [Royaume-Uni] ; P. D. Thompson [Royaume-Uni] ; R. F. Gledhill [Afrique du Sud] ; Marsden [Royaume-Uni] | The syndrome of painful legs and moving toes |
| 005A82 |
J. O. Rinne [Royaume-Uni] ; S. E. Daniel [Royaume-Uni] ; F. Scaravilli [Royaume-Uni] ; M. Pires [Royaume-Uni] ; A. E. Harding [Royaume-Uni] ; Marsden [Royaume-Uni] | The neuropathological features of neuroacanthocytosis |
| 005A95 |
V. M. S. De Bruin [Royaume-Uni] ; Lees [Royaume-Uni] | Subcortical neurofibrillary degeneration presenting as steele‐richardson‐olszewski and other related syndromes: A review of 90 pathologically verified cases |
| 005A96 |
S. B. Blunt [Royaume-Uni] ; D. J. Brooks [Royaume-Uni] ; C. Kennard [Royaume-Uni] | Steroid‐responsive chorea in childhood following cardiac transplantation |
| 005B09 |
Brown [Royaume-Uni] ; J. C. Rothwell [Royaume-Uni] ; P. D. Thompson [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Propriospinal myoclonus: Evidence for spinal “pattern” generators in humans |
| 005B23 |
S. B. Blunt ; G. Fuller ; C. Kennard ; D. Brooks [Royaume-Uni] | Orolingual dystonia with “tip of the tongue” geste |
| 005B30 |
M. S. Lee [Corée du Sud, Royaume-Uni] ; Marsden [Royaume-Uni] | Neurological sequelae following carbon monoxide poisoning clinical course and outcome according to the clinical types and brain computed tomography scan findings |
| 005B34 |
M. S. Lee [Royaume-Uni, Corée du Sud] ; Marsden [Royaume-Uni] | Movement disorders following lesions of the thalamus or subthalamic region |
| 005B56 |
Gilles Fénelon [France] ; Annaék Fève [France] ; Avindra Nath [Canada] ; Douglas E. Hobson [Canada] ; A. H. V. Schapira [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; M. S. Sandy [États-Unis] ; J. W. Langston [États-Unis] ; D. A. Di Monte [États-Unis] ; James J. Gaul [États-Unis] | Letters to the editor |
| 005B60 |
Wenning [Royaume-Uni] ; R. J Ger [Royaume-Uni] ; B. Kendall [Royaume-Uni] ; D. Kingsley [Royaume-Uni] ; S. E. Daniel [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] | Is cranial computerized tomography useful in the diagnosis of multiple system atrophy? |
| 005B65 |
David T. Dexter [Royaume-Uni] ; Anne E. Holley ; William D. Flitter ; Trevor F. Slater ; F. Raymund Wells [Royaume-Uni] ; Susan E. Daniel [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Jenner [Royaume-Uni] ; C. David Marsden [Royaume-Uni] | Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: An HPLC and ESR study |
| 005B80 |
Schapira [Royaume-Uni] | Evidence for mitochondrial dysfunction in Parkinson's disease—a critical appraisal |
| 005B89 |
Gabriel Lera [Royaume-Uni] ; Kailash Bhatia [Royaume-Uni] ; Marsden [Royaume-Uni] | Dystonia as the major manifestation of Leigh's syndrome |
| 005B94 |
P. D. Thompson [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] ; P. Brown [Royaume-Uni] ; M. B. Davis [Royaume-Uni] ; M. Pires [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; P. Luthert [Royaume-Uni] ; M. Honovar [Royaume-Uni] ; M. D. O'Brien [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; Harding [Royaume-Uni] | Cortical myoclonus in huntington's disease |
| 005C02 |
S. Rose [Royaume-Uni] ; Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Chronic administration does not alter the accumulation of L‐dopa into muscle |
| 005C08 |
Judith Emmerson [Royaume-Uni] | Botulinum toxin for spasmodic torticollis in a patient with myasthenia gravis |
| 005C15 |
T. T. Warner ; G. G. Lennox ; I. Janota [Royaume-Uni] ; Harding | Autosomal‐dominant dentatorubropallidoluysian atrophy in the United Kingdom |
| 005C16 |
R. Pratap Chand [Royaume-Uni] ; D. M. Park [Royaume-Uni] | Atypical blepharospasm responsive to sodium valproate |
| 005C18 |
Gregor Wenning [Royaume-Uni] ; Niall Quinn [Royaume-Uni] | Are lewy bodies non‐specific epiphenoma of nigral damage? |
| 005C30 |
S. J. L. Howell [Royaume-Uni] ; H. J. Sagar [Royaume-Uni] | A progressive parkinsonian syndrome developing after chemotherapy and radiotherapy for non‐hodgkin's lymphoma |
| 005C33 |
G. K. Wenning [Royaume-Uni] ; N. Quinn ; M. Magalhaes ; C. Mathias ; S. E. Daniel | «Minimal change» multiple system atrophy |
| 005C40 |
V. Plante-Bordeneuve [Royaume-Uni] ; M. B. Davis ; D. M. Maraganore ; C. D. Marsden ; A. E. Harding | Tyrosine hydroxylase polymorphism in familial and sporadic Parkinson's disease |
| 005C48 |
S. B. Blunt [Royaume-Uni] ; D. J. Brooks ; C. Kennard [Royaume-Uni] | Steroid-responsive clorea in childhood following cardiac transplantation |
| 005C55 |
P. Brown [Royaume-Uni] ; J. C. Rothwell ; P. D. Thompson ; C. D. Marsden | Propriospinal myoclonus: evidence for spinal pattern generators in humans |
| 005C70 |
G. K. Wenning [Royaume-Uni] ; R. J Ger [Royaume-Uni] ; B. Kendall ; D. Kingsley [Royaume-Uni] ; S. E. Daniel ; N. P. Quinn [Royaume-Uni] | Is cranial computerized tomography useful in the diagnosis of multiple system atrophy? |
| 005C72 |
D. T. Dexter [Royaume-Uni] ; A. E. Holley ; W. D. Flitter ; T. F. Slater ; F. R. Wells ; S. E. Daniel ; Andrew Lees (neurologue) [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; C. D. Marsden | Increated levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study |
| 005C80 |
A. H. V. Schapira [Royaume-Uni] | Evidence for mitochondrial dysfunction in Parkinson's disease: a critical appraisal |
| 005C92 |
R. Pratap Chand [Royaume-Uni] ; D. M. Park | Atypical blepharospasm responsive to sodium valproate |
| 005D09 |
Carlo Colosimo [Royaume-Uni] ; Roman S. Kocen [Royaume-Uni] ; Michael Powell [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Adnan Abdallat [Jordanie] | Torticollis after electrocution |
| 005D12 |
P. R. Atchison [Royaume-Uni] ; P. D. Thompson [Royaume-Uni] ; R. S. J. Frackowiak [Royaume-Uni] ; Marsden [Royaume-Uni] | The syndrome of gait ignition failure: A report of six cases |
| 005D17 |
Sawle [Royaume-Uni] | The detection of preclinical Parkinson's disease: What is the role of positron emission tomography? |
| 005D25 |
S. B. Blunt [Royaume-Uni] ; Jenner ; C. D. Marsden [Royaume-Uni] | Suppressive effect of L‐dopa on dopamine cells remaining in the ventral tegmental area of rats previously exposed to the neurotoxin 6‐hydroxydopamine |
| 005D26 |
A. J. Hughes [Royaume-Uni] ; Susan Bishop [Royaume-Uni] ; Birgit Kleedorfer [Royaume-Uni] ; Nora Turjanski [Royaume-Uni] ; W. Fernandez [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; G. M. Stern [Royaume-Uni] | Subcutaneous apomorphine in parkinson's disease: Response to chronic administration for up to five years |
| 005D56 |
Bhatia [Royaume-Uni] ; S. E. Daniel [Royaume-Uni] ; Marsden [Royaume-Uni] | Orofacial dystonia and rest tremor in a patient with normal brain pathology |
| 005D74 |
D. Conway [Royaume-Uni] ; P. G. Bain [Royaume-Uni] ; T. T. Warner [Royaume-Uni] ; M. B. Davis [Royaume-Uni] ; L. J. Findley [Royaume-Uni] ; P. D. Thompson [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; Harding [Royaume-Uni] | Linkage analysis with chromosome 9 markers in hereditary essential tremor |
| 005D79 |
Joseph H. Friedman [États-Unis] ; Niall Quinn [Royaume-Uni] | Letters to the editor |
| 005D82 |
Marcelo Merello [Royaume-Uni] ; Lees [Royaume-Uni] ; Ramon Leiguarda [Argentine] ; Juan Guevara [Argentine] ; Martin Nogués [Argentine] | Inverse masticatory muscle activity due to syringobulbia |
| 005D96 |
P. Brown [Royaume-Uni] ; M. J. Steiger [Royaume-Uni] ; P. D. Thompson [Royaume-Uni] ; J. C. Rothwell [Royaume-Uni] ; B. L. Day [Royaume-Uni] ; M. Salama [Belgique] ; T. Waegemans [Belgique] ; Marsden [Royaume-Uni] | Effectiveness of piracetam in cortical myoclonus |
| 005E00 |
Strange [Royaume-Uni] | Dopamine receptors in the basal ganglia: Relevance to parkinson's disease |
| 005E11 |
S. Roche [Royaume-Uni] ; S. Godward [Royaume-Uni] ; A. Middleton [Royaume-Uni] ; R. J. M. Lane [Royaume-Uni] | Bifrontal glioma presenting as a gross movement disorder |
| 005E43 |
G. V. Sawle [Royaume-Uni] | The detection of preclinical Parkinson's disease: what is the role of positron emission tomography? |
| 005E49 |
A. J. Hughes [Royaume-Uni] ; S. Bishop ; B. Kleedorfer ; N. Turjanski ; W. Fernandez ; Andrew Lees (neurologue) [Royaume-Uni] ; G. M. Stern | Subcateneous apomorphine in Parkinson's disease: response to chronic administration for up to five years |
| 005E68 |
K. Bhatia [Royaume-Uni] ; S. E. Daniel ; C. D. Marsden | Orofacial dystonia and rest tremor in a patient with normal brain pathology |
| 005E87 |
P. G. Strange [Royaume-Uni] | Dopamine receptors in the basal ganglia: relevance to Parkinson's disease |
| 005F14 |
P. D. Thompson [Royaume-Uni] ; J. G. Colebatch [Royaume-Uni] ; P. Brown [Royaume-Uni] ; J. C. Rothwell [Royaume-Uni] ; B. L. Day [Royaume-Uni] ; J. A. Obeso [Royaume-Uni] ; Marsden [Royaume-Uni] | Voluntary stimulus‐sensitive jerks and jumps mimicking myoclonus or pathological startle syndromes |
| 005F18 |
A. C. Williams [Royaume-Uni] | Toxicology and Parkinson's disease |
| 005F24 |
W. Fernandez [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Temporary deterioration in Parkinsonian signs after modest alcohol intake |
| 005F31 |
Gibb [Royaume-Uni] ; L. Kilford [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Severe generalised dystonia associated with a mosaic pattern of striatal gliosis |
| 005F35 |
Mitchell [Royaume-Uni] ; A. R. Crossman [Royaume-Uni] ; U. Liminga [Suède] ; P. Andren [Suède] ; L. M. Gunne [Suède] | Regional changes in 2‐deoxyglucose uptake associated with neuroleptic‐induced tardive dyskinesia in the cebus monkey |
| 005F72 |
David J. Brooks [Royaume-Uni] | PET: Motor function and dysfunction |
| 006001 |
Robert E. Burke [États-Unis] ; N. A. Fletcher [Royaume-Uni] ; A. E. Harding [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; S. Moghal [Canada] ; A. H. Rajput [Canada] ; Andrew J. Hughes [Royaume-Uni] ; Susan E. Daniel [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; G. W. Thickbroom ; F. L. Mastaglia ; J. Artieda [Espagne] ; J. A. Obeso [Espagne] ; R. J. Hardie [Royaume-Uni] ; R. A. Morgan-Hughes [Royaume-Uni] | Letters to the Editor |
| 006004 |
H. Meierkord [Royaume-Uni] ; Fish [Royaume-Uni] ; S. J. M. Smith [Royaume-Uni] ; C. A. Scott [Royaume-Uni] ; S. D. Shorvon [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Is nocturnal paroxysmal dystonia a form of frontal lobe epilepsy? |
| 006006 |
Stocchi [Italie] ; S. Ruggieri [Italie] ; A. Carta [Italie] ; J. Ryatt [Royaume-Uni] ; N. Quinn [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; A. Agnoli [Italie] | Intravenous boluses and continuous infusions of L‐DOPA methyl ester in fluctuating patients with Parkinson's disease |
| 006015 |
Steiger [Royaume-Uni] ; M. Pires [Royaume-Uni] ; F. Scaravilli [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Hemiballism and chorea in a patient with parkinsonism due to a multisystem degeneration |
| 006025 |
Emre [Suisse] ; U. K. Rinne [Finlande] ; A. Rascol [France] ; A. Lees [Royaume-Uni] ; Yves Agid [France] ; X. Lataste [Suisse] | Effects of a selective partil D1 agonist, CY 208‐243, in de novo patients with Parkinson disease |
| 006035 |
C. E. Clarke [Royaume-Uni] ; J. M. Bamford [Royaume-Uni] ; A. House [Royaume-Uni] | Dyskinesia in creutzfeldt–Jakob disease precipitated by antidepressant therapy |
| 006038 |
V. M. S. De Bruin [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; S. E. Daniel [Royaume-Uni] | Diffuse lewy body disease presenting with supranuclear gaze palsy, parkinsonism, and dementia: A case report |
| 006039 |
A. E. Harding [Royaume-Uni] | Degenerative ataxias: Genetic aspects |
| 006040 |
P. J. Morrison [Royaume-Uni] ; V. H. Patterson [Royaume-Uni] | Cranial dystonia (Meige syndrome) in postencephalitic parkinsonism |
| 006043 |
J. William Langston [États-Unis] ; Hakan Widner [Suède] ; Goetz [États-Unis] ; David Brooks [Royaume-Uni] ; Stanley Fahn [États-Unis] ; Thomas Freeman [États-Unis] ; Ray Watts [États-Unis] | Core assessment program for intracerebral transplantations (CAPIT) |
| 006062 |
Andrew Lees (neurologue) [Royaume-Uni] | When did Ray Kennedy's Parkinson's disease begin? |
| 006066 |
W. R. G. Gibb [Royaume-Uni] ; L. Kilford ; C. D. Marsden | Severe generalised dystonia associated with a mosaic pattern of striatal gliosis |
| 006068 |
I. J. Mitchell [Royaume-Uni] ; A. R. Crossman ; U. Liminga ; P. Andren ; L. M. Gunne | Regional changes in 2-deoxyglucose uptake associated with neuroleptic-induced tardive dyskinesia in the cebus monkey |
| 006093 |
M. J. Steiger [Royaume-Uni] ; M. Pires ; F. Scaravilli ; N. P. Quinn ; C. D. Marsden | Hemiballism and chorea in a patient with parkinsonism due to a multisystem degeneration |
| 006112 |
J. Rivest [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Marsden [Royaume-Uni] | Writer's cramp: Treatment with botulinum toxin injections |
| 006114 |
Berardelli [Italie] ; P. D. Thompson [Royaume-Uni] ; M. Zaccagnini [Italie] ; O. Giardini [Italie] ; P. D'Eufemia [Italie] ; R. Massoud [Italie] ; M. Manfredi [Italie] | Two sisters with generalized dystonia associated with homocystinuria |
| 006117 |
R. C. Peatfield [Royaume-Uni] ; B. R. Boothman [Royaume-Uni] | Transient myoclonus after exposure to oven cleaner |
| 006124 |
M. J. Steiger [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Sickness due to levodopa‐induced neck dyskinesias in Parkinson's disease |
| 006129 |
J. S. Duncan [Royaume-Uni] ; P. Brown [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Progressive myoclonus and histidinaemia |
| 006133 |
Andrew J. Hughes [Royaume-Uni] ; Lees [Royaume-Uni] ; C. David Marsden [Royaume-Uni] | Paroxysmal dystonic head tremor |
| 006134 |
P. Brown [Royaume-Uni] ; P. D. Thompson [Royaume-Uni] ; J. C. Rothwell [Royaume-Uni] ; B. L. Day [Royaume-Uni] ; Marsden [Royaume-Uni] | Paroxysmal axial spasms of spinal origin |
| 006141 |
M. J. Steiger [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; B. Toone [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Off‐period screaming accompanying motor fluctuations in Parkinson's disease |
| 006142 |
Gibb [Royaume-Uni] ; T. Scott [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Neuronal inclusions of Parkinson's disease |
| 006148 |
I. J. Mitchell [Royaume-Uni] ; J. M. Brotchie [Royaume-Uni] ; G. D. A. Brown ; A. R. Crossman [Royaume-Uni] | Modeling the functional organization of the basal ganglia. A parallel distributed processing approach |
| 006156 |
T. Z. Aziz [Royaume-Uni] ; D. Peggs [Royaume-Uni] ; M. A. Sambrook [Royaume-Uni] ; Crossman [Royaume-Uni] | Lesion of the subthalamic nucleus for the alleviation of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced parkinsonism in the primate |
| 006161 |
Fletcher [Royaume-Uni] ; A. E. Harding [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Intrafamilial correlation in idiopathic torsion dystonia |
| 006163 |
Nightingale [Royaume-Uni] ; M. E. Barton [Royaume-Uni] | Intermittent vertical supranuclear ophthalmoplegia and ataxia |
| 006166 |
Andrew J. Hughes [Royaume-Uni] ; Daniel [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Idiopathic Parkinson's disease combined with multiple system atrophy. A clinicopathological report |
| 006174 |
K. R. Nair [Inde] ; R. Bhaskaran [Inde] ; C. D. Marsden [Royaume-Uni] | Essential tremor associated with paroxysmal kinesigenic dystonia |
| 006176 |
Faber [États-Unis] ; Michael R. Trimble [Royaume-Uni] | Electroconvulsive therapy in Parkinson's disease and other movement disorders |
| 006186 |
D. M. Maraganore [États-Unis] ; Andrew Lees (neurologue) [Royaume-Uni] ; Marsden [Royaume-Uni] | Complex stereotypies after right putaminal infarction: A case report |
| 006189 |
Vecht [Pays-Bas] ; Meerwaldt [Pays-Bas] ; Andrew Lees (neurologue) [Royaume-Uni] ; C. David Marsden [Royaume-Uni] ; Stanley Fahn [États-Unis] | Case 2, 1991: Unusual tremor, myoclonus, and a limping gait |
| 006199 |
Jonathan M. Brotchie [Royaume-Uni] ; Mitchell [Royaume-Uni] ; Michael A. Sambrook [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] | Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate |
| 006203 |
P. Brown [Royaume-Uni] ; P. D. Thompson [Royaume-Uni] ; J. C. Rothwell [Royaume-Uni] ; B. L. Day [Royaume-Uni] ; Marsden [Royaume-Uni] | A therapeutic trial of milacemide in myoclonus and the stiff‐person syndrome |
| 006205 |
Maraganore [Royaume-Uni] ; A. E. Harding [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | A clinical and genetic study of familial Parkinson's disease |
| 006206 |
Fletcher [Royaume-Uni] ; A. E. Harding [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | A case‐control study of idiopathic torsion dystonia |
| 006207 |
P. Brown [Royaume-Uni] ; P. D. Thompson [Royaume-Uni] ; J. C. Rothwell [Royaume-Uni] ; B. L. Day [Royaume-Uni] ; Marsden [Royaume-Uni] | A case of postanoxic encephalopathy with cortical action and brainstem reticular reflex myoclonus |
| 006209 |
C. J. Vecht [Pays-Bas] ; J. D. Meerwaldt ; Andrew Lees (neurologue) [Royaume-Uni] ; D. Marsden ; S. Fahn | What is it? Case 2, 1991 : unusual tremor, myoclonus, and a limping gait |
| 006221 |
W. R. G. Gibb ; T. Scott ; Andrew Lees (neurologue) [Royaume-Uni] | Neuronal inclusions of Parkinson's disease |
| 006229 |
N. A. Fletcher [Royaume-Uni] ; A. E. Harding ; C. D. Marsden | Intrafamilial correlation in idiopathic torsion dystonia |
| 006248 |
N. A. Fletcher [Royaume-Uni] ; A. E. Harding ; C. D. Marsden | A case-control study of idiopathic torsion dystonia |
| 006264 |
J. Rivest [Royaume-Uni] ; N. Quinn [Royaume-Uni] ; J. Gibbs [Royaume-Uni] ; Marsden [Royaume-Uni] | Unilateral abolition of extrapyramidal rigidity after ipsilateral cerebellar, infarction |
| 006267 |
J. Rivest [Royaume-Uni] ; Marsden [Royaume-Uni] | Trunk and head tremor as isolated manifestations of dystonia |
| 006273 |
Rupniak [Royaume-Uni] ; S. J. Tye [Royaume-Uni] ; M. J. Steventon [Royaume-Uni] ; S. Boyce [Royaume-Uni] ; S. D. Iversen [Royaume-Uni] | Spontaneous orofacial dyskinesias in a captive cynomolgus monkey: Implications for tardive dyskinesia |
| 006296 |
I. J. Mitchell [Royaume-Uni] ; R. Luquin [Espagne] ; S. Boyce [Royaume-Uni] ; C. E. Clarke [Royaume-Uni] ; R. G. Robertson [Royaume-Uni] ; M. A. Sambrook [Royaume-Uni] ; Crossman [Royaume-Uni] | Neural mechanisms of dystonia: Evidence from a 2‐deoxyglucose uptake study in a primate model of dopamine agonist‐induced dystonia |
| 006298 |
Truong [Royaume-Uni, États-Unis] ; Harding [Royaume-Uni] ; F. Scaravilli [Royaume-Uni] ; S. J. M. Smith [Royaume-Uni] ; J. A. Morgan-Hughes [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Movement disorders in mitochondrial myopathies. A study of nine cases with two autopsy studies |
| 006300 |
Schapira [Royaume-Uni] ; I. J. Holt [Royaume-Uni] ; M. Sweeney [Royaume-Uni] ; A. E. Harding [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Mitochondrial DNA analysis in Parkinson's disease |
| 006306 |
S. G. Sturman [Royaume-Uni] ; G. B. Steventon [Royaume-Uni] ; R. H. Waring [Royaume-Uni] ; A. C. Williams [Royaume-Uni] | MAO‐B and Parkinson's disease |
| 006308 |
G. A. M. Verheul [Pays-Bas] ; C. C. Tyssen [Pays-Bas] ; Stewart A. Factor [États-Unis] ; Anthony E. Lang [Canada] ; Niall Quinn [Royaume-Uni] ; Richard Hardie [Royaume-Uni] ; Un Jung Kang [États-Unis] ; Stanley Fahn [Pays-Bas, États-Unis, Canada, Royaume-Uni] | Letters to the editor |
| 006309 |
Andrew Lees (neurologue) [Royaume-Uni] ; A. R. Cools [Pays-Bas] ; J. H. L. Van Den Bercken [Pays-Bas] ; M. W. I. Horstink [Pays-Bas] ; K. P. M. Van Spaendonck [Pays-Bas] ; H. J. C. Berger [Pays-Bas] ; Gajanan Nilaver [États-Unis] ; Sidney Whiting [États-Unis] ; John G. Nutt [États-Unis] ; P. Martínez-Martín [Espagne] ; K. Rajasekharan Nair [Inde] ; Daniel D. Truong [États-Unis] ; Neal S. Hermanowicz [États-Unis] ; Abraham Rapoport [Israël] ; Mirela Skomorovsky [Israël] ; Robert E. Burke [États-Unis] ; Un Jung Kang [États-Unis] ; Stanley Fahn [États-Unis] ; Joseph Jankovic [États-Unis] ; Lucinda G. Miller [États-Unis] ; Satish Kadakia [États-Unis] ; Gary Mcabee [États-Unis] ; Eric Siemers [États-Unis] ; Robert Pascuzzi [États-Unis] | Letters to the editor |
| 006310 |
F. Grandas [Espagne] ; N. Quinn [Royaume-Uni] ; J. Elston [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; Arthur S. Walters ; Wayne Hening ; Sudhansu Chokroverty ; Hisamasa Imai [Japon] ; Hirotaro Narabayashi [Japon] ; Niall Quinn [Royaume-Uni] ; C. David Marsden [Royaume-Uni] | Letters to the editor |
| 006311 |
Paolo Decina [États-Unis] ; Giovanni Caracci [États-Unis] ; Pier Luigi Scapicchio [Italie] ; Christopher G. Goetz [États-Unis] ; Caroline M. Tanner [États-Unis] ; Jack A. Cohen [États-Unis] ; Jean A. Thelen [États-Unis] ; V. Susan Carroll [États-Unis] ; Harold L. Klawans [États-Unis] ; Ruggero G. Fariello [États-Unis] ; Francis O. Walker [États-Unis] ; J. Michael Walker [États-Unis] ; Rae R. Matsumoto [États-Unis] ; Wayne D. Bowen [États-Unis] ; Jesse M. Cedarbaum [États-Unis] ; A. R. Crossman [Royaume-Uni] | Letters to the editor |
| 006314 |
S. Boyce [Royaume-Uni] ; C. E. Clarke [Royaume-Uni] ; R. Luquin [Royaume-Uni, Espagne] ; D. Peggs [Royaume-Uni] ; R. G. Robertson [Royaume-Uni] ; I. J. Mitchell [Royaume-Uni] ; M. A. Sambrook [Royaume-Uni] ; Crossman [Royaume-Uni] | Induction of chorea and dystonia in parkinsonian primates |
| 006323 |
J. G. Colebatch [Royaume-Uni] ; G. Barrett [Royaume-Uni] ; Lees [Royaume-Uni] | Exaggerated startle reflexes in an elderly woman |
| 006332 |
G. Iliceto [Royaume-Uni] ; P. D. Thompson [Royaume-Uni] ; B. L. Day [Royaume-Uni] ; J. C. Rothwell [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Marsden [Royaume-Uni] | Diaphragmatic flutter, the moving umbilicus syndrome, and “belly dancer's” dyskinesia |
| 006335 |
P. Brown [Royaume-Uni] ; T. C. Britton [Royaume-Uni] | Cortico‐motor neurone conduction in dopa responsive dystonia |
| 006348 |
Winer [Royaume-Uni] ; D. R. Fish [Royaume-Uni] ; D. Sawyers [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | A movement disorder as a presenting feature of recurrent hypoglycaemia |
| 006349 |
Crossman [Royaume-Uni] | A hypothesis on the pathophysiological mechanisms that underlie levodopa‐ or dopamine agonist‐induced dyskinesia in Parkinson's disease: Implications for future strategies in treatment |
| 006403 |
C D Marsden [Royaume-Uni] | Slowness of movement in Parkinson's disease. |
| 006414 |
C. D. Marsden [Royaume-Uni] ; J. A. Obeso [Espagne] | Viewpoints on the Ramsay Hunt syndrome. The Ramsay Hunt syndrome is a useful clinical entity |
| 006418 |
Rajagopalan [Royaume-Uni] ; P. R. D. Humphrey [Royaume-Uni] ; R. C. Bucknall [Royaume-Uni] | Torticollis and blepharospasm in systemic lupus erythematosus |
| 006422 |
Gibb [Royaume-Uni] ; M. Terruli [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | The evolution and distribution of morphological changes in the nervous system of the common marmoset following the acute administration of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine |
| 006424 |
Coleman [Royaume-Uni] ; K. W. Lange [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; A. E. Loper [États-Unis] ; J. V. Bondi [États-Unis] ; M. Hichens [États-Unis] ; S. M. Stahl [Royaume-Uni, États-Unis] ; C. D. Marsden [Royaume-Uni] | The antiparkinsonian actions and pharmacokinetics of transdermal (+)‐4‐Propyl‐9‐hydroxynaphthoxazine (+ PHNO): Preliminary results |
| 006428 |
Gresty [Royaume-Uni] | Stability of the head in pitch (neck flexion‐extension): Studies in normal subjects and patients with axial rigidity |
| 006429 |
M. H. Marion [France] ; R. F. Gledhill [Afrique du Sud] ; Thompson [Royaume-Uni] | Spasms of amputation stumps: A report of 2 cases |
| 006430 |
Plant [Royaume-Uni] ; A. G. Kermode [Royaume-Uni] ; E. P. G. H. Du Boulay [Royaume-Uni] ; W. I. Mcdonald [Royaume-Uni] | Spasmodic torticollis due to a midbrain lesion in a case of multiple sclerosis |
| 006431 |
Marsden [Royaume-Uni] | Slowness of movement in Parkinson's disease |
| 006434 |
Harding [Royaume-Uni] | Ramsay Hunt syndrome, Unverricht‐Lundborg disease, or what? |
| 006435 |
N. P. Quinn ; P. Luthert ; M. Honavar ; C. D. Marsden [Royaume-Uni] | Pure akinesia due to lewy body Parkinson's disease: A case with pathology |
| 006443 |
D. T. Dexter [Royaume-Uni] ; Jenner [Royaume-Uni] ; Marsden [Royaume-Uni] | Oxyferriscorbone elevates the total iron content of blood but not brain |
| 006445 |
P. A. Kempster [Royaume-Uni] ; Lees [Royaume-Uni] ; P. Crichton [Royaume-Uni] ; J. P. Frankel [Royaume-Uni] ; P. Shorvon [Royaume-Uni] | Off‐period belching due to a reversible disturbance of oesophageal motility in Parkinso's disease and its treatment with apomorphine |
| 006473 |
Martin Deahl [Royaume-Uni] | Betel nut‐induced extrapyramidal syndrome: An unusual drug interaction |
| 006475 |
Stell [Royaume-Uni] ; A. M. Bronstein [Royaume-Uni] ; G. T. Plant [Royaume-Uni] ; A. E. Harding [Royaume-Uni] | Ataxia telangiectasia: A reappraisal of the ocular motor features and their value in the diagnosis of atypical cases |
| 006476 |
J. A. Temlett [Suisse] ; N. P. Quinn [Royaume-Uni] ; P. G. Jenner [Suisse] ; C. D. Marsden [Royaume-Uni] ; E. Pourcher [France] ; A. Bonnet [France] ; Yves Agid [France] ; R. Markstein [Suisse] ; X. Lataste [Suisse] | Antiparkinsonian activity of CY 208–243, a partial D‐1 dopamine receptor agonist, in MPTP‐treated marmosets and patients with Parkinson's disease |
| 006493 |
W. R. G. Gibb ; M. Terruli ; Andrew Lees (neurologue) [Royaume-Uni] ; P. Jenner ; C. D. Marsden | The evolution and distribution of morphological changes in the nervous system of the common marmoset following the acute administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| 006516 |
Harrington [Royaume-Uni] ; Angelika Wieck [Royaume-Uni] ; Isaac M. Marks [Royaume-Uni] ; C. David Marsden [Royaume-Uni] | Writer's cramp: Not associated with anxiety |
| 006517 |
Walshe [Royaume-Uni] | Wilson's disease: Yesterday, today, and tomorrow |
| 006525 |
S. Rose [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; Marsden [Royaume-Uni] | The effect of carbidopa on plasma and muscle levels of L‐dopa, dopamine, and their metabolites following L‐dopa administration to rats |
| 006526 |
R. J. Coleman [Royaume-Uni] ; S. A. Robb [Royaume-Uni] ; B. D. Lake [Royaume-Uni] ; E. M. Brett [Royaume-Uni] ; Harding [Royaume-Uni] | The diverse neurological features of Niemann‐Pick disease type C: A report of two cases |
| 006532 |
Gibb [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Pathological report of four patients presenting with cranial dystonias |
| 006537 |
Coleman [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Multiple sclerosis presenting as adult onset dystonia |
| 006539 |
J. V. Kinnier Wilson [Royaume-Uni] | Memories of my father |
| 006546 |
V. Peter Misra [Royaume-Uni] ; Michael Baraitser [Royaume-Uni] ; Harding [Royaume-Uni] | Genetic prediction in Huntington's disease: What are the limitations imposed by pedigree structure |
| 006552 |
Fletcher [Royaume-Uni] ; R. Stell [Royaume-Uni] ; A. E. Harding [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Degenerative cerebellar ataxia and focal dystonia |
| 006561 |
Simon Behrman [Royaume-Uni] ; Scott [Royaume-Uni] | Blepharoclonus provoked by voluntary eye closure |
| 006565 |
Brown [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | An investigation of the phenomenon of “set” in Parkinson's disease |
| 006576 |
W. R. G. Gibb ; Andrew Lees (neurologue) [Royaume-Uni] ; C. D. Marsden | Pathological report of four patients presenting with cranial dystonias |
| 006594 |
Niall Quinn [Royaume-Uni] ; Peter Critchley [Royaume-Uni] ; Marsden [Royaume-Uni] | Young onset Parkinson's disease |
| 006601 |
Gresty [Royaume-Uni] | Stability of the head: Studies in normal subjects and in patients with labyrinthine disease, head tremor, and dystonia |
| 006618 |
P. D. Thompson [Royaume-Uni] ; Marsden [Royaume-Uni] | Gait disorder of subcortical arteriosclerotic encephalopathy: Binswanger's disease |
| 006627 |
Stern [Royaume-Uni] | Central stridor from an ependymoma |
| 006631 |
M. Nomoto [Royaume-Uni] ; S. Stahl [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; Marsden [Royaume-Uni] | Antiparkinsonian activity of (+)‐PHNO in the MPTP‐treated common marmoset |
| 006632 |
M. Nomoto [Royaume-Uni] ; P. D. Thompson [Royaume-Uni] ; M. P. Sheehy [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Anticholinergic‐induced chorea in the treatment of focal dystonia |
| 006670 |
J. P. R. Dick [Royaume-Uni] ; R. Benecke [Royaume-Uni] ; J. C. Rothwell [Royaume-Uni] ; B. L. Day [Royaume-Uni] ; Marsden [Royaume-Uni] | Simple and complex movements in a patient with infarction of the right supplementary motor area |
| 006671 |
Lu [Royaume-Uni] ; Philip D. Thompson [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; J. D. Parkes [Royaume-Uni] ; Marsden [Royaume-Uni] | Ramsay hunt syndrome and coeliac disease: A new association? |
| 006672 |
Niall Quinn [Royaume-Uni] ; David Parkes [Royaume-Uni] ; Ivan Janota [Royaume-Uni] ; Marsden [Royaume-Uni] | Preservation of the substanitia nigra and locus coeruleus in a patient receiving levodopa (2 kg) plus decarboxylase inhibitor over a four‐year period |
| 006678 |
Quinn [Royaume-Uni] ; C. David Marsden [Royaume-Uni] | Menstrual‐related fluctuations in Parkinson's disease |
| 006681 |
Leenders [Royaume-Uni] ; R. S. J. Frackowiak [Royaume-Uni] ; N. Quinn [Royaume-Uni] ; D. Brooks [Royaume-Uni] ; D. Sumner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Ipsilateral blepharospasm and contralateral hemidystonia and parkinsonism in a patient with a unilateral rostral brainstem– thalamic lesion: Structural and functional abnormalities studied with CT, MRI, and PET scanning |
| 006685 |
P. D. Thompson [Royaume-Uni] ; J. P. R. Dick [Royaume-Uni] ; B. L. Day [Royaume-Uni] ; J. C. Rothwell [Royaume-Uni] ; A. Berardelli [Royaume-Uni] ; T. Kachi [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Electrophysiology of the corticomotoneurone pathways in patients with movement disorders |
| 006687 |
M. L. De Ceballos [Royaume-Uni] ; M. Baker [Royaume-Uni] ; S. Rose [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; Marsden [Royaume-Uni] | Do enkephalins in basal ganglia mediate a physiological motor rest mechanism? |
| 006697 |
Leenders [Royaume-Uni] ; R. S. J. Frackowiak [Royaume-Uni] ; N. Quinn [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography |
| 006701 |
J. Garvey [Royaume-Uni] ; M. Petersen ; C. M. Waters ; S. P. Rose [Royaume-Uni] ; S. Hunt ; R. Briggs ; P. Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Administration of MPTP to the common marmoset does not alter cortical cholinergic function |
